id	sid	tid	token	lemma	pos
dpc-3493	1	1	dermatology	dermatology	NOUN
dpc-3493	1	2	:	:	PUNCT
dpc-3493	1	3	practical	practical	ADJ
dpc-3493	1	4	and	and	CCONJ
dpc-3493	1	5	conceptual	conceptual	ADJ
dpc-3493	1	6	original	original	ADJ
dpc-3493	1	7	article	article	NOUN
dpc-3493	1	8	|	|	ADV
dpc-3493	1	9	dermatol	dermatol	ADJ
dpc-3493	1	10	pract	pract	NOUN
dpc-3493	1	11	concept	concept	NOUN
dpc-3493	1	12	.	.	PUNCT
dpc-3493	2	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	2	2	1	1	NUM
dpc-3493	2	3	can	can	AUX
dpc-3493	2	4	biologic	biologic	VERB
dpc-3493	2	5	agents	agent	NOUN
dpc-3493	2	6	improve	improve	VERB
dpc-3493	2	7	treatment	treatment	NOUN
dpc-3493	2	8	success	success	NOUN
dpc-3493	2	9	in	in	ADP
dpc-3493	2	10	obese	obese	ADJ
dpc-3493	2	11	patients	patient	NOUN
dpc-3493	2	12	with	with	ADP
dpc-3493	2	13	psoriasis	psoriasis	NOUN
dpc-3493	2	14	vulgaris	vulgaris	NOUN
dpc-3493	2	15	:	:	PUNCT
dpc-3493	2	16	a	a	DET
dpc-3493	2	17	 	 	SPACE
dpc-3493	2	18	retrospective	retrospective	ADJ
dpc-3493	2	19	review	review	NOUN
dpc-3493	2	20	of	of	ADP
dpc-3493	2	21	320	320	NUM
dpc-3493	2	22	patients	patient	NOUN
dpc-3493	2	23	with	with	ADP
dpc-3493	2	24	 	 	SPACE
dpc-3493	2	25	psoriasis	psoriasis	NOUN
dpc-3493	2	26	vulgaris	vulgaris	NOUN
dpc-3493	2	27	atıl	atıl	PROPN
dpc-3493	2	28	avcı1	avcı1	PROPN
dpc-3493	2	29	,	,	PUNCT
dpc-3493	2	30	deniz	deniz	PROPN
dpc-3493	2	31	avcı2	avcı2	PROPN
dpc-3493	2	32	,	,	PUNCT
dpc-3493	2	33	yılmaz	yılmaz	PROPN
dpc-3493	2	34	ulaş1	ulaş1	PROPN
dpc-3493	2	35	,	,	PUNCT
dpc-3493	2	36	ragip	ragip	PROPN
dpc-3493	2	37	ertaş1	ertaş1	PROPN
dpc-3493	2	38	1	1	NUM
dpc-3493	2	39	department	department	NOUN
dpc-3493	2	40	of	of	ADP
dpc-3493	2	41	dermatology	dermatology	NOUN
dpc-3493	2	42	,	,	PUNCT
dpc-3493	2	43	kayseri	kayseri	PROPN
dpc-3493	2	44	city	city	PROPN
dpc-3493	2	45	education	education	PROPN
dpc-3493	2	46	and	and	CCONJ
dpc-3493	2	47	research	research	NOUN
dpc-3493	2	48	hospital	hospital	NOUN
dpc-3493	2	49	,	,	PUNCT
dpc-3493	2	50	kayseri	kayseri	PROPN
dpc-3493	2	51	,	,	PUNCT
dpc-3493	2	52	turkey	turkey	PROPN
dpc-3493	2	53	2	2	NUM
dpc-3493	2	54	department	department	NOUN
dpc-3493	2	55	of	of	ADP
dpc-3493	2	56	internal	internal	ADJ
dpc-3493	2	57	medicine	medicine	NOUN
dpc-3493	2	58	,	,	PUNCT
dpc-3493	2	59	kayseri	kayseri	PROPN
dpc-3493	2	60	city	city	PROPN
dpc-3493	2	61	education	education	PROPN
dpc-3493	2	62	and	and	CCONJ
dpc-3493	2	63	research	research	NOUN
dpc-3493	2	64	hospital	hospital	NOUN
dpc-3493	2	65	,	,	PUNCT
dpc-3493	2	66	kayseri	kayseri	PROPN
dpc-3493	2	67	,	,	PUNCT
dpc-3493	2	68	turkey	turkey	PROPN
dpc-3493	2	69	key	key	ADJ
dpc-3493	2	70	words	word	NOUN
dpc-3493	2	71	:	:	PUNCT
dpc-3493	2	72	psoriasis	psoriasis	NOUN
dpc-3493	2	73	,	,	PUNCT
dpc-3493	2	74	obesity	obesity	NOUN
dpc-3493	2	75	,	,	PUNCT
dpc-3493	2	76	biological	biological	ADJ
dpc-3493	2	77	agents	agent	NOUN
dpc-3493	2	78	,	,	PUNCT
dpc-3493	2	79	body	body	NOUN
dpc-3493	2	80	mass	mass	NOUN
dpc-3493	2	81	index	index	NOUN
dpc-3493	2	82	citation	citation	NOUN
dpc-3493	2	83	:	:	PUNCT
dpc-3493	2	84	avcı	avcı	PROPN
dpc-3493	2	85	a	a	PROPN
dpc-3493	2	86	,	,	PUNCT
dpc-3493	2	87	avcı	avcı	PROPN
dpc-3493	2	88	a	a	PRON
dpc-3493	2	89	,	,	PUNCT
dpc-3493	2	90	ulaş	ulaş	ADJ
dpc-3493	2	91	y	y	NOUN
dpc-3493	2	92	,	,	PUNCT
dpc-3493	2	93	etaş	etaş	PROPN
dpc-3493	2	94	r.	r.	PROPN
dpc-3493	2	95	can	can	AUX
dpc-3493	2	96	biologic	biologic	VERB
dpc-3493	2	97	agents	agent	NOUN
dpc-3493	2	98	improve	improve	VERB
dpc-3493	2	99	treatment	treatment	NOUN
dpc-3493	2	100	success	success	NOUN
dpc-3493	2	101	in	in	ADP
dpc-3493	2	102	obese	obese	ADJ
dpc-3493	2	103	patients	patient	NOUN
dpc-3493	2	104	with	with	ADP
dpc-3493	2	105	psoriasis	psoriasis	NOUN
dpc-3493	2	106	vulgaris	vulgaris	NOUN
dpc-3493	2	107	:	:	PUNCT
dpc-3493	2	108	a	a	DET
dpc-3493	2	109	retrospective	retrospective	ADJ
dpc-3493	2	110	review	review	NOUN
dpc-3493	2	111	of	of	ADP
dpc-3493	2	112	320	320	NUM
dpc-3493	2	113	patients	patient	NOUN
dpc-3493	2	114	with	with	ADP
dpc-3493	2	115	psoriasis	psoriasis	NOUN
dpc-3493	2	116	vulgaris	vulgaris	NOUN
dpc-3493	2	117	.	.	PUNCT
dpc-3493	3	1	dermatol	dermatol	NOUN
dpc-3493	3	2	pract	pract	PROPN
dpc-3493	3	3	concept	concept	NOUN
dpc-3493	3	4	.	.	PUNCT
dpc-3493	4	1	2024;14(1):e2024058	2024;14(1):e2024058	X
dpc-3493	4	2	.	.	X
dpc-3493	4	3	doi	doi	NOUN
dpc-3493	4	4	:	:	PUNCT
dpc-3493	4	5	https://doi.org/10.5826/dpc.1401a58	https://doi.org/10.5826/dpc.1401a58	NOUN
dpc-3493	4	6	accepted	accept	VERB
dpc-3493	4	7	:	:	PUNCT
dpc-3493	4	8	august	august	PROPN
dpc-3493	4	9	29	29	NUM
dpc-3493	4	10	,	,	PUNCT
dpc-3493	4	11	2023	2023	NUM
dpc-3493	4	12	;	;	PUNCT
dpc-3493	4	13	published	publish	VERB
dpc-3493	4	14	:	:	PUNCT
dpc-3493	5	1	january2024	january2024	NOUN
dpc-3493	5	2	copyright	copyright	NOUN
dpc-3493	5	3	:	:	PUNCT
dpc-3493	5	4	©	©	PROPN
dpc-3493	5	5	2024	2024	NUM
dpc-3493	5	6	avcı	avcı	PROPN
dpc-3493	5	7	et	et	PROPN
dpc-3493	5	8	al	al	PROPN
dpc-3493	5	9	.	.	PUNCT
dpc-3493	6	1	this	this	PRON
dpc-3493	6	2	is	be	AUX
dpc-3493	6	3	an	an	DET
dpc-3493	6	4	open	open	ADJ
dpc-3493	6	5	-	-	PUNCT
dpc-3493	6	6	access	access	NOUN
dpc-3493	6	7	article	article	NOUN
dpc-3493	6	8	distributed	distribute	VERB
dpc-3493	6	9	under	under	ADP
dpc-3493	6	10	the	the	DET
dpc-3493	6	11	terms	term	NOUN
dpc-3493	6	12	of	of	ADP
dpc-3493	6	13	the	the	DET
dpc-3493	6	14	creative	creative	ADJ
dpc-3493	6	15	commons	common	NOUN
dpc-3493	6	16	attribution	attribution	NOUN
dpc-3493	6	17	-	-	PUNCT
dpc-3493	6	18	noncommercial	noncommercial	ADJ
dpc-3493	6	19	license	license	NOUN
dpc-3493	6	20	(	(	PUNCT
dpc-3493	6	21	by	by	ADP
dpc-3493	6	22	-	-	PUNCT
dpc-3493	6	23	nc-4.0	nc-4.0	NOUN
dpc-3493	6	24	)	)	PUNCT
dpc-3493	6	25	,	,	PUNCT
dpc-3493	6	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3493	6	27	,	,	PUNCT
dpc-3493	6	28	which	which	PRON
dpc-3493	6	29	permits	permit	VERB
dpc-3493	6	30	unrestricted	unrestricted	ADJ
dpc-3493	6	31	noncommercial	noncommercial	ADJ
dpc-3493	6	32	use	use	NOUN
dpc-3493	6	33	,	,	PUNCT
dpc-3493	6	34	distribution	distribution	NOUN
dpc-3493	6	35	,	,	PUNCT
dpc-3493	6	36	and	and	CCONJ
dpc-3493	6	37	reproduction	reproduction	NOUN
dpc-3493	6	38	in	in	ADP
dpc-3493	6	39	any	any	DET
dpc-3493	6	40	medium	medium	NOUN
dpc-3493	6	41	,	,	PUNCT
dpc-3493	6	42	provided	provide	VERB
dpc-3493	6	43	the	the	DET
dpc-3493	6	44	original	original	ADJ
dpc-3493	6	45	authors	author	NOUN
dpc-3493	6	46	and	and	CCONJ
dpc-3493	6	47	source	source	NOUN
dpc-3493	6	48	are	be	AUX
dpc-3493	6	49	credited	credit	VERB
dpc-3493	6	50	.	.	PUNCT
dpc-3493	7	1	funding	funding	NOUN
dpc-3493	7	2	:	:	PUNCT
dpc-3493	7	3	none	none	NOUN
dpc-3493	7	4	.	.	PUNCT
dpc-3493	8	1	competing	compete	VERB
dpc-3493	8	2	interests	interest	NOUN
dpc-3493	8	3	:	:	PUNCT
dpc-3493	8	4	none	none	NOUN
dpc-3493	8	5	.	.	PUNCT
dpc-3493	9	1	authorship	authorship	NOUN
dpc-3493	9	2	:	:	PUNCT
dpc-3493	9	3	all	all	DET
dpc-3493	9	4	authors	author	NOUN
dpc-3493	9	5	have	have	AUX
dpc-3493	9	6	contributed	contribute	VERB
dpc-3493	9	7	significantly	significantly	ADV
dpc-3493	9	8	to	to	ADP
dpc-3493	9	9	this	this	DET
dpc-3493	9	10	publication	publication	NOUN
dpc-3493	9	11	.	.	PUNCT
dpc-3493	10	1	corresponding	correspond	VERB
dpc-3493	10	2	author	author	NOUN
dpc-3493	10	3	:	:	PUNCT
dpc-3493	10	4	atıl	atıl	PROPN
dpc-3493	10	5	avcı	avcı	PROPN
dpc-3493	10	6	,	,	PUNCT
dpc-3493	10	7	md	md	PROPN
dpc-3493	10	8	.	.	PUNCT
dpc-3493	10	9	(	(	PUNCT
dpc-3493	10	10	associate	associate	NOUN
dpc-3493	10	11	professor	professor	NOUN
dpc-3493	10	12	)	)	PUNCT
dpc-3493	10	13	,	,	PUNCT
dpc-3493	10	14	kayseri	kayseri	PROPN
dpc-3493	10	15	city	city	PROPN
dpc-3493	10	16	education	education	PROPN
dpc-3493	10	17	and	and	CCONJ
dpc-3493	10	18	research	research	NOUN
dpc-3493	10	19	hospital	hospital	NOUN
dpc-3493	10	20	,	,	PUNCT
dpc-3493	10	21	department	department	NOUN
dpc-3493	10	22	of	of	ADP
dpc-3493	10	23	dermatology	dermatology	NOUN
dpc-3493	10	24	and	and	CCONJ
dpc-3493	10	25	allergykayseri	allergykayseri	PROPN
dpc-3493	10	26	,	,	PUNCT
dpc-3493	10	27	turkey	turkey	PROPN
dpc-3493	10	28	.	.	PUNCT
dpc-3493	11	1	tel	tel	ADP
dpc-3493	11	2	:	:	PUNCT
dpc-3493	11	3	+90	+90	NOUN
dpc-3493	11	4	352	352	NUM
dpc-3493	11	5	315	315	NUM
dpc-3493	11	6	77	77	NUM
dpc-3493	11	7	00	00	NUM
dpc-3493	11	8	cell	cell	NOUN
dpc-3493	11	9	phone	phone	NOUN
dpc-3493	11	10	:	:	PUNCT
dpc-3493	12	1	+90	+90	NOUN
dpc-3493	12	2	507	507	NUM
dpc-3493	12	3	240	240	NUM
dpc-3493	12	4	93	93	NUM
dpc-3493	12	5	65	65	NUM
dpc-3493	12	6	e	e	NOUN
dpc-3493	12	7	-	-	NOUN
dpc-3493	12	8	mail	mail	NOUN
dpc-3493	12	9	:	:	PUNCT
dpc-3493	12	10	atilavci@hotmail.com	atilavci@hotmail.com	X
dpc-3493	12	11	introduction	introduction	NOUN
dpc-3493	12	12	:	:	PUNCT
dpc-3493	12	13	obesity	obesity	NOUN
dpc-3493	12	14	plays	play	VERB
dpc-3493	12	15	a	a	DET
dpc-3493	12	16	major	major	ADJ
dpc-3493	12	17	role	role	NOUN
dpc-3493	12	18	in	in	ADP
dpc-3493	12	19	the	the	DET
dpc-3493	12	20	development	development	NOUN
dpc-3493	12	21	of	of	ADP
dpc-3493	12	22	many	many	ADJ
dpc-3493	12	23	inflammatory	inflammatory	ADJ
dpc-3493	12	24	disorders	disorder	NOUN
dpc-3493	12	25	including	include	VERB
dpc-3493	12	26	psoriasis	psoriasis	NOUN
dpc-3493	12	27	.	.	PUNCT
dpc-3493	13	1	objectives	objective	NOUN
dpc-3493	13	2	:	:	PUNCT
dpc-3493	13	3	we	we	PRON
dpc-3493	13	4	aimed	aim	VERB
dpc-3493	13	5	to	to	PART
dpc-3493	13	6	demonstrate	demonstrate	VERB
dpc-3493	13	7	how	how	SCONJ
dpc-3493	13	8	treatment	treatment	NOUN
dpc-3493	13	9	responses	response	NOUN
dpc-3493	13	10	change	change	VERB
dpc-3493	13	11	according	accord	VERB
dpc-3493	13	12	to	to	ADP
dpc-3493	13	13	body	body	NOUN
dpc-3493	13	14	mass	mass	NOUN
dpc-3493	13	15	index	index	NOUN
dpc-3493	13	16	(	(	PUNCT
dpc-3493	13	17	bmi	bmi	PROPN
dpc-3493	13	18	)	)	PUNCT
dpc-3493	13	19	among	among	ADP
dpc-3493	13	20	patients	patient	NOUN
dpc-3493	13	21	with	with	ADP
dpc-3493	13	22	psoriasis	psoriasis	NOUN
dpc-3493	13	23	.	.	PUNCT
dpc-3493	14	1	methods	method	NOUN
dpc-3493	14	2	:	:	PUNCT
dpc-3493	14	3	in	in	ADP
dpc-3493	14	4	our	our	PRON
dpc-3493	14	5	study	study	NOUN
dpc-3493	14	6	,	,	PUNCT
dpc-3493	14	7	psoriasis	psoriasis	NOUN
dpc-3493	14	8	area	area	NOUN
dpc-3493	14	9	and	and	CCONJ
dpc-3493	14	10	severity	severity	NOUN
dpc-3493	14	11	index	index	NOUN
dpc-3493	14	12	(	(	PUNCT
dpc-3493	14	13	pasi	pasi	NOUN
dpc-3493	14	14	)	)	PUNCT
dpc-3493	14	15	75	75	NUM
dpc-3493	14	16	and	and	CCONJ
dpc-3493	14	17	pasi	pasi	VERB
dpc-3493	14	18	90	90	NUM
dpc-3493	14	19	responses	response	NOUN
dpc-3493	14	20	were	be	AUX
dpc-3493	14	21	assessed	assess	VERB
dpc-3493	14	22	at	at	ADP
dpc-3493	14	23	baseline	baseline	NOUN
dpc-3493	14	24	and	and	CCONJ
dpc-3493	14	25	at	at	ADP
dpc-3493	14	26	months	month	NOUN
dpc-3493	14	27	1	1	NUM
dpc-3493	14	28	and	and	CCONJ
dpc-3493	14	29	3	3	NUM
dpc-3493	14	30	among	among	ADP
dpc-3493	14	31	patients	patient	NOUN
dpc-3493	14	32	who	who	PRON
dpc-3493	14	33	received	receive	VERB
dpc-3493	14	34	tnf	tnf	PROPN
dpc-3493	14	35	-	-	PUNCT
dpc-3493	14	36	α	α	NOUN
dpc-3493	14	37	inhibitors	inhibitor	NOUN
dpc-3493	14	38	,	,	PUNCT
dpc-3493	14	39	ustekinumab	ustekinumab	NOUN
dpc-3493	14	40	,	,	PUNCT
dpc-3493	14	41	il-17	il-17	PART
dpc-3493	14	42	blockers	blocker	NOUN
dpc-3493	14	43	,	,	PUNCT
dpc-3493	14	44	and	and	CCONJ
dpc-3493	14	45	il-23	il-23	NOUN
dpc-3493	14	46	blockers	blocker	NOUN
dpc-3493	14	47	.	.	PUNCT
dpc-3493	15	1	the	the	DET
dpc-3493	15	2	same	same	ADJ
dpc-3493	15	3	responses	response	NOUN
dpc-3493	15	4	were	be	AUX
dpc-3493	15	5	also	also	ADV
dpc-3493	15	6	assessed	assess	VERB
dpc-3493	15	7	with	with	ADP
dpc-3493	15	8	methotrexate	methotrexate	NOUN
dpc-3493	15	9	and	and	CCONJ
dpc-3493	15	10	acitretin	acitretin	NOUN
dpc-3493	15	11	for	for	ADP
dpc-3493	15	12	a	a	DET
dpc-3493	15	13	comparison	comparison	NOUN
dpc-3493	15	14	group	group	NOUN
dpc-3493	15	15	.	.	PUNCT
dpc-3493	16	1	analyses	analysis	NOUN
dpc-3493	16	2	were	be	AUX
dpc-3493	16	3	performed	perform	VERB
dpc-3493	16	4	retrospectively	retrospectively	ADV
dpc-3493	16	5	.	.	PUNCT
dpc-3493	17	1	results	result	NOUN
dpc-3493	17	2	:	:	PUNCT
dpc-3493	17	3	the	the	DET
dpc-3493	17	4	study	study	NOUN
dpc-3493	17	5	included	include	VERB
dpc-3493	17	6	317	317	NUM
dpc-3493	17	7	patients	patient	NOUN
dpc-3493	17	8	who	who	PRON
dpc-3493	17	9	received	receive	VERB
dpc-3493	17	10	222	222	NUM
dpc-3493	17	11	biological	biological	ADJ
dpc-3493	17	12	and	and	CCONJ
dpc-3493	17	13	95	95	NUM
dpc-3493	17	14	conventional	conventional	ADJ
dpc-3493	17	15	treatments	treatment	NOUN
dpc-3493	17	16	.	.	PUNCT
dpc-3493	18	1	in	in	ADP
dpc-3493	18	2	the	the	DET
dpc-3493	18	3	group	group	NOUN
dpc-3493	18	4	with	with	ADP
dpc-3493	18	5	bmi	bmi	PROPN
dpc-3493	18	6	≥30	≥30	PROPN
dpc-3493	18	7	,	,	PUNCT
dpc-3493	18	8	the	the	DET
dpc-3493	18	9	proportion	proportion	NOUN
dpc-3493	18	10	of	of	ADP
dpc-3493	18	11	patients	patient	NOUN
dpc-3493	18	12	who	who	PRON
dpc-3493	18	13	achieved	achieve	VERB
dpc-3493	18	14	pasi	pasi	NOUN
dpc-3493	18	15	75	75	NUM
dpc-3493	18	16	response	response	NOUN
dpc-3493	18	17	was	be	AUX
dpc-3493	18	18	40.0	40.0	NUM
dpc-3493	18	19	%	%	NOUN
dpc-3493	18	20	(	(	PUNCT
dpc-3493	18	21	n	n	NOUN
dpc-3493	18	22	=	=	SYM
dpc-3493	18	23	26	26	NUM
dpc-3493	18	24	)	)	PUNCT
dpc-3493	18	25	at	at	ADP
dpc-3493	18	26	month	month	NOUN
dpc-3493	18	27	1	1	NUM
dpc-3493	18	28	and	and	CCONJ
dpc-3493	18	29	55.4	55.4	NUM
dpc-3493	18	30	%	%	NOUN
dpc-3493	18	31	(	(	PUNCT
dpc-3493	18	32	n	n	NOUN
dpc-3493	18	33	=	=	SYM
dpc-3493	18	34	36	36	NUM
dpc-3493	18	35	)	)	PUNCT
dpc-3493	18	36	at	at	ADP
dpc-3493	18	37	month	month	NOUN
dpc-3493	18	38	3	3	NUM
dpc-3493	18	39	.	.	PUNCT
dpc-3493	19	1	the	the	DET
dpc-3493	19	2	proportion	proportion	NOUN
dpc-3493	19	3	of	of	ADP
dpc-3493	19	4	patients	patient	NOUN
dpc-3493	19	5	who	who	PRON
dpc-3493	19	6	achieved	achieve	VERB
dpc-3493	19	7	pasi	pasi	NOUN
dpc-3493	19	8	90	90	NUM
dpc-3493	19	9	response	response	NOUN
dpc-3493	19	10	was	be	AUX
dpc-3493	19	11	33.8	33.8	NUM
dpc-3493	19	12	%	%	NOUN
dpc-3493	19	13	(	(	PUNCT
dpc-3493	19	14	n	n	NOUN
dpc-3493	19	15	=	=	SYM
dpc-3493	19	16	22	22	NUM
dpc-3493	19	17	)	)	PUNCT
dpc-3493	19	18	at	at	ADP
dpc-3493	19	19	month	month	NOUN
dpc-3493	19	20	1	1	NUM
dpc-3493	19	21	and	and	CCONJ
dpc-3493	19	22	44.6	44.6	NUM
dpc-3493	19	23	%	%	NOUN
dpc-3493	19	24	(	(	PUNCT
dpc-3493	19	25	n	n	NOUN
dpc-3493	19	26	=	=	NUM
dpc-3493	19	27	29	29	NUM
dpc-3493	19	28	)	)	PUNCT
dpc-3493	19	29	at	at	ADP
dpc-3493	19	30	month	month	NOUN
dpc-3493	19	31	3	3	NUM
dpc-3493	19	32	among	among	ADP
dpc-3493	19	33	those	those	PRON
dpc-3493	19	34	receiving	receive	VERB
dpc-3493	19	35	biological	biological	ADJ
dpc-3493	19	36	agents	agent	NOUN
dpc-3493	19	37	.	.	PUNCT
dpc-3493	20	1	improvement	improvement	NOUN
dpc-3493	20	2	was	be	AUX
dpc-3493	20	3	significantly	significantly	ADV
dpc-3493	20	4	more	more	ADV
dpc-3493	20	5	difficult	difficult	ADJ
dpc-3493	20	6	among	among	ADP
dpc-3493	20	7	obese	obese	ADJ
dpc-3493	20	8	patients	patient	NOUN
dpc-3493	20	9	.	.	PUNCT
dpc-3493	21	1	the	the	DET
dpc-3493	21	2	proportion	proportion	NOUN
dpc-3493	21	3	of	of	ADP
dpc-3493	21	4	patients	patient	NOUN
dpc-3493	21	5	who	who	PRON
dpc-3493	21	6	achieved	achieve	VERB
dpc-3493	21	7	pasi	pasi	NOUN
dpc-3493	21	8	75	75	NUM
dpc-3493	21	9	response	response	NOUN
dpc-3493	21	10	was	be	AUX
dpc-3493	21	11	3.6	3.6	NUM
dpc-3493	21	12	%	%	NOUN
dpc-3493	21	13	at	at	ADP
dpc-3493	21	14	month	month	NOUN
dpc-3493	21	15	1	1	NUM
dpc-3493	21	16	and	and	CCONJ
dpc-3493	21	17	25.0	25.0	NUM
dpc-3493	21	18	%	%	NOUN
dpc-3493	21	19	(	(	PUNCT
dpc-3493	21	20	n	n	NOUN
dpc-3493	21	21	=	=	SYM
dpc-3493	21	22	7	7	NUM
dpc-3493	21	23	)	)	PUNCT
dpc-3493	21	24	at	at	ADP
dpc-3493	21	25	month	month	NOUN
dpc-3493	21	26	3	3	NUM
dpc-3493	21	27	abstract	abstract	ADJ
dpc-3493	21	28	2	2	NUM
dpc-3493	21	29	original	original	ADJ
dpc-3493	21	30	article	article	NOUN
dpc-3493	21	31	|	|	ADV
dpc-3493	21	32	dermatol	dermatol	ADJ
dpc-3493	21	33	pract	pract	NOUN
dpc-3493	21	34	concept	concept	NOUN
dpc-3493	21	35	.	.	PUNCT
dpc-3493	22	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	22	2	among	among	ADP
dpc-3493	22	3	patients	patient	NOUN
dpc-3493	22	4	receiving	receive	VERB
dpc-3493	22	5	conventional	conventional	ADJ
dpc-3493	22	6	systemic	systemic	ADJ
dpc-3493	22	7	treatments	treatment	NOUN
dpc-3493	22	8	.	.	PUNCT
dpc-3493	23	1	while	while	SCONJ
dpc-3493	23	2	the	the	DET
dpc-3493	23	3	presence	presence	NOUN
dpc-3493	23	4	of	of	ADP
dpc-3493	23	5	joint	joint	ADJ
dpc-3493	23	6	involvement	involvement	NOUN
dpc-3493	23	7	affected	affect	VERB
dpc-3493	23	8	the	the	DET
dpc-3493	23	9	success	success	NOUN
dpc-3493	23	10	of	of	ADP
dpc-3493	23	11	treatment	treatment	NOUN
dpc-3493	23	12	among	among	ADP
dpc-3493	23	13	obese	obese	ADJ
dpc-3493	23	14	patients	patient	NOUN
dpc-3493	23	15	with	with	ADP
dpc-3493	23	16	psoriasis	psoriasis	NOUN
dpc-3493	23	17	,	,	PUNCT
dpc-3493	23	18	no	no	DET
dpc-3493	23	19	relationships	relationship	NOUN
dpc-3493	23	20	were	be	AUX
dpc-3493	23	21	found	find	VERB
dpc-3493	23	22	for	for	ADP
dpc-3493	23	23	smoking	smoking	NOUN
dpc-3493	23	24	,	,	PUNCT
dpc-3493	23	25	the	the	DET
dpc-3493	23	26	presence	presence	NOUN
dpc-3493	23	27	of	of	ADP
dpc-3493	23	28	concomitant	concomitant	ADJ
dpc-3493	23	29	psychiatric	psychiatric	ADJ
dpc-3493	23	30	diseases	disease	NOUN
dpc-3493	23	31	,	,	PUNCT
dpc-3493	23	32	or	or	CCONJ
dpc-3493	23	33	the	the	DET
dpc-3493	23	34	presence	presence	NOUN
dpc-3493	23	35	of	of	ADP
dpc-3493	23	36	pruritus	pruritus	PROPN
dpc-3493	23	37	in	in	ADP
dpc-3493	23	38	psoriasis	psoriasis	NOUN
dpc-3493	23	39	.	.	PUNCT
dpc-3493	24	1	conclusions	conclusion	NOUN
dpc-3493	24	2	:	:	PUNCT
dpc-3493	24	3	biological	biological	ADJ
dpc-3493	24	4	agents	agent	NOUN
dpc-3493	24	5	were	be	AUX
dpc-3493	24	6	more	more	ADV
dpc-3493	24	7	successful	successful	ADJ
dpc-3493	24	8	in	in	ADP
dpc-3493	24	9	achieving	achieve	VERB
dpc-3493	24	10	pasi	pasi	NOUN
dpc-3493	24	11	75	75	NUM
dpc-3493	24	12	and	and	CCONJ
dpc-3493	24	13	pasi	pasi	VERB
dpc-3493	24	14	90	90	NUM
dpc-3493	24	15	responses	response	NOUN
dpc-3493	24	16	in	in	ADP
dpc-3493	24	17	both	both	DET
dpc-3493	24	18	non	non	ADJ
dpc-3493	24	19	-	-	ADJ
dpc-3493	24	20	obese	obese	ADJ
dpc-3493	24	21	and	and	CCONJ
dpc-3493	24	22	obese	obese	ADJ
dpc-3493	24	23	individuals	individual	NOUN
dpc-3493	24	24	.	.	PUNCT
dpc-3493	25	1	based	base	VERB
dpc-3493	25	2	on	on	ADP
dpc-3493	25	3	our	our	PRON
dpc-3493	25	4	study	study	NOUN
dpc-3493	25	5	,	,	PUNCT
dpc-3493	25	6	among	among	ADP
dpc-3493	25	7	biological	biological	ADJ
dpc-3493	25	8	agents	agent	NOUN
dpc-3493	25	9	,	,	PUNCT
dpc-3493	25	10	il-17	il-17	NUM
dpc-3493	25	11	and	and	CCONJ
dpc-3493	25	12	il-23	il-23	NOUN
dpc-3493	25	13	inhibitors	inhibitor	NOUN
dpc-3493	25	14	may	may	AUX
dpc-3493	25	15	be	be	AUX
dpc-3493	25	16	more	more	ADV
dpc-3493	25	17	successful	successful	ADJ
dpc-3493	25	18	among	among	ADP
dpc-3493	25	19	obese	obese	ADJ
dpc-3493	25	20	individuals	individual	NOUN
dpc-3493	25	21	,	,	PUNCT
dpc-3493	25	22	but	but	CCONJ
dpc-3493	25	23	neither	neither	PRON
dpc-3493	25	24	of	of	ADP
dpc-3493	25	25	them	they	PRON
dpc-3493	25	26	shows	show	VERB
dpc-3493	25	27	superiority	superiority	NOUN
dpc-3493	25	28	over	over	ADP
dpc-3493	25	29	the	the	DET
dpc-3493	25	30	other	other	ADJ
dpc-3493	25	31	.	.	PUNCT
dpc-3493	26	1	introduction	introduction	NOUN
dpc-3493	26	2	psoriasis	psoriasis	NOUN
dpc-3493	26	3	is	be	AUX
dpc-3493	26	4	a	a	DET
dpc-3493	26	5	chronic	chronic	NOUN
dpc-3493	26	6	,	,	PUNCT
dpc-3493	26	7	immune	immune	NOUN
dpc-3493	26	8	-	-	PUNCT
dpc-3493	26	9	related	relate	VERB
dpc-3493	26	10	,	,	PUNCT
dpc-3493	26	11	systemic	systemic	ADJ
dpc-3493	26	12	inflammatory	inflammatory	ADJ
dpc-3493	26	13	disease	disease	NOUN
dpc-3493	26	14	that	that	PRON
dpc-3493	26	15	may	may	AUX
dpc-3493	26	16	be	be	AUX
dpc-3493	26	17	accompanied	accompany	VERB
dpc-3493	26	18	by	by	ADP
dpc-3493	26	19	many	many	ADJ
dpc-3493	26	20	comorbid	comorbid	NOUN
dpc-3493	26	21	conditions	condition	NOUN
dpc-3493	26	22	including	include	VERB
dpc-3493	26	23	psoriatic	psoriatic	ADJ
dpc-3493	26	24	arthritis	arthritis	NOUN
dpc-3493	26	25	,	,	PUNCT
dpc-3493	26	26	cardiovascular	cardiovascular	ADJ
dpc-3493	26	27	disorders	disorder	NOUN
dpc-3493	26	28	,	,	PUNCT
dpc-3493	26	29	cancer	cancer	NOUN
dpc-3493	26	30	,	,	PUNCT
dpc-3493	26	31	depression	depression	NOUN
dpc-3493	26	32	,	,	PUNCT
dpc-3493	26	33	metabolic	metabolic	NOUN
dpc-3493	26	34	syndrome	syndrome	NOUN
dpc-3493	26	35	,	,	PUNCT
dpc-3493	26	36	and	and	CCONJ
dpc-3493	26	37	obesity	obesity	NOUN
dpc-3493	26	38	[	[	X
dpc-3493	26	39	1	1	NUM
dpc-3493	26	40	-	-	SYM
dpc-3493	26	41	5	5	NUM
dpc-3493	26	42	]	]	PUNCT
dpc-3493	26	43	.	.	PUNCT
dpc-3493	27	1	morphologically	morphologically	ADV
dpc-3493	27	2	,	,	PUNCT
dpc-3493	27	3	the	the	DET
dpc-3493	27	4	skin	skin	NOUN
dpc-3493	27	5	has	have	VERB
dpc-3493	27	6	an	an	DET
dpc-3493	27	7	erythematous	erythematous	ADJ
dpc-3493	27	8	and	and	CCONJ
dpc-3493	27	9	scaly	scaly	NOUN
dpc-3493	27	10	appearance	appearance	NOUN
dpc-3493	27	11	in	in	ADP
dpc-3493	27	12	cases	case	NOUN
dpc-3493	27	13	of	of	ADP
dpc-3493	27	14	psoriasis	psoriasis	NOUN
dpc-3493	27	15	;	;	PUNCT
dpc-3493	27	16	this	this	PRON
dpc-3493	27	17	is	be	AUX
dpc-3493	27	18	due	due	ADJ
dpc-3493	27	19	to	to	ADP
dpc-3493	27	20	overstimulation	overstimulation	NOUN
dpc-3493	27	21	of	of	ADP
dpc-3493	27	22	keratinocytes	keratinocyte	NOUN
dpc-3493	27	23	as	as	ADV
dpc-3493	27	24	well	well	ADV
dpc-3493	27	25	as	as	ADP
dpc-3493	27	26	increased	increase	VERB
dpc-3493	27	27	angiogenesis	angiogenesis	NOUN
dpc-3493	27	28	of	of	ADP
dpc-3493	27	29	dilated	dilate	VERB
dpc-3493	27	30	blood	blood	NOUN
dpc-3493	27	31	vessels	vessel	NOUN
dpc-3493	27	32	and	and	CCONJ
dpc-3493	27	33	infiltration	infiltration	NOUN
dpc-3493	27	34	of	of	ADP
dpc-3493	27	35	t	t	PROPN
dpc-3493	27	36	lymphocyte	lymphocyte	NOUN
dpc-3493	27	37	associated	associate	VERB
dpc-3493	27	38	immune	immune	ADJ
dpc-3493	27	39	cells	cell	NOUN
dpc-3493	27	40	[	[	X
dpc-3493	27	41	6,7	6,7	NUM
dpc-3493	27	42	]	]	PUNCT
dpc-3493	27	43	.	.	PUNCT
dpc-3493	28	1	obesity	obesity	NOUN
dpc-3493	28	2	plays	play	VERB
dpc-3493	28	3	a	a	DET
dpc-3493	28	4	major	major	ADJ
dpc-3493	28	5	role	role	NOUN
dpc-3493	28	6	in	in	ADP
dpc-3493	28	7	the	the	DET
dpc-3493	28	8	development	development	NOUN
dpc-3493	28	9	of	of	ADP
dpc-3493	28	10	many	many	ADJ
dpc-3493	28	11	disorders	disorder	NOUN
dpc-3493	28	12	by	by	ADP
dpc-3493	28	13	increasing	increase	VERB
dpc-3493	28	14	insulin	insulin	NOUN
dpc-3493	28	15	resistance	resistance	NOUN
dpc-3493	28	16	and	and	CCONJ
dpc-3493	28	17	fatty	fatty	NOUN
dpc-3493	28	18	acid	acid	NOUN
dpc-3493	28	19	synthesis	synthesis	NOUN
dpc-3493	28	20	.	.	PUNCT
dpc-3493	29	1	it	it	PRON
dpc-3493	29	2	also	also	ADV
dpc-3493	29	3	increases	increase	VERB
dpc-3493	29	4	fatty	fatty	NOUN
dpc-3493	29	5	acid	acid	NOUN
dpc-3493	29	6	release	release	NOUN
dpc-3493	29	7	from	from	ADP
dpc-3493	29	8	visceral	visceral	ADJ
dpc-3493	29	9	adipose	adipose	ADJ
dpc-3493	29	10	tissues	tissue	NOUN
dpc-3493	29	11	to	to	ADP
dpc-3493	29	12	organs	organ	NOUN
dpc-3493	29	13	such	such	ADJ
dpc-3493	29	14	as	as	ADP
dpc-3493	29	15	the	the	DET
dpc-3493	29	16	liver	liver	NOUN
dpc-3493	29	17	and	and	CCONJ
dpc-3493	29	18	skeletal	skeletal	ADJ
dpc-3493	29	19	muscles	muscle	NOUN
dpc-3493	29	20	[	[	X
dpc-3493	29	21	8,9	8,9	NUM
dpc-3493	29	22	]	]	PUNCT
dpc-3493	29	23	.	.	PUNCT
dpc-3493	30	1	if	if	SCONJ
dpc-3493	30	2	nutritional	nutritional	ADJ
dpc-3493	30	3	choices	choice	NOUN
dpc-3493	30	4	remain	remain	VERB
dpc-3493	30	5	similar	similar	ADJ
dpc-3493	30	6	to	to	ADP
dpc-3493	30	7	the	the	DET
dpc-3493	30	8	current	current	ADJ
dpc-3493	30	9	preferences	preference	NOUN
dpc-3493	30	10	,	,	PUNCT
dpc-3493	30	11	it	it	PRON
dpc-3493	30	12	is	be	AUX
dpc-3493	30	13	estimated	estimate	VERB
dpc-3493	30	14	that	that	SCONJ
dpc-3493	30	15	38	38	NUM
dpc-3493	30	16	%	%	NOUN
dpc-3493	30	17	of	of	ADP
dpc-3493	30	18	the	the	DET
dpc-3493	30	19	world	world	NOUN
dpc-3493	30	20	population	population	NOUN
dpc-3493	30	21	will	will	AUX
dpc-3493	30	22	be	be	AUX
dpc-3493	30	23	overweight	overweight	ADJ
dpc-3493	30	24	with	with	ADP
dpc-3493	30	25	body	body	NOUN
dpc-3493	30	26	mass	mass	NOUN
dpc-3493	30	27	index	index	NOUN
dpc-3493	30	28	(	(	PUNCT
dpc-3493	30	29	bmi	bmi	PROPN
dpc-3493	30	30	)	)	PUNCT
dpc-3493	30	31	values	value	NOUN
dpc-3493	30	32	>	>	PUNCT
dpc-3493	30	33	25	25	NUM
dpc-3493	30	34	and	and	CCONJ
dpc-3493	30	35	20	20	NUM
dpc-3493	30	36	%	%	NOUN
dpc-3493	30	37	will	will	AUX
dpc-3493	30	38	be	be	AUX
dpc-3493	30	39	obese	obese	ADJ
dpc-3493	30	40	with	with	ADP
dpc-3493	30	41	bmi	bmi	PROPN
dpc-3493	30	42	>	>	X
dpc-3493	30	43	30	30	NUM
dpc-3493	30	44	in	in	ADP
dpc-3493	30	45	2030	2030	NUM
dpc-3493	31	1	[	[	X
dpc-3493	31	2	8	8	NUM
dpc-3493	31	3	]	]	PUNCT
dpc-3493	31	4	.	.	PUNCT
dpc-3493	32	1	obesity	obesity	NOUN
dpc-3493	32	2	is	be	AUX
dpc-3493	32	3	involved	involve	VERB
dpc-3493	32	4	in	in	ADP
dpc-3493	32	5	the	the	DET
dpc-3493	32	6	etiopathogenesis	etiopathogenesis	NOUN
dpc-3493	32	7	of	of	ADP
dpc-3493	32	8	many	many	ADJ
dpc-3493	32	9	skin	skin	NOUN
dpc-3493	32	10	disorders	disorder	NOUN
dpc-3493	32	11	including	include	VERB
dpc-3493	32	12	acanthosis	acanthosis	NOUN
dpc-3493	32	13	nigricans	nigrican	NOUN
dpc-3493	32	14	,	,	PUNCT
dpc-3493	32	15	acne	acne	NOUN
dpc-3493	32	16	,	,	PUNCT
dpc-3493	32	17	hyperhidrosis	hyperhidrosis	NOUN
dpc-3493	32	18	,	,	PUNCT
dpc-3493	32	19	intertriginous	intertriginous	ADJ
dpc-3493	32	20	dermatitis	dermatitis	NOUN
dpc-3493	32	21	,	,	PUNCT
dpc-3493	32	22	and	and	CCONJ
dpc-3493	32	23	acrochordons	acrochordon	NOUN
dpc-3493	32	24	[	[	X
dpc-3493	32	25	10	10	NUM
dpc-3493	32	26	]	]	PUNCT
dpc-3493	32	27	.	.	PUNCT
dpc-3493	33	1	in	in	ADP
dpc-3493	33	2	addition	addition	NOUN
dpc-3493	33	3	,	,	PUNCT
dpc-3493	33	4	obesity	obesity	NOUN
dpc-3493	33	5	may	may	AUX
dpc-3493	33	6	be	be	AUX
dpc-3493	33	7	accompanied	accompany	VERB
dpc-3493	33	8	by	by	ADP
dpc-3493	33	9	plantar	plantar	NOUN
dpc-3493	33	10	hyperkeratosis	hyperkeratosis	NOUN
dpc-3493	33	11	,	,	PUNCT
dpc-3493	33	12	cellulitis	cellulitis	NOUN
dpc-3493	33	13	,	,	PUNCT
dpc-3493	33	14	keratosis	keratosis	NOUN
dpc-3493	33	15	pilaris	pilaris	NOUN
dpc-3493	33	16	,	,	PUNCT
dpc-3493	33	17	stria	stria	NOUN
dpc-3493	33	18	distensae	distensae	NOUN
dpc-3493	33	19	,	,	PUNCT
dpc-3493	33	20	hidradenitis	hidradenitis	PROPN
dpc-3493	33	21	suppurativa	suppurativa	PROPN
dpc-3493	33	22	,	,	PUNCT
dpc-3493	33	23	and	and	CCONJ
dpc-3493	33	24	skin	skin	NOUN
dpc-3493	33	25	infections	infection	NOUN
dpc-3493	33	26	[	[	X
dpc-3493	33	27	11	11	NUM
dpc-3493	33	28	-	-	SYM
dpc-3493	33	29	13	13	NUM
dpc-3493	33	30	]	]	PUNCT
dpc-3493	33	31	.	.	PUNCT
dpc-3493	34	1	obesity	obesity	NOUN
dpc-3493	34	2	is	be	AUX
dpc-3493	34	3	also	also	ADV
dpc-3493	34	4	an	an	DET
dpc-3493	34	5	independent	independent	ADJ
dpc-3493	34	6	risk	risk	NOUN
dpc-3493	34	7	factor	factor	NOUN
dpc-3493	34	8	for	for	ADP
dpc-3493	34	9	psoriasis	psoriasis	NOUN
dpc-3493	34	10	.	.	PUNCT
dpc-3493	35	1	the	the	DET
dpc-3493	35	2	increase	increase	NOUN
dpc-3493	35	3	in	in	ADP
dpc-3493	35	4	the	the	DET
dpc-3493	35	5	incidence	incidence	NOUN
dpc-3493	35	6	and	and	CCONJ
dpc-3493	35	7	prevalence	prevalence	NOUN
dpc-3493	35	8	of	of	ADP
dpc-3493	35	9	obesity	obesity	NOUN
dpc-3493	35	10	is	be	AUX
dpc-3493	35	11	almost	almost	ADV
dpc-3493	35	12	parallel	parallel	ADJ
dpc-3493	35	13	to	to	ADP
dpc-3493	35	14	clinical	clinical	ADJ
dpc-3493	35	15	exacerbation	exacerbation	NOUN
dpc-3493	35	16	in	in	ADP
dpc-3493	35	17	the	the	DET
dpc-3493	35	18	course	course	NOUN
dpc-3493	35	19	of	of	ADP
dpc-3493	35	20	psoriasis	psoriasis	NOUN
dpc-3493	35	21	[	[	X
dpc-3493	35	22	14	14	NUM
dpc-3493	35	23	]	]	PUNCT
dpc-3493	35	24	.	.	PUNCT
dpc-3493	36	1	objectives	objective	NOUN
dpc-3493	36	2	in	in	ADP
dpc-3493	36	3	this	this	DET
dpc-3493	36	4	study	study	NOUN
dpc-3493	36	5	,	,	PUNCT
dpc-3493	36	6	patients	patient	NOUN
dpc-3493	36	7	with	with	ADP
dpc-3493	36	8	bmi	bmi	NOUN
dpc-3493	36	9	values	value	NOUN
dpc-3493	36	10	≥30	≥30	PROPN
dpc-3493	36	11	were	be	AUX
dpc-3493	36	12	defined	define	VERB
dpc-3493	36	13	as	as	ADP
dpc-3493	36	14	obese	obese	ADJ
dpc-3493	36	15	while	while	SCONJ
dpc-3493	36	16	those	those	PRON
dpc-3493	36	17	with	with	ADP
dpc-3493	36	18	bmi	bmi	NOUN
dpc-3493	36	19	<	<	X
dpc-3493	36	20	30	30	NUM
dpc-3493	36	21	were	be	AUX
dpc-3493	36	22	defined	define	VERB
dpc-3493	36	23	as	as	ADP
dpc-3493	36	24	non	non	ADJ
dpc-3493	36	25	-	-	ADJ
dpc-3493	36	26	obese	obese	ADJ
dpc-3493	36	27	.	.	PUNCT
dpc-3493	37	1	we	we	PRON
dpc-3493	37	2	collected	collect	VERB
dpc-3493	37	3	data	datum	NOUN
dpc-3493	37	4	regarding	regard	VERB
dpc-3493	37	5	improvement	improvement	NOUN
dpc-3493	37	6	in	in	ADP
dpc-3493	37	7	the	the	DET
dpc-3493	37	8	psoriasis	psoriasis	NOUN
dpc-3493	37	9	area	area	NOUN
dpc-3493	37	10	and	and	CCONJ
dpc-3493	37	11	severity	severity	NOUN
dpc-3493	37	12	index	index	NOUN
dpc-3493	37	13	(	(	PUNCT
dpc-3493	37	14	pasi	pasi	NOUN
dpc-3493	37	15	)	)	PUNCT
dpc-3493	37	16	75	75	NUM
dpc-3493	37	17	and	and	CCONJ
dpc-3493	37	18	pasi	pasi	VERB
dpc-3493	37	19	90	90	NUM
dpc-3493	37	20	scores	score	NOUN
dpc-3493	37	21	of	of	ADP
dpc-3493	37	22	patients	patient	NOUN
dpc-3493	37	23	with	with	ADP
dpc-3493	37	24	psoriasis	psoriasis	NOUN
dpc-3493	37	25	receiving	receive	VERB
dpc-3493	37	26	biological	biological	ADJ
dpc-3493	37	27	agents	agent	NOUN
dpc-3493	37	28	and	and	CCONJ
dpc-3493	37	29	conventional	conventional	ADJ
dpc-3493	37	30	treatments	treatment	NOUN
dpc-3493	37	31	.	.	PUNCT
dpc-3493	38	1	we	we	PRON
dpc-3493	38	2	retrospectively	retrospectively	ADV
dpc-3493	38	3	assessed	assess	VERB
dpc-3493	38	4	the	the	DET
dpc-3493	38	5	data	datum	NOUN
dpc-3493	38	6	and	and	CCONJ
dpc-3493	38	7	compared	compare	VERB
dpc-3493	38	8	the	the	DET
dpc-3493	38	9	findings	finding	NOUN
dpc-3493	38	10	according	accord	VERB
dpc-3493	38	11	to	to	ADP
dpc-3493	38	12	the	the	DET
dpc-3493	38	13	patients	patient	NOUN
dpc-3493	38	14	bmi	bmi	VERB
dpc-3493	38	15	values	value	NOUN
dpc-3493	38	16	.	.	PUNCT
dpc-3493	39	1	in	in	ADP
dpc-3493	39	2	addition	addition	NOUN
dpc-3493	39	3	,	,	PUNCT
dpc-3493	39	4	we	we	PRON
dpc-3493	39	5	assessed	assess	VERB
dpc-3493	39	6	biological	biological	ADJ
dpc-3493	39	7	agents	agent	NOUN
dpc-3493	39	8	and	and	CCONJ
dpc-3493	39	9	conventional	conventional	ADJ
dpc-3493	39	10	agents	agent	NOUN
dpc-3493	39	11	(	(	PUNCT
dpc-3493	39	12	methotrexate	methotrexate	NOUN
dpc-3493	39	13	and	and	CCONJ
dpc-3493	39	14	acitretin	acitretin	NOUN
dpc-3493	39	15	)	)	PUNCT
dpc-3493	39	16	in	in	ADP
dpc-3493	39	17	terms	term	NOUN
dpc-3493	39	18	of	of	ADP
dpc-3493	39	19	success	success	NOUN
dpc-3493	39	20	in	in	ADP
dpc-3493	39	21	achieving	achieve	VERB
dpc-3493	39	22	pasi	pasi	NOUN
dpc-3493	39	23	75	75	NUM
dpc-3493	39	24	and	and	CCONJ
dpc-3493	39	25	pasi	pasi	VERB
dpc-3493	39	26	90	90	NUM
dpc-3493	39	27	responses	response	NOUN
dpc-3493	39	28	based	base	VERB
dpc-3493	39	29	on	on	ADP
dpc-3493	39	30	the	the	DET
dpc-3493	39	31	presence	presence	NOUN
dpc-3493	39	32	of	of	ADP
dpc-3493	39	33	joint	joint	ADJ
dpc-3493	39	34	involvement	involvement	NOUN
dpc-3493	39	35	,	,	PUNCT
dpc-3493	39	36	smoking	smoking	NOUN
dpc-3493	39	37	habit	habit	NOUN
dpc-3493	39	38	,	,	PUNCT
dpc-3493	39	39	concomitant	concomitant	ADJ
dpc-3493	39	40	presence	presence	NOUN
dpc-3493	39	41	of	of	ADP
dpc-3493	39	42	psychiatric	psychiatric	ADJ
dpc-3493	39	43	disease	disease	NOUN
dpc-3493	39	44	,	,	PUNCT
dpc-3493	39	45	and	and	CCONJ
dpc-3493	39	46	pruritus	pruritus	PROPN
dpc-3493	39	47	.	.	PUNCT
dpc-3493	40	1	methods	method	NOUN
dpc-3493	40	2	this	this	DET
dpc-3493	40	3	study	study	NOUN
dpc-3493	40	4	was	be	AUX
dpc-3493	40	5	conducted	conduct	VERB
dpc-3493	40	6	in	in	ADP
dpc-3493	40	7	the	the	DET
dpc-3493	40	8	chronic	chronic	ADJ
dpc-3493	40	9	diseases	disease	NOUN
dpc-3493	40	10	unit	unit	NOUN
dpc-3493	40	11	of	of	ADP
dpc-3493	40	12	the	the	DET
dpc-3493	40	13	dermatology	dermatology	NOUN
dpc-3493	40	14	department	department	NOUN
dpc-3493	40	15	of	of	ADP
dpc-3493	40	16	the	the	DET
dpc-3493	40	17	health	health	PROPN
dpc-3493	40	18	sciences	sciences	PROPN
dpc-3493	40	19	university	university	PROPN
dpc-3493	40	20	kayseri	kayseri	PROPN
dpc-3493	40	21	teaching	teaching	PROPN
dpc-3493	40	22	and	and	CCONJ
dpc-3493	40	23	research	research	NOUN
dpc-3493	40	24	hospital	hospital	NOUN
dpc-3493	40	25	.	.	PUNCT
dpc-3493	41	1	since	since	SCONJ
dpc-3493	41	2	2016	2016	NUM
dpc-3493	41	3	,	,	PUNCT
dpc-3493	41	4	all	all	DET
dpc-3493	41	5	patients	patient	NOUN
dpc-3493	41	6	were	be	AUX
dpc-3493	41	7	registered	register	VERB
dpc-3493	41	8	with	with	ADP
dpc-3493	41	9	the	the	DET
dpc-3493	41	10	psortaxis	psortaxis	ADJ
dpc-3493	41	11	database	database	NOUN
dpc-3493	41	12	 	 	SPACE
dpc-3493	42	1	[	[	X
dpc-3493	42	2	15	15	NUM
dpc-3493	42	3	]	]	PUNCT
dpc-3493	42	4	.	.	PUNCT
dpc-3493	43	1	the	the	DET
dpc-3493	43	2	database	database	NOUN
dpc-3493	43	3	was	be	AUX
dpc-3493	43	4	updated	update	VERB
dpc-3493	43	5	periodically	periodically	ADV
dpc-3493	43	6	with	with	ADP
dpc-3493	43	7	data	datum	NOUN
dpc-3493	43	8	from	from	ADP
dpc-3493	43	9	follow	follow	NOUN
dpc-3493	43	10	-	-	PUNCT
dpc-3493	43	11	up	up	NOUN
dpc-3493	43	12	,	,	PUNCT
dpc-3493	43	13	and	and	CCONJ
dpc-3493	43	14	photographs	photograph	NOUN
dpc-3493	43	15	at	at	ADP
dpc-3493	43	16	baseline	baseline	NOUN
dpc-3493	43	17	and	and	CCONJ
dpc-3493	43	18	after	after	ADP
dpc-3493	43	19	treatment	treatment	NOUN
dpc-3493	43	20	were	be	AUX
dpc-3493	43	21	also	also	ADV
dpc-3493	43	22	added	add	VERB
dpc-3493	43	23	to	to	ADP
dpc-3493	43	24	the	the	DET
dpc-3493	43	25	psortaxis	psortaxis	ADJ
dpc-3493	43	26	database	database	NOUN
dpc-3493	43	27	.	.	PUNCT
dpc-3493	44	1	treatments	treatment	NOUN
dpc-3493	44	2	were	be	AUX
dpc-3493	44	3	changed	change	VERB
dpc-3493	44	4	based	base	VERB
dpc-3493	44	5	on	on	ADP
dpc-3493	44	6	treatment	treatment	NOUN
dpc-3493	44	7	responses	response	NOUN
dpc-3493	44	8	during	during	ADP
dpc-3493	44	9	follow	follow	NOUN
dpc-3493	44	10	-	-	PUNCT
dpc-3493	44	11	up	up	NOUN
dpc-3493	44	12	.	.	PUNCT
dpc-3493	45	1	most	most	ADJ
dpc-3493	45	2	of	of	ADP
dpc-3493	45	3	the	the	DET
dpc-3493	45	4	patients	patient	NOUN
dpc-3493	45	5	are	be	AUX
dpc-3493	45	6	still	still	ADV
dpc-3493	45	7	attending	attend	VERB
dpc-3493	45	8	regular	regular	ADJ
dpc-3493	45	9	follow	follow	NOUN
dpc-3493	45	10	-	-	PUNCT
dpc-3493	45	11	up	up	ADP
dpc-3493	45	12	appointments	appointment	NOUN
dpc-3493	45	13	.	.	PUNCT
dpc-3493	46	1	in	in	ADP
dpc-3493	46	2	the	the	DET
dpc-3493	46	3	course	course	NOUN
dpc-3493	46	4	of	of	ADP
dpc-3493	46	5	the	the	DET
dpc-3493	46	6	present	present	ADJ
dpc-3493	46	7	study	study	NOUN
dpc-3493	46	8	,	,	PUNCT
dpc-3493	46	9	the	the	DET
dpc-3493	46	10	electronic	electronic	ADJ
dpc-3493	46	11	database	database	NOUN
dpc-3493	46	12	was	be	AUX
dpc-3493	46	13	screened	screen	VERB
dpc-3493	46	14	for	for	SCONJ
dpc-3493	46	15	patients	patient	NOUN
dpc-3493	46	16	with	with	ADP
dpc-3493	46	17	plaque	plaque	NOUN
dpc-3493	46	18	psoriasis	psoriasis	NOUN
dpc-3493	46	19	and	and	CCONJ
dpc-3493	46	20	the	the	DET
dpc-3493	46	21	records	record	NOUN
dpc-3493	46	22	of	of	ADP
dpc-3493	46	23	these	these	DET
dpc-3493	46	24	patients	patient	NOUN
dpc-3493	46	25	were	be	AUX
dpc-3493	46	26	extracted	extract	VERB
dpc-3493	46	27	.	.	PUNCT
dpc-3493	47	1	patients	patient	NOUN
dpc-3493	47	2	receiving	receive	VERB
dpc-3493	47	3	biological	biological	ADJ
dpc-3493	47	4	agents	agent	NOUN
dpc-3493	47	5	and	and	CCONJ
dpc-3493	47	6	conventional	conventional	ADJ
dpc-3493	47	7	agents	agent	NOUN
dpc-3493	47	8	were	be	AUX
dpc-3493	47	9	included	include	VERB
dpc-3493	47	10	in	in	ADP
dpc-3493	47	11	the	the	DET
dpc-3493	47	12	research	research	NOUN
dpc-3493	47	13	as	as	ADP
dpc-3493	47	14	the	the	DET
dpc-3493	47	15	study	study	NOUN
dpc-3493	47	16	and	and	CCONJ
dpc-3493	47	17	control	control	NOUN
dpc-3493	47	18	groups	group	NOUN
dpc-3493	47	19	,	,	PUNCT
dpc-3493	47	20	respectively	respectively	ADV
dpc-3493	47	21	.	.	PUNCT
dpc-3493	48	1	inclusion	inclusion	NOUN
dpc-3493	48	2	criteria	criterion	NOUN
dpc-3493	48	3	patients	patient	NOUN
dpc-3493	48	4	aged	age	VERB
dpc-3493	48	5	≤18	≤18	ADJ
dpc-3493	48	6	years	year	NOUN
dpc-3493	48	7	diagnosed	diagnose	VERB
dpc-3493	48	8	with	with	ADP
dpc-3493	48	9	psoriasis	psoriasis	NOUN
dpc-3493	48	10	vulgaris	vulgaris	NOUN
dpc-3493	48	11	who	who	PRON
dpc-3493	48	12	received	receive	VERB
dpc-3493	48	13	any	any	DET
dpc-3493	48	14	systemic	systemic	ADJ
dpc-3493	48	15	agents	agent	NOUN
dpc-3493	48	16	(	(	PUNCT
dpc-3493	48	17	biological	biological	ADJ
dpc-3493	48	18	agents	agent	NOUN
dpc-3493	48	19	,	,	PUNCT
dpc-3493	48	20	methotrexate	methotrexate	NOUN
dpc-3493	48	21	,	,	PUNCT
dpc-3493	48	22	or	or	CCONJ
dpc-3493	48	23	acitretin	acitretin	NOUN
dpc-3493	48	24	)	)	PUNCT
dpc-3493	48	25	for	for	ADP
dpc-3493	48	26	therapeutic	therapeutic	ADJ
dpc-3493	48	27	purposes	purpose	NOUN
dpc-3493	48	28	.	.	PUNCT
dpc-3493	49	1	exclusion	exclusion	NOUN
dpc-3493	49	2	criteria	criterion	NOUN
dpc-3493	49	3	psoriasis	psoriasis	NOUN
dpc-3493	49	4	patients	patient	NOUN
dpc-3493	49	5	with	with	ADP
dpc-3493	49	6	a	a	DET
dpc-3493	49	7	diagnosis	diagnosis	NOUN
dpc-3493	49	8	other	other	ADJ
dpc-3493	49	9	than	than	ADP
dpc-3493	49	10	psoriasis	psoriasis	NOUN
dpc-3493	49	11	vulgaris	vulgaris	NOUN
dpc-3493	49	12	(	(	PUNCT
dpc-3493	49	13	nail	nail	NOUN
dpc-3493	49	14	psoriasis	psoriasis	NOUN
dpc-3493	49	15	,	,	PUNCT
dpc-3493	49	16	pustular	pustular	ADJ
dpc-3493	49	17	psoriasis	psoriasis	NOUN
dpc-3493	49	18	,	,	PUNCT
dpc-3493	49	19	erythrodermic	erythrodermic	ADJ
dpc-3493	49	20	psoriasis	psoriasis	NOUN
dpc-3493	49	21	,	,	PUNCT
dpc-3493	49	22	etc	etc	X
dpc-3493	49	23	)	)	PUNCT
dpc-3493	50	1	;	;	PUNCT
dpc-3493	50	2	patients	patient	NOUN
dpc-3493	50	3	aged	age	VERB
dpc-3493	50	4	<	<	X
dpc-3493	50	5	18	18	NUM
dpc-3493	50	6	years	year	NOUN
dpc-3493	50	7	;	;	PUNCT
dpc-3493	50	8	those	those	PRON
dpc-3493	50	9	receiving	receive	VERB
dpc-3493	50	10	topical	topical	ADJ
dpc-3493	50	11	treatment	treatment	NOUN
dpc-3493	50	12	alone	alone	ADV
dpc-3493	50	13	;	;	PUNCT
dpc-3493	50	14	those	those	PRON
dpc-3493	50	15	with	with	ADP
dpc-3493	50	16	small	small	ADJ
dpc-3493	50	17	intestine	intestine	NOUN
dpc-3493	50	18	disorders	disorder	NOUN
dpc-3493	50	19	(	(	PUNCT
dpc-3493	50	20	celiac	celiac	ADJ
dpc-3493	50	21	disease	disease	NOUN
dpc-3493	50	22	,	,	PUNCT
dpc-3493	50	23	enteropathy	enteropathy	ADJ
dpc-3493	50	24	,	,	PUNCT
dpc-3493	50	25	etc	etc	X
dpc-3493	50	26	)	)	PUNCT
dpc-3493	50	27	,	,	PUNCT
dpc-3493	50	28	pancreas	pancreas	NOUN
dpc-3493	50	29	disorders	disorder	NOUN
dpc-3493	50	30	,	,	PUNCT
dpc-3493	50	31	or	or	CCONJ
dpc-3493	50	32	hepatobiliary	hepatobiliary	ADJ
dpc-3493	50	33	disorders	disorder	NOUN
dpc-3493	50	34	that	that	PRON
dpc-3493	50	35	may	may	AUX
dpc-3493	50	36	affect	affect	VERB
dpc-3493	50	37	drug	drug	NOUN
dpc-3493	50	38	levels	level	NOUN
dpc-3493	50	39	or	or	CCONJ
dpc-3493	50	40	bmi	bmi	NOUN
dpc-3493	50	41	;	;	PUNCT
dpc-3493	50	42	those	those	PRON
dpc-3493	50	43	with	with	ADP
dpc-3493	50	44	diseases	disease	NOUN
dpc-3493	50	45	that	that	PRON
dpc-3493	50	46	may	may	AUX
dpc-3493	50	47	cause	cause	VERB
dpc-3493	50	48	lymphatic	lymphatic	ADJ
dpc-3493	50	49	obstruction	obstruction	NOUN
dpc-3493	50	50	(	(	PUNCT
dpc-3493	50	51	tuberculosis	tuberculosis	NOUN
dpc-3493	50	52	,	,	PUNCT
dpc-3493	50	53	lymphoma	lymphoma	NOUN
dpc-3493	50	54	,	,	PUNCT
dpc-3493	50	55	etc	etc	X
dpc-3493	50	56	.	.	X
dpc-3493	50	57	)	)	PUNCT
dpc-3493	50	58	;	;	PUNCT
dpc-3493	50	59	those	those	PRON
dpc-3493	50	60	with	with	ADP
dpc-3493	50	61	any	any	DET
dpc-3493	50	62	malignancies	malignancy	NOUN
dpc-3493	50	63	;	;	PUNCT
dpc-3493	50	64	and	and	CCONJ
dpc-3493	50	65	those	those	PRON
dpc-3493	50	66	with	with	ADP
dpc-3493	50	67	renal	renal	ADJ
dpc-3493	50	68	or	or	CCONJ
dpc-3493	50	69	hepatic	hepatic	ADJ
dpc-3493	50	70	failure	failure	NOUN
dpc-3493	50	71	.	.	PUNCT
dpc-3493	51	1	in	in	ADP
dpc-3493	51	2	this	this	DET
dpc-3493	51	3	study	study	NOUN
dpc-3493	51	4	,	,	PUNCT
dpc-3493	51	5	tnf	tnf	PROPN
dpc-3493	51	6	-	-	PUNCT
dpc-3493	51	7	α	α	PROPN
dpc-3493	51	8	inhibitors	inhibitor	NOUN
dpc-3493	51	9	(	(	PUNCT
dpc-3493	51	10	adalimumab	adalimumab	NOUN
dpc-3493	51	11	,	,	PUNCT
dpc-3493	51	12	etanercept	etanercept	NOUN
dpc-3493	51	13	,	,	PUNCT
dpc-3493	51	14	infliximab	infliximab	NOUN
dpc-3493	51	15	,	,	PUNCT
dpc-3493	51	16	and	and	CCONJ
dpc-3493	51	17	certolizumab	certolizumab	NOUN
dpc-3493	51	18	pegol	pegol	PROPN
dpc-3493	51	19	)	)	PUNCT
dpc-3493	51	20	,	,	PUNCT
dpc-3493	51	21	an	an	DET
dpc-3493	51	22	il12/13	il12/13	NOUN
dpc-3493	51	23	inhibitor	inhibitor	NOUN
dpc-3493	51	24	(	(	PUNCT
dpc-3493	51	25	ustekinumab	ustekinumab	NOUN
dpc-3493	51	26	)	)	PUNCT
dpc-3493	51	27	,	,	PUNCT
dpc-3493	51	28	il-17	il-17	NUM
dpc-3493	51	29	blockers	blocker	NOUN
dpc-3493	51	30	(	(	PUNCT
dpc-3493	51	31	secukinumab	secukinumab	NOUN
dpc-3493	51	32	and	and	CCONJ
dpc-3493	51	33	original	original	ADJ
dpc-3493	51	34	article	article	NOUN
dpc-3493	51	35	|	|	ADV
dpc-3493	51	36	dermatol	dermatol	ADJ
dpc-3493	51	37	pract	pract	NOUN
dpc-3493	51	38	concept	concept	NOUN
dpc-3493	51	39	.	.	PUNCT
dpc-3493	52	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	52	2	3	3	NUM
dpc-3493	52	3	ixekizumab	ixekizumab	NOUN
dpc-3493	52	4	)	)	PUNCT
dpc-3493	52	5	,	,	PUNCT
dpc-3493	52	6	and	and	CCONJ
dpc-3493	52	7	il-23	il-23	NOUN
dpc-3493	52	8	blockers	blocker	NOUN
dpc-3493	52	9	(	(	PUNCT
dpc-3493	52	10	risankizumab	risankizumab	NOUN
dpc-3493	52	11	and	and	CCONJ
dpc-3493	52	12	guselkumab	guselkumab	NOUN
dpc-3493	52	13	)	)	PUNCT
dpc-3493	52	14	were	be	AUX
dpc-3493	52	15	assessed	assess	VERB
dpc-3493	52	16	as	as	ADP
dpc-3493	52	17	biological	biological	ADJ
dpc-3493	52	18	agents	agent	NOUN
dpc-3493	52	19	.	.	PUNCT
dpc-3493	53	1	in	in	ADP
dpc-3493	53	2	addition	addition	NOUN
dpc-3493	53	3	,	,	PUNCT
dpc-3493	53	4	methotrexate	methotrexate	NOUN
dpc-3493	53	5	and	and	CCONJ
dpc-3493	53	6	acitretin	acitretin	NOUN
dpc-3493	53	7	were	be	AUX
dpc-3493	53	8	assessed	assess	VERB
dpc-3493	53	9	as	as	ADP
dpc-3493	53	10	systemic	systemic	ADJ
dpc-3493	53	11	conventional	conventional	ADJ
dpc-3493	53	12	agents	agent	NOUN
dpc-3493	53	13	.	.	PUNCT
dpc-3493	54	1	bmi	bmi	PROPN
dpc-3493	54	2	was	be	AUX
dpc-3493	54	3	calculated	calculate	VERB
dpc-3493	54	4	for	for	ADP
dpc-3493	54	5	all	all	DET
dpc-3493	54	6	patients	patient	NOUN
dpc-3493	54	7	using	use	VERB
dpc-3493	54	8	the	the	DET
dpc-3493	54	9	following	follow	VERB
dpc-3493	54	10	formula	formula	NOUN
dpc-3493	54	11	:	:	PUNCT
dpc-3493	54	12	bmi	bmi	PROPN
dpc-3493	54	13	=	=	SYM
dpc-3493	54	14	weight	weight	NOUN
dpc-3493	54	15	(	(	PUNCT
dpc-3493	54	16	kg)/height2	kg)/height2	PROPN
dpc-3493	54	17	(	(	PUNCT
dpc-3493	54	18	m2	m2	PROPN
dpc-3493	54	19	)	)	PUNCT
dpc-3493	54	20	.	.	PUNCT
dpc-3493	55	1	the	the	DET
dpc-3493	55	2	patients	patient	NOUN
dpc-3493	55	3	were	be	AUX
dpc-3493	55	4	classified	classify	VERB
dpc-3493	55	5	as	as	ADP
dpc-3493	55	6	obese	obese	NOUN
dpc-3493	55	7	(	(	PUNCT
dpc-3493	55	8	bmi	bmi	X
dpc-3493	55	9	≥30	≥30	INTJ
dpc-3493	55	10	mg	mg	PROPN
dpc-3493	55	11	/	/	SYM
dpc-3493	55	12	m2	m2	PROPN
dpc-3493	55	13	)	)	PUNCT
dpc-3493	55	14	and	and	CCONJ
dpc-3493	55	15	non	non	ADJ
dpc-3493	55	16	-	-	ADJ
dpc-3493	55	17	obese	obese	ADJ
dpc-3493	55	18	(	(	PUNCT
dpc-3493	55	19	bmi	bmi	X
dpc-3493	55	20	<	<	X
dpc-3493	55	21	30	30	NUM
dpc-3493	55	22	mg	mg	PROPN
dpc-3493	55	23	/	/	SYM
dpc-3493	55	24	m2	m2	PROPN
dpc-3493	55	25	;	;	PUNCT
dpc-3493	55	26	normal	normal	ADJ
dpc-3493	55	27	and	and	CCONJ
dpc-3493	55	28	overweight	overweight	ADJ
dpc-3493	55	29	)	)	PUNCT
dpc-3493	55	30	.	.	PUNCT
dpc-3493	56	1	pasi	pasi	NOUN
dpc-3493	56	2	75	75	NUM
dpc-3493	56	3	and	and	CCONJ
dpc-3493	56	4	pasi	pasi	VERB
dpc-3493	56	5	90	90	NUM
dpc-3493	56	6	responses	response	NOUN
dpc-3493	56	7	were	be	AUX
dpc-3493	56	8	assessed	assess	VERB
dpc-3493	56	9	at	at	ADP
dpc-3493	56	10	baseline	baseline	NOUN
dpc-3493	56	11	and	and	CCONJ
dpc-3493	56	12	at	at	ADP
dpc-3493	56	13	months	month	NOUN
dpc-3493	56	14	1	1	NUM
dpc-3493	56	15	and	and	CCONJ
dpc-3493	56	16	3	3	NUM
dpc-3493	56	17	,	,	PUNCT
dpc-3493	56	18	and	and	CCONJ
dpc-3493	56	19	percentage	percentage	NOUN
dpc-3493	56	20	changes	change	NOUN
dpc-3493	56	21	were	be	AUX
dpc-3493	56	22	recorded	record	VERB
dpc-3493	56	23	for	for	ADP
dpc-3493	56	24	the	the	DET
dpc-3493	56	25	pasi	pasi	NOUN
dpc-3493	56	26	scores	score	NOUN
dpc-3493	56	27	.	.	PUNCT
dpc-3493	57	1	the	the	DET
dpc-3493	57	2	achievement	achievement	NOUN
dpc-3493	57	3	of	of	ADP
dpc-3493	57	4	pasi	pasi	NOUN
dpc-3493	57	5	75	75	NUM
dpc-3493	57	6	or	or	CCONJ
dpc-3493	57	7	pasi	pasi	VERB
dpc-3493	57	8	90	90	NUM
dpc-3493	57	9	response	response	NOUN
dpc-3493	57	10	was	be	AUX
dpc-3493	57	11	considered	consider	VERB
dpc-3493	57	12	as	as	ADP
dpc-3493	57	13	the	the	DET
dpc-3493	57	14	criterion	criterion	NOUN
dpc-3493	57	15	of	of	ADP
dpc-3493	57	16	success	success	NOUN
dpc-3493	57	17	for	for	ADP
dpc-3493	57	18	each	each	DET
dpc-3493	57	19	individual	individual	ADJ
dpc-3493	57	20	agent	agent	NOUN
dpc-3493	57	21	used	use	VERB
dpc-3493	57	22	.	.	PUNCT
dpc-3493	58	1	approval	approval	NOUN
dpc-3493	58	2	for	for	ADP
dpc-3493	58	3	this	this	DET
dpc-3493	58	4	study	study	NOUN
dpc-3493	58	5	was	be	AUX
dpc-3493	58	6	obtained	obtain	VERB
dpc-3493	58	7	from	from	ADP
dpc-3493	58	8	the	the	DET
dpc-3493	58	9	ethics	ethic	NOUN
dpc-3493	58	10	committee	committee	PROPN
dpc-3493	58	11	of	of	ADP
dpc-3493	58	12	kayseri	kayseri	PROPN
dpc-3493	58	13	city	city	PROPN
dpc-3493	58	14	education	education	PROPN
dpc-3493	58	15	and	and	CCONJ
dpc-3493	58	16	research	research	NOUN
dpc-3493	58	17	hospital	hospital	NOUN
dpc-3493	58	18	(	(	PUNCT
dpc-3493	58	19	21.02.2023/800	21.02.2023/800	NUM
dpc-3493	58	20	)	)	PUNCT
dpc-3493	58	21	.	.	PUNCT
dpc-3493	59	1	statistical	statistical	ADJ
dpc-3493	59	2	analysis	analysis	NOUN
dpc-3493	59	3	the	the	DET
dpc-3493	59	4	normal	normal	ADJ
dpc-3493	59	5	distribution	distribution	NOUN
dpc-3493	59	6	of	of	ADP
dpc-3493	59	7	the	the	DET
dpc-3493	59	8	data	datum	NOUN
dpc-3493	59	9	was	be	AUX
dpc-3493	59	10	tested	test	VERB
dpc-3493	59	11	using	use	VERB
dpc-3493	59	12	the	the	DET
dpc-3493	59	13	shapiro	shapiro	PROPN
dpc-3493	59	14	-	-	PUNCT
dpc-3493	59	15	wilk	wilk	NOUN
dpc-3493	59	16	test	test	NOUN
dpc-3493	59	17	and	and	CCONJ
dpc-3493	59	18	histograms	histogram	NOUN
dpc-3493	59	19	.	.	PUNCT
dpc-3493	60	1	data	datum	NOUN
dpc-3493	60	2	with	with	ADP
dpc-3493	60	3	normal	normal	ADJ
dpc-3493	60	4	distribution	distribution	NOUN
dpc-3493	60	5	are	be	AUX
dpc-3493	60	6	presented	present	VERB
dpc-3493	60	7	as	as	ADP
dpc-3493	60	8	mean	mean	NOUN
dpc-3493	60	9	±	±	NUM
dpc-3493	60	10	standard	standard	ADJ
dpc-3493	60	11	deviation	deviation	NOUN
dpc-3493	60	12	while	while	SCONJ
dpc-3493	60	13	data	datum	NOUN
dpc-3493	60	14	with	with	ADP
dpc-3493	60	15	skewed	skewed	ADJ
dpc-3493	60	16	distribution	distribution	NOUN
dpc-3493	60	17	are	be	AUX
dpc-3493	60	18	presented	present	VERB
dpc-3493	60	19	as	as	ADP
dpc-3493	60	20	median	median	NOUN
dpc-3493	60	21	(	(	PUNCT
dpc-3493	60	22	min	min	NOUN
dpc-3493	60	23	-	-	PUNCT
dpc-3493	60	24	max	max	NOUN
dpc-3493	60	25	)	)	PUNCT
dpc-3493	60	26	.	.	PUNCT
dpc-3493	61	1	categorical	categorical	ADJ
dpc-3493	61	2	data	datum	NOUN
dpc-3493	61	3	were	be	AUX
dpc-3493	61	4	analyzed	analyze	VERB
dpc-3493	61	5	using	use	VERB
dpc-3493	61	6	the	the	DET
dpc-3493	61	7	chi	chi	PROPN
dpc-3493	61	8	square	square	PROPN
dpc-3493	61	9	test	test	NOUN
dpc-3493	61	10	and	and	CCONJ
dpc-3493	61	11	fisher	fisher	PROPN
dpc-3493	61	12	exact	exact	ADJ
dpc-3493	61	13	test	test	NOUN
dpc-3493	61	14	.	.	PUNCT
dpc-3493	62	1	continuous	continuous	ADJ
dpc-3493	62	2	data	datum	NOUN
dpc-3493	62	3	with	with	ADP
dpc-3493	62	4	normal	normal	ADJ
dpc-3493	62	5	distribution	distribution	NOUN
dpc-3493	62	6	were	be	AUX
dpc-3493	62	7	analyzed	analyze	VERB
dpc-3493	62	8	using	use	VERB
dpc-3493	62	9	student	student	NOUN
dpc-3493	62	10	t	t	PROPN
dpc-3493	62	11	-	-	PUNCT
dpc-3493	62	12	test	test	NOUN
dpc-3493	62	13	while	while	SCONJ
dpc-3493	62	14	nonparametric	nonparametric	ADJ
dpc-3493	62	15	data	datum	NOUN
dpc-3493	62	16	with	with	ADP
dpc-3493	62	17	skewed	skewed	ADJ
dpc-3493	62	18	distribution	distribution	NOUN
dpc-3493	62	19	were	be	AUX
dpc-3493	62	20	analyzed	analyze	VERB
dpc-3493	62	21	using	use	VERB
dpc-3493	62	22	the	the	DET
dpc-3493	62	23	mann	mann	PROPN
dpc-3493	62	24	-	-	PUNCT
dpc-3493	62	25	whitney	whitney	PROPN
dpc-3493	62	26	u	u	PROPN
dpc-3493	62	27	test	test	NOUN
dpc-3493	62	28	.	.	PUNCT
dpc-3493	63	1	all	all	DET
dpc-3493	63	2	data	datum	NOUN
dpc-3493	63	3	analyses	analysis	NOUN
dpc-3493	63	4	were	be	AUX
dpc-3493	63	5	performed	perform	VERB
dpc-3493	63	6	using	use	VERB
dpc-3493	63	7	ibm	ibm	PROPN
dpc-3493	63	8	spss	spss	PROPN
dpc-3493	63	9	statistics	statistic	NOUN
dpc-3493	63	10	23.0	23.0	NUM
dpc-3493	63	11	(	(	PUNCT
dpc-3493	63	12	ibm	ibm	PROPN
dpc-3493	63	13	corp	corp	PROPN
dpc-3493	63	14	.	.	PROPN
dpc-3493	63	15	)	)	PUNCT
dpc-3493	63	16	.	.	PUNCT
dpc-3493	64	1	results	result	VERB
dpc-3493	64	2	this	this	DET
dpc-3493	64	3	study	study	NOUN
dpc-3493	64	4	included	include	VERB
dpc-3493	64	5	317	317	NUM
dpc-3493	64	6	patients	patient	NOUN
dpc-3493	64	7	who	who	PRON
dpc-3493	64	8	received	receive	VERB
dpc-3493	64	9	222	222	NUM
dpc-3493	64	10	biological	biological	ADJ
dpc-3493	64	11	and	and	CCONJ
dpc-3493	64	12	95	95	NUM
dpc-3493	64	13	conventional	conventional	ADJ
dpc-3493	64	14	treatments	treatment	NOUN
dpc-3493	64	15	.	.	PUNCT
dpc-3493	65	1	the	the	DET
dpc-3493	65	2	mean	mean	ADJ
dpc-3493	65	3	age	age	NOUN
dpc-3493	65	4	was	be	AUX
dpc-3493	65	5	45.2	45.2	NUM
dpc-3493	65	6	years	year	NOUN
dpc-3493	65	7	in	in	ADP
dpc-3493	65	8	the	the	DET
dpc-3493	65	9	entire	entire	ADJ
dpc-3493	65	10	study	study	NOUN
dpc-3493	65	11	population	population	NOUN
dpc-3493	65	12	,	,	PUNCT
dpc-3493	65	13	while	while	SCONJ
dpc-3493	65	14	it	it	PRON
dpc-3493	65	15	was	be	AUX
dpc-3493	65	16	47.6±12.1	47.6±12.1	NUM
dpc-3493	65	17	years	year	NOUN
dpc-3493	65	18	among	among	ADP
dpc-3493	65	19	patients	patient	NOUN
dpc-3493	65	20	treated	treat	VERB
dpc-3493	65	21	with	with	ADP
dpc-3493	65	22	biological	biological	ADJ
dpc-3493	65	23	agents	agent	NOUN
dpc-3493	65	24	and	and	CCONJ
dpc-3493	65	25	46.1±12.2	46.1±12.2	NUM
dpc-3493	65	26	years	year	NOUN
dpc-3493	65	27	among	among	ADP
dpc-3493	65	28	patients	patient	NOUN
dpc-3493	65	29	treated	treat	VERB
dpc-3493	65	30	with	with	ADP
dpc-3493	65	31	conventional	conventional	ADJ
dpc-3493	65	32	agents	agent	NOUN
dpc-3493	65	33	,	,	PUNCT
dpc-3493	65	34	with	with	ADP
dpc-3493	65	35	no	no	DET
dpc-3493	65	36	significant	significant	ADJ
dpc-3493	65	37	difference	difference	NOUN
dpc-3493	65	38	between	between	ADP
dpc-3493	65	39	these	these	DET
dpc-3493	65	40	groups	group	NOUN
dpc-3493	65	41	(	(	PUNCT
dpc-3493	65	42	p	p	X
dpc-3493	65	43	=	=	NOUN
dpc-3493	65	44	0.075	0.075	NUM
dpc-3493	65	45	)	)	PUNCT
dpc-3493	65	46	(	(	PUNCT
dpc-3493	65	47	table	table	NOUN
dpc-3493	65	48	1	1	NUM
dpc-3493	65	49	)	)	PUNCT
dpc-3493	65	50	.	.	PUNCT
dpc-3493	66	1	in	in	ADP
dpc-3493	66	2	the	the	DET
dpc-3493	66	3	group	group	NOUN
dpc-3493	66	4	treated	treat	VERB
dpc-3493	66	5	with	with	ADP
dpc-3493	66	6	biological	biological	ADJ
dpc-3493	66	7	agents	agent	NOUN
dpc-3493	66	8	,	,	PUNCT
dpc-3493	66	9	the	the	DET
dpc-3493	66	10	highest	high	ADJ
dpc-3493	66	11	mean	mean	ADJ
dpc-3493	66	12	age	age	NOUN
dpc-3493	66	13	was	be	AUX
dpc-3493	66	14	found	find	VERB
dpc-3493	66	15	for	for	ADP
dpc-3493	66	16	ixekizumab	ixekizumab	NOUN
dpc-3493	66	17	while	while	SCONJ
dpc-3493	66	18	the	the	DET
dpc-3493	66	19	lowest	low	ADJ
dpc-3493	66	20	mean	mean	NOUN
dpc-3493	66	21	age	age	NOUN
dpc-3493	66	22	was	be	AUX
dpc-3493	66	23	found	find	VERB
dpc-3493	66	24	for	for	ADP
dpc-3493	66	25	guselkumab	guselkumab	NOUN
dpc-3493	66	26	(	(	PUNCT
dpc-3493	66	27	table	table	NOUN
dpc-3493	66	28	2	2	NUM
dpc-3493	66	29	)	)	PUNCT
dpc-3493	66	30	.	.	PUNCT
dpc-3493	67	1	there	there	PRON
dpc-3493	67	2	were	be	VERB
dpc-3493	67	3	127	127	NUM
dpc-3493	67	4	men	man	NOUN
dpc-3493	67	5	(	(	PUNCT
dpc-3493	67	6	57	57	NUM
dpc-3493	67	7	%	%	NOUN
dpc-3493	67	8	)	)	PUNCT
dpc-3493	67	9	and	and	CCONJ
dpc-3493	67	10	95	95	NUM
dpc-3493	67	11	women	woman	NOUN
dpc-3493	67	12	(	(	PUNCT
dpc-3493	67	13	43	43	NUM
dpc-3493	67	14	%	%	NOUN
dpc-3493	67	15	)	)	PUNCT
dpc-3493	67	16	in	in	ADP
dpc-3493	67	17	the	the	DET
dpc-3493	67	18	group	group	NOUN
dpc-3493	67	19	treated	treat	VERB
dpc-3493	67	20	with	with	ADP
dpc-3493	67	21	biological	biological	ADJ
dpc-3493	67	22	agents	agent	NOUN
dpc-3493	67	23	while	while	SCONJ
dpc-3493	67	24	there	there	PRON
dpc-3493	67	25	were	be	VERB
dpc-3493	67	26	63	63	NUM
dpc-3493	67	27	men	man	NOUN
dpc-3493	67	28	and	and	CCONJ
dpc-3493	67	29	32	32	NUM
dpc-3493	67	30	women	woman	NOUN
dpc-3493	67	31	in	in	ADP
dpc-3493	67	32	the	the	DET
dpc-3493	67	33	group	group	NOUN
dpc-3493	67	34	treated	treat	VERB
dpc-3493	67	35	with	with	ADP
dpc-3493	67	36	conventional	conventional	ADJ
dpc-3493	67	37	agents	agent	NOUN
dpc-3493	67	38	,	,	PUNCT
dpc-3493	67	39	indicating	indicate	VERB
dpc-3493	67	40	no	no	DET
dpc-3493	67	41	significant	significant	ADJ
dpc-3493	67	42	difference	difference	NOUN
dpc-3493	67	43	in	in	ADP
dpc-3493	67	44	genders	gender	NOUN
dpc-3493	67	45	between	between	ADP
dpc-3493	67	46	the	the	DET
dpc-3493	67	47	groups	group	NOUN
dpc-3493	67	48	(	(	PUNCT
dpc-3493	67	49	p	p	X
dpc-3493	67	50	=	=	NOUN
dpc-3493	67	51	0.310	0.310	NUM
dpc-3493	67	52	)	)	PUNCT
dpc-3493	67	53	.	.	PUNCT
dpc-3493	68	1	the	the	DET
dpc-3493	68	2	mean	mean	ADJ
dpc-3493	68	3	bmi	bmi	NOUN
dpc-3493	68	4	was	be	AUX
dpc-3493	68	5	28.2±5.3	28.2±5.3	NUM
dpc-3493	68	6	kg	kg	NOUN
dpc-3493	68	7	/	/	SYM
dpc-3493	68	8	m2	m2	PROPN
dpc-3493	68	9	in	in	ADP
dpc-3493	68	10	the	the	DET
dpc-3493	68	11	group	group	NOUN
dpc-3493	68	12	treated	treat	VERB
dpc-3493	68	13	with	with	ADP
dpc-3493	68	14	biological	biological	ADJ
dpc-3493	68	15	agents	agent	NOUN
dpc-3493	68	16	and	and	CCONJ
dpc-3493	68	17	27.6±5.9	27.6±5.9	NUM
dpc-3493	68	18	kg	kg	NOUN
dpc-3493	68	19	/	/	SYM
dpc-3493	68	20	m2	m2	PROPN
dpc-3493	68	21	in	in	ADP
dpc-3493	68	22	the	the	DET
dpc-3493	68	23	group	group	NOUN
dpc-3493	68	24	treated	treat	VERB
dpc-3493	68	25	with	with	ADP
dpc-3493	68	26	conventional	conventional	ADJ
dpc-3493	68	27	agents	agent	NOUN
dpc-3493	68	28	.	.	PUNCT
dpc-3493	69	1	the	the	DET
dpc-3493	69	2	groups	group	NOUN
dpc-3493	69	3	were	be	AUX
dpc-3493	69	4	comparable	comparable	ADJ
dpc-3493	69	5	regarding	regard	VERB
dpc-3493	69	6	bmi	bmi	NOUN
dpc-3493	69	7	(	(	PUNCT
dpc-3493	69	8	p	p	NOUN
dpc-3493	69	9	=	=	NOUN
dpc-3493	69	10	0.360	0.360	NUM
dpc-3493	69	11	)	)	PUNCT
dpc-3493	69	12	.	.	PUNCT
dpc-3493	70	1	furthermore	furthermore	ADV
dpc-3493	70	2	,	,	PUNCT
dpc-3493	70	3	there	there	PRON
dpc-3493	70	4	was	be	VERB
dpc-3493	70	5	no	no	DET
dpc-3493	70	6	significant	significant	ADJ
dpc-3493	70	7	difference	difference	NOUN
dpc-3493	70	8	in	in	ADP
dpc-3493	70	9	bmi	bmi	NOUN
dpc-3493	70	10	between	between	ADP
dpc-3493	70	11	patients	patient	NOUN
dpc-3493	70	12	treated	treat	VERB
dpc-3493	70	13	with	with	ADP
dpc-3493	70	14	different	different	ADJ
dpc-3493	70	15	conventional	conventional	ADJ
dpc-3493	70	16	agents	agent	NOUN
dpc-3493	70	17	(	(	PUNCT
dpc-3493	70	18	p	p	X
dpc-3493	70	19	=	=	NOUN
dpc-3493	70	20	0.264	0.264	NUM
dpc-3493	70	21	)	)	PUNCT
dpc-3493	70	22	.	.	PUNCT
dpc-3493	71	1	among	among	ADP
dpc-3493	71	2	these	these	DET
dpc-3493	71	3	patients	patient	NOUN
dpc-3493	71	4	with	with	ADP
dpc-3493	71	5	psoriasis	psoriasis	NOUN
dpc-3493	71	6	vulgaris	vulgaris	NOUN
dpc-3493	71	7	,	,	PUNCT
dpc-3493	71	8	the	the	DET
dpc-3493	71	9	mean	mean	ADJ
dpc-3493	71	10	disease	disease	NOUN
dpc-3493	71	11	duration	duration	NOUN
dpc-3493	71	12	was	be	AUX
dpc-3493	71	13	17.7±10.5	17.7±10.5	NUM
dpc-3493	71	14	years	year	NOUN
dpc-3493	71	15	for	for	ADP
dpc-3493	71	16	patients	patient	NOUN
dpc-3493	71	17	treated	treat	VERB
dpc-3493	71	18	with	with	ADP
dpc-3493	71	19	biological	biological	ADJ
dpc-3493	71	20	agents	agent	NOUN
dpc-3493	71	21	while	while	SCONJ
dpc-3493	71	22	it	it	PRON
dpc-3493	71	23	was	be	AUX
dpc-3493	71	24	10.1±7.9	10.1±7.9	NUM
dpc-3493	71	25	years	year	NOUN
dpc-3493	71	26	for	for	ADP
dpc-3493	71	27	patients	patient	NOUN
dpc-3493	71	28	treated	treat	VERB
dpc-3493	71	29	with	with	ADP
dpc-3493	71	30	conventional	conventional	ADJ
dpc-3493	71	31	agents	agent	NOUN
dpc-3493	71	32	,	,	PUNCT
dpc-3493	71	33	and	and	CCONJ
dpc-3493	71	34	the	the	DET
dpc-3493	71	35	difference	difference	NOUN
dpc-3493	71	36	was	be	AUX
dpc-3493	71	37	significant	significant	ADJ
dpc-3493	71	38	(	(	PUNCT
dpc-3493	71	39	p	p	X
dpc-3493	71	40	<	<	X
dpc-3493	71	41	0.001	0.001	NUM
dpc-3493	71	42	)	)	PUNCT
dpc-3493	71	43	.	.	PUNCT
dpc-3493	72	1	the	the	DET
dpc-3493	72	2	mean	mean	ADJ
dpc-3493	72	3	disease	disease	NOUN
dpc-3493	72	4	duration	duration	NOUN
dpc-3493	72	5	was	be	AUX
dpc-3493	72	6	15.4±10.4	15.4±10.4	NUM
dpc-3493	72	7	years	year	NOUN
dpc-3493	72	8	for	for	ADP
dpc-3493	72	9	the	the	DET
dpc-3493	72	10	entire	entire	ADJ
dpc-3493	72	11	study	study	NOUN
dpc-3493	72	12	population	population	NOUN
dpc-3493	72	13	.	.	PUNCT
dpc-3493	73	1	of	of	ADP
dpc-3493	73	2	the	the	DET
dpc-3493	73	3	patients	patient	NOUN
dpc-3493	73	4	treated	treat	VERB
dpc-3493	73	5	with	with	ADP
dpc-3493	73	6	biological	biological	ADJ
dpc-3493	73	7	agents	agent	NOUN
dpc-3493	73	8	,	,	PUNCT
dpc-3493	73	9	65.3	65.3	NUM
dpc-3493	73	10	%	%	NOUN
dpc-3493	73	11	(	(	PUNCT
dpc-3493	73	12	n	n	NOUN
dpc-3493	73	13	=	=	SYM
dpc-3493	73	14	145	145	NUM
dpc-3493	73	15	)	)	PUNCT
dpc-3493	73	16	were	be	AUX
dpc-3493	73	17	biological	biological	ADJ
dpc-3493	73	18	-	-	PUNCT
dpc-3493	73	19	naive	naive	ADJ
dpc-3493	73	20	patients	patient	NOUN
dpc-3493	73	21	at	at	ADP
dpc-3493	73	22	baseline	baseline	NOUN
dpc-3493	73	23	while	while	SCONJ
dpc-3493	73	24	34.7	34.7	NUM
dpc-3493	73	25	%	%	NOUN
dpc-3493	73	26	(	(	PUNCT
dpc-3493	73	27	n	n	NOUN
dpc-3493	73	28	=	=	SYM
dpc-3493	73	29	77	77	NUM
dpc-3493	73	30	)	)	PUNCT
dpc-3493	73	31	had	have	AUX
dpc-3493	73	32	switched	switch	VERB
dpc-3493	73	33	from	from	ADP
dpc-3493	73	34	a	a	DET
dpc-3493	73	35	different	different	ADJ
dpc-3493	73	36	biological	biological	ADJ
dpc-3493	73	37	agent	agent	NOUN
dpc-3493	73	38	.	.	PUNCT
dpc-3493	74	1	the	the	DET
dpc-3493	74	2	most	most	ADV
dpc-3493	74	3	commonly	commonly	ADV
dpc-3493	74	4	used	use	VERB
dpc-3493	74	5	biological	biological	ADJ
dpc-3493	74	6	agent	agent	NOUN
dpc-3493	74	7	after	after	ADP
dpc-3493	74	8	switching	switch	VERB
dpc-3493	74	9	was	be	AUX
dpc-3493	74	10	secukinumab	secukinumab	NOUN
dpc-3493	74	11	(	(	PUNCT
dpc-3493	74	12	52.5	52.5	NUM
dpc-3493	74	13	%	%	NOUN
dpc-3493	74	14	;	;	PUNCT
dpc-3493	74	15	n	n	PROPN
dpc-3493	74	16	=	=	SYM
dpc-3493	74	17	31	31	NUM
dpc-3493	74	18	)	)	PUNCT
dpc-3493	74	19	(	(	PUNCT
dpc-3493	74	20	table	table	NOUN
dpc-3493	74	21	3	3	NUM
dpc-3493	74	22	)	)	PUNCT
dpc-3493	74	23	.	.	PUNCT
dpc-3493	75	1	patients	patient	NOUN
dpc-3493	75	2	with	with	ADP
dpc-3493	75	3	bmi	bmi	PROPN
dpc-3493	75	4	<	<	X
dpc-3493	75	5	30	30	NUM
dpc-3493	75	6	among	among	ADP
dpc-3493	75	7	the	the	DET
dpc-3493	75	8	patients	patient	NOUN
dpc-3493	75	9	who	who	PRON
dpc-3493	75	10	had	have	AUX
dpc-3493	75	11	achieved	achieve	VERB
dpc-3493	75	12	pasi	pasi	NOUN
dpc-3493	75	13	75	75	NUM
dpc-3493	75	14	at	at	ADP
dpc-3493	75	15	month	month	NOUN
dpc-3493	75	16	1	1	NUM
dpc-3493	75	17	,	,	PUNCT
dpc-3493	75	18	the	the	DET
dpc-3493	75	19	highest	high	ADJ
dpc-3493	75	20	rate	rate	NOUN
dpc-3493	75	21	was	be	AUX
dpc-3493	75	22	observed	observe	VERB
dpc-3493	75	23	with	with	ADP
dpc-3493	75	24	ixekizumab	ixekizumab	NOUN
dpc-3493	75	25	(	(	PUNCT
dpc-3493	75	26	81.8	81.8	NUM
dpc-3493	75	27	%	%	NOUN
dpc-3493	75	28	;	;	PUNCT
dpc-3493	75	29	n	n	NOUN
dpc-3493	75	30	=	=	SYM
dpc-3493	75	31	9	9	NUM
dpc-3493	75	32	)	)	PUNCT
dpc-3493	75	33	while	while	SCONJ
dpc-3493	75	34	the	the	DET
dpc-3493	75	35	lowest	low	ADJ
dpc-3493	75	36	rate	rate	NOUN
dpc-3493	75	37	was	be	AUX
dpc-3493	75	38	observed	observe	VERB
dpc-3493	75	39	with	with	ADP
dpc-3493	75	40	etanercept	etanercept	NOUN
dpc-3493	75	41	(	(	PUNCT
dpc-3493	75	42	12.5	12.5	NUM
dpc-3493	75	43	%	%	NOUN
dpc-3493	75	44	;	;	PUNCT
dpc-3493	75	45	n	n	NOUN
dpc-3493	75	46	=	=	SYM
dpc-3493	75	47	1	1	NUM
dpc-3493	75	48	)	)	PUNCT
dpc-3493	75	49	(	(	PUNCT
dpc-3493	75	50	table	table	NOUN
dpc-3493	75	51	4	4	NUM
dpc-3493	75	52	)	)	PUNCT
dpc-3493	75	53	.	.	PUNCT
dpc-3493	76	1	the	the	DET
dpc-3493	76	2	proportion	proportion	NOUN
dpc-3493	76	3	of	of	ADP
dpc-3493	76	4	patients	patient	NOUN
dpc-3493	76	5	who	who	PRON
dpc-3493	76	6	achieved	achieve	VERB
dpc-3493	76	7	pasi	pasi	NOUN
dpc-3493	76	8	75	75	NUM
dpc-3493	76	9	response	response	NOUN
dpc-3493	76	10	was	be	AUX
dpc-3493	76	11	13.4	13.4	NUM
dpc-3493	76	12	%	%	NOUN
dpc-3493	76	13	at	at	ADP
dpc-3493	76	14	month	month	NOUN
dpc-3493	76	15	1	1	NUM
dpc-3493	76	16	and	and	CCONJ
dpc-3493	76	17	29.90	29.90	NUM
dpc-3493	76	18	%	%	NOUN
dpc-3493	76	19	(	(	PUNCT
dpc-3493	76	20	n	n	NOUN
dpc-3493	76	21	=	=	SYM
dpc-3493	76	22	20	20	NUM
dpc-3493	76	23	)	)	PUNCT
dpc-3493	76	24	at	at	ADP
dpc-3493	76	25	month	month	NOUN
dpc-3493	76	26	3	3	NUM
dpc-3493	76	27	among	among	ADP
dpc-3493	76	28	patients	patient	NOUN
dpc-3493	76	29	treated	treat	VERB
dpc-3493	76	30	with	with	ADP
dpc-3493	76	31	conventional	conventional	ADJ
dpc-3493	76	32	agents	agent	NOUN
dpc-3493	76	33	(	(	PUNCT
dpc-3493	76	34	table	table	NOUN
dpc-3493	76	35	5	5	NUM
dpc-3493	76	36	)	)	PUNCT
dpc-3493	76	37	.	.	PUNCT
dpc-3493	77	1	among	among	ADP
dpc-3493	77	2	those	those	PRON
dpc-3493	77	3	treated	treat	VERB
dpc-3493	77	4	with	with	ADP
dpc-3493	77	5	biological	biological	ADJ
dpc-3493	77	6	agents	agent	NOUN
dpc-3493	77	7	,	,	PUNCT
dpc-3493	77	8	the	the	DET
dpc-3493	77	9	proportion	proportion	NOUN
dpc-3493	77	10	of	of	ADP
dpc-3493	77	11	patients	patient	NOUN
dpc-3493	77	12	who	who	PRON
dpc-3493	77	13	achieved	achieve	VERB
dpc-3493	77	14	pasi	pasi	NOUN
dpc-3493	77	15	75	75	NUM
dpc-3493	77	16	response	response	NOUN
dpc-3493	77	17	was	be	AUX
dpc-3493	77	18	49.0	49.0	NUM
dpc-3493	77	19	%	%	NOUN
dpc-3493	77	20	(	(	PUNCT
dpc-3493	77	21	n	n	NOUN
dpc-3493	77	22	=	=	SYM
dpc-3493	77	23	77	77	NUM
dpc-3493	77	24	)	)	PUNCT
dpc-3493	77	25	at	at	ADP
dpc-3493	77	26	month	month	NOUN
dpc-3493	77	27	1	1	NUM
dpc-3493	77	28	and	and	CCONJ
dpc-3493	77	29	70.1	70.1	NUM
dpc-3493	77	30	%	%	NOUN
dpc-3493	77	31	(	(	PUNCT
dpc-3493	77	32	n	n	NOUN
dpc-3493	77	33	=	=	SYM
dpc-3493	77	34	110	110	NUM
dpc-3493	77	35	)	)	PUNCT
dpc-3493	77	36	at	at	ADP
dpc-3493	77	37	month	month	NOUN
dpc-3493	77	38	3	3	NUM
dpc-3493	77	39	,	,	PUNCT
dpc-3493	77	40	while	while	SCONJ
dpc-3493	77	41	table	table	NOUN
dpc-3493	77	42	1	1	NUM
dpc-3493	77	43	.	.	PUNCT
dpc-3493	78	1	characteristics	characteristic	NOUN
dpc-3493	78	2	of	of	ADP
dpc-3493	78	3	patients	patient	NOUN
dpc-3493	78	4	receiving	receive	VERB
dpc-3493	78	5	biologic	biologic	NOUN
dpc-3493	78	6	agents	agent	NOUN
dpc-3493	78	7	and	and	CCONJ
dpc-3493	78	8	conventional	conventional	ADJ
dpc-3493	78	9	systemic	systemic	ADJ
dpc-3493	78	10	therapy	therapy	NOUN
dpc-3493	78	11	.	.	PUNCT
dpc-3493	79	1	continuous	continuous	ADJ
dpc-3493	79	2	variables	variable	NOUN
dpc-3493	79	3	biologics	biologic	NOUN
dpc-3493	79	4	(	(	PUNCT
dpc-3493	79	5	all	all	ADV
dpc-3493	79	6	)	)	PUNCT
dpc-3493	79	7	(	(	PUNCT
dpc-3493	79	8	n	n	NOUN
dpc-3493	79	9	=	=	SYM
dpc-3493	79	10	222	222	NUM
dpc-3493	79	11	)	)	PUNCT
dpc-3493	79	12	conventional	conventional	ADJ
dpc-3493	79	13	treatment	treatment	NOUN
dpc-3493	79	14	(	(	PUNCT
dpc-3493	79	15	n	n	NOUN
dpc-3493	79	16	=	=	SYM
dpc-3493	79	17	103	103	NUM
dpc-3493	79	18	)	)	PUNCT
dpc-3493	79	19	mtx	mtx	NOUN
dpc-3493	79	20	(	(	PUNCT
dpc-3493	79	21	n	n	NOUN
dpc-3493	79	22	=	=	SYM
dpc-3493	79	23	57	57	NUM
dpc-3493	79	24	)	)	PUNCT
dpc-3493	79	25	acitretin	acitretin	NOUN
dpc-3493	79	26	(	(	PUNCT
dpc-3493	79	27	n	n	NOUN
dpc-3493	79	28	=	=	SYM
dpc-3493	79	29	46	46	NUM
dpc-3493	79	30	)	)	PUNCT
dpc-3493	79	31	age	age	NOUN
dpc-3493	79	32	(	(	PUNCT
dpc-3493	79	33	years)/mean±sd	years)/mean±sd	PROPN
dpc-3493	79	34	46.14±12.16	46.14±12.16	NOUN
dpc-3493	79	35	42.99±13.88	42.99±13.88	NUM
dpc-3493	79	36	41.65±13.34	41.65±13.34	NOUN
dpc-3493	80	1	44.65±14.51	44.65±14.51	NOUN
dpc-3493	80	2	body	body	NOUN
dpc-3493	80	3	mass	mass	NOUN
dpc-3493	80	4	index	index	NOUN
dpc-3493	80	5	mean±sd	mean±sd	ADP
dpc-3493	80	6	28.15±5.31	28.15±5.31	NUM
dpc-3493	80	7	27.09±6.05	27.09±6.05	NUM
dpc-3493	80	8	27.35±6.04	27.35±6.04	NUM
dpc-3493	80	9	26.75±6.12	26.75±6.12	NUM
dpc-3493	80	10	pasi	pasi	NOUN
dpc-3493	80	11	improvement	improvement	NOUN
dpc-3493	80	12	during	during	ADP
dpc-3493	80	13	the	the	DET
dpc-3493	80	14	first	first	ADJ
dpc-3493	80	15	month	month	NOUN
dpc-3493	80	16	66.67(-150	66.67(-150	NUM
dpc-3493	80	17	-	-	PUNCT
dpc-3493	80	18	100	100	NUM
dpc-3493	80	19	)	)	PUNCT
dpc-3493	80	20	40.00(0	40.00(0	PROPN
dpc-3493	80	21	-	-	PUNCT
dpc-3493	80	22	100	100	NUM
dpc-3493	80	23	)	)	PUNCT
dpc-3493	80	24	33.33(0	33.33(0	NOUN
dpc-3493	80	25	-	-	PUNCT
dpc-3493	80	26	100	100	NUM
dpc-3493	80	27	)	)	PUNCT
dpc-3493	80	28	50.00(0	50.00(0	NUM
dpc-3493	80	29	-	-	PUNCT
dpc-3493	80	30	100	100	NUM
dpc-3493	80	31	)	)	PUNCT
dpc-3493	80	32	pasi	pasi	NOUN
dpc-3493	80	33	improvement	improvement	NOUN
dpc-3493	80	34	during	during	ADP
dpc-3493	80	35	the	the	DET
dpc-3493	80	36	third	third	ADJ
dpc-3493	80	37	month	month	NOUN
dpc-3493	80	38	100±(-150	100±(-150	NUM
dpc-3493	80	39	-	-	SYM
dpc-3493	80	40	100	100	NUM
dpc-3493	80	41	)	)	PUNCT
dpc-3493	80	42	50.00(0	50.00(0	NUM
dpc-3493	80	43	-	-	PUNCT
dpc-3493	80	44	100	100	NUM
dpc-3493	80	45	)	)	PUNCT
dpc-3493	80	46	50.00(0	50.00(0	NUM
dpc-3493	80	47	-	-	PUNCT
dpc-3493	80	48	100	100	NUM
dpc-3493	80	49	)	)	PUNCT
dpc-3493	80	50	50.00(0	50.00(0	NUM
dpc-3493	80	51	-	-	PUNCT
dpc-3493	80	52	100	100	NUM
dpc-3493	80	53	)	)	PUNCT
dpc-3493	80	54	duration	duration	NOUN
dpc-3493	80	55	of	of	ADP
dpc-3493	80	56	the	the	DET
dpc-3493	80	57	disease	disease	NOUN
dpc-3493	80	58	(	(	PUNCT
dpc-3493	80	59	years	year	NOUN
dpc-3493	80	60	)	)	PUNCT
dpc-3493	80	61	,	,	PUNCT
dpc-3493	80	62	mean	mean	VERB
dpc-3493	80	63	±sd	±sd	PRON
dpc-3493	80	64	17.68±10.54	17.68±10.54	SYM
dpc-3493	80	65	9.74±7.77	9.74±7.77	NOUN
dpc-3493	80	66	10.42±7.29	10.42±7.29	NUM
dpc-3493	80	67	8.89±8.33	8.89±8.33	NUM
dpc-3493	80	68	mtx	mtx	NOUN
dpc-3493	80	69	=	=	PUNCT
dpc-3493	80	70	methotrexate	methotrexate	NOUN
dpc-3493	80	71	;	;	PUNCT
dpc-3493	80	72	pasi	pasi	NOUN
dpc-3493	80	73	=	=	SYM
dpc-3493	80	74	psoriasis	psoriasis	NOUN
dpc-3493	80	75	area	area	NOUN
dpc-3493	80	76	and	and	CCONJ
dpc-3493	80	77	severity	severity	NOUN
dpc-3493	80	78	index	index	NOUN
dpc-3493	80	79	;	;	PUNCT
dpc-3493	80	80	sd	sd	NOUN
dpc-3493	80	81	=	=	SYM
dpc-3493	80	82	standard	standard	ADJ
dpc-3493	80	83	deviation	deviation	NOUN
dpc-3493	80	84	.	.	PUNCT
dpc-3493	81	1	4	4	NUM
dpc-3493	81	2	original	original	ADJ
dpc-3493	81	3	article	article	NOUN
dpc-3493	81	4	|	|	ADV
dpc-3493	81	5	dermatol	dermatol	ADJ
dpc-3493	81	6	pract	pract	NOUN
dpc-3493	81	7	concept	concept	NOUN
dpc-3493	81	8	.	.	PUNCT
dpc-3493	82	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	82	2	ta	ta	PART
dpc-3493	82	3	b	b	PROPN
dpc-3493	82	4	le	le	ADP
dpc-3493	82	5	2	2	NUM
dpc-3493	82	6	.	.	PUNCT
dpc-3493	83	1	a	a	DET
dpc-3493	83	2	ge	ge	PROPN
dpc-3493	83	3	,	,	PUNCT
dpc-3493	83	4	b	b	PROPN
dpc-3493	83	5	od	od	NUM
dpc-3493	83	6	y	y	PROPN
dpc-3493	83	7	m	m	ADV
dpc-3493	83	8	as	as	ADP
dpc-3493	83	9	s	s	PRON
dpc-3493	83	10	in	in	ADP
dpc-3493	83	11	de	de	X
dpc-3493	83	12	x	x	X
dpc-3493	83	13	,	,	PUNCT
dpc-3493	83	14	d	d	X
dpc-3493	83	15	ur	ur	INTJ
dpc-3493	83	16	at	at	ADP
dpc-3493	83	17	io	io	PROPN
dpc-3493	83	18	n	n	ADP
dpc-3493	83	19	of	of	ADP
dpc-3493	83	20	d	d	PROPN
dpc-3493	83	21	is	be	AUX
dpc-3493	83	22	ea	ea	X
dpc-3493	83	23	se	se	X
dpc-3493	83	24	a	a	PRON
dpc-3493	83	25	nd	nd	NOUN
dpc-3493	83	26	p	p	NOUN
dpc-3493	83	27	so	so	ADV
dpc-3493	83	28	ri	ri	PROPN
dpc-3493	83	29	as	as	SCONJ
dpc-3493	83	30	is	be	AUX
dpc-3493	83	31	a	a	PRON
dpc-3493	83	32	re	re	NOUN
dpc-3493	83	33	a	a	DET
dpc-3493	83	34	an	an	PROPN
dpc-3493	83	35	d	d	X
dpc-3493	83	36	se	se	X
dpc-3493	83	37	ve	ve	VERB
dpc-3493	83	38	ri	ri	INTJ
dpc-3493	84	1	ty	ty	INTJ
dpc-3493	84	2	i	i	PRON
dpc-3493	84	3	nd	nd	INTJ
dpc-3493	84	4	ex	ex	VERB
dpc-3493	85	1	i	i	PRON
dpc-3493	85	2	m	m	VERB
dpc-3493	85	3	pr	pr	INTJ
dpc-3493	85	4	ov	ov	INTJ
dpc-3493	85	5	em	em	PRON
dpc-3493	85	6	en	en	ADV
dpc-3493	85	7	ts	ts	X
dpc-3493	85	8	in	in	ADP
dpc-3493	85	9	p	p	NOUN
dpc-3493	85	10	at	at	ADP
dpc-3493	85	11	ie	ie	X
dpc-3493	85	12	nt	not	PART
dpc-3493	85	13	s	s	PART
dpc-3493	85	14	re	re	VERB
dpc-3493	85	15	ce	ce	PROPN
dpc-3493	85	16	iv	iv	NUM
dpc-3493	85	17	in	in	ADP
dpc-3493	85	18	g	g	PROPN
dpc-3493	85	19	bi	bi	NOUN
dpc-3493	85	20	ol	ol	PROPN
dpc-3493	86	1	og	og	PROPN
dpc-3493	86	2	ic	ic	PROPN
dpc-3493	86	3	a	a	DET
dpc-3493	86	4	ge	ge	PROPN
dpc-3493	86	5	nt	nt	PROPN
dpc-3493	86	6	s.	s.	PROPN
dpc-3493	87	1	c	c	PROPN
dpc-3493	87	2	o	o	PROPN
dpc-3493	87	3	n	n	CCONJ
dpc-3493	87	4	ti	ti	NOUN
dpc-3493	87	5	n	n	CCONJ
dpc-3493	87	6	u	u	NOUN
dpc-3493	87	7	o	o	X
dpc-3493	87	8	u	u	NOUN
dpc-3493	87	9	s	s	PROPN
dpc-3493	87	10	v	v	NUM
dpc-3493	87	11	ar	ar	PROPN
dpc-3493	87	12	ia	ia	PROPN
dpc-3493	87	13	b	b	PROPN
dpc-3493	87	14	le	le	PROPN
dpc-3493	87	15	s	s	PROPN
dpc-3493	87	16	a	a	DET
dpc-3493	87	17	d	d	PROPN
dpc-3493	87	18	a	a	DET
dpc-3493	87	19	li	li	PROPN
dpc-3493	87	20	m	m	VERB
dpc-3493	87	21	u	u	NOUN
dpc-3493	87	22	m	m	PROPN
dpc-3493	87	23	a	a	DET
dpc-3493	87	24	b	b	PROPN
dpc-3493	87	25	(	(	PUNCT
dpc-3493	87	26	n	n	NOUN
dpc-3493	87	27	=	=	SYM
dpc-3493	87	28	3	3	NUM
dpc-3493	87	29	9	9	NUM
dpc-3493	87	30	)	)	PUNCT
dpc-3493	87	31	et	et	NOUN
dpc-3493	87	32	a	a	PRON
dpc-3493	87	33	n	n	INTJ
dpc-3493	87	34	er	er	INTJ
dpc-3493	87	35	c	c	PROPN
dpc-3493	87	36	ep	ep	PROPN
dpc-3493	87	37	t	t	PROPN
dpc-3493	87	38	(	(	PUNCT
dpc-3493	87	39	n	n	NOUN
dpc-3493	87	40	=	=	SYM
dpc-3493	87	41	1	1	NUM
dpc-3493	87	42	0	0	NUM
dpc-3493	87	43	)	)	PUNCT
dpc-3493	87	44	in	in	ADP
dpc-3493	87	45	fl	fl	PRON
dpc-3493	87	46	ix	ix	INTJ
dpc-3493	88	1	i	i	PRON
dpc-3493	88	2	m	m	VERB
dpc-3493	88	3	a	a	DET
dpc-3493	88	4	b	b	PROPN
dpc-3493	88	5	(	(	PUNCT
dpc-3493	88	6	n	n	NOUN
dpc-3493	88	7	=	=	SYM
dpc-3493	88	8	1	1	NUM
dpc-3493	88	9	4	4	NUM
dpc-3493	88	10	)	)	PUNCT
dpc-3493	89	1	se	se	ADP
dpc-3493	90	1	r	r	NOUN
dpc-3493	90	2	to	to	ADP
dpc-3493	90	3	li	li	PROPN
dpc-3493	90	4	zu	zu	PROPN
dpc-3493	90	5	m	m	PROPN
dpc-3493	90	6	a	a	DET
dpc-3493	90	7	b	b	NOUN
dpc-3493	90	8	pe	pe	INTJ
dpc-3493	90	9	g	g	NOUN
dpc-3493	90	10	o	o	PROPN
dpc-3493	90	11	l	l	NOUN
dpc-3493	90	12	(	(	PUNCT
dpc-3493	90	13	n	n	NOUN
dpc-3493	90	14	=	=	SYM
dpc-3493	90	15	1	1	NUM
dpc-3493	90	16	0	0	NUM
dpc-3493	90	17	)	)	PUNCT
dpc-3493	90	18	u	u	PROPN
dpc-3493	90	19	st	st	PROPN
dpc-3493	90	20	ek	ek	PROPN
dpc-3493	90	21	in	in	ADP
dpc-3493	90	22	u	u	PROPN
dpc-3493	90	23	m	m	PROPN
dpc-3493	90	24	a	a	DET
dpc-3493	90	25	b	b	PROPN
dpc-3493	90	26	(	(	PUNCT
dpc-3493	90	27	n	n	NOUN
dpc-3493	90	28	=	=	SYM
dpc-3493	90	29	5	5	NUM
dpc-3493	90	30	6	6	NUM
dpc-3493	90	31	)	)	PUNCT
dpc-3493	90	32	se	se	X
dpc-3493	91	1	c	c	PROPN
dpc-3493	91	2	u	u	PROPN
dpc-3493	91	3	k	k	PROPN
dpc-3493	91	4	in	in	ADP
dpc-3493	91	5	u	u	PROPN
dpc-3493	91	6	m	m	VERB
dpc-3493	91	7	a	a	DET
dpc-3493	91	8	b	b	PROPN
dpc-3493	91	9	(	(	PUNCT
dpc-3493	91	10	n	n	NOUN
dpc-3493	91	11	=	=	SYM
dpc-3493	91	12	5	5	NUM
dpc-3493	91	13	9	9	NUM
dpc-3493	91	14	)	)	PUNCT
dpc-3493	91	15	ix	ix	ADP
dpc-3493	91	16	ek	ek	NOUN
dpc-3493	92	1	iz	iz	INTJ
dpc-3493	92	2	u	u	VERB
dpc-3493	92	3	m	m	VERB
dpc-3493	92	4	a	a	DET
dpc-3493	92	5	b	b	PROPN
dpc-3493	92	6	(	(	PUNCT
dpc-3493	92	7	n	n	NOUN
dpc-3493	92	8	=	=	SYM
dpc-3493	92	9	1	1	NUM
dpc-3493	92	10	6	6	NUM
dpc-3493	92	11	)	)	PUNCT
dpc-3493	92	12	r	r	NOUN
dpc-3493	92	13	is	be	AUX
dpc-3493	92	14	a	a	DET
dpc-3493	92	15	n	n	ADV
dpc-3493	93	1	k	k	NOUN
dpc-3493	93	2	iz	iz	INTJ
dpc-3493	93	3	u	u	VERB
dpc-3493	93	4	m	m	VERB
dpc-3493	93	5	a	a	DET
dpc-3493	93	6	b	b	PROPN
dpc-3493	93	7	(	(	PUNCT
dpc-3493	93	8	n	n	NOUN
dpc-3493	93	9	=	=	SYM
dpc-3493	93	10	1	1	NUM
dpc-3493	93	11	0	0	NUM
dpc-3493	93	12	)	)	PUNCT
dpc-3493	93	13	g	g	PROPN
dpc-3493	93	14	u	u	PROPN
dpc-3493	93	15	se	se	PROPN
dpc-3493	93	16	lk	lk	PROPN
dpc-3493	93	17	u	u	PROPN
dpc-3493	93	18	m	m	PROPN
dpc-3493	93	19	a	a	DET
dpc-3493	93	20	b	b	PROPN
dpc-3493	93	21	(	(	PUNCT
dpc-3493	93	22	n	n	NOUN
dpc-3493	93	23	=	=	SYM
dpc-3493	93	24	8	8	NUM
dpc-3493	93	25	)	)	PUNCT
dpc-3493	93	26	a	a	DET
dpc-3493	93	27	ge	ge	PROPN
dpc-3493	93	28	(	(	PUNCT
dpc-3493	93	29	ye	ye	PROPN
dpc-3493	93	30	ar	ar	PROPN
dpc-3493	93	31	s	s	PROPN
dpc-3493	93	32	)	)	PUNCT
dpc-3493	93	33	m	m	VERB
dpc-3493	93	34	ea	ea	NOUN
dpc-3493	93	35	n	n	PROPN
dpc-3493	93	36	±s	±s	PRON
dpc-3493	93	37	d	d	PROPN
dpc-3493	93	38	49	49	NUM
dpc-3493	93	39	.6	.6	NUM
dpc-3493	93	40	9±	9±	NUM
dpc-3493	93	41	12	12	NUM
dpc-3493	94	1	.4	.4	NUM
dpc-3493	94	2	9	9	NUM
dpc-3493	94	3	45	45	NUM
dpc-3493	94	4	.9	.9	NUM
dpc-3493	94	5	0±	0±	NUM
dpc-3493	94	6	11	11	NUM
dpc-3493	94	7	.8	.8	PROPN
dpc-3493	94	8	6	6	NUM
dpc-3493	94	9	48	48	NUM
dpc-3493	94	10	.0	.0	NUM
dpc-3493	94	11	7±	7±	NUM
dpc-3493	94	12	10	10	NUM
dpc-3493	94	13	.3	.3	NUM
dpc-3493	94	14	5	5	NUM
dpc-3493	94	15	43	43	NUM
dpc-3493	94	16	.0	.0	NUM
dpc-3493	94	17	0±	0±	NOUN
dpc-3493	94	18	16	16	NUM
dpc-3493	94	19	.5	.5	NUM
dpc-3493	94	20	0	0	NUM
dpc-3493	95	1	47	47	NUM
dpc-3493	95	2	.9	.9	NUM
dpc-3493	95	3	1±	1±	NUM
dpc-3493	95	4	10	10	NUM
dpc-3493	95	5	.8	.8	NUM
dpc-3493	95	6	3	3	NUM
dpc-3493	95	7	47	47	NUM
dpc-3493	95	8	.4	.4	NUM
dpc-3493	95	9	7±	7±	NUM
dpc-3493	95	10	10	10	NUM
dpc-3493	95	11	.3	.3	NUM
dpc-3493	95	12	0	0	NUM
dpc-3493	96	1	49	49	NUM
dpc-3493	97	1	.0	.0	NUM
dpc-3493	98	1	0±	0±	NOUN
dpc-3493	99	1	9	9	NUM
dpc-3493	99	2	.	.	NOUN
dpc-3493	99	3	64	64	NUM
dpc-3493	99	4	46	46	NUM
dpc-3493	99	5	.5	.5	NUM
dpc-3493	100	1	0±	0±	NOUN
dpc-3493	100	2	6	6	NUM
dpc-3493	100	3	.	.	NOUN
dpc-3493	100	4	98	98	NUM
dpc-3493	100	5	41	41	NUM
dpc-3493	100	6	.6	.6	NUM
dpc-3493	100	7	3±	3±	NUM
dpc-3493	100	8	8	8	NUM
dpc-3493	100	9	.	.	PUNCT
dpc-3493	101	1	78	78	NUM
dpc-3493	101	2	b	b	X
dpc-3493	101	3	od	od	NUM
dpc-3493	101	4	y	y	NOUN
dpc-3493	101	5	m	m	ADV
dpc-3493	101	6	as	as	ADP
dpc-3493	101	7	s	s	PRON
dpc-3493	101	8	in	in	ADP
dpc-3493	101	9	de	de	X
dpc-3493	101	10	x	x	X
dpc-3493	101	11	m	m	PROPN
dpc-3493	101	12	ea	ea	NOUN
dpc-3493	101	13	n	n	PROPN
dpc-3493	101	14	±s	±s	PRON
dpc-3493	101	15	d	d	NUM
dpc-3493	101	16	27	27	NUM
dpc-3493	101	17	.4	.4	NUM
dpc-3493	101	18	6±	6±	NUM
dpc-3493	101	19	4	4	NUM
dpc-3493	101	20	.	.	NUM
dpc-3493	101	21	89	89	NUM
dpc-3493	101	22	27	27	NUM
dpc-3493	101	23	.1	.1	NUM
dpc-3493	101	24	9±	9±	NUM
dpc-3493	101	25	3	3	X
dpc-3493	101	26	.	.	NOUN
dpc-3493	101	27	19	19	NUM
dpc-3493	101	28	28	28	NUM
dpc-3493	101	29	.0	.0	NUM
dpc-3493	101	30	7±	7±	NUM
dpc-3493	101	31	6	6	NUM
dpc-3493	101	32	.	.	NOUN
dpc-3493	101	33	27	27	NUM
dpc-3493	101	34	29	29	NUM
dpc-3493	101	35	.8	.8	NUM
dpc-3493	101	36	4±	4±	PROPN
dpc-3493	101	37	6	6	NUM
dpc-3493	101	38	.	.	X
dpc-3493	101	39	14	14	NUM
dpc-3493	101	40	28	28	NUM
dpc-3493	101	41	.7	.7	NUM
dpc-3493	101	42	4±	4±	PROPN
dpc-3493	101	43	6	6	NUM
dpc-3493	101	44	.	.	SYM
dpc-3493	101	45	24	24	NUM
dpc-3493	101	46	27	27	NUM
dpc-3493	101	47	.6	.6	NUM
dpc-3493	101	48	4±	4±	PROPN
dpc-3493	101	49	4	4	NUM
dpc-3493	101	50	.	.	SYM
dpc-3493	102	1	34	34	NUM
dpc-3493	102	2	30	30	NUM
dpc-3493	102	3	.0	.0	NUM
dpc-3493	102	4	3±	3±	NUM
dpc-3493	102	5	6	6	NUM
dpc-3493	102	6	.	.	NOUN
dpc-3493	102	7	46	46	NUM
dpc-3493	102	8	27	27	NUM
dpc-3493	102	9	.4	.4	NUM
dpc-3493	102	10	1±	1±	NUM
dpc-3493	102	11	4	4	NUM
dpc-3493	102	12	.	.	NOUN
dpc-3493	102	13	90	90	NUM
dpc-3493	102	14	26	26	NUM
dpc-3493	102	15	.2	.2	NUM
dpc-3493	102	16	6±	6±	NUM
dpc-3493	102	17	3	3	NUM
dpc-3493	102	18	.	.	NUM
dpc-3493	102	19	94	94	NUM
dpc-3493	103	1	pa	pa	NOUN
dpc-3493	103	2	si	si	PROPN
dpc-3493	104	1	i	i	PRON
dpc-3493	104	2	m	m	VERB
dpc-3493	104	3	pr	pr	INTJ
dpc-3493	104	4	ov	ov	INTJ
dpc-3493	104	5	em	em	PRON
dpc-3493	104	6	en	en	PROPN
dpc-3493	104	7	t	t	PROPN
dpc-3493	104	8	du	du	PROPN
dpc-3493	104	9	ri	ri	PROPN
dpc-3493	104	10	ng	ng	PROPN
dpc-3493	104	11	t	t	PROPN
dpc-3493	105	1	he	he	PRON
dpc-3493	105	2	fi	fi	INTJ
dpc-3493	105	3	rs	rs	INTJ
dpc-3493	105	4	t	t	PROPN
dpc-3493	105	5	m	m	VERB
dpc-3493	105	6	on	on	ADP
dpc-3493	105	7	th	th	NUM
dpc-3493	105	8	75	75	NUM
dpc-3493	105	9	.0	.0	NUM
dpc-3493	105	10	0	0	PUNCT
dpc-3493	106	1	(	(	PUNCT
dpc-3493	106	2	10	10	NUM
dpc-3493	106	3	010	010	NUM
dpc-3493	106	4	0	0	NUM
dpc-3493	106	5	)	)	PUNCT
dpc-3493	106	6	50	50	NUM
dpc-3493	106	7	.0	.0	NUM
dpc-3493	106	8	0	0	NUM
dpc-3493	106	9	(	(	PUNCT
dpc-3493	106	10	075	075	NUM
dpc-3493	106	11	)	)	PUNCT
dpc-3493	106	12	55	55	NUM
dpc-3493	106	13	.0	.0	NUM
dpc-3493	106	14	0	0	PUNCT
dpc-3493	106	15	(	(	PUNCT
dpc-3493	106	16	15	15	NUM
dpc-3493	106	17	010	010	NUM
dpc-3493	106	18	0	0	NUM
dpc-3493	106	19	)	)	PUNCT
dpc-3493	106	20	61	61	NUM
dpc-3493	106	21	.9	.9	NUM
dpc-3493	106	22	0	0	PUNCT
dpc-3493	107	1	(	(	PUNCT
dpc-3493	107	2	2	2	NUM
dpc-3493	107	3	510	510	NUM
dpc-3493	107	4	0	0	NUM
dpc-3493	107	5	)	)	PUNCT
dpc-3493	107	6	66	66	NUM
dpc-3493	107	7	.6	.6	NUM
dpc-3493	107	8	7	7	NUM
dpc-3493	107	9	(	(	PUNCT
dpc-3493	107	10	50	50	NUM
dpc-3493	107	11	-1	-1	NUM
dpc-3493	107	12	00	00	NUM
dpc-3493	107	13	)	)	PUNCT
dpc-3493	107	14	71	71	NUM
dpc-3493	108	1	.4	.4	NUM
dpc-3493	108	2	3	3	NUM
dpc-3493	108	3	(	(	PUNCT
dpc-3493	108	4	0	0	NUM
dpc-3493	108	5	-1	-1	NUM
dpc-3493	108	6	00	00	NUM
dpc-3493	108	7	)	)	PUNCT
dpc-3493	108	8	83	83	NUM
dpc-3493	109	1	.9	.9	NUM
dpc-3493	109	2	7	7	NUM
dpc-3493	109	3	(	(	PUNCT
dpc-3493	109	4	3	3	NUM
dpc-3493	109	5	310	310	NUM
dpc-3493	109	6	0	0	NUM
dpc-3493	109	7	)	)	PUNCT
dpc-3493	109	8	30	30	NUM
dpc-3493	109	9	.9	.9	NUM
dpc-3493	109	10	5	5	NUM
dpc-3493	109	11	(	(	PUNCT
dpc-3493	109	12	0	0	NUM
dpc-3493	109	13	-1	-1	NUM
dpc-3493	109	14	00	00	NUM
dpc-3493	109	15	)	)	PUNCT
dpc-3493	109	16	50	50	NUM
dpc-3493	109	17	(	(	PUNCT
dpc-3493	109	18	25	25	NUM
dpc-3493	109	19	-1	-1	NUM
dpc-3493	109	20	00	00	PUNCT
dpc-3493	109	21	)	)	PUNCT
dpc-3493	110	1	pa	pa	NOUN
dpc-3493	110	2	si	si	PROPN
dpc-3493	111	1	i	i	PRON
dpc-3493	111	2	m	m	VERB
dpc-3493	111	3	pr	pr	INTJ
dpc-3493	111	4	ov	ov	INTJ
dpc-3493	111	5	em	em	PRON
dpc-3493	111	6	en	en	PROPN
dpc-3493	112	1	t	t	PROPN
dpc-3493	112	2	du	du	PROPN
dpc-3493	112	3	ri	ri	PROPN
dpc-3493	112	4	ng	ng	PROPN
dpc-3493	112	5	t	t	PROPN
dpc-3493	113	1	he	he	PRON
dpc-3493	113	2	t	t	PROPN
dpc-3493	113	3	hi	hi	INTJ
dpc-3493	113	4	rd	rd	PROPN
dpc-3493	113	5	m	m	PROPN
dpc-3493	113	6	on	on	ADP
dpc-3493	113	7	th	th	NUM
dpc-3493	113	8	10	10	NUM
dpc-3493	113	9	0	0	NUM
dpc-3493	113	10	(	(	PUNCT
dpc-3493	113	11	10	10	NUM
dpc-3493	113	12	010	010	NUM
dpc-3493	113	13	0	0	NUM
dpc-3493	113	14	)	)	PUNCT
dpc-3493	113	15	66	66	NUM
dpc-3493	114	1	.6	.6	NUM
dpc-3493	114	2	7	7	NUM
dpc-3493	114	3	(	(	PUNCT
dpc-3493	114	4	0	0	NUM
dpc-3493	114	5	-1	-1	NUM
dpc-3493	114	6	00	00	NUM
dpc-3493	114	7	)	)	PUNCT
dpc-3493	114	8	56	56	NUM
dpc-3493	114	9	.2	.2	NUM
dpc-3493	114	10	5	5	NUM
dpc-3493	114	11	(	(	PUNCT
dpc-3493	114	12	15	15	NUM
dpc-3493	114	13	010	010	NUM
dpc-3493	114	14	0	0	NUM
dpc-3493	114	15	)	)	PUNCT
dpc-3493	114	16	72	72	NUM
dpc-3493	114	17	.5	.5	NUM
dpc-3493	114	18	0	0	PUNCT
dpc-3493	114	19	(	(	PUNCT
dpc-3493	114	20	2	2	NUM
dpc-3493	114	21	510	510	NUM
dpc-3493	114	22	0	0	NUM
dpc-3493	114	23	)	)	PUNCT
dpc-3493	114	24	10	10	NUM
dpc-3493	114	25	0	0	NUM
dpc-3493	114	26	(	(	PUNCT
dpc-3493	114	27	10	10	NUM
dpc-3493	114	28	010	010	NUM
dpc-3493	114	29	0	0	NUM
dpc-3493	114	30	)	)	PUNCT
dpc-3493	114	31	10	10	NUM
dpc-3493	114	32	0	0	NUM
dpc-3493	114	33	(	(	PUNCT
dpc-3493	114	34	10	10	NUM
dpc-3493	114	35	010	010	NUM
dpc-3493	114	36	0	0	NUM
dpc-3493	114	37	)	)	PUNCT
dpc-3493	114	38	10	10	NUM
dpc-3493	114	39	0	0	NUM
dpc-3493	114	40	(	(	PUNCT
dpc-3493	114	41	3	3	NUM
dpc-3493	114	42	310	310	NUM
dpc-3493	114	43	0	0	NUM
dpc-3493	114	44	)	)	PUNCT
dpc-3493	114	45	60	60	NUM
dpc-3493	114	46	.7	.7	NUM
dpc-3493	114	47	1	1	NUM
dpc-3493	114	48	(	(	PUNCT
dpc-3493	114	49	0	0	NUM
dpc-3493	114	50	-1	-1	NUM
dpc-3493	114	51	00	00	PUNCT
dpc-3493	114	52	)	)	PUNCT
dpc-3493	114	53	70	70	NUM
dpc-3493	114	54	.8	.8	NUM
dpc-3493	114	55	3	3	NUM
dpc-3493	114	56	(	(	PUNCT
dpc-3493	114	57	5	5	NUM
dpc-3493	114	58	010	010	NUM
dpc-3493	114	59	0	0	NUM
dpc-3493	114	60	)	)	PUNCT
dpc-3493	115	1	d	d	NOUN
dpc-3493	115	2	ur	ur	INTJ
dpc-3493	115	3	at	at	ADP
dpc-3493	115	4	io	io	PROPN
dpc-3493	115	5	n	n	ADP
dpc-3493	115	6	of	of	ADP
dpc-3493	115	7	t	t	PROPN
dpc-3493	115	8	he	he	PRON
dpc-3493	115	9	di	di	X
dpc-3493	115	10	se	se	PROPN
dpc-3493	115	11	as	as	SCONJ
dpc-3493	115	12	e	e	PROPN
dpc-3493	115	13	(	(	PUNCT
dpc-3493	115	14	y	y	PROPN
dpc-3493	115	15	ea	ea	PROPN
dpc-3493	115	16	rs	rs	PROPN
dpc-3493	115	17	)	)	PUNCT
dpc-3493	115	18	m	m	VERB
dpc-3493	115	19	ea	ea	NOUN
dpc-3493	115	20	n	n	PROPN
dpc-3493	115	21	±s	±s	PRON
dpc-3493	115	22	d	d	PROPN
dpc-3493	115	23	20	20	NUM
dpc-3493	115	24	.8	.8	NUM
dpc-3493	115	25	5±	5±	NUM
dpc-3493	115	26	13	13	NUM
dpc-3493	115	27	.9	.9	NUM
dpc-3493	115	28	4	4	NUM
dpc-3493	115	29	18	18	NUM
dpc-3493	115	30	.4	.4	NUM
dpc-3493	115	31	0±	0±	NUM
dpc-3493	115	32	8	8	NUM
dpc-3493	115	33	.	.	X
dpc-3493	115	34	89	89	NUM
dpc-3493	115	35	16	16	NUM
dpc-3493	115	36	.2	.2	NUM
dpc-3493	115	37	1±	1±	NUM
dpc-3493	115	38	8	8	NUM
dpc-3493	115	39	.	.	X
dpc-3493	115	40	88	88	NUM
dpc-3493	115	41	17	17	NUM
dpc-3493	115	42	.0	.0	NUM
dpc-3493	115	43	0±	0±	NOUN
dpc-3493	115	44	10	10	NUM
dpc-3493	115	45	.7	.7	NUM
dpc-3493	115	46	2	2	NUM
dpc-3493	115	47	16	16	NUM
dpc-3493	115	48	.8	.8	NUM
dpc-3493	115	49	8±	8±	NUM
dpc-3493	115	50	10	10	NUM
dpc-3493	115	51	.1	.1	NUM
dpc-3493	115	52	3	3	NUM
dpc-3493	115	53	18	18	NUM
dpc-3493	115	54	.9	.9	NUM
dpc-3493	115	55	7±	7±	NUM
dpc-3493	115	56	10	10	NUM
dpc-3493	115	57	.3	.3	NUM
dpc-3493	115	58	2	2	NUM
dpc-3493	115	59	14	14	NUM
dpc-3493	115	60	.8	.8	NUM
dpc-3493	115	61	1±	1±	NUM
dpc-3493	115	62	6	6	NUM
dpc-3493	115	63	.	.	PUNCT
dpc-3493	115	64	94	94	NUM
dpc-3493	116	1	12	12	NUM
dpc-3493	116	2	.6	.6	NUM
dpc-3493	116	3	0±	0±	NUM
dpc-3493	116	4	6	6	NUM
dpc-3493	116	5	.	.	PUNCT
dpc-3493	117	1	62	62	NUM
dpc-3493	117	2	13	13	NUM
dpc-3493	117	3	.0	.0	NUM
dpc-3493	117	4	0±	0±	NOUN
dpc-3493	117	5	6	6	NUM
dpc-3493	117	6	.	.	SYM
dpc-3493	117	7	67	67	NUM
dpc-3493	118	1	pa	pa	NOUN
dpc-3493	118	2	si	si	PROPN
dpc-3493	118	3	=	=	NOUN
dpc-3493	118	4	p	p	PROPN
dpc-3493	118	5	so	so	ADV
dpc-3493	118	6	ri	ri	PROPN
dpc-3493	118	7	as	as	SCONJ
dpc-3493	118	8	is	be	AUX
dpc-3493	118	9	a	a	PRON
dpc-3493	118	10	re	re	NOUN
dpc-3493	118	11	a	a	DET
dpc-3493	118	12	an	an	PROPN
dpc-3493	118	13	d	d	X
dpc-3493	118	14	se	se	X
dpc-3493	118	15	ve	ve	VERB
dpc-3493	118	16	ri	ri	INTJ
dpc-3493	119	1	ty	ty	INTJ
dpc-3493	119	2	i	i	PRON
dpc-3493	119	3	nd	nd	ADV
dpc-3493	119	4	ex	ex	X
dpc-3493	119	5	;	;	PUNCT
dpc-3493	119	6	s	s	X
dpc-3493	119	7	d	d	NOUN
dpc-3493	119	8	=	=	SYM
dpc-3493	119	9	s	s	PROPN
dpc-3493	119	10	ta	ta	PROPN
dpc-3493	119	11	nd	nd	INTJ
dpc-3493	119	12	ar	ar	PROPN
dpc-3493	119	13	d	d	PROPN
dpc-3493	119	14	de	de	X
dpc-3493	119	15	vi	vi	PROPN
dpc-3493	119	16	at	at	ADP
dpc-3493	119	17	io	io	X
dpc-3493	119	18	n.	n.	PROPN
dpc-3493	119	19	original	original	ADJ
dpc-3493	119	20	article	article	NOUN
dpc-3493	119	21	|	|	ADV
dpc-3493	120	1	dermatol	dermatol	ADJ
dpc-3493	120	2	pract	pract	NOUN
dpc-3493	120	3	concept	concept	NOUN
dpc-3493	120	4	.	.	PUNCT
dpc-3493	121	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	121	2	5	5	NUM
dpc-3493	121	3	table	table	NOUN
dpc-3493	121	4	3	3	NUM
dpc-3493	121	5	.	.	PUNCT
dpc-3493	122	1	the	the	DET
dpc-3493	122	2	percentages	percentage	NOUN
dpc-3493	122	3	of	of	ADP
dpc-3493	122	4	patients	patient	NOUN
dpc-3493	122	5	are	be	AUX
dpc-3493	122	6	shown	show	VERB
dpc-3493	122	7	according	accord	VERB
dpc-3493	122	8	to	to	ADP
dpc-3493	122	9	obesity	obesity	NOUN
dpc-3493	122	10	,	,	PUNCT
dpc-3493	122	11	smoking	smoking	NOUN
dpc-3493	122	12	,	,	PUNCT
dpc-3493	122	13	psychiatric	psychiatric	ADJ
dpc-3493	122	14	disease	disease	NOUN
dpc-3493	122	15	,	,	PUNCT
dpc-3493	122	16	joint	joint	ADJ
dpc-3493	122	17	involvement	involvement	NOUN
dpc-3493	122	18	and	and	CCONJ
dpc-3493	122	19	pruritus	pruritus	PROPN
dpc-3493	122	20	(	(	PUNCT
dpc-3493	122	21	percentages	percentage	NOUN
dpc-3493	122	22	related	relate	VERB
dpc-3493	122	23	to	to	ADP
dpc-3493	122	24	the	the	DET
dpc-3493	122	25	switching	switching	NOUN
dpc-3493	122	26	of	of	ADP
dpc-3493	122	27	drugs	drug	NOUN
dpc-3493	122	28	are	be	AUX
dpc-3493	122	29	also	also	ADV
dpc-3493	122	30	shown	show	VERB
dpc-3493	122	31	in	in	ADP
dpc-3493	122	32	the	the	DET
dpc-3493	122	33	table	table	NOUN
dpc-3493	122	34	)	)	PUNCT
dpc-3493	122	35	.	.	PUNCT
dpc-3493	123	1	obesity	obesity	NOUN
dpc-3493	123	2	switch	switch	NOUN
dpc-3493	123	3	smoking	smoke	VERB
dpc-3493	123	4	phsychiatric	phsychiatric	ADJ
dpc-3493	123	5	disease	disease	NOUN
dpc-3493	123	6	joint	joint	ADJ
dpc-3493	123	7	involvement	involvement	NOUN
dpc-3493	123	8	pruritis	pruritis	ADJ
dpc-3493	123	9	total	total	NOUN
dpc-3493	123	10	(	(	PUNCT
dpc-3493	123	11	biologic	biologic	NOUN
dpc-3493	123	12	)	)	PUNCT
dpc-3493	123	13	28.6	28.6	NUM
dpc-3493	123	14	%	%	NOUN
dpc-3493	123	15	(	(	PUNCT
dpc-3493	123	16	n=65	n=65	NOUN
dpc-3493	123	17	)	)	PUNCT
dpc-3493	123	18	23.7	23.7	NUM
dpc-3493	123	19	%	%	NOUN
dpc-3493	123	20	(	(	PUNCT
dpc-3493	123	21	n=77	n=77	NOUN
dpc-3493	123	22	)	)	PUNCT
dpc-3493	123	23	53.6	53.6	NUM
dpc-3493	123	24	%	%	NOUN
dpc-3493	123	25	(	(	PUNCT
dpc-3493	123	26	n=119	n=119	PROPN
dpc-3493	123	27	)	)	PUNCT
dpc-3493	123	28	16.7	16.7	NUM
dpc-3493	123	29	%	%	NOUN
dpc-3493	123	30	(	(	PUNCT
dpc-3493	123	31	n=37	n=37	PROPN
dpc-3493	123	32	)	)	PUNCT
dpc-3493	123	33	31.9	31.9	NUM
dpc-3493	123	34	%	%	NOUN
dpc-3493	123	35	(	(	PUNCT
dpc-3493	123	36	n=71	n=71	NOUN
dpc-3493	123	37	)	)	PUNCT
dpc-3493	123	38	77.0	77.0	NUM
dpc-3493	123	39	%	%	NOUN
dpc-3493	123	40	(	(	PUNCT
dpc-3493	123	41	n=171	n=171	NOUN
dpc-3493	123	42	)	)	PUNCT
dpc-3493	123	43	adalimumab	adalimumab	NOUN
dpc-3493	123	44	25.6	25.6	NUM
dpc-3493	123	45	%	%	NOUN
dpc-3493	123	46	(	(	PUNCT
dpc-3493	123	47	n=10	n=10	NOUN
dpc-3493	123	48	)	)	PUNCT
dpc-3493	123	49	17.9	17.9	NUM
dpc-3493	123	50	%	%	NOUN
dpc-3493	123	51	(	(	PUNCT
dpc-3493	123	52	n=7	n=7	PROPN
dpc-3493	123	53	)	)	PUNCT
dpc-3493	123	54	53.8	53.8	NUM
dpc-3493	123	55	%	%	NOUN
dpc-3493	123	56	(	(	PUNCT
dpc-3493	123	57	n=21	n=21	NOUN
dpc-3493	123	58	)	)	PUNCT
dpc-3493	123	59	15.4	15.4	NUM
dpc-3493	123	60	%	%	NOUN
dpc-3493	123	61	(	(	PUNCT
dpc-3493	123	62	n=6	n=6	NOUN
dpc-3493	123	63	)	)	PUNCT
dpc-3493	123	64	34.2	34.2	NUM
dpc-3493	123	65	%	%	NOUN
dpc-3493	123	66	(	(	PUNCT
dpc-3493	123	67	n=13	n=13	NOUN
dpc-3493	123	68	)	)	PUNCT
dpc-3493	123	69	74.4	74.4	NUM
dpc-3493	123	70	%	%	NOUN
dpc-3493	123	71	(	(	PUNCT
dpc-3493	123	72	n=29	n=29	NOUN
dpc-3493	123	73	)	)	PUNCT
dpc-3493	123	74	etanercept	etanercept	VERB
dpc-3493	123	75	20.0	20.0	NUM
dpc-3493	123	76	%	%	NOUN
dpc-3493	123	77	(	(	PUNCT
dpc-3493	123	78	n=2	n=2	ADV
dpc-3493	123	79	)	)	PUNCT
dpc-3493	123	80	20.0	20.0	NUM
dpc-3493	123	81	%	%	NOUN
dpc-3493	123	82	(	(	PUNCT
dpc-3493	123	83	n=2	n=2	ADV
dpc-3493	123	84	)	)	PUNCT
dpc-3493	123	85	50.0	50.0	NUM
dpc-3493	123	86	%	%	NOUN
dpc-3493	123	87	(	(	PUNCT
dpc-3493	123	88	n=5	n=5	PROPN
dpc-3493	123	89	)	)	PUNCT
dpc-3493	123	90	0.0	0.0	NUM
dpc-3493	123	91	%	%	NOUN
dpc-3493	123	92	(	(	PUNCT
dpc-3493	123	93	n=0	n=0	NUM
dpc-3493	123	94	)	)	PUNCT
dpc-3493	123	95	44.4	44.4	NUM
dpc-3493	123	96	%	%	NOUN
dpc-3493	123	97	(	(	PUNCT
dpc-3493	123	98	n=4	n=4	NOUN
dpc-3493	123	99	)	)	PUNCT
dpc-3493	123	100	70.0	70.0	NUM
dpc-3493	123	101	%	%	NOUN
dpc-3493	123	102	(	(	PUNCT
dpc-3493	123	103	n=7	n=7	PROPN
dpc-3493	123	104	)	)	PUNCT
dpc-3493	123	105	infliximab	infliximab	NOUN
dpc-3493	123	106	28.6	28.6	NUM
dpc-3493	123	107	%	%	NOUN
dpc-3493	123	108	(	(	PUNCT
dpc-3493	123	109	n=4	n=4	NOUN
dpc-3493	123	110	)	)	PUNCT
dpc-3493	123	111	21.4	21.4	NUM
dpc-3493	123	112	%	%	NOUN
dpc-3493	123	113	(	(	PUNCT
dpc-3493	123	114	n=3	n=3	NOUN
dpc-3493	123	115	)	)	PUNCT
dpc-3493	123	116	57.1	57.1	NUM
dpc-3493	123	117	%	%	NOUN
dpc-3493	123	118	(	(	PUNCT
dpc-3493	123	119	n=8	n=8	NUM
dpc-3493	123	120	)	)	PUNCT
dpc-3493	123	121	21.4	21.4	NUM
dpc-3493	123	122	%	%	NOUN
dpc-3493	123	123	(	(	PUNCT
dpc-3493	123	124	n=3	n=3	NOUN
dpc-3493	123	125	)	)	PUNCT
dpc-3493	123	126	42.9	42.9	NUM
dpc-3493	123	127	%	%	NOUN
dpc-3493	123	128	(	(	PUNCT
dpc-3493	123	129	n=6	n=6	NOUN
dpc-3493	123	130	)	)	PUNCT
dpc-3493	123	131	92.9	92.9	NUM
dpc-3493	123	132	%	%	NOUN
dpc-3493	123	133	(	(	PUNCT
dpc-3493	123	134	n=13	n=13	NOUN
dpc-3493	123	135	)	)	PUNCT
dpc-3493	123	136	sertolizumab	sertolizumab	NOUN
dpc-3493	123	137	40.0	40.0	NUM
dpc-3493	123	138	%	%	NOUN
dpc-3493	123	139	(	(	PUNCT
dpc-3493	123	140	n=4	n=4	NOUN
dpc-3493	123	141	)	)	PUNCT
dpc-3493	123	142	40.0	40.0	NUM
dpc-3493	123	143	%	%	NOUN
dpc-3493	123	144	(	(	PUNCT
dpc-3493	123	145	n=4	n=4	NOUN
dpc-3493	123	146	)	)	PUNCT
dpc-3493	123	147	40.0	40.0	NUM
dpc-3493	123	148	%	%	NOUN
dpc-3493	123	149	(	(	PUNCT
dpc-3493	123	150	n=4	n=4	NOUN
dpc-3493	123	151	)	)	PUNCT
dpc-3493	123	152	10.0	10.0	NUM
dpc-3493	123	153	%	%	NOUN
dpc-3493	123	154	(	(	PUNCT
dpc-3493	123	155	n=1	n=1	PROPN
dpc-3493	123	156	)	)	PUNCT
dpc-3493	123	157	57.1	57.1	NUM
dpc-3493	123	158	%	%	NOUN
dpc-3493	123	159	(	(	PUNCT
dpc-3493	123	160	n=4	n=4	NOUN
dpc-3493	123	161	)	)	PUNCT
dpc-3493	123	162	70.0	70.0	NUM
dpc-3493	123	163	%	%	NOUN
dpc-3493	123	164	(	(	PUNCT
dpc-3493	123	165	n=7	n=7	PROPN
dpc-3493	123	166	)	)	PUNCT
dpc-3493	123	167	ustekinumab	ustekinumab	NOUN
dpc-3493	123	168	30.4	30.4	NUM
dpc-3493	123	169	%	%	NOUN
dpc-3493	123	170	(	(	PUNCT
dpc-3493	123	171	n=17	n=17	NOUN
dpc-3493	123	172	)	)	PUNCT
dpc-3493	123	173	17.9	17.9	NUM
dpc-3493	123	174	%	%	NOUN
dpc-3493	123	175	(	(	PUNCT
dpc-3493	123	176	n=10	n=10	NOUN
dpc-3493	123	177	)	)	PUNCT
dpc-3493	123	178	64.3	64.3	NUM
dpc-3493	123	179	%	%	NOUN
dpc-3493	123	180	(	(	PUNCT
dpc-3493	123	181	n=36	n=36	PROPN
dpc-3493	123	182	)	)	PUNCT
dpc-3493	123	183	14.3	14.3	NUM
dpc-3493	123	184	%	%	NOUN
dpc-3493	123	185	(	(	PUNCT
dpc-3493	123	186	n=8	n=8	NUM
dpc-3493	123	187	)	)	PUNCT
dpc-3493	123	188	26.5	26.5	NUM
dpc-3493	123	189	%	%	NOUN
dpc-3493	123	190	(	(	PUNCT
dpc-3493	123	191	n=13	n=13	NOUN
dpc-3493	123	192	)	)	PUNCT
dpc-3493	123	193	73.2	73.2	NUM
dpc-3493	123	194	%	%	NOUN
dpc-3493	123	195	(	(	PUNCT
dpc-3493	123	196	n=41	n=41	PROPN
dpc-3493	123	197	)	)	PUNCT
dpc-3493	123	198	secukinumab	secukinumab	NOUN
dpc-3493	123	199	32.2	32.2	NUM
dpc-3493	123	200	%	%	NOUN
dpc-3493	123	201	(	(	PUNCT
dpc-3493	123	202	n=19	n=19	PROPN
dpc-3493	123	203	)	)	PUNCT
dpc-3493	123	204	52.5	52.5	NUM
dpc-3493	123	205	%	%	NOUN
dpc-3493	123	206	(	(	PUNCT
dpc-3493	123	207	n=31	n=31	PROPN
dpc-3493	123	208	)	)	PUNCT
dpc-3493	123	209	47.5	47.5	NUM
dpc-3493	123	210	%	%	NOUN
dpc-3493	123	211	(	(	PUNCT
dpc-3493	123	212	n=28	n=28	NOUN
dpc-3493	123	213	)	)	PUNCT
dpc-3493	123	214	23.7	23.7	NUM
dpc-3493	123	215	%	%	NOUN
dpc-3493	123	216	(	(	PUNCT
dpc-3493	123	217	n=14	n=14	NOUN
dpc-3493	123	218	)	)	PUNCT
dpc-3493	123	219	38.0	38.0	NUM
dpc-3493	123	220	%	%	NOUN
dpc-3493	123	221	(	(	PUNCT
dpc-3493	123	222	n=19	n=19	PROPN
dpc-3493	123	223	)	)	PUNCT
dpc-3493	123	224	78.0	78.0	NUM
dpc-3493	123	225	%	%	NOUN
dpc-3493	123	226	(	(	PUNCT
dpc-3493	123	227	n=46	n=46	NOUN
dpc-3493	123	228	)	)	PUNCT
dpc-3493	123	229	ixekizumab	ixekizumab	NOUN
dpc-3493	123	230	31.3	31.3	NUM
dpc-3493	123	231	%	%	NOUN
dpc-3493	123	232	(	(	PUNCT
dpc-3493	123	233	n=5	n=5	PROPN
dpc-3493	123	234	)	)	PUNCT
dpc-3493	123	235	50.0	50.0	NUM
dpc-3493	123	236	%	%	NOUN
dpc-3493	123	237	(	(	PUNCT
dpc-3493	123	238	n=8	n=8	NUM
dpc-3493	123	239	)	)	PUNCT
dpc-3493	123	240	50.0	50.0	NUM
dpc-3493	123	241	%	%	NOUN
dpc-3493	123	242	(	(	PUNCT
dpc-3493	123	243	n=8	n=8	NUM
dpc-3493	123	244	)	)	PUNCT
dpc-3493	123	245	6.3	6.3	NUM
dpc-3493	123	246	%	%	NOUN
dpc-3493	123	247	(	(	PUNCT
dpc-3493	123	248	n=1	n=1	PROPN
dpc-3493	123	249	)	)	PUNCT
dpc-3493	123	250	28.6	28.6	NUM
dpc-3493	123	251	%	%	NOUN
dpc-3493	123	252	(	(	PUNCT
dpc-3493	123	253	n=4	n=4	NOUN
dpc-3493	123	254	)	)	PUNCT
dpc-3493	123	255	81.3	81.3	NUM
dpc-3493	123	256	%	%	NOUN
dpc-3493	123	257	(	(	PUNCT
dpc-3493	123	258	n=13	n=13	NOUN
dpc-3493	123	259	)	)	PUNCT
dpc-3493	123	260	risankizumab	risankizumab	VERB
dpc-3493	123	261	20.0	20.0	NUM
dpc-3493	123	262	%	%	NOUN
dpc-3493	123	263	(	(	PUNCT
dpc-3493	123	264	n=2	n=2	ADV
dpc-3493	123	265	)	)	PUNCT
dpc-3493	123	266	60.0	60.0	NUM
dpc-3493	123	267	%	%	NOUN
dpc-3493	123	268	(	(	PUNCT
dpc-3493	123	269	n=4	n=4	NOUN
dpc-3493	123	270	)	)	PUNCT
dpc-3493	123	271	40.0	40.0	NUM
dpc-3493	123	272	%	%	NOUN
dpc-3493	123	273	(	(	PUNCT
dpc-3493	123	274	n=4	n=4	NOUN
dpc-3493	123	275	)	)	PUNCT
dpc-3493	123	276	10.0	10.0	NUM
dpc-3493	123	277	%	%	NOUN
dpc-3493	123	278	(	(	PUNCT
dpc-3493	123	279	n=1	n=1	PROPN
dpc-3493	123	280	)	)	PUNCT
dpc-3493	123	281	40.0	40.0	NUM
dpc-3493	123	282	%	%	NOUN
dpc-3493	123	283	(	(	PUNCT
dpc-3493	123	284	n=4	n=4	NOUN
dpc-3493	123	285	)	)	PUNCT
dpc-3493	123	286	90.0	90.0	NUM
dpc-3493	123	287	%	%	NOUN
dpc-3493	123	288	(	(	PUNCT
dpc-3493	123	289	n=9	n=9	NOUN
dpc-3493	123	290	)	)	PUNCT
dpc-3493	123	291	guselkumab	guselkumab	NOUN
dpc-3493	123	292	25.0	25.0	NUM
dpc-3493	123	293	%	%	NOUN
dpc-3493	123	294	(	(	PUNCT
dpc-3493	123	295	n=2	n=2	ADV
dpc-3493	123	296	)	)	PUNCT
dpc-3493	123	297	75.0	75.0	NUM
dpc-3493	123	298	%	%	NOUN
dpc-3493	123	299	(	(	PUNCT
dpc-3493	123	300	n=6	n=6	NOUN
dpc-3493	123	301	)	)	PUNCT
dpc-3493	123	302	62.5	62.5	NUM
dpc-3493	123	303	%	%	NOUN
dpc-3493	123	304	(	(	PUNCT
dpc-3493	123	305	n=5	n=5	PROPN
dpc-3493	123	306	)	)	PUNCT
dpc-3493	123	307	37.5	37.5	NUM
dpc-3493	123	308	%	%	NOUN
dpc-3493	123	309	(	(	PUNCT
dpc-3493	123	310	n=3	n=3	NOUN
dpc-3493	123	311	)	)	PUNCT
dpc-3493	123	312	57.1	57.1	NUM
dpc-3493	123	313	%	%	NOUN
dpc-3493	123	314	(	(	PUNCT
dpc-3493	123	315	n=4	n=4	NOUN
dpc-3493	123	316	)	)	PUNCT
dpc-3493	123	317	75.0	75.0	NUM
dpc-3493	123	318	%	%	NOUN
dpc-3493	123	319	(	(	PUNCT
dpc-3493	123	320	n=6	n=6	NOUN
dpc-3493	123	321	)	)	PUNCT
dpc-3493	123	322	total	total	NOUN
dpc-3493	123	323	(	(	PUNCT
dpc-3493	123	324	conventional	conventional	ADJ
dpc-3493	123	325	)	)	PUNCT
dpc-3493	123	326	27.2	27.2	NUM
dpc-3493	123	327	%	%	NOUN
dpc-3493	123	328	(	(	PUNCT
dpc-3493	123	329	n=28	n=28	NOUN
dpc-3493	123	330	)	)	PUNCT
dpc-3493	123	331	----------54.4	----------54.4	NUM
dpc-3493	123	332	%	%	NOUN
dpc-3493	123	333	(	(	PUNCT
dpc-3493	123	334	n=	n=	ADJ
dpc-3493	123	335	)	)	PUNCT
dpc-3493	123	336	22.3	22.3	NUM
dpc-3493	123	337	%	%	NOUN
dpc-3493	123	338	(	(	PUNCT
dpc-3493	123	339	n=23	n=23	PROPN
dpc-3493	123	340	)	)	PUNCT
dpc-3493	123	341	17.4	17.4	NUM
dpc-3493	123	342	%	%	NOUN
dpc-3493	123	343	(	(	PUNCT
dpc-3493	123	344	n=18	n=18	NOUN
dpc-3493	123	345	)	)	PUNCT
dpc-3493	123	346	81.5	81.5	NUM
dpc-3493	123	347	%	%	NOUN
dpc-3493	123	348	(	(	PUNCT
dpc-3493	123	349	n=103	n=103	NOUN
dpc-3493	123	350	)	)	PUNCT
dpc-3493	123	351	methotrexate	methotrexate	VERB
dpc-3493	123	352	31.6	31.6	NUM
dpc-3493	123	353	%	%	NOUN
dpc-3493	123	354	(	(	PUNCT
dpc-3493	123	355	n=18	n=18	NOUN
dpc-3493	123	356	)	)	PUNCT
dpc-3493	124	1	----------54.4	----------54.4	NUM
dpc-3493	125	1	%	%	NOUN
dpc-3493	125	2	(	(	PUNCT
dpc-3493	125	3	n=31	n=31	PROPN
dpc-3493	125	4	)	)	PUNCT
dpc-3493	125	5	21.1	21.1	NUM
dpc-3493	125	6	%	%	NOUN
dpc-3493	125	7	(	(	PUNCT
dpc-3493	125	8	n=12	n=12	NOUN
dpc-3493	125	9	)	)	PUNCT
dpc-3493	125	10	17.5	17.5	NUM
dpc-3493	125	11	%	%	NOUN
dpc-3493	125	12	(	(	PUNCT
dpc-3493	125	13	n=10	n=10	NOUN
dpc-3493	125	14	)	)	PUNCT
dpc-3493	125	15	82.5	82.5	NUM
dpc-3493	125	16	%	%	NOUN
dpc-3493	125	17	(	(	PUNCT
dpc-3493	125	18	n=47	n=47	PROPN
dpc-3493	125	19	)	)	PUNCT
dpc-3493	125	20	acitretin	acitretin	VERB
dpc-3493	125	21	21.7	21.7	NUM
dpc-3493	125	22	%	%	NOUN
dpc-3493	125	23	(	(	PUNCT
dpc-3493	125	24	n=10	n=10	NOUN
dpc-3493	125	25	)	)	PUNCT
dpc-3493	125	26	----------58.7	----------58.7	NUM
dpc-3493	125	27	%	%	NOUN
dpc-3493	125	28	(	(	PUNCT
dpc-3493	125	29	n=27	n=27	PROPN
dpc-3493	125	30	)	)	PUNCT
dpc-3493	125	31	23.9	23.9	NUM
dpc-3493	125	32	%	%	NOUN
dpc-3493	125	33	(	(	PUNCT
dpc-3493	125	34	n=11	n=11	NOUN
dpc-3493	125	35	)	)	PUNCT
dpc-3493	125	36	17.4	17.4	NUM
dpc-3493	125	37	%	%	NOUN
dpc-3493	125	38	(	(	PUNCT
dpc-3493	125	39	n=8	n=8	ADP
dpc-3493	125	40	)	)	PUNCT
dpc-3493	125	41	80.4	80.4	NUM
dpc-3493	125	42	%	%	NOUN
dpc-3493	125	43	(	(	PUNCT
dpc-3493	125	44	n=37	n=37	PROPN
dpc-3493	125	45	)	)	PUNCT
dpc-3493	125	46	the	the	DET
dpc-3493	125	47	proportion	proportion	NOUN
dpc-3493	125	48	of	of	ADP
dpc-3493	125	49	patients	patient	NOUN
dpc-3493	125	50	who	who	PRON
dpc-3493	125	51	achieved	achieve	VERB
dpc-3493	125	52	pasi	pasi	NOUN
dpc-3493	125	53	90	90	NUM
dpc-3493	125	54	response	response	NOUN
dpc-3493	125	55	was	be	AUX
dpc-3493	125	56	33.8	33.8	NUM
dpc-3493	125	57	%	%	NOUN
dpc-3493	125	58	(	(	PUNCT
dpc-3493	125	59	n	n	NOUN
dpc-3493	125	60	=	=	SYM
dpc-3493	125	61	53	53	NUM
dpc-3493	125	62	)	)	PUNCT
dpc-3493	125	63	at	at	ADP
dpc-3493	125	64	month	month	NOUN
dpc-3493	125	65	1	1	NUM
dpc-3493	125	66	and	and	CCONJ
dpc-3493	125	67	58.6	58.6	NUM
dpc-3493	125	68	%	%	NOUN
dpc-3493	125	69	(	(	PUNCT
dpc-3493	125	70	n	n	NOUN
dpc-3493	125	71	=	=	SYM
dpc-3493	125	72	92	92	NUM
dpc-3493	125	73	)	)	PUNCT
dpc-3493	125	74	at	at	ADP
dpc-3493	125	75	month	month	NOUN
dpc-3493	125	76	3	3	NUM
dpc-3493	125	77	(	(	PUNCT
dpc-3493	125	78	table	table	NOUN
dpc-3493	125	79	5	5	NUM
dpc-3493	125	80	)	)	PUNCT
dpc-3493	125	81	.	.	PUNCT
dpc-3493	126	1	in	in	ADP
dpc-3493	126	2	the	the	DET
dpc-3493	126	3	group	group	NOUN
dpc-3493	126	4	treated	treat	VERB
dpc-3493	126	5	with	with	ADP
dpc-3493	126	6	conventional	conventional	ADJ
dpc-3493	126	7	systemic	systemic	ADJ
dpc-3493	126	8	agents	agent	NOUN
dpc-3493	126	9	,	,	PUNCT
dpc-3493	126	10	the	the	DET
dpc-3493	126	11	proportion	proportion	NOUN
dpc-3493	126	12	of	of	ADP
dpc-3493	126	13	patients	patient	NOUN
dpc-3493	126	14	who	who	PRON
dpc-3493	126	15	achieved	achieve	VERB
dpc-3493	126	16	pasi	pasi	NOUN
dpc-3493	126	17	90	90	NUM
dpc-3493	126	18	response	response	NOUN
dpc-3493	126	19	was	be	AUX
dpc-3493	126	20	9.0	9.0	NUM
dpc-3493	126	21	%	%	NOUN
dpc-3493	126	22	(	(	PUNCT
dpc-3493	126	23	n	n	NOUN
dpc-3493	126	24	=	=	SYM
dpc-3493	126	25	6	6	NUM
dpc-3493	126	26	)	)	PUNCT
dpc-3493	126	27	at	at	ADP
dpc-3493	126	28	month	month	NOUN
dpc-3493	126	29	1	1	NUM
dpc-3493	126	30	,	,	PUNCT
dpc-3493	126	31	and	and	CCONJ
dpc-3493	126	32	this	this	DET
dpc-3493	126	33	figure	figure	NOUN
dpc-3493	126	34	increased	increase	VERB
dpc-3493	126	35	to	to	ADP
dpc-3493	126	36	23.9	23.9	NUM
dpc-3493	126	37	%	%	NOUN
dpc-3493	126	38	(	(	PUNCT
dpc-3493	126	39	n	n	NOUN
dpc-3493	126	40	=	=	SYM
dpc-3493	126	41	16	16	NUM
dpc-3493	126	42	)	)	PUNCT
dpc-3493	126	43	at	at	ADP
dpc-3493	126	44	month	month	NOUN
dpc-3493	126	45	3	3	NUM
dpc-3493	126	46	.	.	PUNCT
dpc-3493	127	1	patients	patient	NOUN
dpc-3493	127	2	with	with	ADP
dpc-3493	127	3	bmi	bmi	PROPN
dpc-3493	127	4	≥30	≥30	PROPN
dpc-3493	127	5	the	the	DET
dpc-3493	127	6	proportion	proportion	NOUN
dpc-3493	127	7	of	of	ADP
dpc-3493	127	8	patients	patient	NOUN
dpc-3493	127	9	who	who	PRON
dpc-3493	127	10	achieved	achieve	VERB
dpc-3493	127	11	pasi	pasi	NOUN
dpc-3493	127	12	75	75	NUM
dpc-3493	127	13	response	response	NOUN
dpc-3493	127	14	was	be	AUX
dpc-3493	127	15	40.0	40.0	NUM
dpc-3493	127	16	%	%	NOUN
dpc-3493	127	17	(	(	PUNCT
dpc-3493	127	18	n	n	NOUN
dpc-3493	127	19	=	=	SYM
dpc-3493	127	20	26	26	NUM
dpc-3493	127	21	)	)	PUNCT
dpc-3493	127	22	at	at	ADP
dpc-3493	127	23	month	month	NOUN
dpc-3493	127	24	1	1	NUM
dpc-3493	127	25	and	and	CCONJ
dpc-3493	127	26	55.4	55.4	NUM
dpc-3493	127	27	%	%	NOUN
dpc-3493	127	28	(	(	PUNCT
dpc-3493	127	29	n	n	NOUN
dpc-3493	127	30	=	=	SYM
dpc-3493	127	31	36	36	NUM
dpc-3493	127	32	)	)	PUNCT
dpc-3493	127	33	at	at	ADP
dpc-3493	127	34	month	month	NOUN
dpc-3493	127	35	3	3	NUM
dpc-3493	127	36	among	among	ADP
dpc-3493	127	37	patients	patient	NOUN
dpc-3493	127	38	treated	treat	VERB
dpc-3493	127	39	with	with	ADP
dpc-3493	127	40	biological	biological	ADJ
dpc-3493	127	41	agents	agent	NOUN
dpc-3493	127	42	.	.	PUNCT
dpc-3493	128	1	the	the	DET
dpc-3493	128	2	highest	high	ADJ
dpc-3493	128	3	rate	rate	NOUN
dpc-3493	128	4	was	be	AUX
dpc-3493	128	5	observed	observe	VERB
dpc-3493	128	6	with	with	ADP
dpc-3493	128	7	ixekizumab	ixekizumab	NOUN
dpc-3493	128	8	(	(	PUNCT
dpc-3493	128	9	60.0	60.0	NUM
dpc-3493	128	10	%	%	NOUN
dpc-3493	128	11	;	;	PUNCT
dpc-3493	128	12	n	n	NOUN
dpc-3493	128	13	=	=	SYM
dpc-3493	128	14	3	3	X
dpc-3493	128	15	)	)	PUNCT
dpc-3493	128	16	while	while	SCONJ
dpc-3493	128	17	the	the	DET
dpc-3493	128	18	lowest	low	ADJ
dpc-3493	128	19	rate	rate	NOUN
dpc-3493	128	20	was	be	AUX
dpc-3493	128	21	observed	observe	VERB
dpc-3493	128	22	with	with	ADP
dpc-3493	128	23	etanercept	etanercept	NOUN
dpc-3493	128	24	(	(	PUNCT
dpc-3493	128	25	0	0	NUM
dpc-3493	128	26	%	%	NOUN
dpc-3493	128	27	;	;	PUNCT
dpc-3493	129	1	n	n	NOUN
dpc-3493	129	2	=	=	SYM
dpc-3493	129	3	0	0	NUM
dpc-3493	129	4	)	)	PUNCT
dpc-3493	129	5	.	.	PUNCT
dpc-3493	130	1	the	the	DET
dpc-3493	130	2	proportion	proportion	NOUN
dpc-3493	130	3	of	of	ADP
dpc-3493	130	4	patients	patient	NOUN
dpc-3493	130	5	who	who	PRON
dpc-3493	130	6	achieved	achieve	VERB
dpc-3493	130	7	pasi	pasi	NOUN
dpc-3493	130	8	75	75	NUM
dpc-3493	130	9	response	response	NOUN
dpc-3493	130	10	was	be	AUX
dpc-3493	130	11	3.6	3.6	NUM
dpc-3493	130	12	%	%	NOUN
dpc-3493	130	13	at	at	ADP
dpc-3493	130	14	month	month	NOUN
dpc-3493	130	15	1	1	NUM
dpc-3493	130	16	and	and	CCONJ
dpc-3493	130	17	25.0	25.0	NUM
dpc-3493	130	18	%	%	NOUN
dpc-3493	130	19	(	(	PUNCT
dpc-3493	130	20	n	n	NOUN
dpc-3493	130	21	=	=	SYM
dpc-3493	130	22	7	7	NUM
dpc-3493	130	23	)	)	PUNCT
dpc-3493	130	24	at	at	ADP
dpc-3493	130	25	month	month	NOUN
dpc-3493	130	26	3	3	NUM
dpc-3493	130	27	among	among	ADP
dpc-3493	130	28	patients	patient	NOUN
dpc-3493	130	29	treated	treat	VERB
dpc-3493	130	30	with	with	ADP
dpc-3493	130	31	conventional	conventional	ADJ
dpc-3493	130	32	agents	agent	NOUN
dpc-3493	130	33	.	.	PUNCT
dpc-3493	131	1	the	the	DET
dpc-3493	131	2	proportion	proportion	NOUN
dpc-3493	131	3	of	of	ADP
dpc-3493	131	4	patients	patient	NOUN
dpc-3493	131	5	who	who	PRON
dpc-3493	131	6	achieved	achieve	VERB
dpc-3493	131	7	pasi	pasi	NOUN
dpc-3493	131	8	90	90	NUM
dpc-3493	131	9	response	response	NOUN
dpc-3493	131	10	was	be	AUX
dpc-3493	131	11	33.8	33.8	NUM
dpc-3493	131	12	%	%	NOUN
dpc-3493	131	13	(	(	PUNCT
dpc-3493	131	14	n	n	NOUN
dpc-3493	131	15	=	=	SYM
dpc-3493	131	16	22	22	NUM
dpc-3493	131	17	)	)	PUNCT
dpc-3493	131	18	at	at	ADP
dpc-3493	131	19	month	month	NOUN
dpc-3493	131	20	1	1	NUM
dpc-3493	131	21	and	and	CCONJ
dpc-3493	131	22	44.6	44.6	NUM
dpc-3493	131	23	%	%	NOUN
dpc-3493	131	24	(	(	PUNCT
dpc-3493	131	25	n	n	NOUN
dpc-3493	131	26	=	=	NUM
dpc-3493	131	27	29	29	NUM
dpc-3493	131	28	)	)	PUNCT
dpc-3493	131	29	at	at	ADP
dpc-3493	131	30	month	month	NOUN
dpc-3493	131	31	3	3	NUM
dpc-3493	131	32	among	among	ADP
dpc-3493	131	33	patients	patient	NOUN
dpc-3493	131	34	treated	treat	VERB
dpc-3493	131	35	with	with	ADP
dpc-3493	131	36	biological	biological	ADJ
dpc-3493	131	37	agents	agent	NOUN
dpc-3493	131	38	(	(	PUNCT
dpc-3493	131	39	table	table	NOUN
dpc-3493	131	40	5	5	NUM
dpc-3493	131	41	)	)	PUNCT
dpc-3493	131	42	.	.	PUNCT
dpc-3493	132	1	the	the	DET
dpc-3493	132	2	highest	high	ADJ
dpc-3493	132	3	rate	rate	NOUN
dpc-3493	132	4	was	be	AUX
dpc-3493	132	5	observed	observe	VERB
dpc-3493	132	6	with	with	ADP
dpc-3493	132	7	ixekizumab	ixekizumab	NOUN
dpc-3493	132	8	(	(	PUNCT
dpc-3493	132	9	42.1	42.1	NUM
dpc-3493	132	10	%	%	NOUN
dpc-3493	132	11	;	;	PUNCT
dpc-3493	132	12	n	n	PROPN
dpc-3493	132	13	=	=	SYM
dpc-3493	132	14	8)	8)	NUM
dpc-3493	132	15	(	(	PUNCT
dpc-3493	132	16	table	table	NOUN
dpc-3493	132	17	6	6	NUM
dpc-3493	132	18	)	)	PUNCT
dpc-3493	132	19	.	.	PUNCT
dpc-3493	133	1	in	in	ADP
dpc-3493	133	2	the	the	DET
dpc-3493	133	3	group	group	NOUN
dpc-3493	133	4	treated	treat	VERB
dpc-3493	133	5	with	with	ADP
dpc-3493	133	6	conventional	conventional	ADJ
dpc-3493	133	7	systemic	systemic	ADJ
dpc-3493	133	8	agents	agent	NOUN
dpc-3493	133	9	,	,	PUNCT
dpc-3493	133	10	no	no	DET
dpc-3493	133	11	patient	patient	NOUN
dpc-3493	133	12	achieved	achieve	VERB
dpc-3493	133	13	pasi	pasi	NOUN
dpc-3493	133	14	90	90	NUM
dpc-3493	133	15	response	response	NOUN
dpc-3493	133	16	at	at	ADP
dpc-3493	133	17	month	month	NOUN
dpc-3493	133	18	1	1	NUM
dpc-3493	133	19	,	,	PUNCT
dpc-3493	133	20	while	while	SCONJ
dpc-3493	133	21	the	the	DET
dpc-3493	133	22	proportion	proportion	NOUN
dpc-3493	133	23	of	of	ADP
dpc-3493	133	24	patients	patient	NOUN
dpc-3493	133	25	who	who	PRON
dpc-3493	133	26	achieved	achieve	VERB
dpc-3493	133	27	pasi	pasi	NOUN
dpc-3493	133	28	90	90	NUM
dpc-3493	133	29	response	response	NOUN
dpc-3493	133	30	at	at	ADP
dpc-3493	133	31	month	month	NOUN
dpc-3493	133	32	3	3	NUM
dpc-3493	133	33	was	be	AUX
dpc-3493	133	34	3.6	3.6	NUM
dpc-3493	133	35	%	%	NOUN
dpc-3493	133	36	(	(	PUNCT
dpc-3493	133	37	n	n	NOUN
dpc-3493	133	38	=	=	SYM
dpc-3493	133	39	1	1	NUM
dpc-3493	133	40	)	)	PUNCT
dpc-3493	133	41	(	(	PUNCT
dpc-3493	133	42	table	table	NOUN
dpc-3493	133	43	5	5	NUM
dpc-3493	133	44	)	)	PUNCT
dpc-3493	133	45	.	.	PUNCT
dpc-3493	134	1	in	in	ADP
dpc-3493	134	2	summary	summary	NOUN
dpc-3493	134	3	,	,	PUNCT
dpc-3493	134	4	when	when	SCONJ
dpc-3493	134	5	the	the	DET
dpc-3493	134	6	entire	entire	ADJ
dpc-3493	134	7	study	study	NOUN
dpc-3493	134	8	population	population	NOUN
dpc-3493	134	9	was	be	AUX
dpc-3493	134	10	considered	consider	VERB
dpc-3493	134	11	,	,	PUNCT
dpc-3493	134	12	bmi	bmi	PROPN
dpc-3493	134	13	was	be	AUX
dpc-3493	134	14	≥30	≥30	PROPN
dpc-3493	134	15	kg	kg	PROPN
dpc-3493	134	16	/	/	SYM
dpc-3493	134	17	m2	m2	PROPN
dpc-3493	134	18	for	for	ADP
dpc-3493	134	19	224	224	NUM
dpc-3493	134	20	patients	patient	NOUN
dpc-3493	134	21	and	and	CCONJ
dpc-3493	134	22	<	<	X
dpc-3493	134	23	30	30	NUM
dpc-3493	134	24	kg/	kg/	NOUN
dpc-3493	134	25	m2	m2	PROPN
dpc-3493	134	26	for	for	ADP
dpc-3493	134	27	93	93	NUM
dpc-3493	134	28	patients	patient	NOUN
dpc-3493	134	29	.	.	PUNCT
dpc-3493	135	1	the	the	DET
dpc-3493	135	2	pasi	pasi	NOUN
dpc-3493	135	3	assessments	assessment	NOUN
dpc-3493	135	4	changed	change	VERB
dpc-3493	135	5	as	as	SCONJ
dpc-3493	135	6	seen	see	VERB
dpc-3493	135	7	in	in	ADP
dpc-3493	135	8	table	table	NOUN
dpc-3493	135	9	7	7	NUM
dpc-3493	135	10	when	when	SCONJ
dpc-3493	135	11	the	the	DET
dpc-3493	135	12	entire	entire	ADJ
dpc-3493	135	13	study	study	NOUN
dpc-3493	135	14	population	population	NOUN
dpc-3493	135	15	was	be	AUX
dpc-3493	135	16	not	not	PART
dpc-3493	135	17	classified	classify	VERB
dpc-3493	135	18	into	into	ADP
dpc-3493	135	19	treatment	treatment	NOUN
dpc-3493	135	20	groups	group	NOUN
dpc-3493	135	21	.	.	PUNCT
dpc-3493	136	1	at	at	ADP
dpc-3493	136	2	month	month	NOUN
dpc-3493	136	3	3	3	NUM
dpc-3493	136	4	,	,	PUNCT
dpc-3493	136	5	pasi	pasi	NOUN
dpc-3493	136	6	scores	score	NOUN
dpc-3493	136	7	showed	show	VERB
dpc-3493	136	8	improvement	improvement	NOUN
dpc-3493	136	9	in	in	ADP
dpc-3493	136	10	48.2	48.2	NUM
dpc-3493	136	11	%	%	NOUN
dpc-3493	136	12	(	(	PUNCT
dpc-3493	136	13	n	n	NOUN
dpc-3493	136	14	=	=	SYM
dpc-3493	136	15	108	108	NUM
dpc-3493	136	16	)	)	PUNCT
dpc-3493	136	17	of	of	ADP
dpc-3493	136	18	the	the	DET
dpc-3493	136	19	non	non	ADJ
dpc-3493	136	20	-	-	ADJ
dpc-3493	136	21	obese	obese	ADJ
dpc-3493	136	22	patients	patient	NOUN
dpc-3493	136	23	and	and	CCONJ
dpc-3493	136	24	32.3	32.3	NUM
dpc-3493	136	25	%	%	NOUN
dpc-3493	136	26	(	(	PUNCT
dpc-3493	136	27	n	n	NOUN
dpc-3493	136	28	=	=	SYM
dpc-3493	136	29	30	30	NUM
dpc-3493	136	30	)	)	PUNCT
dpc-3493	136	31	of	of	ADP
dpc-3493	136	32	the	the	DET
dpc-3493	136	33	obese	obese	ADJ
dpc-3493	136	34	patients	patient	NOUN
dpc-3493	136	35	.	.	PUNCT
dpc-3493	137	1	the	the	DET
dpc-3493	137	2	rate	rate	NOUN
dpc-3493	137	3	of	of	ADP
dpc-3493	137	4	improvement	improvement	NOUN
dpc-3493	137	5	was	be	AUX
dpc-3493	137	6	significantly	significantly	ADV
dpc-3493	137	7	worse	bad	ADJ
dpc-3493	137	8	among	among	ADP
dpc-3493	137	9	obese	obese	ADJ
dpc-3493	137	10	patients	patient	NOUN
dpc-3493	137	11	(	(	PUNCT
dpc-3493	137	12	p	p	X
dpc-3493	137	13	  	  	SPACE
dpc-3493	137	14	=	=	NOUN
dpc-3493	137	15	0.009	0.009	NUM
dpc-3493	137	16	)	)	PUNCT
dpc-3493	137	17	.	.	PUNCT
dpc-3493	138	1	although	although	SCONJ
dpc-3493	138	2	a	a	DET
dpc-3493	138	3	difference	difference	NOUN
dpc-3493	138	4	could	could	AUX
dpc-3493	138	5	be	be	AUX
dpc-3493	138	6	observed	observe	VERB
dpc-3493	138	7	at	at	ADP
dpc-3493	138	8	month	month	NOUN
dpc-3493	138	9	1	1	NUM
dpc-3493	138	10	,	,	PUNCT
dpc-3493	138	11	it	it	PRON
dpc-3493	138	12	was	be	AUX
dpc-3493	138	13	not	not	PART
dpc-3493	138	14	reflected	reflect	VERB
dpc-3493	138	15	at	at	ADP
dpc-3493	138	16	the	the	DET
dpc-3493	138	17	same	same	ADJ
dpc-3493	138	18	extent	extent	NOUN
dpc-3493	138	19	in	in	ADP
dpc-3493	138	20	our	our	PRON
dpc-3493	138	21	entire	entire	ADJ
dpc-3493	138	22	study	study	NOUN
dpc-3493	138	23	population	population	NOUN
dpc-3493	138	24	(	(	PUNCT
dpc-3493	138	25	p	p	X
dpc-3493	138	26	=	=	NOUN
dpc-3493	138	27	0.063	0.063	NUM
dpc-3493	138	28	)	)	PUNCT
dpc-3493	138	29	.	.	PUNCT
dpc-3493	139	1	for	for	ADP
dpc-3493	139	2	pasi	pasi	NOUN
dpc-3493	139	3	75	75	NUM
dpc-3493	139	4	response	response	NOUN
dpc-3493	139	5	,	,	PUNCT
dpc-3493	139	6	there	there	PRON
dpc-3493	139	7	was	be	VERB
dpc-3493	139	8	improvement	improvement	NOUN
dpc-3493	139	9	in	in	ADP
dpc-3493	139	10	favor	favor	NOUN
dpc-3493	139	11	of	of	ADP
dpc-3493	139	12	non	non	ADJ
dpc-3493	139	13	-	-	ADJ
dpc-3493	139	14	obese	obese	ADJ
dpc-3493	139	15	patients	patient	NOUN
dpc-3493	139	16	at	at	ADP
dpc-3493	139	17	months	month	NOUN
dpc-3493	139	18	1	1	NUM
dpc-3493	139	19	and	and	CCONJ
dpc-3493	139	20	3	3	NUM
dpc-3493	139	21	,	,	PUNCT
dpc-3493	139	22	but	but	CCONJ
dpc-3493	139	23	these	these	DET
dpc-3493	139	24	differences	difference	NOUN
dpc-3493	139	25	did	do	AUX
dpc-3493	139	26	not	not	PART
dpc-3493	139	27	reach	reach	VERB
dpc-3493	139	28	statistical	statistical	ADJ
dpc-3493	139	29	significance	significance	NOUN
dpc-3493	139	30	(	(	PUNCT
dpc-3493	139	31	p	p	X
dpc-3493	139	32	 	 	SPACE
dpc-3493	139	33	=	=	NOUN
dpc-3493	139	34	0.124	0.124	NUM
dpc-3493	139	35	and	and	CCONJ
dpc-3493	139	36	p	p	X
dpc-3493	139	37	=	=	NOUN
dpc-3493	139	38	0.673	0.673	NUM
dpc-3493	139	39	,	,	PUNCT
dpc-3493	139	40	respectively	respectively	ADV
dpc-3493	139	41	)	)	PUNCT
dpc-3493	139	42	.	.	PUNCT
dpc-3493	140	1	6	6	NUM
dpc-3493	140	2	original	original	ADJ
dpc-3493	140	3	article	article	NOUN
dpc-3493	140	4	|	|	ADV
dpc-3493	140	5	dermatol	dermatol	ADJ
dpc-3493	140	6	pract	pract	NOUN
dpc-3493	140	7	concept	concept	NOUN
dpc-3493	140	8	.	.	PUNCT
dpc-3493	141	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	141	2	ta	ta	PART
dpc-3493	141	3	b	b	PROPN
dpc-3493	141	4	le	le	X
dpc-3493	141	5	4	4	NUM
dpc-3493	141	6	.	.	PUNCT
dpc-3493	142	1	p	p	X
dpc-3493	142	2	a	a	DET
dpc-3493	142	3	si	si	NOUN
dpc-3493	142	4	7	7	NUM
dpc-3493	142	5	5	5	NUM
dpc-3493	142	6	an	an	DET
dpc-3493	142	7	d	d	X
dpc-3493	142	8	pa	pa	NOUN
dpc-3493	142	9	si	si	PROPN
dpc-3493	142	10	9	9	NUM
dpc-3493	142	11	0	0	NUM
dpc-3493	142	12	re	re	NOUN
dpc-3493	142	13	sp	sp	ADP
dpc-3493	142	14	on	on	ADP
dpc-3493	142	15	se	se	PROPN
dpc-3493	142	16	s	s	PROPN
dpc-3493	142	17	du	du	PROPN
dpc-3493	142	18	ri	ri	PROPN
dpc-3493	142	19	ng	ng	PROPN
dpc-3493	142	20	t	t	PROPN
dpc-3493	143	1	he	he	PRON
dpc-3493	143	2	fi	fi	INTJ
dpc-3493	143	3	rs	rs	PROPN
dpc-3493	143	4	t	t	PROPN
dpc-3493	143	5	an	an	PRON
dpc-3493	143	6	d	d	X
dpc-3493	143	7	th	th	X
dpc-3493	143	8	ir	ir	PROPN
dpc-3493	144	1	d	d	X
dpc-3493	144	2	m	m	PROPN
dpc-3493	144	3	on	on	ADP
dpc-3493	144	4	th	th	NUM
dpc-3493	144	5	s	s	NOUN
dpc-3493	144	6	in	in	ADP
dpc-3493	144	7	p	p	NOUN
dpc-3493	144	8	at	at	ADP
dpc-3493	144	9	ie	ie	X
dpc-3493	144	10	nt	nt	PROPN
dpc-3493	144	11	s	s	PART
dpc-3493	144	12	w	w	NOUN
dpc-3493	144	13	it	it	PRON
dpc-3493	145	1	h	h	NOUN
dpc-3493	145	2	a	a	DET
dpc-3493	145	3	bo	bo	PROPN
dpc-3493	145	4	dy	dy	X
dpc-3493	145	5	m	m	NOUN
dpc-3493	145	6	as	as	ADP
dpc-3493	145	7	s	s	PRON
dpc-3493	145	8	in	in	ADP
dpc-3493	145	9	de	de	X
dpc-3493	145	10	x	x	X
dpc-3493	145	11	<3	<3	NOUN
dpc-3493	145	12	0	0	PUNCT
dpc-3493	145	13	(	(	PUNCT
dpc-3493	145	14	n	n	NOUN
dpc-3493	145	15	or	or	CCONJ
dpc-3493	145	16	m	m	VERB
dpc-3493	145	17	al	al	PROPN
dpc-3493	146	1	a	a	DET
dpc-3493	146	2	nd	nd	INTJ
dpc-3493	146	3	o	o	NOUN
dpc-3493	146	4	ve	ve	VERB
dpc-3493	146	5	rw	rw	NOUN
dpc-3493	146	6	ei	ei	PROPN
dpc-3493	146	7	gh	gh	PROPN
dpc-3493	146	8	t	t	PROPN
dpc-3493	146	9	)	)	PUNCT
dpc-3493	146	10	w	w	PROPN
dpc-3493	146	11	he	he	PRON
dpc-3493	146	12	n	n	CCONJ
dpc-3493	146	13	th	th	X
dpc-3493	146	14	e	e	NOUN
dpc-3493	146	15	  	  	SPACE
dpc-3493	146	16	bi	bi	ADJ
dpc-3493	146	17	ol	ol	PROPN
dpc-3493	146	18	og	og	PROPN
dpc-3493	147	1	ic	ic	PROPN
dpc-3493	147	2	s	s	PROPN
dpc-3493	147	3	w	w	PROPN
dpc-3493	147	4	er	er	INTJ
dpc-3493	147	5	e	e	X
dpc-3493	147	6	ev	ev	PROPN
dpc-3493	147	7	al	al	PROPN
dpc-3493	147	8	ua	ua	PROPN
dpc-3493	147	9	te	te	PROPN
dpc-3493	147	10	d	d	PROPN
dpc-3493	147	11	se	se	PROPN
dpc-3493	147	12	pa	pa	PROPN
dpc-3493	147	13	ra	ra	PROPN
dpc-3493	148	1	te	te	INTJ
dpc-3493	148	2	ly	ly	X
dpc-3493	148	3	.	.	PUNCT
dpc-3493	149	1	c	c	NOUN
dpc-3493	149	2	o	o	NOUN
dpc-3493	149	3	n	n	CCONJ
dpc-3493	149	4	ti	ti	NOUN
dpc-3493	149	5	n	n	CCONJ
dpc-3493	149	6	u	u	NOUN
dpc-3493	149	7	o	o	X
dpc-3493	149	8	u	u	NOUN
dpc-3493	149	9	s	s	PROPN
dpc-3493	149	10	v	v	NUM
dpc-3493	149	11	ar	ar	PROPN
dpc-3493	149	12	ia	ia	PROPN
dpc-3493	149	13	b	b	PROPN
dpc-3493	149	14	le	le	PROPN
dpc-3493	149	15	s	s	PROPN
dpc-3493	149	16	a	a	DET
dpc-3493	149	17	d	d	PROPN
dpc-3493	149	18	a	a	DET
dpc-3493	149	19	li	li	PROPN
dpc-3493	149	20	m	m	VERB
dpc-3493	149	21	u	u	NOUN
dpc-3493	149	22	m	m	PROPN
dpc-3493	149	23	a	a	DET
dpc-3493	149	24	b	b	PROPN
dpc-3493	149	25	(	(	PUNCT
dpc-3493	149	26	n	n	NOUN
dpc-3493	149	27	=	=	SYM
dpc-3493	149	28	29	29	NUM
dpc-3493	149	29	)	)	PUNCT
dpc-3493	149	30	et	et	NOUN
dpc-3493	149	31	a	a	PRON
dpc-3493	149	32	n	n	INTJ
dpc-3493	149	33	er	er	INTJ
dpc-3493	149	34	c	c	PROPN
dpc-3493	149	35	ep	ep	PROPN
dpc-3493	149	36	t	t	PROPN
dpc-3493	149	37	(	(	PUNCT
dpc-3493	149	38	n	n	NOUN
dpc-3493	149	39	=	=	SYM
dpc-3493	149	40	8)	8)	NUM
dpc-3493	149	41	in	in	ADP
dpc-3493	149	42	fl	fl	PRON
dpc-3493	149	43	ix	ix	INTJ
dpc-3493	150	1	i	i	PRON
dpc-3493	150	2	m	m	VERB
dpc-3493	150	3	a	a	DET
dpc-3493	150	4	b	b	PROPN
dpc-3493	150	5	(	(	PUNCT
dpc-3493	150	6	n	n	NOUN
dpc-3493	150	7	=	=	SYM
dpc-3493	150	8	10	10	NUM
dpc-3493	150	9	)	)	PUNCT
dpc-3493	151	1	se	se	ADP
dpc-3493	152	1	r	r	NOUN
dpc-3493	152	2	to	to	ADP
dpc-3493	152	3	li	li	PROPN
dpc-3493	152	4	zu	zu	PROPN
dpc-3493	152	5	m	m	PROPN
dpc-3493	152	6	a	a	DET
dpc-3493	152	7	b	b	NOUN
dpc-3493	152	8	pe	pe	INTJ
dpc-3493	152	9	g	g	NOUN
dpc-3493	152	10	o	o	PROPN
dpc-3493	152	11	l	l	NOUN
dpc-3493	152	12	(	(	PUNCT
dpc-3493	152	13	n	n	NOUN
dpc-3493	152	14	=	=	SYM
dpc-3493	152	15	6	6	NUM
dpc-3493	152	16	)	)	PUNCT
dpc-3493	152	17	u	u	PROPN
dpc-3493	152	18	st	st	PROPN
dpc-3493	152	19	ek	ek	PROPN
dpc-3493	152	20	in	in	ADP
dpc-3493	152	21	u	u	PROPN
dpc-3493	152	22	m	m	PROPN
dpc-3493	152	23	a	a	DET
dpc-3493	152	24	b	b	PROPN
dpc-3493	152	25	(	(	PUNCT
dpc-3493	152	26	n	n	NOUN
dpc-3493	152	27	=	=	SYM
dpc-3493	152	28	39	39	NUM
dpc-3493	152	29	)	)	PUNCT
dpc-3493	152	30	se	se	X
dpc-3493	152	31	c	c	PROPN
dpc-3493	152	32	u	u	PROPN
dpc-3493	152	33	k	k	PROPN
dpc-3493	152	34	in	in	ADP
dpc-3493	152	35	u	u	PROPN
dpc-3493	152	36	m	m	VERB
dpc-3493	152	37	a	a	DET
dpc-3493	152	38	b	b	PROPN
dpc-3493	152	39	(	(	PUNCT
dpc-3493	152	40	n	n	NOUN
dpc-3493	152	41	=	=	SYM
dpc-3493	152	42	39	39	NUM
dpc-3493	152	43	)	)	PUNCT
dpc-3493	152	44	ix	ix	ADP
dpc-3493	152	45	ek	ek	NOUN
dpc-3493	153	1	iz	iz	INTJ
dpc-3493	153	2	u	u	VERB
dpc-3493	153	3	m	m	VERB
dpc-3493	153	4	a	a	DET
dpc-3493	153	5	b	b	PROPN
dpc-3493	153	6	(	(	PUNCT
dpc-3493	153	7	n	n	NOUN
dpc-3493	153	8	=	=	SYM
dpc-3493	153	9	12	12	NUM
dpc-3493	153	10	)	)	PUNCT
dpc-3493	154	1	r	r	NOUN
dpc-3493	154	2	is	be	AUX
dpc-3493	154	3	a	a	DET
dpc-3493	154	4	n	n	ADV
dpc-3493	155	1	k	k	NOUN
dpc-3493	155	2	iz	iz	INTJ
dpc-3493	155	3	u	u	VERB
dpc-3493	155	4	m	m	VERB
dpc-3493	155	5	a	a	DET
dpc-3493	155	6	b	b	PROPN
dpc-3493	155	7	(	(	PUNCT
dpc-3493	155	8	n	n	NOUN
dpc-3493	155	9	=	=	SYM
dpc-3493	155	10	8)	8)	NUM
dpc-3493	155	11	g	g	NOUN
dpc-3493	155	12	u	u	PROPN
dpc-3493	155	13	se	se	PROPN
dpc-3493	155	14	lk	lk	PROPN
dpc-3493	155	15	u	u	PROPN
dpc-3493	155	16	m	m	PROPN
dpc-3493	155	17	a	a	DET
dpc-3493	155	18	b	b	PROPN
dpc-3493	155	19	(	(	PUNCT
dpc-3493	155	20	n	n	NOUN
dpc-3493	155	21	=	=	NUM
dpc-3493	155	22	6	6	NUM
dpc-3493	155	23	)	)	PUNCT
dpc-3493	155	24	to	to	ADP
dpc-3493	155	25	ta	ta	ADP
dpc-3493	155	26	l	l	PROPN
dpc-3493	155	27	b	b	PROPN
dpc-3493	155	28	io	io	PROPN
dpc-3493	155	29	lo	lo	PROPN
dpc-3493	155	30	g	g	PROPN
dpc-3493	155	31	ic	ic	PROPN
dpc-3493	155	32	(	(	PUNCT
dpc-3493	155	33	n	n	NOUN
dpc-3493	155	34	=	=	SYM
dpc-3493	155	35	15	15	NUM
dpc-3493	155	36	7	7	NUM
dpc-3493	155	37	)	)	PUNCT
dpc-3493	155	38	pa	pa	NOUN
dpc-3493	155	39	ti	ti	PROPN
dpc-3493	155	40	en	en	X
dpc-3493	155	41	ts	ts	PROPN
dpc-3493	155	42	w	w	PROPN
dpc-3493	155	43	ho	ho	PROPN
dpc-3493	155	44	ac	ac	PROPN
dpc-3493	156	1	hi	hi	INTJ
dpc-3493	156	2	ev	ev	INTJ
dpc-3493	156	3	ed	ed	PROPN
dpc-3493	156	4	pa	pa	PROPN
dpc-3493	156	5	si	si	PROPN
dpc-3493	156	6	7	7	NUM
dpc-3493	156	7	5	5	NUM
dpc-3493	156	8	du	du	PROPN
dpc-3493	156	9	ri	ri	PROPN
dpc-3493	156	10	ng	ng	PROPN
dpc-3493	156	11	t	t	PROPN
dpc-3493	156	12	he	he	PRON
dpc-3493	156	13	fir	fir	PROPN
dpc-3493	156	14	st	st	PROPN
dpc-3493	156	15	m	m	PROPN
dpc-3493	156	16	on	on	ADP
dpc-3493	156	17	th	th	NUM
dpc-3493	156	18	48	48	NUM
dpc-3493	156	19	.3	.3	NUM
dpc-3493	156	20	%	%	NOUN
dpc-3493	156	21	(	(	PUNCT
dpc-3493	156	22	n	n	NOUN
dpc-3493	156	23	=	=	NOUN
dpc-3493	156	24	1	1	NUM
dpc-3493	156	25	4	4	NUM
dpc-3493	156	26	)	)	PUNCT
dpc-3493	156	27	12	12	NUM
dpc-3493	156	28	.5	.5	NUM
dpc-3493	156	29	%	%	NOUN
dpc-3493	156	30	(	(	PUNCT
dpc-3493	156	31	n	n	NOUN
dpc-3493	156	32	=	=	NOUN
dpc-3493	156	33	1	1	NUM
dpc-3493	156	34	)	)	PUNCT
dpc-3493	156	35	50	50	NUM
dpc-3493	156	36	%	%	NOUN
dpc-3493	156	37	(	(	PUNCT
dpc-3493	156	38	n	n	NOUN
dpc-3493	156	39	=	=	NOUN
dpc-3493	156	40	5	5	NUM
dpc-3493	156	41	)	)	PUNCT
dpc-3493	156	42	33	33	NUM
dpc-3493	156	43	.3	.3	NUM
dpc-3493	156	44	%	%	NOUN
dpc-3493	156	45	(	(	PUNCT
dpc-3493	156	46	n	n	NOUN
dpc-3493	156	47	=	=	NOUN
dpc-3493	156	48	2	2	NUM
dpc-3493	156	49	)	)	PUNCT
dpc-3493	156	50	53	53	NUM
dpc-3493	156	51	.8	.8	NUM
dpc-3493	156	52	%	%	NOUN
dpc-3493	156	53	(	(	PUNCT
dpc-3493	156	54	n	n	NOUN
dpc-3493	156	55	=	=	NOUN
dpc-3493	156	56	2	2	NUM
dpc-3493	156	57	1	1	NUM
dpc-3493	156	58	)	)	PUNCT
dpc-3493	156	59	52	52	NUM
dpc-3493	156	60	.5	.5	NUM
dpc-3493	156	61	%	%	NOUN
dpc-3493	156	62	(	(	PUNCT
dpc-3493	156	63	n	n	NOUN
dpc-3493	156	64	=	=	NOUN
dpc-3493	156	65	2	2	NUM
dpc-3493	156	66	1	1	NUM
dpc-3493	156	67	)	)	PUNCT
dpc-3493	156	68	81	81	NUM
dpc-3493	156	69	.8	.8	NUM
dpc-3493	156	70	%	%	NOUN
dpc-3493	156	71	(	(	PUNCT
dpc-3493	156	72	n	n	NOUN
dpc-3493	156	73	=	=	NOUN
dpc-3493	156	74	9	9	NUM
dpc-3493	156	75	)	)	PUNCT
dpc-3493	156	76	25	25	NUM
dpc-3493	156	77	%	%	NOUN
dpc-3493	156	78	(	(	PUNCT
dpc-3493	156	79	n	n	NOUN
dpc-3493	156	80	=	=	NOUN
dpc-3493	156	81	2	2	NUM
dpc-3493	156	82	)	)	PUNCT
dpc-3493	156	83	33	33	NUM
dpc-3493	156	84	.3	.3	NUM
dpc-3493	156	85	%	%	NOUN
dpc-3493	156	86	(	(	PUNCT
dpc-3493	156	87	n	n	NOUN
dpc-3493	156	88	=	=	NOUN
dpc-3493	156	89	2	2	NUM
dpc-3493	156	90	)	)	PUNCT
dpc-3493	156	91	49	49	NUM
dpc-3493	156	92	.0	.0	NUM
dpc-3493	156	93	%	%	NOUN
dpc-3493	156	94	(	(	PUNCT
dpc-3493	156	95	n	n	NOUN
dpc-3493	156	96	=	=	NOUN
dpc-3493	156	97	7	7	NUM
dpc-3493	156	98	7	7	NUM
dpc-3493	156	99	)	)	PUNCT
dpc-3493	156	100	pa	pa	NOUN
dpc-3493	156	101	ti	ti	PROPN
dpc-3493	156	102	en	en	X
dpc-3493	156	103	ts	ts	PROPN
dpc-3493	156	104	w	w	PROPN
dpc-3493	156	105	ho	ho	PROPN
dpc-3493	156	106	ac	ac	PROPN
dpc-3493	157	1	hi	hi	INTJ
dpc-3493	157	2	ev	ev	INTJ
dpc-3493	157	3	ed	ed	PROPN
dpc-3493	157	4	pa	pa	PROPN
dpc-3493	157	5	si	si	PROPN
dpc-3493	157	6	7	7	NUM
dpc-3493	157	7	5	5	NUM
dpc-3493	157	8	th	th	ADP
dpc-3493	157	9	e	e	X
dpc-3493	157	10	th	th	X
dpc-3493	157	11	ir	ir	PROPN
dpc-3493	158	1	d	d	X
dpc-3493	158	2	m	m	PROPN
dpc-3493	158	3	on	on	ADP
dpc-3493	158	4	th	th	NUM
dpc-3493	158	5	69	69	NUM
dpc-3493	158	6	.0	.0	NUM
dpc-3493	158	7	%	%	NOUN
dpc-3493	158	8	(	(	PUNCT
dpc-3493	158	9	n	n	NOUN
dpc-3493	158	10	=	=	NOUN
dpc-3493	158	11	2	2	NUM
dpc-3493	158	12	0	0	NUM
dpc-3493	158	13	)	)	PUNCT
dpc-3493	158	14	37	37	NUM
dpc-3493	158	15	.7	.7	NUM
dpc-3493	158	16	%	%	NOUN
dpc-3493	158	17	(	(	PUNCT
dpc-3493	158	18	n	n	CCONJ
dpc-3493	158	19	=3	=3	VERB
dpc-3493	158	20	)	)	PUNCT
dpc-3493	159	1	40	40	NUM
dpc-3493	159	2	.0	.0	NUM
dpc-3493	159	3	%	%	NOUN
dpc-3493	159	4	(	(	PUNCT
dpc-3493	159	5	n	n	NOUN
dpc-3493	159	6	=	=	NOUN
dpc-3493	159	7	4	4	NUM
dpc-3493	159	8	)	)	PUNCT
dpc-3493	159	9	50	50	NUM
dpc-3493	159	10	.0	.0	NUM
dpc-3493	159	11	%	%	NOUN
dpc-3493	159	12	(	(	PUNCT
dpc-3493	159	13	n	n	CCONJ
dpc-3493	159	14	=3	=3	ADJ
dpc-3493	159	15	)	)	PUNCT
dpc-3493	159	16	76	76	NUM
dpc-3493	160	1	.9	.9	NUM
dpc-3493	160	2	%	%	NOUN
dpc-3493	160	3	(	(	PUNCT
dpc-3493	160	4	n	n	CCONJ
dpc-3493	160	5	=3	=3	VERB
dpc-3493	160	6	0	0	NUM
dpc-3493	160	7	)	)	PUNCT
dpc-3493	160	8	84	84	NUM
dpc-3493	161	1	.5	.5	NUM
dpc-3493	161	2	%	%	NOUN
dpc-3493	161	3	(	(	PUNCT
dpc-3493	161	4	n	n	CCONJ
dpc-3493	161	5	=3	=3	VERB
dpc-3493	161	6	3	3	NUM
dpc-3493	161	7	)	)	PUNCT
dpc-3493	161	8	10	10	NUM
dpc-3493	161	9	0	0	NUM
dpc-3493	161	10	%	%	NOUN
dpc-3493	161	11	(	(	PUNCT
dpc-3493	161	12	n	n	NOUN
dpc-3493	161	13	=	=	NOUN
dpc-3493	161	14	1	1	NUM
dpc-3493	161	15	1	1	NUM
dpc-3493	161	16	)	)	PUNCT
dpc-3493	161	17	50	50	NUM
dpc-3493	161	18	.0	.0	NUM
dpc-3493	161	19	%	%	NOUN
dpc-3493	161	20	(	(	PUNCT
dpc-3493	161	21	n	n	NOUN
dpc-3493	161	22	=	=	NOUN
dpc-3493	161	23	4	4	NUM
dpc-3493	161	24	)	)	PUNCT
dpc-3493	161	25	33	33	NUM
dpc-3493	161	26	.3	.3	NUM
dpc-3493	161	27	%	%	NOUN
dpc-3493	161	28	(	(	PUNCT
dpc-3493	161	29	n	n	NOUN
dpc-3493	161	30	=	=	NOUN
dpc-3493	161	31	2	2	NUM
dpc-3493	161	32	)	)	PUNCT
dpc-3493	161	33	70	70	NUM
dpc-3493	161	34	.1	.1	NUM
dpc-3493	161	35	%	%	NOUN
dpc-3493	161	36	(	(	PUNCT
dpc-3493	161	37	n	n	NOUN
dpc-3493	161	38	=	=	NOUN
dpc-3493	161	39	1	1	NUM
dpc-3493	161	40	10	10	NUM
dpc-3493	161	41	)	)	PUNCT
dpc-3493	161	42	pa	pa	NOUN
dpc-3493	161	43	ti	ti	PROPN
dpc-3493	161	44	en	en	X
dpc-3493	161	45	ts	ts	PROPN
dpc-3493	161	46	w	w	PROPN
dpc-3493	161	47	ho	ho	PROPN
dpc-3493	161	48	ac	ac	PROPN
dpc-3493	161	49	hi	hi	INTJ
dpc-3493	161	50	ev	ev	INTJ
dpc-3493	161	51	ed	ed	PROPN
dpc-3493	161	52	pa	pa	PROPN
dpc-3493	161	53	si	si	PROPN
dpc-3493	161	54	9	9	NUM
dpc-3493	161	55	0	0	NUM
dpc-3493	161	56	th	th	X
dpc-3493	161	57	e	e	PROPN
dpc-3493	161	58	fir	fir	PROPN
dpc-3493	161	59	st	st	PROPN
dpc-3493	161	60	m	m	PROPN
dpc-3493	161	61	on	on	ADP
dpc-3493	161	62	th	th	NUM
dpc-3493	161	63	31	31	NUM
dpc-3493	161	64	.0	.0	NUM
dpc-3493	161	65	%	%	NOUN
dpc-3493	161	66	(	(	PUNCT
dpc-3493	161	67	n	n	NOUN
dpc-3493	161	68	=	=	NOUN
dpc-3493	161	69	9	9	NUM
dpc-3493	161	70	)	)	PUNCT
dpc-3493	161	71	0	0	NUM
dpc-3493	161	72	.	.	X
dpc-3493	161	73	0	0	NUM
dpc-3493	161	74	%	%	NOUN
dpc-3493	161	75	(	(	PUNCT
dpc-3493	161	76	n	n	NOUN
dpc-3493	161	77	=	=	NOUN
dpc-3493	161	78	0	0	NUM
dpc-3493	161	79	)	)	PUNCT
dpc-3493	161	80	50	50	NUM
dpc-3493	161	81	.0	.0	NUM
dpc-3493	161	82	%	%	NOUN
dpc-3493	161	83	(	(	PUNCT
dpc-3493	161	84	n	n	NOUN
dpc-3493	161	85	=	=	NOUN
dpc-3493	161	86	5	5	NUM
dpc-3493	161	87	)	)	PUNCT
dpc-3493	161	88	0	0	NUM
dpc-3493	161	89	.	.	X
dpc-3493	161	90	0	0	NUM
dpc-3493	161	91	%	%	NOUN
dpc-3493	161	92	(	(	PUNCT
dpc-3493	161	93	n	n	NOUN
dpc-3493	161	94	=	=	NOUN
dpc-3493	161	95	0	0	NUM
dpc-3493	161	96	)	)	PUNCT
dpc-3493	161	97	48	48	NUM
dpc-3493	161	98	.7	.7	NUM
dpc-3493	161	99	%	%	NOUN
dpc-3493	161	100	(	(	PUNCT
dpc-3493	161	101	n	n	NOUN
dpc-3493	161	102	=	=	NOUN
dpc-3493	161	103	1	1	NUM
dpc-3493	161	104	9	9	NUM
dpc-3493	161	105	)	)	PUNCT
dpc-3493	161	106	33	33	NUM
dpc-3493	161	107	.3	.3	NUM
dpc-3493	161	108	%	%	NOUN
dpc-3493	161	109	(	(	PUNCT
dpc-3493	161	110	n	n	NOUN
dpc-3493	161	111	=	=	NOUN
dpc-3493	161	112	1	1	NUM
dpc-3493	161	113	3	3	NUM
dpc-3493	161	114	)	)	PUNCT
dpc-3493	161	115	45	45	NUM
dpc-3493	161	116	.5	.5	NUM
dpc-3493	161	117	%	%	NOUN
dpc-3493	161	118	(	(	PUNCT
dpc-3493	161	119	n	n	NOUN
dpc-3493	161	120	=	=	NOUN
dpc-3493	161	121	5	5	NUM
dpc-3493	161	122	)	)	PUNCT
dpc-3493	161	123	12	12	NUM
dpc-3493	161	124	.5	.5	NUM
dpc-3493	161	125	%	%	NOUN
dpc-3493	161	126	(	(	PUNCT
dpc-3493	161	127	n	n	NOUN
dpc-3493	161	128	=	=	NOUN
dpc-3493	161	129	1	1	NUM
dpc-3493	161	130	)	)	PUNCT
dpc-3493	161	131	16	16	NUM
dpc-3493	161	132	.7	.7	NUM
dpc-3493	161	133	%	%	NOUN
dpc-3493	161	134	(	(	PUNCT
dpc-3493	161	135	n	n	NOUN
dpc-3493	161	136	=	=	NOUN
dpc-3493	161	137	1	1	NUM
dpc-3493	161	138	)	)	PUNCT
dpc-3493	161	139	33	33	NUM
dpc-3493	161	140	.8	.8	NUM
dpc-3493	161	141	%	%	NOUN
dpc-3493	161	142	(	(	PUNCT
dpc-3493	161	143	n	n	NOUN
dpc-3493	161	144	=	=	NOUN
dpc-3493	161	145	5	5	NUM
dpc-3493	161	146	3	3	NUM
dpc-3493	161	147	)	)	PUNCT
dpc-3493	161	148	pa	pa	NOUN
dpc-3493	161	149	ti	ti	PROPN
dpc-3493	161	150	en	en	X
dpc-3493	161	151	ts	ts	PROPN
dpc-3493	161	152	w	w	PROPN
dpc-3493	161	153	ho	ho	PROPN
dpc-3493	161	154	ac	ac	PROPN
dpc-3493	161	155	hi	hi	INTJ
dpc-3493	161	156	ev	ev	INTJ
dpc-3493	161	157	ed	ed	PROPN
dpc-3493	161	158	pa	pa	PROPN
dpc-3493	161	159	si	si	PROPN
dpc-3493	161	160	7	7	NUM
dpc-3493	161	161	5	5	NUM
dpc-3493	161	162	th	th	ADP
dpc-3493	161	163	e	e	X
dpc-3493	161	164	th	th	X
dpc-3493	161	165	ir	ir	PROPN
dpc-3493	162	1	d	d	X
dpc-3493	162	2	m	m	PROPN
dpc-3493	162	3	on	on	ADP
dpc-3493	162	4	th	th	NUM
dpc-3493	162	5	58	58	NUM
dpc-3493	162	6	.6	.6	NUM
dpc-3493	162	7	%	%	NOUN
dpc-3493	162	8	(	(	PUNCT
dpc-3493	162	9	n	n	NOUN
dpc-3493	162	10	=	=	NOUN
dpc-3493	162	11	1	1	NUM
dpc-3493	162	12	7	7	NUM
dpc-3493	162	13	)	)	PUNCT
dpc-3493	162	14	12	12	NUM
dpc-3493	162	15	.5	.5	NUM
dpc-3493	162	16	%	%	NOUN
dpc-3493	162	17	(	(	PUNCT
dpc-3493	162	18	n	n	NOUN
dpc-3493	162	19	=	=	NOUN
dpc-3493	162	20	1	1	NUM
dpc-3493	162	21	)	)	PUNCT
dpc-3493	162	22	30	30	NUM
dpc-3493	163	1	.0	.0	NUM
dpc-3493	164	1	%	%	NOUN
dpc-3493	164	2	(	(	PUNCT
dpc-3493	164	3	n	n	CCONJ
dpc-3493	164	4	=3	=3	VERB
dpc-3493	164	5	)	)	PUNCT
dpc-3493	164	6	33	33	NUM
dpc-3493	164	7	.3	.3	NUM
dpc-3493	164	8	%	%	NOUN
dpc-3493	164	9	(	(	PUNCT
dpc-3493	164	10	n	n	NOUN
dpc-3493	164	11	=	=	NOUN
dpc-3493	164	12	2	2	NUM
dpc-3493	164	13	)	)	PUNCT
dpc-3493	164	14	69	69	NUM
dpc-3493	165	1	.2	.2	NUM
dpc-3493	165	2	%	%	NOUN
dpc-3493	165	3	(	(	PUNCT
dpc-3493	165	4	n	n	NOUN
dpc-3493	165	5	=	=	NOUN
dpc-3493	165	6	2	2	NUM
dpc-3493	165	7	7	7	NUM
dpc-3493	165	8	)	)	PUNCT
dpc-3493	165	9	67	67	NUM
dpc-3493	165	10	.5	.5	NUM
dpc-3493	165	11	%	%	NOUN
dpc-3493	165	12	(	(	PUNCT
dpc-3493	165	13	n	n	NOUN
dpc-3493	165	14	=	=	NOUN
dpc-3493	165	15	2	2	NUM
dpc-3493	165	16	7	7	NUM
dpc-3493	165	17	)	)	PUNCT
dpc-3493	165	18	10	10	NUM
dpc-3493	165	19	0	0	NUM
dpc-3493	165	20	%	%	NOUN
dpc-3493	165	21	(	(	PUNCT
dpc-3493	165	22	n	n	NOUN
dpc-3493	165	23	=	=	NOUN
dpc-3493	165	24	1	1	NUM
dpc-3493	165	25	1	1	NUM
dpc-3493	165	26	)	)	PUNCT
dpc-3493	165	27	37	37	NUM
dpc-3493	165	28	.5	.5	NUM
dpc-3493	165	29	%	%	NOUN
dpc-3493	165	30	(	(	PUNCT
dpc-3493	165	31	n	n	CCONJ
dpc-3493	165	32	=3	=3	ADJ
dpc-3493	165	33	)	)	PUNCT
dpc-3493	165	34	16	16	NUM
dpc-3493	166	1	.7	.7	NUM
dpc-3493	166	2	%	%	NOUN
dpc-3493	166	3	(	(	PUNCT
dpc-3493	166	4	n	n	NOUN
dpc-3493	166	5	=	=	NOUN
dpc-3493	166	6	1	1	NUM
dpc-3493	166	7	)	)	PUNCT
dpc-3493	166	8	58	58	NUM
dpc-3493	167	1	.6	.6	NUM
dpc-3493	167	2	%	%	NOUN
dpc-3493	167	3	(	(	PUNCT
dpc-3493	167	4	n	n	NOUN
dpc-3493	167	5	=	=	NOUN
dpc-3493	167	6	9	9	NUM
dpc-3493	167	7	2	2	NUM
dpc-3493	167	8	)	)	PUNCT
dpc-3493	167	9	pa	pa	NOUN
dpc-3493	167	10	si	si	PROPN
dpc-3493	168	1	=	=	PUNCT
dpc-3493	168	2	p	p	PROPN
dpc-3493	168	3	so	so	ADV
dpc-3493	168	4	ri	ri	PROPN
dpc-3493	168	5	as	as	SCONJ
dpc-3493	168	6	is	be	AUX
dpc-3493	168	7	a	a	PRON
dpc-3493	168	8	re	re	NOUN
dpc-3493	168	9	a	a	DET
dpc-3493	168	10	an	an	PROPN
dpc-3493	168	11	d	d	X
dpc-3493	168	12	se	se	X
dpc-3493	168	13	ve	ve	VERB
dpc-3493	168	14	ri	ri	INTJ
dpc-3493	169	1	ty	ty	INTJ
dpc-3493	169	2	i	i	PRON
dpc-3493	169	3	nd	nd	ADV
dpc-3493	169	4	ex	ex	X
dpc-3493	169	5	.	.	PUNCT
dpc-3493	170	1	original	original	ADJ
dpc-3493	170	2	article	article	NOUN
dpc-3493	170	3	|	|	ADV
dpc-3493	170	4	dermatol	dermatol	ADJ
dpc-3493	170	5	pract	pract	NOUN
dpc-3493	170	6	concept	concept	NOUN
dpc-3493	170	7	.	.	PUNCT
dpc-3493	171	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	171	2	7	7	NUM
dpc-3493	171	3	table	table	NOUN
dpc-3493	171	4	5	5	NUM
dpc-3493	171	5	.	.	PUNCT
dpc-3493	172	1	patients	patient	NOUN
dpc-3493	172	2	were	be	AUX
dpc-3493	172	3	classified	classify	VERB
dpc-3493	172	4	into	into	ADP
dpc-3493	172	5	two	two	NUM
dpc-3493	172	6	groups	group	NOUN
dpc-3493	172	7	as	as	ADP
dpc-3493	172	8	those	those	PRON
dpc-3493	172	9	treated	treat	VERB
dpc-3493	172	10	with	with	ADP
dpc-3493	172	11	biological	biological	ADJ
dpc-3493	172	12	agents	agent	NOUN
dpc-3493	172	13	and	and	CCONJ
dpc-3493	172	14	conventional	conventional	ADJ
dpc-3493	172	15	agents	agent	NOUN
dpc-3493	172	16	.	.	PUNCT
dpc-3493	173	1	no	no	DET
dpc-3493	173	2	significant	significant	ADJ
dpc-3493	173	3	difference	difference	NOUN
dpc-3493	173	4	was	be	AUX
dpc-3493	173	5	observed	observe	VERB
dpc-3493	173	6	in	in	ADP
dpc-3493	173	7	the	the	DET
dpc-3493	173	8	achieving	achieving	NOUN
dpc-3493	173	9	of	of	ADP
dpc-3493	173	10	pasi	pasi	NOUN
dpc-3493	173	11	75	75	NUM
dpc-3493	173	12	and	and	CCONJ
dpc-3493	173	13	pasi	pasi	VERB
dpc-3493	173	14	90	90	NUM
dpc-3493	173	15	responses	response	NOUN
dpc-3493	173	16	during	during	ADP
dpc-3493	173	17	the	the	DET
dpc-3493	173	18	first	first	ADJ
dpc-3493	173	19	and	and	CCONJ
dpc-3493	173	20	third	third	ADJ
dpc-3493	173	21	months	month	NOUN
dpc-3493	173	22	biological	biological	ADJ
dpc-3493	173	23	conventional	conventional	ADJ
dpc-3493	173	24	bmi	bmi	NOUN
dpc-3493	173	25	<	<	X
dpc-3493	173	26	30	30	NUM
dpc-3493	173	27	(	(	PUNCT
dpc-3493	173	28	n=157	n=157	NOUN
dpc-3493	173	29	)	)	PUNCT
dpc-3493	173	30	bmi	bmi	NOUN
dpc-3493	173	31	>	>	X
dpc-3493	173	32	30	30	NUM
dpc-3493	173	33	(	(	PUNCT
dpc-3493	173	34	n=65	n=65	NOUN
dpc-3493	173	35	)	)	PUNCT
dpc-3493	173	36	p	p	NOUN
dpc-3493	173	37	bmi	bmi	X
dpc-3493	173	38	<	<	X
dpc-3493	173	39	30	30	NUM
dpc-3493	173	40	(	(	PUNCT
dpc-3493	173	41	n=67	n=67	PROPN
dpc-3493	173	42	)	)	PUNCT
dpc-3493	173	43	bmi	bmi	NOUN
dpc-3493	173	44	>	>	X
dpc-3493	173	45	30	30	NUM
dpc-3493	173	46	(	(	PUNCT
dpc-3493	173	47	n=28	n=28	NOUN
dpc-3493	173	48	)	)	PUNCT
dpc-3493	173	49	p	p	NOUN
dpc-3493	173	50	pasi	pasi	NOUN
dpc-3493	173	51	75	75	NUM
dpc-3493	173	52	during	during	ADP
dpc-3493	173	53	the	the	DET
dpc-3493	173	54	first	first	ADJ
dpc-3493	173	55	 	 	SPACE
dpc-3493	173	56	month	month	NOUN
dpc-3493	173	57	49.0	49.0	NUM
dpc-3493	173	58	%	%	NOUN
dpc-3493	173	59	(	(	PUNCT
dpc-3493	173	60	n=77	n=77	NOUN
dpc-3493	173	61	)	)	PUNCT
dpc-3493	173	62	40.0	40.0	NUM
dpc-3493	173	63	%	%	NOUN
dpc-3493	173	64	(	(	PUNCT
dpc-3493	173	65	n=26	n=26	PROPN
dpc-3493	173	66	)	)	PUNCT
dpc-3493	173	67	0.239	0.239	NUM
dpc-3493	173	68	13.4	13.4	NUM
dpc-3493	173	69	%	%	NOUN
dpc-3493	173	70	(	(	PUNCT
dpc-3493	173	71	n=9	n=9	NOUN
dpc-3493	173	72	)	)	PUNCT
dpc-3493	173	73	3.6	3.6	NUM
dpc-3493	173	74	%	%	NOUN
dpc-3493	173	75	(	(	PUNCT
dpc-3493	173	76	n=1	n=1	PROPN
dpc-3493	173	77	)	)	PUNCT
dpc-3493	173	78	0.272	0.272	NUM
dpc-3493	173	79	pasi	pasi	NOUN
dpc-3493	173	80	90	90	NUM
dpc-3493	173	81	during	during	ADP
dpc-3493	173	82	the	the	DET
dpc-3493	173	83	first	first	ADJ
dpc-3493	173	84	 	 	SPACE
dpc-3493	173	85	month	month	NOUN
dpc-3493	173	86	33.8	33.8	NUM
dpc-3493	173	87	%	%	NOUN
dpc-3493	173	88	(	(	PUNCT
dpc-3493	173	89	n=53	n=53	ADV
dpc-3493	173	90	)	)	PUNCT
dpc-3493	173	91	33.8	33.8	NUM
dpc-3493	173	92	%	%	NOUN
dpc-3493	173	93	(	(	PUNCT
dpc-3493	173	94	n=22	n=22	PROPN
dpc-3493	173	95	)	)	PUNCT
dpc-3493	173	96	1.000	1.000	NUM
dpc-3493	173	97	9.0	9.0	NUM
dpc-3493	173	98	%	%	NOUN
dpc-3493	173	99	(	(	PUNCT
dpc-3493	173	100	n=6	n=6	NOUN
dpc-3493	173	101	)	)	PUNCT
dpc-3493	173	102	0.0	0.0	NUM
dpc-3493	173	103	%	%	NOUN
dpc-3493	173	104	(	(	PUNCT
dpc-3493	173	105	n=0	n=0	NUM
dpc-3493	173	106	)	)	PUNCT
dpc-3493	173	107	0.175	0.175	NUM
dpc-3493	173	108	pasi	pasi	NOUN
dpc-3493	173	109	75	75	NUM
dpc-3493	173	110	during	during	ADP
dpc-3493	173	111	the	the	DET
dpc-3493	173	112	third	third	ADJ
dpc-3493	173	113	 	 	SPACE
dpc-3493	173	114	month	month	NOUN
dpc-3493	173	115	70.1	70.1	NUM
dpc-3493	173	116	%	%	NOUN
dpc-3493	173	117	(	(	PUNCT
dpc-3493	173	118	n=110	n=110	PROPN
dpc-3493	173	119	)	)	PUNCT
dpc-3493	173	120	55.4	55.4	NUM
dpc-3493	173	121	%	%	NOUN
dpc-3493	173	122	(	(	PUNCT
dpc-3493	173	123	n=36	n=36	PROPN
dpc-3493	173	124	)	)	PUNCT
dpc-3493	173	125	0.044	0.044	NUM
dpc-3493	173	126	29.9	29.9	NUM
dpc-3493	173	127	%	%	NOUN
dpc-3493	173	128	(	(	PUNCT
dpc-3493	173	129	n=20	n=20	PROPN
dpc-3493	173	130	)	)	PUNCT
dpc-3493	173	131	25.0	25.0	NUM
dpc-3493	173	132	%	%	NOUN
dpc-3493	173	133	(	(	PUNCT
dpc-3493	173	134	n=7	n=7	PROPN
dpc-3493	173	135	)	)	PUNCT
dpc-3493	173	136	0.804	0.804	NUM
dpc-3493	173	137	pasi	pasi	NOUN
dpc-3493	173	138	90	90	NUM
dpc-3493	173	139	during	during	ADP
dpc-3493	173	140	the	the	DET
dpc-3493	173	141	third	third	ADJ
dpc-3493	173	142	 	 	SPACE
dpc-3493	173	143	month	month	NOUN
dpc-3493	173	144	58.6	58.6	NUM
dpc-3493	173	145	%	%	NOUN
dpc-3493	173	146	(	(	PUNCT
dpc-3493	173	147	n=92	n=92	PROPN
dpc-3493	173	148	)	)	PUNCT
dpc-3493	173	149	44.6	44.6	NUM
dpc-3493	173	150	%	%	NOUN
dpc-3493	173	151	(	(	PUNCT
dpc-3493	173	152	n=29	n=29	ADJ
dpc-3493	173	153	)	)	PUNCT
dpc-3493	173	154	0.075	0.075	NUM
dpc-3493	173	155	23.9	23.9	NUM
dpc-3493	173	156	%	%	NOUN
dpc-3493	173	157	(	(	PUNCT
dpc-3493	173	158	n=16	n=16	NOUN
dpc-3493	173	159	)	)	PUNCT
dpc-3493	173	160	3.6	3.6	NUM
dpc-3493	173	161	%	%	NOUN
dpc-3493	173	162	(	(	PUNCT
dpc-3493	173	163	n=1	n=1	PROPN
dpc-3493	173	164	)	)	PUNCT
dpc-3493	173	165	0.014	0.014	NUM
dpc-3493	173	166	bmi	bmi	NOUN
dpc-3493	173	167	=	=	PUNCT
dpc-3493	173	168	body	body	NOUN
dpc-3493	173	169	mass	mass	PROPN
dpc-3493	173	170	index	index	NOUN
dpc-3493	173	171	;	;	PUNCT
dpc-3493	173	172	pasi	pasi	NOUN
dpc-3493	173	173	=	=	SYM
dpc-3493	173	174	psoriasis	psoriasis	NOUN
dpc-3493	173	175	area	area	NOUN
dpc-3493	173	176	and	and	CCONJ
dpc-3493	173	177	severity	severity	NOUN
dpc-3493	173	178	index	index	NOUN
dpc-3493	173	179	.	.	PUNCT
dpc-3493	174	1	when	when	SCONJ
dpc-3493	174	2	patients	patient	NOUN
dpc-3493	174	3	were	be	AUX
dpc-3493	174	4	classified	classify	VERB
dpc-3493	174	5	into	into	ADP
dpc-3493	174	6	two	two	NUM
dpc-3493	174	7	groups	group	NOUN
dpc-3493	174	8	as	as	ADP
dpc-3493	174	9	those	those	PRON
dpc-3493	174	10	treated	treat	VERB
dpc-3493	174	11	with	with	ADP
dpc-3493	174	12	biological	biological	ADJ
dpc-3493	174	13	agents	agent	NOUN
dpc-3493	174	14	and	and	CCONJ
dpc-3493	174	15	conventional	conventional	ADJ
dpc-3493	174	16	agents	agent	NOUN
dpc-3493	174	17	,	,	PUNCT
dpc-3493	174	18	no	no	DET
dpc-3493	174	19	significant	significant	ADJ
dpc-3493	174	20	difference	difference	NOUN
dpc-3493	174	21	was	be	AUX
dpc-3493	174	22	observed	observe	VERB
dpc-3493	174	23	in	in	ADP
dpc-3493	174	24	achieving	achieve	VERB
dpc-3493	174	25	pasi	pasi	NOUN
dpc-3493	174	26	75	75	NUM
dpc-3493	174	27	and	and	CCONJ
dpc-3493	174	28	pasi	pasi	VERB
dpc-3493	174	29	90	90	NUM
dpc-3493	174	30	responses	response	NOUN
dpc-3493	174	31	at	at	ADP
dpc-3493	174	32	months	month	NOUN
dpc-3493	174	33	1	1	NUM
dpc-3493	174	34	and	and	CCONJ
dpc-3493	174	35	3	3	NUM
dpc-3493	174	36	(	(	PUNCT
dpc-3493	174	37	table	table	NOUN
dpc-3493	174	38	5	5	NUM
dpc-3493	174	39	)	)	PUNCT
dpc-3493	174	40	.	.	PUNCT
dpc-3493	175	1	at	at	ADP
dpc-3493	175	2	month	month	NOUN
dpc-3493	175	3	3	3	NUM
dpc-3493	175	4	,	,	PUNCT
dpc-3493	175	5	the	the	DET
dpc-3493	175	6	proportion	proportion	NOUN
dpc-3493	175	7	of	of	ADP
dpc-3493	175	8	patients	patient	NOUN
dpc-3493	175	9	who	who	PRON
dpc-3493	175	10	achieved	achieve	VERB
dpc-3493	175	11	pasi	pasi	NOUN
dpc-3493	175	12	75	75	NUM
dpc-3493	175	13	response	response	NOUN
dpc-3493	175	14	was	be	AUX
dpc-3493	175	15	70.1	70.1	NUM
dpc-3493	175	16	%	%	NOUN
dpc-3493	175	17	(	(	PUNCT
dpc-3493	175	18	n	n	NOUN
dpc-3493	175	19	=	=	SYM
dpc-3493	175	20	110	110	NUM
dpc-3493	175	21	)	)	PUNCT
dpc-3493	175	22	among	among	ADP
dpc-3493	175	23	non	non	ADJ
dpc-3493	175	24	-	-	ADJ
dpc-3493	175	25	obese	obese	ADJ
dpc-3493	175	26	patients	patient	NOUN
dpc-3493	175	27	and	and	CCONJ
dpc-3493	175	28	44.6	44.6	NUM
dpc-3493	175	29	%	%	NOUN
dpc-3493	175	30	(	(	PUNCT
dpc-3493	175	31	n=29	n=29	NOUN
dpc-3493	175	32	)	)	PUNCT
dpc-3493	175	33	among	among	ADP
dpc-3493	175	34	obese	obese	ADJ
dpc-3493	175	35	patients	patient	NOUN
dpc-3493	175	36	treated	treat	VERB
dpc-3493	175	37	with	with	ADP
dpc-3493	175	38	biological	biological	ADJ
dpc-3493	175	39	agents	agent	NOUN
dpc-3493	175	40	,	,	PUNCT
dpc-3493	175	41	reflecting	reflect	VERB
dpc-3493	175	42	a	a	DET
dpc-3493	175	43	significant	significant	ADJ
dpc-3493	175	44	difference	difference	NOUN
dpc-3493	175	45	(	(	PUNCT
dpc-3493	175	46	p=0.044	p=0.044	NOUN
dpc-3493	175	47	)	)	PUNCT
dpc-3493	175	48	.	.	PUNCT
dpc-3493	176	1	a	a	DET
dpc-3493	176	2	similar	similar	ADJ
dpc-3493	176	3	trend	trend	NOUN
dpc-3493	176	4	was	be	AUX
dpc-3493	176	5	observed	observe	VERB
dpc-3493	176	6	for	for	ADP
dpc-3493	176	7	pasi	pasi	NOUN
dpc-3493	176	8	90	90	NUM
dpc-3493	176	9	achievement	achievement	NOUN
dpc-3493	176	10	at	at	ADP
dpc-3493	176	11	month	month	NOUN
dpc-3493	176	12	3	3	NUM
dpc-3493	176	13	in	in	ADP
dpc-3493	176	14	favor	favor	NOUN
dpc-3493	176	15	of	of	ADP
dpc-3493	176	16	non	non	ADJ
dpc-3493	176	17	-	-	ADJ
dpc-3493	176	18	obese	obese	ADJ
dpc-3493	176	19	patients	patient	NOUN
dpc-3493	176	20	(	(	PUNCT
dpc-3493	176	21	p=0.075	p=0.075	NOUN
dpc-3493	176	22	)	)	PUNCT
dpc-3493	176	23	.	.	PUNCT
dpc-3493	177	1	among	among	ADP
dpc-3493	177	2	patients	patient	NOUN
dpc-3493	177	3	treated	treat	VERB
dpc-3493	177	4	with	with	ADP
dpc-3493	177	5	conventional	conventional	ADJ
dpc-3493	177	6	agents	agent	NOUN
dpc-3493	177	7	,	,	PUNCT
dpc-3493	177	8	the	the	DET
dpc-3493	177	9	difference	difference	NOUN
dpc-3493	177	10	was	be	AUX
dpc-3493	177	11	statistically	statistically	ADV
dpc-3493	177	12	significant	significant	ADJ
dpc-3493	177	13	(	(	PUNCT
dpc-3493	177	14	p	p	X
dpc-3493	177	15	=	=	NOUN
dpc-3493	177	16	0.014	0.014	NUM
dpc-3493	177	17	)	)	PUNCT
dpc-3493	177	18	.	.	PUNCT
dpc-3493	178	1	joint	joint	ADJ
dpc-3493	178	2	involvement	involvement	NOUN
dpc-3493	178	3	it	it	PRON
dpc-3493	178	4	is	be	AUX
dpc-3493	178	5	apparent	apparent	ADJ
dpc-3493	178	6	that	that	SCONJ
dpc-3493	178	7	joint	joint	ADJ
dpc-3493	178	8	involvement	involvement	NOUN
dpc-3493	178	9	is	be	AUX
dpc-3493	178	10	a	a	DET
dpc-3493	178	11	good	good	ADJ
dpc-3493	178	12	predictor	predictor	NOUN
dpc-3493	178	13	for	for	ADP
dpc-3493	178	14	achievement	achievement	NOUN
dpc-3493	178	15	of	of	ADP
dpc-3493	178	16	pasi	pasi	NOUN
dpc-3493	178	17	75	75	NUM
dpc-3493	178	18	and	and	CCONJ
dpc-3493	178	19	pasi	pasi	VERB
dpc-3493	178	20	90	90	NUM
dpc-3493	178	21	responses	response	NOUN
dpc-3493	178	22	(	(	PUNCT
dpc-3493	178	23	p	p	X
dpc-3493	178	24	=	=	NOUN
dpc-3493	178	25	0.007	0.007	NUM
dpc-3493	178	26	for	for	ADP
dpc-3493	178	27	pasi	pasi	NOUN
dpc-3493	178	28	75	75	NUM
dpc-3493	178	29	at	at	ADP
dpc-3493	178	30	month	month	NOUN
dpc-3493	178	31	1	1	NUM
dpc-3493	178	32	,	,	PUNCT
dpc-3493	178	33	p	p	X
dpc-3493	178	34	=	=	NOUN
dpc-3493	178	35	0.044	0.044	NUM
dpc-3493	178	36	for	for	ADP
dpc-3493	178	37	pasi	pasi	NOUN
dpc-3493	178	38	90	90	NUM
dpc-3493	178	39	at	at	ADP
dpc-3493	178	40	month	month	NOUN
dpc-3493	178	41	1	1	NUM
dpc-3493	178	42	;	;	PUNCT
dpc-3493	178	43	p	p	X
dpc-3493	178	44	=	=	NOUN
dpc-3493	178	45	0.003	0.003	NUM
dpc-3493	178	46	for	for	ADP
dpc-3493	178	47	pasi	pasi	NOUN
dpc-3493	178	48	75	75	NUM
dpc-3493	178	49	at	at	ADP
dpc-3493	178	50	month	month	NOUN
dpc-3493	178	51	3	3	NUM
dpc-3493	178	52	;	;	PUNCT
dpc-3493	178	53	p	p	X
dpc-3493	178	54	=	=	NOUN
dpc-3493	178	55	0.011	0.011	NUM
dpc-3493	178	56	for	for	ADP
dpc-3493	178	57	pasi	pasi	NOUN
dpc-3493	178	58	90	90	NUM
dpc-3493	178	59	at	at	ADP
dpc-3493	178	60	month	month	NOUN
dpc-3493	178	61	3	3	NUM
dpc-3493	178	62	)	)	PUNCT
dpc-3493	178	63	.	.	PUNCT
dpc-3493	179	1	joint	joint	ADJ
dpc-3493	179	2	involvement	involvement	NOUN
dpc-3493	179	3	was	be	AUX
dpc-3493	179	4	more	more	ADV
dpc-3493	179	5	common	common	ADJ
dpc-3493	179	6	among	among	ADP
dpc-3493	179	7	older	old	ADJ
dpc-3493	179	8	patients	patient	NOUN
dpc-3493	179	9	.	.	PUNCT
dpc-3493	180	1	the	the	DET
dpc-3493	180	2	mean	mean	ADJ
dpc-3493	180	3	age	age	NOUN
dpc-3493	180	4	was	be	AUX
dpc-3493	180	5	49.2±10.2	49.2±10.2	NUM
dpc-3493	180	6	years	year	NOUN
dpc-3493	180	7	among	among	ADP
dpc-3493	180	8	patients	patient	NOUN
dpc-3493	180	9	with	with	ADP
dpc-3493	180	10	joint	joint	ADJ
dpc-3493	180	11	involvement	involvement	NOUN
dpc-3493	180	12	and	and	CCONJ
dpc-3493	180	13	it	it	PRON
dpc-3493	180	14	was	be	AUX
dpc-3493	180	15	45.6±11.9	45.6±11.9	NUM
dpc-3493	180	16	years	year	NOUN
dpc-3493	180	17	among	among	ADP
dpc-3493	180	18	those	those	PRON
dpc-3493	180	19	without	without	ADP
dpc-3493	180	20	joint	joint	ADJ
dpc-3493	180	21	involvement	involvement	NOUN
dpc-3493	180	22	(	(	PUNCT
dpc-3493	180	23	p	p	X
dpc-3493	180	24	=	=	NOUN
dpc-3493	180	25	0.013	0.013	NUM
dpc-3493	180	26	)	)	PUNCT
dpc-3493	180	27	.	.	PUNCT
dpc-3493	181	1	disease	disease	NOUN
dpc-3493	181	2	duration	duration	NOUN
dpc-3493	181	3	showed	show	VERB
dpc-3493	181	4	no	no	DET
dpc-3493	181	5	significant	significant	ADJ
dpc-3493	181	6	difference	difference	NOUN
dpc-3493	181	7	regarding	regard	VERB
dpc-3493	181	8	joint	joint	ADJ
dpc-3493	181	9	involvement	involvement	NOUN
dpc-3493	181	10	.	.	PUNCT
dpc-3493	182	1	the	the	DET
dpc-3493	182	2	mean	mean	ADJ
dpc-3493	182	3	disease	disease	NOUN
dpc-3493	182	4	duration	duration	NOUN
dpc-3493	182	5	was	be	AUX
dpc-3493	182	6	15.8±9.4	15.8±9.4	NUM
dpc-3493	182	7	years	year	NOUN
dpc-3493	182	8	among	among	ADP
dpc-3493	182	9	patients	patient	NOUN
dpc-3493	182	10	with	with	ADP
dpc-3493	182	11	joint	joint	ADJ
dpc-3493	182	12	involvement	involvement	NOUN
dpc-3493	182	13	and	and	CCONJ
dpc-3493	182	14	14.5±10.8	14.5±10.8	NUM
dpc-3493	182	15	years	year	NOUN
dpc-3493	182	16	among	among	ADP
dpc-3493	182	17	those	those	PRON
dpc-3493	182	18	without	without	ADP
dpc-3493	182	19	joint	joint	ADJ
dpc-3493	182	20	involvement	involvement	NOUN
dpc-3493	182	21	(	(	PUNCT
dpc-3493	182	22	p	p	X
dpc-3493	182	23	 	 	SPACE
dpc-3493	182	24	=	=	NOUN
dpc-3493	182	25	0.366	0.366	NUM
dpc-3493	182	26	)	)	PUNCT
dpc-3493	182	27	.	.	PUNCT
dpc-3493	183	1	pruritus	pruritus	PROPN
dpc-3493	183	2	there	there	PRON
dpc-3493	183	3	was	be	VERB
dpc-3493	183	4	no	no	DET
dpc-3493	183	5	significant	significant	ADJ
dpc-3493	183	6	correlation	correlation	NOUN
dpc-3493	183	7	between	between	ADP
dpc-3493	183	8	pruritus	pruritus	NOUN
dpc-3493	183	9	and	and	CCONJ
dpc-3493	183	10	achievement	achievement	NOUN
dpc-3493	183	11	of	of	ADP
dpc-3493	183	12	pasi	pasi	NOUN
dpc-3493	183	13	75	75	NUM
dpc-3493	183	14	and	and	CCONJ
dpc-3493	183	15	pasi	pasi	VERB
dpc-3493	183	16	90	90	NUM
dpc-3493	183	17	responses	response	NOUN
dpc-3493	183	18	at	at	ADP
dpc-3493	183	19	months	month	NOUN
dpc-3493	183	20	1	1	NUM
dpc-3493	183	21	and	and	CCONJ
dpc-3493	183	22	3	3	NUM
dpc-3493	183	23	(	(	PUNCT
dpc-3493	183	24	p	p	X
dpc-3493	183	25	=	=	NOUN
dpc-3493	183	26	0.338	0.338	NUM
dpc-3493	183	27	for	for	ADP
dpc-3493	183	28	pasi	pasi	NOUN
dpc-3493	183	29	75	75	NUM
dpc-3493	183	30	at	at	ADP
dpc-3493	183	31	month	month	NOUN
dpc-3493	183	32	1	1	NUM
dpc-3493	183	33	,	,	PUNCT
dpc-3493	183	34	p	p	NOUN
dpc-3493	183	35	=	=	NOUN
dpc-3493	183	36	0.502	0.502	NUM
dpc-3493	183	37	for	for	ADP
dpc-3493	183	38	pasi	pasi	NOUN
dpc-3493	183	39	90	90	NUM
dpc-3493	183	40	at	at	ADP
dpc-3493	183	41	month	month	NOUN
dpc-3493	183	42	1	1	NUM
dpc-3493	183	43	;	;	PUNCT
dpc-3493	183	44	p	p	X
dpc-3493	183	45	=	=	NOUN
dpc-3493	183	46	0.64	0.64	NUM
dpc-3493	183	47	for	for	ADP
dpc-3493	183	48	pasi	pasi	NOUN
dpc-3493	183	49	75	75	NUM
dpc-3493	183	50	at	at	ADP
dpc-3493	183	51	month	month	NOUN
dpc-3493	183	52	3	3	NUM
dpc-3493	183	53	,	,	PUNCT
dpc-3493	183	54	p	p	NOUN
dpc-3493	183	55	=	=	NOUN
dpc-3493	183	56	0.110	0.110	NUM
dpc-3493	183	57	for	for	ADP
dpc-3493	183	58	pasi	pasi	NOUN
dpc-3493	183	59	90	90	NUM
dpc-3493	183	60	at	at	ADP
dpc-3493	183	61	month	month	NOUN
dpc-3493	183	62	3	3	NUM
dpc-3493	183	63	)	)	PUNCT
dpc-3493	183	64	.	.	PUNCT
dpc-3493	184	1	at	at	ADP
dpc-3493	184	2	month	month	NOUN
dpc-3493	184	3	3	3	NUM
dpc-3493	184	4	,	,	PUNCT
dpc-3493	184	5	the	the	DET
dpc-3493	184	6	rates	rate	NOUN
dpc-3493	184	7	of	of	ADP
dpc-3493	184	8	achieving	achieve	VERB
dpc-3493	184	9	pasi	pasi	NOUN
dpc-3493	184	10	75	75	NUM
dpc-3493	184	11	and	and	CCONJ
dpc-3493	184	12	pasi	pasi	VERB
dpc-3493	184	13	90	90	NUM
dpc-3493	184	14	responses	response	NOUN
dpc-3493	184	15	were	be	AUX
dpc-3493	184	16	better	well	ADJ
dpc-3493	184	17	among	among	ADP
dpc-3493	184	18	patients	patient	NOUN
dpc-3493	184	19	without	without	ADP
dpc-3493	184	20	pruritus	pruritus	PROPN
dpc-3493	184	21	.	.	PUNCT
dpc-3493	185	1	psychiatric	psychiatric	ADJ
dpc-3493	185	2	disorders	disorder	NOUN
dpc-3493	185	3	there	there	PRON
dpc-3493	185	4	was	be	VERB
dpc-3493	185	5	a	a	DET
dpc-3493	185	6	concomitant	concomitant	ADJ
dpc-3493	185	7	psychiatric	psychiatric	ADJ
dpc-3493	185	8	disorder	disorder	NOUN
dpc-3493	185	9	among	among	ADP
dpc-3493	185	10	16.7	16.7	NUM
dpc-3493	185	11	%	%	NOUN
dpc-3493	185	12	(	(	PUNCT
dpc-3493	185	13	n	n	NOUN
dpc-3493	185	14	=	=	SYM
dpc-3493	185	15	37	37	NUM
dpc-3493	185	16	)	)	PUNCT
dpc-3493	185	17	of	of	ADP
dpc-3493	185	18	the	the	DET
dpc-3493	185	19	patients	patient	NOUN
dpc-3493	185	20	treated	treat	VERB
dpc-3493	185	21	with	with	ADP
dpc-3493	185	22	biological	biological	ADJ
dpc-3493	185	23	agents	agent	NOUN
dpc-3493	185	24	and	and	CCONJ
dpc-3493	185	25	22.3	22.3	NUM
dpc-3493	185	26	%	%	NOUN
dpc-3493	185	27	(	(	PUNCT
dpc-3493	185	28	n	n	NOUN
dpc-3493	185	29	=	=	SYM
dpc-3493	185	30	23	23	NUM
dpc-3493	185	31	)	)	PUNCT
dpc-3493	185	32	of	of	ADP
dpc-3493	185	33	the	the	DET
dpc-3493	185	34	patients	patient	NOUN
dpc-3493	185	35	treated	treat	VERB
dpc-3493	185	36	with	with	ADP
dpc-3493	185	37	conventional	conventional	ADJ
dpc-3493	185	38	agents	agent	NOUN
dpc-3493	185	39	(	(	PUNCT
dpc-3493	185	40	p	p	X
dpc-3493	185	41	=	=	NOUN
dpc-3493	185	42	0.121	0.121	NUM
dpc-3493	185	43	)	)	PUNCT
dpc-3493	185	44	.	.	PUNCT
dpc-3493	186	1	smoking	smoke	VERB
dpc-3493	186	2	there	there	PRON
dpc-3493	186	3	was	be	VERB
dpc-3493	186	4	no	no	DET
dpc-3493	186	5	significant	significant	ADJ
dpc-3493	186	6	correlation	correlation	NOUN
dpc-3493	186	7	between	between	ADP
dpc-3493	186	8	smoking	smoking	NOUN
dpc-3493	186	9	and	and	CCONJ
dpc-3493	186	10	the	the	DET
dpc-3493	186	11	achievement	achievement	NOUN
dpc-3493	186	12	of	of	ADP
dpc-3493	186	13	pasi	pasi	NOUN
dpc-3493	186	14	75	75	NUM
dpc-3493	186	15	and	and	CCONJ
dpc-3493	186	16	pasi	pasi	VERB
dpc-3493	186	17	90	90	NUM
dpc-3493	186	18	responses	response	NOUN
dpc-3493	186	19	at	at	ADP
dpc-3493	186	20	months	month	NOUN
dpc-3493	186	21	1	1	NUM
dpc-3493	186	22	or	or	CCONJ
dpc-3493	186	23	3	3	NUM
dpc-3493	186	24	(	(	PUNCT
dpc-3493	186	25	p	p	X
dpc-3493	186	26	=	=	NOUN
dpc-3493	186	27	0.420	0.420	NUM
dpc-3493	186	28	for	for	ADP
dpc-3493	186	29	pasi	pasi	NOUN
dpc-3493	186	30	75	75	NUM
dpc-3493	186	31	at	at	ADP
dpc-3493	186	32	month	month	NOUN
dpc-3493	186	33	1	1	NUM
dpc-3493	186	34	,	,	PUNCT
dpc-3493	186	35	p	p	X
dpc-3493	186	36	=	=	PUNCT
dpc-3493	186	37	0.322	0.322	NUM
dpc-3493	186	38	for	for	ADP
dpc-3493	186	39	pasi	pasi	NOUN
dpc-3493	186	40	90	90	NUM
dpc-3493	186	41	at	at	ADP
dpc-3493	186	42	month	month	NOUN
dpc-3493	186	43	1	1	NUM
dpc-3493	186	44	;	;	PUNCT
dpc-3493	186	45	p	p	NOUN
dpc-3493	186	46	=	=	PROPN
dpc-3493	186	47	0.670	0.670	NUM
dpc-3493	186	48	for	for	ADP
dpc-3493	186	49	pasi	pasi	NOUN
dpc-3493	186	50	75	75	NUM
dpc-3493	186	51	at	at	ADP
dpc-3493	186	52	month	month	NOUN
dpc-3493	186	53	3	3	NUM
dpc-3493	186	54	,	,	PUNCT
dpc-3493	186	55	p	p	NOUN
dpc-3493	186	56	=	=	PROPN
dpc-3493	186	57	0	0	NUM
dpc-3493	186	58	.591	.591	NUM
dpc-3493	186	59	for	for	ADP
dpc-3493	186	60	pasi	pasi	NOUN
dpc-3493	186	61	90	90	NUM
dpc-3493	186	62	at	at	ADP
dpc-3493	186	63	month	month	NOUN
dpc-3493	186	64	3	3	NUM
dpc-3493	186	65	)	)	PUNCT
dpc-3493	186	66	.	.	PUNCT
dpc-3493	187	1	conclusions	conclusion	NOUN
dpc-3493	187	2	psoriasis	psoriasis	NOUN
dpc-3493	187	3	develops	develop	VERB
dpc-3493	187	4	when	when	SCONJ
dpc-3493	187	5	an	an	DET
dpc-3493	187	6	interaction	interaction	NOUN
dpc-3493	187	7	occurs	occur	VERB
dpc-3493	187	8	between	between	ADP
dpc-3493	187	9	keratinocytes	keratinocyte	NOUN
dpc-3493	187	10	and	and	CCONJ
dpc-3493	187	11	immune	immune	ADJ
dpc-3493	187	12	cells	cell	NOUN
dpc-3493	187	13	.	.	PUNCT
dpc-3493	188	1	it	it	PRON
dpc-3493	188	2	may	may	AUX
dpc-3493	188	3	be	be	AUX
dpc-3493	188	4	induced	induce	VERB
dpc-3493	188	5	by	by	ADP
dpc-3493	188	6	damage	damage	NOUN
dpc-3493	188	7	to	to	ADP
dpc-3493	188	8	the	the	DET
dpc-3493	188	9	keratinocytes	keratinocyte	NOUN
dpc-3493	188	10	due	due	ADJ
dpc-3493	188	11	to	to	ADP
dpc-3493	188	12	congenital	congenital	ADJ
dpc-3493	188	13	immune	immune	ADJ
dpc-3493	188	14	system	system	NOUN
dpc-3493	188	15	activation	activation	NOUN
dpc-3493	188	16	or	or	CCONJ
dpc-3493	188	17	neutrophil	neutrophil	ADJ
dpc-3493	188	18	activation	activation	NOUN
dpc-3493	188	19	due	due	ADJ
dpc-3493	188	20	to	to	ADP
dpc-3493	188	21	infection	infection	NOUN
dpc-3493	188	22	,	,	PUNCT
dpc-3493	188	23	increased	increased	ADJ
dpc-3493	188	24	angiogenesis	angiogenesis	NOUN
dpc-3493	188	25	,	,	PUNCT
dpc-3493	188	26	and	and	CCONJ
dpc-3493	188	27	dendritic	dendritic	ADJ
dpc-3493	188	28	cell	cell	NOUN
dpc-3493	188	29	activation	activation	NOUN
dpc-3493	188	30	[	[	X
dpc-3493	188	31	16	16	NUM
dpc-3493	188	32	]	]	PUNCT
dpc-3493	188	33	.	.	PUNCT
dpc-3493	189	1	the	the	DET
dpc-3493	189	2	il-23	il-23	NOUN
dpc-3493	189	3	released	release	VERB
dpc-3493	189	4	from	from	ADP
dpc-3493	189	5	dendritic	dendritic	ADJ
dpc-3493	189	6	cells	cell	NOUN
dpc-3493	189	7	converts	convert	VERB
dpc-3493	189	8	t	t	NOUN
dpc-3493	189	9	cells	cell	NOUN
dpc-3493	189	10	into	into	ADP
dpc-3493	189	11	th-17	th-17	NUM
dpc-3493	189	12	cells	cell	NOUN
dpc-3493	189	13	to	to	PART
dpc-3493	189	14	produce	produce	VERB
dpc-3493	189	15	il-17	il-17	NUM
dpc-3493	189	16	and	and	CCONJ
dpc-3493	189	17	il-22	il-22	NOUN
dpc-3493	189	18	.	.	PUNCT
dpc-3493	190	1	as	as	ADP
dpc-3493	190	2	a	a	DET
dpc-3493	190	3	result	result	NOUN
dpc-3493	190	4	,	,	PUNCT
dpc-3493	190	5	psoriatic	psoriatic	ADJ
dpc-3493	190	6	plaque	plaque	NOUN
dpc-3493	190	7	formation	formation	NOUN
dpc-3493	190	8	starts	start	VERB
dpc-3493	190	9	due	due	ADJ
dpc-3493	190	10	to	to	ADP
dpc-3493	190	11	keratinocyte	keratinocyte	NOUN
dpc-3493	190	12	hyperproliferation	hyperproliferation	NOUN
dpc-3493	190	13	and	and	CCONJ
dpc-3493	190	14	differentiation	differentiation	NOUN
dpc-3493	190	15	.	.	PUNCT
dpc-3493	191	1	in	in	ADP
dpc-3493	191	2	brief	brief	ADJ
dpc-3493	191	3	,	,	PUNCT
dpc-3493	191	4	the	the	DET
dpc-3493	191	5	il-23	il-23	NOUN
dpc-3493	191	6	/	/	SYM
dpc-3493	191	7	th17	th17	PROPN
dpc-3493	191	8	axis	axis	NOUN
dpc-3493	191	9	plays	play	VERB
dpc-3493	191	10	a	a	DET
dpc-3493	191	11	pivotal	pivotal	ADJ
dpc-3493	191	12	role	role	NOUN
dpc-3493	191	13	in	in	ADP
dpc-3493	191	14	the	the	DET
dpc-3493	191	15	pathogenesis	pathogenesis	NOUN
dpc-3493	191	16	of	of	ADP
dpc-3493	191	17	psoriasis	psoriasis	NOUN
dpc-3493	191	18	[	[	X
dpc-3493	191	19	16	16	NUM
dpc-3493	191	20	-	-	SYM
dpc-3493	191	21	18	18	NUM
dpc-3493	191	22	]	]	PUNCT
dpc-3493	191	23	.	.	PUNCT
dpc-3493	192	1	obesity	obesity	NOUN
dpc-3493	192	2	is	be	AUX
dpc-3493	192	3	considered	consider	VERB
dpc-3493	192	4	an	an	DET
dpc-3493	192	5	independent	independent	ADJ
dpc-3493	192	6	risk	risk	NOUN
dpc-3493	192	7	factor	factor	NOUN
dpc-3493	192	8	for	for	ADP
dpc-3493	192	9	psoriasis	psoriasis	NOUN
dpc-3493	192	10	,	,	PUNCT
dpc-3493	192	11	increasing	increase	VERB
dpc-3493	192	12	the	the	DET
dpc-3493	192	13	risk	risk	NOUN
dpc-3493	192	14	of	of	ADP
dpc-3493	192	15	psoriasis	psoriasis	NOUN
dpc-3493	192	16	development	development	NOUN
dpc-3493	192	17	.	.	PUNCT
dpc-3493	193	1	it	it	PRON
dpc-3493	193	2	has	have	AUX
dpc-3493	193	3	been	be	AUX
dpc-3493	193	4	reported	report	VERB
dpc-3493	193	5	that	that	SCONJ
dpc-3493	193	6	each	each	DET
dpc-3493	193	7	1	1	NUM
dpc-3493	193	8	kg	kg	NOUN
dpc-3493	193	9	/	/	SYM
dpc-3493	193	10	m2	m2	PROPN
dpc-3493	193	11	increase	increase	NOUN
dpc-3493	193	12	in	in	ADP
dpc-3493	193	13	bmi	bmi	NOUN
dpc-3493	193	14	corresponds	correspond	VERB
dpc-3493	193	15	8	8	NUM
dpc-3493	193	16	original	original	ADJ
dpc-3493	193	17	article	article	NOUN
dpc-3493	193	18	|	|	ADV
dpc-3493	193	19	dermatol	dermatol	ADJ
dpc-3493	193	20	pract	pract	NOUN
dpc-3493	193	21	concept	concept	NOUN
dpc-3493	193	22	.	.	PUNCT
dpc-3493	194	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	194	2	ta	ta	X
dpc-3493	194	3	b	b	PROPN
dpc-3493	194	4	le	le	X
dpc-3493	194	5	6	6	NUM
dpc-3493	194	6	.	.	PUNCT
dpc-3493	195	1	p	p	X
dpc-3493	195	2	a	a	DET
dpc-3493	195	3	si	si	NOUN
dpc-3493	195	4	7	7	NUM
dpc-3493	195	5	5	5	NUM
dpc-3493	195	6	an	an	DET
dpc-3493	195	7	d	d	X
dpc-3493	195	8	pa	pa	NOUN
dpc-3493	195	9	si	si	PROPN
dpc-3493	195	10	9	9	NUM
dpc-3493	195	11	0	0	NUM
dpc-3493	195	12	re	re	NOUN
dpc-3493	195	13	sp	sp	ADP
dpc-3493	195	14	on	on	ADP
dpc-3493	195	15	se	se	PROPN
dpc-3493	195	16	s	s	PROPN
dpc-3493	195	17	du	du	PROPN
dpc-3493	195	18	ri	ri	PROPN
dpc-3493	195	19	ng	ng	PROPN
dpc-3493	195	20	t	t	PROPN
dpc-3493	196	1	he	he	PRON
dpc-3493	196	2	fi	fi	INTJ
dpc-3493	196	3	rs	rs	PROPN
dpc-3493	196	4	t	t	PROPN
dpc-3493	196	5	an	an	PRON
dpc-3493	196	6	d	d	X
dpc-3493	196	7	th	th	X
dpc-3493	196	8	ir	ir	PROPN
dpc-3493	197	1	d	d	X
dpc-3493	197	2	m	m	PROPN
dpc-3493	197	3	on	on	ADP
dpc-3493	197	4	th	th	NUM
dpc-3493	197	5	s	s	NOUN
dpc-3493	197	6	in	in	ADP
dpc-3493	197	7	p	p	NOUN
dpc-3493	197	8	at	at	ADP
dpc-3493	197	9	ie	ie	X
dpc-3493	197	10	nt	nt	PROPN
dpc-3493	197	11	s	s	PART
dpc-3493	197	12	w	w	NOUN
dpc-3493	197	13	it	it	PRON
dpc-3493	198	1	h	h	DET
dpc-3493	199	1	a	a	DET
dpc-3493	199	2	b	b	NOUN
dpc-3493	199	3	m	m	VERB
dpc-3493	199	4	i	i	PRON
dpc-3493	199	5	>	>	X
dpc-3493	199	6	3	3	NUM
dpc-3493	199	7	0	0	NUM
dpc-3493	200	1	(	(	PUNCT
dpc-3493	200	2	o	o	INTJ
dpc-3493	200	3	be	be	AUX
dpc-3493	200	4	se	se	X
dpc-3493	200	5	)	)	PUNCT
dpc-3493	201	1	w	w	VERB
dpc-3493	201	2	he	he	PRON
dpc-3493	201	3	n	n	ADV
dpc-3493	201	4	th	th	X
dpc-3493	201	5	e	e	X
dpc-3493	201	6	bi	bi	NOUN
dpc-3493	201	7	ol	ol	PROPN
dpc-3493	202	1	og	og	PROPN
dpc-3493	202	2	ic	ic	PROPN
dpc-3493	202	3	s	s	PROPN
dpc-3493	202	4	w	w	PROPN
dpc-3493	202	5	er	er	INTJ
dpc-3493	202	6	e	e	NOUN
dpc-3493	202	7	  	  	SPACE
dpc-3493	202	8	ev	ev	PROPN
dpc-3493	202	9	al	al	PROPN
dpc-3493	202	10	ua	ua	PROPN
dpc-3493	202	11	te	te	PROPN
dpc-3493	202	12	d	d	X
dpc-3493	202	13	  	  	SPACE
dpc-3493	202	14	se	se	X
dpc-3493	202	15	pa	pa	PROPN
dpc-3493	202	16	ra	ra	PROPN
dpc-3493	202	17	te	te	INTJ
dpc-3493	202	18	ly	ly	X
dpc-3493	202	19	.	.	PUNCT
dpc-3493	203	1	c	c	NOUN
dpc-3493	203	2	o	o	NOUN
dpc-3493	203	3	n	n	CCONJ
dpc-3493	203	4	ti	ti	NOUN
dpc-3493	203	5	n	n	CCONJ
dpc-3493	203	6	u	u	NOUN
dpc-3493	203	7	o	o	X
dpc-3493	203	8	u	u	PROPN
dpc-3493	203	9	s	s	PROPN
dpc-3493	203	10	va	va	PROPN
dpc-3493	203	11	ri	ri	PROPN
dpc-3493	203	12	ab	ab	PROPN
dpc-3493	203	13	le	le	PROPN
dpc-3493	203	14	s	s	PROPN
dpc-3493	203	15	a	a	PRON
dpc-3493	203	16	d	d	PROPN
dpc-3493	203	17	a	a	DET
dpc-3493	203	18	li	li	PROPN
dpc-3493	203	19	m	m	VERB
dpc-3493	203	20	u	u	NOUN
dpc-3493	203	21	m	m	PROPN
dpc-3493	203	22	a	a	DET
dpc-3493	203	23	b	b	PROPN
dpc-3493	203	24	(	(	PUNCT
dpc-3493	203	25	n	n	NOUN
dpc-3493	203	26	=	=	SYM
dpc-3493	203	27	10	10	NUM
dpc-3493	203	28	)	)	PUNCT
dpc-3493	203	29	et	et	PROPN
dpc-3493	203	30	a	a	PRON
dpc-3493	203	31	n	n	INTJ
dpc-3493	204	1	er	er	INTJ
dpc-3493	204	2	c	c	PROPN
dpc-3493	204	3	ep	ep	PROPN
dpc-3493	204	4	t	t	PROPN
dpc-3493	204	5	(	(	PUNCT
dpc-3493	204	6	n	n	NOUN
dpc-3493	204	7	=	=	SYM
dpc-3493	204	8	2	2	NUM
dpc-3493	204	9	)	)	PUNCT
dpc-3493	204	10	in	in	ADP
dpc-3493	204	11	fl	fl	PRON
dpc-3493	204	12	ix	ix	INTJ
dpc-3493	204	13	i	i	PRON
dpc-3493	204	14	m	m	VERB
dpc-3493	204	15	a	a	DET
dpc-3493	204	16	b	b	PROPN
dpc-3493	204	17	(	(	PUNCT
dpc-3493	204	18	n	n	NOUN
dpc-3493	204	19	=	=	SYM
dpc-3493	204	20	4	4	NUM
dpc-3493	204	21	)	)	PUNCT
dpc-3493	204	22	se	se	X
dpc-3493	205	1	r	r	NOUN
dpc-3493	205	2	to	to	ADP
dpc-3493	205	3	li	li	PROPN
dpc-3493	205	4	zu	zu	PROPN
dpc-3493	205	5	m	m	PROPN
dpc-3493	205	6	a	a	DET
dpc-3493	205	7	b	b	NOUN
dpc-3493	205	8	pe	pe	INTJ
dpc-3493	205	9	g	g	NOUN
dpc-3493	205	10	o	o	PROPN
dpc-3493	205	11	l	l	NOUN
dpc-3493	205	12	(	(	PUNCT
dpc-3493	205	13	n	n	NOUN
dpc-3493	205	14	=	=	SYM
dpc-3493	205	15	4	4	NUM
dpc-3493	205	16	)	)	PUNCT
dpc-3493	205	17	u	u	PROPN
dpc-3493	205	18	st	st	PROPN
dpc-3493	205	19	ek	ek	PROPN
dpc-3493	205	20	in	in	ADP
dpc-3493	205	21	u	u	PROPN
dpc-3493	205	22	m	m	PROPN
dpc-3493	205	23	a	a	DET
dpc-3493	205	24	b	b	PROPN
dpc-3493	205	25	(	(	PUNCT
dpc-3493	205	26	n	n	NOUN
dpc-3493	205	27	=	=	SYM
dpc-3493	205	28	17	17	NUM
dpc-3493	205	29	)	)	PUNCT
dpc-3493	205	30	se	se	X
dpc-3493	206	1	c	c	PROPN
dpc-3493	206	2	u	u	PROPN
dpc-3493	206	3	k	k	PROPN
dpc-3493	206	4	in	in	ADP
dpc-3493	206	5	u	u	PROPN
dpc-3493	206	6	m	m	VERB
dpc-3493	206	7	a	a	DET
dpc-3493	206	8	b	b	PROPN
dpc-3493	206	9	(	(	PUNCT
dpc-3493	206	10	n	n	NOUN
dpc-3493	206	11	=	=	SYM
dpc-3493	206	12	19	19	NUM
dpc-3493	206	13	)	)	PUNCT
dpc-3493	206	14	ix	ix	ADP
dpc-3493	206	15	ek	ek	NOUN
dpc-3493	207	1	iz	iz	INTJ
dpc-3493	207	2	u	u	VERB
dpc-3493	207	3	m	m	VERB
dpc-3493	207	4	a	a	PRON
dpc-3493	207	5	b	b	PROPN
dpc-3493	207	6	(	(	PUNCT
dpc-3493	207	7	n	n	NOUN
dpc-3493	207	8	=	=	SYM
dpc-3493	207	9	5	5	NUM
dpc-3493	207	10	)	)	PUNCT
dpc-3493	207	11	r	r	NOUN
dpc-3493	207	12	is	be	AUX
dpc-3493	207	13	a	a	DET
dpc-3493	207	14	n	n	ADV
dpc-3493	208	1	k	k	NOUN
dpc-3493	208	2	iz	iz	INTJ
dpc-3493	208	3	u	u	VERB
dpc-3493	208	4	m	m	VERB
dpc-3493	208	5	a	a	DET
dpc-3493	208	6	b	b	PROPN
dpc-3493	208	7	(	(	PUNCT
dpc-3493	208	8	n	n	NOUN
dpc-3493	208	9	=	=	SYM
dpc-3493	208	10	2	2	NUM
dpc-3493	208	11	)	)	PUNCT
dpc-3493	208	12	g	g	PROPN
dpc-3493	208	13	u	u	PROPN
dpc-3493	208	14	se	se	PROPN
dpc-3493	208	15	lk	lk	PROPN
dpc-3493	208	16	u	u	PROPN
dpc-3493	208	17	m	m	PROPN
dpc-3493	208	18	a	a	DET
dpc-3493	208	19	b	b	PROPN
dpc-3493	208	20	(	(	PUNCT
dpc-3493	208	21	n	n	NOUN
dpc-3493	208	22	=	=	SYM
dpc-3493	208	23	2	2	NUM
dpc-3493	208	24	)	)	PUNCT
dpc-3493	208	25	to	to	ADP
dpc-3493	208	26	ta	ta	ADP
dpc-3493	208	27	l	l	PROPN
dpc-3493	208	28	b	b	PROPN
dpc-3493	208	29	io	io	PROPN
dpc-3493	208	30	lo	lo	PROPN
dpc-3493	208	31	g	g	PROPN
dpc-3493	208	32	ic	ic	PROPN
dpc-3493	208	33	(	(	PUNCT
dpc-3493	208	34	n	n	NOUN
dpc-3493	208	35	=	=	SYM
dpc-3493	208	36	65	65	NUM
dpc-3493	208	37	)	)	PUNCT
dpc-3493	208	38	pa	pa	NOUN
dpc-3493	208	39	ti	ti	PROPN
dpc-3493	208	40	en	en	X
dpc-3493	208	41	ts	ts	PROPN
dpc-3493	208	42	w	w	PROPN
dpc-3493	208	43	ho	ho	PROPN
dpc-3493	208	44	ac	ac	PROPN
dpc-3493	209	1	hi	hi	INTJ
dpc-3493	209	2	ev	ev	INTJ
dpc-3493	209	3	ed	ed	PROPN
dpc-3493	209	4	pa	pa	PROPN
dpc-3493	209	5	si	si	PROPN
dpc-3493	209	6	7	7	NUM
dpc-3493	209	7	5	5	NUM
dpc-3493	209	8	th	th	NOUN
dpc-3493	209	9	e	e	PROPN
dpc-3493	209	10	fir	fir	PROPN
dpc-3493	209	11	st	st	PROPN
dpc-3493	209	12	m	m	PROPN
dpc-3493	209	13	on	on	ADP
dpc-3493	209	14	th	th	NUM
dpc-3493	209	15	60	60	NUM
dpc-3493	209	16	.0	.0	NUM
dpc-3493	209	17	%	%	NOUN
dpc-3493	209	18	(	(	PUNCT
dpc-3493	209	19	n	n	NOUN
dpc-3493	209	20	=	=	NOUN
dpc-3493	209	21	6	6	NUM
dpc-3493	209	22	)	)	PUNCT
dpc-3493	209	23	0	0	NUM
dpc-3493	209	24	.	.	X
dpc-3493	209	25	0	0	NUM
dpc-3493	209	26	%	%	NOUN
dpc-3493	209	27	(	(	PUNCT
dpc-3493	209	28	n	n	NOUN
dpc-3493	209	29	=	=	NOUN
dpc-3493	209	30	0	0	NUM
dpc-3493	209	31	)	)	PUNCT
dpc-3493	210	1	25	25	NUM
dpc-3493	210	2	.0	.0	NUM
dpc-3493	210	3	%	%	NOUN
dpc-3493	210	4	(	(	PUNCT
dpc-3493	210	5	n	n	NOUN
dpc-3493	210	6	=	=	NOUN
dpc-3493	210	7	1	1	NUM
dpc-3493	210	8	)	)	PUNCT
dpc-3493	210	9	50	50	NUM
dpc-3493	210	10	.0	.0	NUM
dpc-3493	210	11	%	%	NOUN
dpc-3493	210	12	(	(	PUNCT
dpc-3493	210	13	n	n	NOUN
dpc-3493	210	14	=	=	NOUN
dpc-3493	210	15	2	2	NUM
dpc-3493	210	16	)	)	PUNCT
dpc-3493	210	17	35	35	NUM
dpc-3493	210	18	.3	.3	NUM
dpc-3493	210	19	%	%	NOUN
dpc-3493	210	20	(	(	PUNCT
dpc-3493	210	21	n	n	NOUN
dpc-3493	210	22	=	=	NOUN
dpc-3493	210	23	6	6	NUM
dpc-3493	210	24	)	)	PUNCT
dpc-3493	210	25	42	42	NUM
dpc-3493	210	26	.1	.1	NUM
dpc-3493	210	27	%	%	NOUN
dpc-3493	210	28	(	(	PUNCT
dpc-3493	210	29	n	n	NOUN
dpc-3493	210	30	=	=	NOUN
dpc-3493	210	31	8	8	NUM
dpc-3493	210	32	)	)	PUNCT
dpc-3493	210	33	60	60	NUM
dpc-3493	210	34	.0	.0	NUM
dpc-3493	210	35	%	%	NOUN
dpc-3493	210	36	(	(	PUNCT
dpc-3493	210	37	n	n	CCONJ
dpc-3493	210	38	=3	=3	VERB
dpc-3493	210	39	)	)	PUNCT
dpc-3493	210	40	0	0	NUM
dpc-3493	210	41	.	.	X
dpc-3493	211	1	0	0	NUM
dpc-3493	211	2	%	%	NOUN
dpc-3493	211	3	(	(	PUNCT
dpc-3493	211	4	n	n	NOUN
dpc-3493	211	5	=	=	NOUN
dpc-3493	211	6	0	0	NUM
dpc-3493	211	7	)	)	PUNCT
dpc-3493	211	8	0	0	NUM
dpc-3493	211	9	.	.	X
dpc-3493	211	10	0	0	NUM
dpc-3493	211	11	%	%	NOUN
dpc-3493	211	12	(	(	PUNCT
dpc-3493	211	13	n	n	NOUN
dpc-3493	211	14	=	=	NOUN
dpc-3493	211	15	0	0	NUM
dpc-3493	211	16	)	)	PUNCT
dpc-3493	211	17	40	40	NUM
dpc-3493	211	18	.0	.0	NUM
dpc-3493	212	1	%	%	NOUN
dpc-3493	212	2	(	(	PUNCT
dpc-3493	212	3	n	n	NOUN
dpc-3493	212	4	=	=	NOUN
dpc-3493	212	5	2	2	NUM
dpc-3493	212	6	6	6	NUM
dpc-3493	212	7	)	)	PUNCT
dpc-3493	212	8	pa	pa	NOUN
dpc-3493	212	9	ti	ti	PROPN
dpc-3493	212	10	en	en	X
dpc-3493	212	11	ts	ts	PROPN
dpc-3493	212	12	w	w	PROPN
dpc-3493	212	13	ho	ho	PROPN
dpc-3493	212	14	ac	ac	PROPN
dpc-3493	212	15	hi	hi	INTJ
dpc-3493	212	16	ev	ev	INTJ
dpc-3493	212	17	ed	ed	PROPN
dpc-3493	212	18	pa	pa	PROPN
dpc-3493	212	19	si	si	PROPN
dpc-3493	212	20	7	7	NUM
dpc-3493	212	21	5	5	NUM
dpc-3493	212	22	th	th	ADP
dpc-3493	212	23	e	e	X
dpc-3493	212	24	th	th	X
dpc-3493	212	25	ir	ir	PROPN
dpc-3493	213	1	d	d	X
dpc-3493	213	2	m	m	PROPN
dpc-3493	213	3	on	on	ADP
dpc-3493	213	4	th	th	NUM
dpc-3493	213	5	80	80	NUM
dpc-3493	213	6	.0	.0	NUM
dpc-3493	213	7	%	%	NOUN
dpc-3493	213	8	(	(	PUNCT
dpc-3493	213	9	n	n	NOUN
dpc-3493	213	10	=	=	NOUN
dpc-3493	213	11	8	8	NUM
dpc-3493	213	12	)	)	PUNCT
dpc-3493	213	13	10	10	NUM
dpc-3493	213	14	0	0	NUM
dpc-3493	213	15	%	%	NOUN
dpc-3493	213	16	(	(	PUNCT
dpc-3493	213	17	n	n	NOUN
dpc-3493	213	18	=	=	NOUN
dpc-3493	213	19	2	2	NUM
dpc-3493	213	20	)	)	PUNCT
dpc-3493	213	21	25	25	NUM
dpc-3493	213	22	.0	.0	NUM
dpc-3493	213	23	%	%	NOUN
dpc-3493	213	24	(	(	PUNCT
dpc-3493	213	25	n	n	NOUN
dpc-3493	213	26	=	=	NOUN
dpc-3493	213	27	1	1	NUM
dpc-3493	213	28	)	)	PUNCT
dpc-3493	213	29	50	50	NUM
dpc-3493	213	30	.0	.0	NUM
dpc-3493	213	31	%	%	NOUN
dpc-3493	213	32	(	(	PUNCT
dpc-3493	213	33	n	n	NOUN
dpc-3493	213	34	=	=	NOUN
dpc-3493	213	35	2	2	NUM
dpc-3493	213	36	)	)	PUNCT
dpc-3493	213	37	47	47	NUM
dpc-3493	214	1	.1	.1	NUM
dpc-3493	214	2	%	%	NOUN
dpc-3493	214	3	(	(	PUNCT
dpc-3493	214	4	n	n	NOUN
dpc-3493	214	5	=	=	NOUN
dpc-3493	214	6	8	8	NUM
dpc-3493	214	7	)	)	PUNCT
dpc-3493	214	8	52	52	NUM
dpc-3493	214	9	.6	.6	NUM
dpc-3493	214	10	%	%	NOUN
dpc-3493	214	11	(	(	PUNCT
dpc-3493	214	12	n	n	NOUN
dpc-3493	214	13	=	=	NOUN
dpc-3493	214	14	1	1	NUM
dpc-3493	214	15	0	0	NUM
dpc-3493	214	16	)	)	PUNCT
dpc-3493	214	17	60	60	NUM
dpc-3493	215	1	.0	.0	NUM
dpc-3493	216	1	%	%	NOUN
dpc-3493	216	2	(	(	PUNCT
dpc-3493	216	3	n	n	CCONJ
dpc-3493	216	4	=3	=3	VERB
dpc-3493	216	5	)	)	PUNCT
dpc-3493	216	6	0	0	NUM
dpc-3493	216	7	.	.	X
dpc-3493	217	1	0	0	NUM
dpc-3493	217	2	%	%	NOUN
dpc-3493	217	3	(	(	PUNCT
dpc-3493	217	4	n	n	NOUN
dpc-3493	217	5	=	=	NOUN
dpc-3493	217	6	0	0	NUM
dpc-3493	217	7	)	)	PUNCT
dpc-3493	217	8	10	10	NUM
dpc-3493	217	9	0	0	NUM
dpc-3493	217	10	.	.	NOUN
dpc-3493	217	11	0	0	NUM
dpc-3493	217	12	%	%	NOUN
dpc-3493	217	13	(	(	PUNCT
dpc-3493	217	14	n	n	NOUN
dpc-3493	217	15	=	=	NOUN
dpc-3493	217	16	2	2	NUM
dpc-3493	217	17	)	)	PUNCT
dpc-3493	217	18	55	55	NUM
dpc-3493	217	19	.4	.4	NUM
dpc-3493	217	20	%	%	NOUN
dpc-3493	217	21	(	(	PUNCT
dpc-3493	217	22	n	n	CCONJ
dpc-3493	217	23	=3	=3	VERB
dpc-3493	217	24	6	6	NUM
dpc-3493	217	25	)	)	PUNCT
dpc-3493	217	26	pa	pa	NOUN
dpc-3493	217	27	ti	ti	PROPN
dpc-3493	217	28	en	en	X
dpc-3493	217	29	ts	ts	PROPN
dpc-3493	217	30	w	w	PROPN
dpc-3493	217	31	ho	ho	PROPN
dpc-3493	217	32	ac	ac	PROPN
dpc-3493	218	1	hi	hi	INTJ
dpc-3493	218	2	ev	ev	INTJ
dpc-3493	218	3	ed	ed	PROPN
dpc-3493	218	4	pa	pa	PROPN
dpc-3493	218	5	si	si	PROPN
dpc-3493	218	6	9	9	NUM
dpc-3493	218	7	0	0	NUM
dpc-3493	218	8	th	th	X
dpc-3493	218	9	e	e	PROPN
dpc-3493	218	10	fir	fir	PROPN
dpc-3493	218	11	st	st	PROPN
dpc-3493	218	12	m	m	PROPN
dpc-3493	218	13	on	on	ADP
dpc-3493	218	14	th	th	NUM
dpc-3493	218	15	60	60	NUM
dpc-3493	218	16	.0	.0	NUM
dpc-3493	218	17	%	%	NOUN
dpc-3493	218	18	(	(	PUNCT
dpc-3493	218	19	n	n	NOUN
dpc-3493	218	20	=	=	NOUN
dpc-3493	218	21	6	6	NUM
dpc-3493	218	22	)	)	PUNCT
dpc-3493	218	23	0	0	NUM
dpc-3493	218	24	.	.	X
dpc-3493	218	25	0	0	NUM
dpc-3493	218	26	%	%	NOUN
dpc-3493	218	27	(	(	PUNCT
dpc-3493	218	28	n	n	NOUN
dpc-3493	218	29	=	=	NOUN
dpc-3493	218	30	0	0	NUM
dpc-3493	218	31	)	)	PUNCT
dpc-3493	218	32	25	25	NUM
dpc-3493	218	33	.0	.0	NUM
dpc-3493	218	34	%	%	NOUN
dpc-3493	218	35	(	(	PUNCT
dpc-3493	218	36	n	n	NOUN
dpc-3493	218	37	=	=	NOUN
dpc-3493	218	38	1	1	NUM
dpc-3493	218	39	)	)	PUNCT
dpc-3493	218	40	25	25	NUM
dpc-3493	218	41	.0	.0	NUM
dpc-3493	218	42	%	%	NOUN
dpc-3493	218	43	(	(	PUNCT
dpc-3493	218	44	n	n	NOUN
dpc-3493	218	45	=	=	NOUN
dpc-3493	218	46	1	1	NUM
dpc-3493	218	47	)	)	PUNCT
dpc-3493	218	48	23	23	NUM
dpc-3493	218	49	.5	.5	NUM
dpc-3493	218	50	%	%	NOUN
dpc-3493	218	51	(	(	PUNCT
dpc-3493	218	52	n	n	NOUN
dpc-3493	218	53	=	=	NOUN
dpc-3493	218	54	4	4	NUM
dpc-3493	218	55	)	)	PUNCT
dpc-3493	218	56	42	42	NUM
dpc-3493	219	1	.1	.1	NUM
dpc-3493	219	2	%	%	NOUN
dpc-3493	219	3	(	(	PUNCT
dpc-3493	219	4	n	n	NOUN
dpc-3493	219	5	=	=	NOUN
dpc-3493	219	6	8	8	NUM
dpc-3493	219	7	)	)	PUNCT
dpc-3493	219	8	40	40	NUM
dpc-3493	219	9	.0	.0	NUM
dpc-3493	220	1	%	%	NOUN
dpc-3493	220	2	(	(	PUNCT
dpc-3493	220	3	n	n	NOUN
dpc-3493	220	4	=	=	NOUN
dpc-3493	220	5	2	2	NUM
dpc-3493	220	6	)	)	PUNCT
dpc-3493	220	7	0	0	NUM
dpc-3493	220	8	.	.	X
dpc-3493	220	9	0	0	NUM
dpc-3493	220	10	%	%	NOUN
dpc-3493	220	11	(	(	PUNCT
dpc-3493	220	12	n	n	NOUN
dpc-3493	220	13	=	=	NOUN
dpc-3493	220	14	0	0	NUM
dpc-3493	220	15	)	)	PUNCT
dpc-3493	220	16	0	0	NUM
dpc-3493	220	17	.	.	X
dpc-3493	220	18	0	0	NUM
dpc-3493	220	19	%	%	NOUN
dpc-3493	220	20	(	(	PUNCT
dpc-3493	220	21	n	n	NOUN
dpc-3493	220	22	=	=	NOUN
dpc-3493	220	23	0	0	NUM
dpc-3493	220	24	)	)	PUNCT
dpc-3493	220	25	33	33	NUM
dpc-3493	220	26	.8	.8	NUM
dpc-3493	220	27	%	%	NOUN
dpc-3493	220	28	(	(	PUNCT
dpc-3493	220	29	n	n	NOUN
dpc-3493	220	30	=	=	NOUN
dpc-3493	220	31	2	2	NUM
dpc-3493	220	32	2	2	NUM
dpc-3493	220	33	)	)	PUNCT
dpc-3493	220	34	pa	pa	NOUN
dpc-3493	220	35	ti	ti	PROPN
dpc-3493	220	36	en	en	X
dpc-3493	220	37	ts	ts	PROPN
dpc-3493	220	38	w	w	PROPN
dpc-3493	220	39	ho	ho	PROPN
dpc-3493	220	40	ac	ac	PROPN
dpc-3493	220	41	hi	hi	INTJ
dpc-3493	220	42	ev	ev	INTJ
dpc-3493	220	43	ed	ed	PROPN
dpc-3493	220	44	pa	pa	PROPN
dpc-3493	220	45	si	si	PROPN
dpc-3493	220	46	7	7	NUM
dpc-3493	220	47	5	5	NUM
dpc-3493	220	48	th	th	ADP
dpc-3493	220	49	e	e	X
dpc-3493	220	50	th	th	X
dpc-3493	220	51	ir	ir	PROPN
dpc-3493	221	1	d	d	X
dpc-3493	221	2	m	m	PROPN
dpc-3493	221	3	on	on	ADP
dpc-3493	221	4	th	th	NUM
dpc-3493	221	5	70	70	NUM
dpc-3493	221	6	.0	.0	NUM
dpc-3493	221	7	%	%	NOUN
dpc-3493	221	8	(	(	PUNCT
dpc-3493	221	9	n	n	NOUN
dpc-3493	221	10	=	=	NOUN
dpc-3493	221	11	7	7	NUM
dpc-3493	221	12	)	)	PUNCT
dpc-3493	221	13	0	0	NUM
dpc-3493	221	14	.	.	X
dpc-3493	221	15	0	0	NUM
dpc-3493	221	16	%	%	NOUN
dpc-3493	221	17	(	(	PUNCT
dpc-3493	221	18	n	n	NOUN
dpc-3493	221	19	=	=	NOUN
dpc-3493	221	20	0	0	NUM
dpc-3493	221	21	)	)	PUNCT
dpc-3493	221	22	25	25	NUM
dpc-3493	221	23	.0	.0	NUM
dpc-3493	221	24	%	%	NOUN
dpc-3493	221	25	(	(	PUNCT
dpc-3493	221	26	n	n	NOUN
dpc-3493	221	27	=	=	NOUN
dpc-3493	221	28	1	1	NUM
dpc-3493	221	29	)	)	PUNCT
dpc-3493	221	30	50	50	NUM
dpc-3493	221	31	.0	.0	NUM
dpc-3493	221	32	%	%	NOUN
dpc-3493	221	33	(	(	PUNCT
dpc-3493	221	34	n	n	NOUN
dpc-3493	221	35	=	=	NOUN
dpc-3493	221	36	2	2	NUM
dpc-3493	221	37	)	)	PUNCT
dpc-3493	221	38	35	35	NUM
dpc-3493	221	39	.3	.3	NUM
dpc-3493	221	40	%	%	NOUN
dpc-3493	221	41	(	(	PUNCT
dpc-3493	221	42	n	n	NOUN
dpc-3493	221	43	=	=	NOUN
dpc-3493	221	44	6	6	NUM
dpc-3493	221	45	)	)	PUNCT
dpc-3493	221	46	47	47	NUM
dpc-3493	221	47	.4	.4	NUM
dpc-3493	221	48	%	%	NOUN
dpc-3493	221	49	(	(	PUNCT
dpc-3493	221	50	n	n	NOUN
dpc-3493	221	51	=	=	NOUN
dpc-3493	221	52	9	9	NUM
dpc-3493	221	53	)	)	PUNCT
dpc-3493	221	54	60	60	NUM
dpc-3493	221	55	.0	.0	NUM
dpc-3493	221	56	%	%	NOUN
dpc-3493	221	57	(	(	PUNCT
dpc-3493	221	58	n	n	CCONJ
dpc-3493	221	59	=3	=3	VERB
dpc-3493	221	60	)	)	PUNCT
dpc-3493	221	61	0	0	NUM
dpc-3493	221	62	.	.	X
dpc-3493	221	63	0	0	NUM
dpc-3493	221	64	%	%	NOUN
dpc-3493	221	65	(	(	PUNCT
dpc-3493	221	66	n	n	NOUN
dpc-3493	221	67	=	=	NOUN
dpc-3493	221	68	0	0	NUM
dpc-3493	221	69	)	)	PUNCT
dpc-3493	221	70	50	50	NUM
dpc-3493	222	1	.0	.0	NUM
dpc-3493	222	2	%	%	NOUN
dpc-3493	222	3	(	(	PUNCT
dpc-3493	222	4	n	n	NOUN
dpc-3493	222	5	=	=	NOUN
dpc-3493	222	6	1	1	NUM
dpc-3493	222	7	)	)	PUNCT
dpc-3493	222	8	44	44	NUM
dpc-3493	222	9	.6	.6	NUM
dpc-3493	222	10	%	%	NOUN
dpc-3493	222	11	(	(	PUNCT
dpc-3493	222	12	n	n	NOUN
dpc-3493	222	13	=	=	NOUN
dpc-3493	222	14	2	2	NUM
dpc-3493	222	15	9	9	NUM
dpc-3493	222	16	)	)	PUNCT
dpc-3493	222	17	pa	pa	NOUN
dpc-3493	222	18	si	si	PROPN
dpc-3493	223	1	=	=	PUNCT
dpc-3493	223	2	p	p	PROPN
dpc-3493	223	3	so	so	ADV
dpc-3493	223	4	ri	ri	PROPN
dpc-3493	223	5	as	as	SCONJ
dpc-3493	223	6	is	be	AUX
dpc-3493	223	7	a	a	PRON
dpc-3493	223	8	re	re	NOUN
dpc-3493	223	9	a	a	DET
dpc-3493	223	10	an	an	PROPN
dpc-3493	223	11	d	d	X
dpc-3493	223	12	se	se	X
dpc-3493	223	13	ve	ve	VERB
dpc-3493	223	14	ri	ri	INTJ
dpc-3493	224	1	ty	ty	INTJ
dpc-3493	224	2	i	i	PRON
dpc-3493	224	3	nd	nd	ADV
dpc-3493	224	4	ex	ex	X
dpc-3493	224	5	.	.	PUNCT
dpc-3493	225	1	original	original	ADJ
dpc-3493	225	2	article	article	NOUN
dpc-3493	225	3	|	|	ADV
dpc-3493	225	4	dermatol	dermatol	ADJ
dpc-3493	225	5	pract	pract	NOUN
dpc-3493	225	6	concept	concept	NOUN
dpc-3493	225	7	.	.	PUNCT
dpc-3493	226	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	226	2	9	9	NUM
dpc-3493	226	3	table	table	NOUN
dpc-3493	226	4	7	7	NUM
dpc-3493	226	5	.	.	PUNCT
dpc-3493	227	1	the	the	DET
dpc-3493	227	2	pasi	pasi	NOUN
dpc-3493	227	3	assessments	assessment	NOUN
dpc-3493	227	4	changed	change	VERB
dpc-3493	227	5	as	as	SCONJ
dpc-3493	227	6	shown	show	VERB
dpc-3493	227	7	below	below	ADP
dpc-3493	227	8	when	when	SCONJ
dpc-3493	227	9	the	the	DET
dpc-3493	227	10	entire	entire	ADJ
dpc-3493	227	11	study	study	NOUN
dpc-3493	227	12	population	population	NOUN
dpc-3493	227	13	was	be	AUX
dpc-3493	227	14	not	not	PART
dpc-3493	227	15	classified	classify	VERB
dpc-3493	227	16	into	into	ADP
dpc-3493	227	17	treatment	treatment	NOUN
dpc-3493	227	18	groups	group	NOUN
dpc-3493	227	19	during	during	ADP
dpc-3493	227	20	the	the	DET
dpc-3493	227	21	first	first	ADJ
dpc-3493	227	22	and	and	CCONJ
dpc-3493	227	23	third	third	ADJ
dpc-3493	227	24	months	month	NOUN
dpc-3493	227	25	.	.	PUNCT
dpc-3493	228	1	bmi	bmi	PROPN
dpc-3493	228	2	<	<	X
dpc-3493	228	3	30	30	NUM
dpc-3493	228	4	(	(	PUNCT
dpc-3493	228	5	n=224	n=224	NUM
dpc-3493	228	6	)	)	PUNCT
dpc-3493	228	7	bmi	bmi	NOUN
dpc-3493	228	8	>	>	X
dpc-3493	228	9	30	30	NUM
dpc-3493	228	10	(	(	PUNCT
dpc-3493	228	11	n=93	n=93	NOUN
dpc-3493	228	12	)	)	PUNCT
dpc-3493	228	13	p	p	NOUN
dpc-3493	228	14	pasi	pasi	NOUN
dpc-3493	228	15	75	75	NUM
dpc-3493	228	16	the	the	DET
dpc-3493	228	17	first	first	ADJ
dpc-3493	228	18	month	month	NOUN
dpc-3493	228	19	38.4	38.4	NUM
dpc-3493	228	20	%	%	NOUN
dpc-3493	228	21	(	(	PUNCT
dpc-3493	228	22	n=86	n=86	PROPN
dpc-3493	228	23	)	)	PUNCT
dpc-3493	228	24	29.0	29.0	NUM
dpc-3493	228	25	%	%	NOUN
dpc-3493	228	26	(	(	PUNCT
dpc-3493	228	27	n=27	n=27	PROPN
dpc-3493	228	28	)	)	PUNCT
dpc-3493	228	29	0.124	0.124	NUM
dpc-3493	228	30	pasi	pasi	NOUN
dpc-3493	228	31	90	90	NUM
dpc-3493	228	32	the	the	DET
dpc-3493	228	33	first	first	ADJ
dpc-3493	228	34	month	month	NOUN
dpc-3493	228	35	58.0	58.0	NUM
dpc-3493	228	36	%	%	NOUN
dpc-3493	228	37	(	(	PUNCT
dpc-3493	228	38	n=130	n=130	NOUN
dpc-3493	228	39	)	)	PUNCT
dpc-3493	228	40	46.2	46.2	NUM
dpc-3493	228	41	%	%	NOUN
dpc-3493	228	42	(	(	PUNCT
dpc-3493	228	43	n=43	n=43	X
dpc-3493	228	44	)	)	PUNCT
dpc-3493	228	45	0.063	0.063	NUM
dpc-3493	228	46	pasi	pasi	NOUN
dpc-3493	228	47	75	75	NUM
dpc-3493	228	48	the	the	DET
dpc-3493	228	49	third	third	ADJ
dpc-3493	228	50	month	month	NOUN
dpc-3493	228	51	26.3	26.3	NUM
dpc-3493	228	52	%	%	NOUN
dpc-3493	228	53	(	(	PUNCT
dpc-3493	228	54	n=59	n=59	X
dpc-3493	228	55	)	)	PUNCT
dpc-3493	228	56	23.7	23.7	NUM
dpc-3493	228	57	%	%	NOUN
dpc-3493	228	58	(	(	PUNCT
dpc-3493	228	59	n=22	n=22	PROPN
dpc-3493	228	60	)	)	PUNCT
dpc-3493	228	61	0.673	0.673	NUM
dpc-3493	228	62	pasi	pasi	NOUN
dpc-3493	228	63	90	90	NUM
dpc-3493	228	64	the	the	DET
dpc-3493	228	65	third	third	ADJ
dpc-3493	228	66	month	month	NOUN
dpc-3493	228	67	48.2	48.2	NUM
dpc-3493	228	68	%	%	NOUN
dpc-3493	228	69	(	(	PUNCT
dpc-3493	228	70	n=108	n=108	PROPN
dpc-3493	228	71	)	)	PUNCT
dpc-3493	228	72	32.3	32.3	NUM
dpc-3493	228	73	%	%	NOUN
dpc-3493	228	74	(	(	PUNCT
dpc-3493	228	75	n=30	n=30	NOUN
dpc-3493	228	76	)	)	PUNCT
dpc-3493	228	77	0.009	0.009	NUM
dpc-3493	228	78	bmi	bmi	NOUN
dpc-3493	228	79	=	=	PUNCT
dpc-3493	228	80	body	body	NOUN
dpc-3493	228	81	mass	mass	PROPN
dpc-3493	228	82	index	index	NOUN
dpc-3493	228	83	;	;	PUNCT
dpc-3493	228	84	pasi	pasi	NOUN
dpc-3493	228	85	=	=	SYM
dpc-3493	228	86	psoriasis	psoriasis	NOUN
dpc-3493	228	87	area	area	NOUN
dpc-3493	228	88	and	and	CCONJ
dpc-3493	228	89	severity	severity	NOUN
dpc-3493	228	90	index	index	NOUN
dpc-3493	228	91	.	.	PUNCT
dpc-3493	229	1	to	to	ADP
dpc-3493	229	2	an	an	DET
dpc-3493	229	3	approximately	approximately	ADV
dpc-3493	229	4	4	4	NUM
dpc-3493	229	5	%	%	NOUN
dpc-3493	229	6	increase	increase	NOUN
dpc-3493	229	7	in	in	ADP
dpc-3493	229	8	the	the	DET
dpc-3493	229	9	risk	risk	NOUN
dpc-3493	229	10	of	of	ADP
dpc-3493	229	11	psoriasis	psoriasis	NOUN
dpc-3493	229	12	development	development	NOUN
dpc-3493	229	13	[	[	X
dpc-3493	229	14	19,20	19,20	X
dpc-3493	229	15	]	]	PUNCT
dpc-3493	229	16	.	.	PUNCT
dpc-3493	230	1	in	in	ADP
dpc-3493	230	2	systematic	systematic	ADJ
dpc-3493	230	3	reviews	review	NOUN
dpc-3493	230	4	,	,	PUNCT
dpc-3493	230	5	it	it	PRON
dpc-3493	230	6	was	be	AUX
dpc-3493	230	7	emphasized	emphasize	VERB
dpc-3493	230	8	that	that	SCONJ
dpc-3493	230	9	excessively	excessively	ADV
dpc-3493	230	10	high	high	ADJ
dpc-3493	230	11	bmi	bmi	NOUN
dpc-3493	230	12	values	value	NOUN
dpc-3493	230	13	are	be	AUX
dpc-3493	230	14	positively	positively	ADV
dpc-3493	230	15	associated	associate	VERB
dpc-3493	230	16	with	with	ADP
dpc-3493	230	17	disease	disease	NOUN
dpc-3493	230	18	severity	severity	NOUN
dpc-3493	230	19	in	in	ADP
dpc-3493	230	20	cases	case	NOUN
dpc-3493	230	21	of	of	ADP
dpc-3493	230	22	psoriasis	psoriasis	NOUN
dpc-3493	230	23	[	[	X
dpc-3493	230	24	18,21	18,21	NUM
dpc-3493	230	25	]	]	PUNCT
dpc-3493	230	26	.	.	PUNCT
dpc-3493	231	1	unlike	unlike	ADP
dpc-3493	231	2	other	other	ADJ
dpc-3493	231	3	adipokines	adipokine	NOUN
dpc-3493	231	4	,	,	PUNCT
dpc-3493	231	5	the	the	DET
dpc-3493	231	6	adiponectin	adiponectin	NOUN
dpc-3493	231	7	level	level	NOUN
dpc-3493	231	8	decreases	decrease	NOUN
dpc-3493	231	9	in	in	ADP
dpc-3493	231	10	the	the	DET
dpc-3493	231	11	presence	presence	NOUN
dpc-3493	231	12	of	of	ADP
dpc-3493	231	13	obesity	obesity	NOUN
dpc-3493	231	14	.	.	PUNCT
dpc-3493	232	1	a	a	DET
dpc-3493	232	2	similar	similar	ADJ
dpc-3493	232	3	decrease	decrease	NOUN
dpc-3493	232	4	is	be	AUX
dpc-3493	232	5	also	also	ADV
dpc-3493	232	6	seen	see	VERB
dpc-3493	232	7	in	in	ADP
dpc-3493	232	8	patients	patient	NOUN
dpc-3493	232	9	with	with	ADP
dpc-3493	232	10	psoriasis	psoriasis	NOUN
dpc-3493	232	11	[	[	X
dpc-3493	232	12	22	22	NUM
dpc-3493	232	13	-	-	SYM
dpc-3493	232	14	24	24	NUM
dpc-3493	232	15	]	]	PUNCT
dpc-3493	232	16	.	.	PUNCT
dpc-3493	233	1	at	at	ADP
dpc-3493	233	2	months	month	NOUN
dpc-3493	233	3	1	1	NUM
dpc-3493	233	4	and	and	CCONJ
dpc-3493	233	5	3	3	NUM
dpc-3493	233	6	,	,	PUNCT
dpc-3493	233	7	patients	patient	NOUN
dpc-3493	233	8	treated	treat	VERB
dpc-3493	233	9	with	with	ADP
dpc-3493	233	10	biological	biological	ADJ
dpc-3493	233	11	agents	agent	NOUN
dpc-3493	233	12	(	(	PUNCT
dpc-3493	233	13	n	n	NOUN
dpc-3493	233	14	=	=	SYM
dpc-3493	233	15	222	222	NUM
dpc-3493	233	16	)	)	PUNCT
dpc-3493	233	17	had	have	VERB
dpc-3493	233	18	superior	superior	ADJ
dpc-3493	233	19	results	result	NOUN
dpc-3493	233	20	compared	compare	VERB
dpc-3493	233	21	to	to	ADP
dpc-3493	233	22	patients	patient	NOUN
dpc-3493	233	23	treated	treat	VERB
dpc-3493	233	24	with	with	ADP
dpc-3493	233	25	conventional	conventional	ADJ
dpc-3493	233	26	agents	agent	NOUN
dpc-3493	233	27	(	(	PUNCT
dpc-3493	233	28	n	n	NOUN
dpc-3493	233	29	=	=	SYM
dpc-3493	233	30	95	95	NUM
dpc-3493	233	31	;	;	PUNCT
dpc-3493	233	32	methotrexate	methotrexate	NOUN
dpc-3493	233	33	and	and	CCONJ
dpc-3493	233	34	acitretin	acitretin	NOUN
dpc-3493	233	35	)	)	PUNCT
dpc-3493	233	36	in	in	ADP
dpc-3493	233	37	terms	term	NOUN
dpc-3493	233	38	of	of	ADP
dpc-3493	233	39	achieving	achieve	VERB
dpc-3493	233	40	pasi	pasi	NOUN
dpc-3493	233	41	75	75	NUM
dpc-3493	233	42	and	and	CCONJ
dpc-3493	233	43	pasi	pasi	VERB
dpc-3493	233	44	90	90	NUM
dpc-3493	233	45	responses	response	NOUN
dpc-3493	233	46	in	in	ADP
dpc-3493	233	47	both	both	DET
dpc-3493	233	48	groups	group	NOUN
dpc-3493	233	49	of	of	ADP
dpc-3493	233	50	patients	patient	NOUN
dpc-3493	233	51	with	with	ADP
dpc-3493	233	52	bmi	bmi	PROPN
dpc-3493	233	53	≥30	≥30	PROPN
dpc-3493	233	54	kg	kg	PROPN
dpc-3493	233	55	/	/	SYM
dpc-3493	233	56	m2	m2	PROPN
dpc-3493	233	57	and	and	CCONJ
dpc-3493	233	58	<	<	X
dpc-3493	233	59	30	30	NUM
dpc-3493	233	60	kg	kg	NOUN
dpc-3493	233	61	/	/	SYM
dpc-3493	233	62	m2	m2	PROPN
dpc-3493	233	63	in	in	ADP
dpc-3493	233	64	the	the	DET
dpc-3493	233	65	present	present	ADJ
dpc-3493	233	66	study	study	NOUN
dpc-3493	233	67	.	.	PUNCT
dpc-3493	234	1	this	this	DET
dpc-3493	234	2	adversely	adversely	ADV
dpc-3493	234	3	affected	affect	VERB
dpc-3493	234	4	treatment	treatment	NOUN
dpc-3493	234	5	success	success	NOUN
dpc-3493	234	6	in	in	ADP
dpc-3493	234	7	the	the	DET
dpc-3493	234	8	group	group	NOUN
dpc-3493	234	9	with	with	ADP
dpc-3493	234	10	bmi	bmi	PROPN
dpc-3493	234	11	≥30	≥30	PROPN
dpc-3493	234	12	kg	kg	PROPN
dpc-3493	234	13	/	/	SYM
dpc-3493	234	14	m2	m2	PROPN
dpc-3493	234	15	.	.	PROPN
dpc-3493	234	16	similarly	similarly	ADV
dpc-3493	234	17	,	,	PUNCT
dpc-3493	234	18	previous	previous	ADJ
dpc-3493	234	19	studies	study	NOUN
dpc-3493	234	20	found	find	VERB
dpc-3493	234	21	that	that	SCONJ
dpc-3493	234	22	high	high	ADJ
dpc-3493	234	23	bmi	bmi	NOUN
dpc-3493	234	24	values	value	NOUN
dpc-3493	234	25	increase	increase	VERB
dpc-3493	234	26	disease	disease	NOUN
dpc-3493	234	27	activity	activity	NOUN
dpc-3493	234	28	and	and	CCONJ
dpc-3493	234	29	make	make	VERB
dpc-3493	234	30	it	it	PRON
dpc-3493	234	31	difficult	difficult	ADJ
dpc-3493	234	32	to	to	PART
dpc-3493	234	33	respond	respond	VERB
dpc-3493	234	34	to	to	ADP
dpc-3493	234	35	biological	biological	ADJ
dpc-3493	234	36	treatment	treatment	NOUN
dpc-3493	234	37	agents	agent	NOUN
dpc-3493	235	1	[	[	X
dpc-3493	235	2	1	1	NUM
dpc-3493	235	3	,	,	PUNCT
dpc-3493	235	4	3	3	NUM
dpc-3493	235	5	]	]	PUNCT
dpc-3493	235	6	.	.	PUNCT
dpc-3493	236	1	il-17	il-17	ADP
dpc-3493	236	2	inhibitors	inhibitor	NOUN
dpc-3493	236	3	(	(	PUNCT
dpc-3493	236	4	ixekizumab	ixekizumab	NOUN
dpc-3493	236	5	and	and	CCONJ
dpc-3493	236	6	secukinumab	secukinumab	NOUN
dpc-3493	236	7	)	)	PUNCT
dpc-3493	236	8	and	and	CCONJ
dpc-3493	236	9	il-23	il-23	ADJ
dpc-3493	236	10	inhibitors	inhibitor	NOUN
dpc-3493	236	11	(	(	PUNCT
dpc-3493	236	12	risankizumab	risankizumab	NOUN
dpc-3493	236	13	and	and	CCONJ
dpc-3493	236	14	guselkumab	guselkumab	NOUN
dpc-3493	236	15	)	)	PUNCT
dpc-3493	236	16	may	may	AUX
dpc-3493	236	17	be	be	AUX
dpc-3493	236	18	better	well	ADJ
dpc-3493	236	19	alternatives	alternative	NOUN
dpc-3493	236	20	for	for	ADP
dpc-3493	236	21	obese	obese	ADJ
dpc-3493	236	22	individuals	individual	NOUN
dpc-3493	236	23	compared	compare	VERB
dpc-3493	236	24	to	to	ADP
dpc-3493	236	25	other	other	ADJ
dpc-3493	236	26	biological	biological	ADJ
dpc-3493	236	27	and	and	CCONJ
dpc-3493	236	28	systemic	systemic	ADJ
dpc-3493	236	29	conventional	conventional	ADJ
dpc-3493	236	30	treatments	treatment	NOUN
dpc-3493	236	31	(	(	PUNCT
dpc-3493	236	32	methotrexate	methotrexate	NOUN
dpc-3493	236	33	and	and	CCONJ
dpc-3493	236	34	acitretin	acitretin	NOUN
dpc-3493	236	35	)	)	PUNCT
dpc-3493	236	36	.	.	PUNCT
dpc-3493	237	1	these	these	DET
dpc-3493	237	2	agents	agent	NOUN
dpc-3493	237	3	have	have	VERB
dpc-3493	237	4	higher	high	ADJ
dpc-3493	237	5	treatment	treatment	NOUN
dpc-3493	237	6	success	success	NOUN
dpc-3493	237	7	and	and	CCONJ
dpc-3493	237	8	fewer	few	ADJ
dpc-3493	237	9	adverse	adverse	ADJ
dpc-3493	237	10	effects	effect	NOUN
dpc-3493	237	11	compared	compare	VERB
dpc-3493	237	12	to	to	ADP
dpc-3493	237	13	systemic	systemic	ADJ
dpc-3493	237	14	conventional	conventional	ADJ
dpc-3493	237	15	treatments	treatment	NOUN
dpc-3493	237	16	;	;	PUNCT
dpc-3493	237	17	they	they	PRON
dpc-3493	237	18	can	can	AUX
dpc-3493	237	19	facilitate	facilitate	VERB
dpc-3493	237	20	the	the	DET
dpc-3493	237	21	achievement	achievement	NOUN
dpc-3493	237	22	of	of	ADP
dpc-3493	237	23	pasi	pasi	NOUN
dpc-3493	237	24	75	75	NUM
dpc-3493	237	25	and	and	CCONJ
dpc-3493	237	26	pasi	pasi	VERB
dpc-3493	237	27	90	90	NUM
dpc-3493	237	28	responses	response	NOUN
dpc-3493	237	29	more	more	ADV
dpc-3493	237	30	readily	readily	ADV
dpc-3493	237	31	.	.	PUNCT
dpc-3493	238	1	in	in	ADP
dpc-3493	238	2	a	a	DET
dpc-3493	238	3	study	study	NOUN
dpc-3493	238	4	by	by	ADP
dpc-3493	238	5	anghel	anghel	PROPN
dpc-3493	238	6	et	et	PROPN
dpc-3493	238	7	al	al	PROPN
dpc-3493	238	8	.	.	PROPN
dpc-3493	238	9	,	,	PUNCT
dpc-3493	238	10	it	it	PRON
dpc-3493	238	11	was	be	AUX
dpc-3493	238	12	observed	observe	VERB
dpc-3493	238	13	that	that	SCONJ
dpc-3493	238	14	obese	obese	ADJ
dpc-3493	238	15	patients	patient	NOUN
dpc-3493	238	16	responded	respond	VERB
dpc-3493	238	17	more	more	ADV
dpc-3493	238	18	poorly	poorly	ADV
dpc-3493	238	19	to	to	ADP
dpc-3493	238	20	tnf	tnf	PROPN
dpc-3493	238	21	-	-	PUNCT
dpc-3493	238	22	α	α	NOUN
dpc-3493	238	23	inhibitors	inhibitor	NOUN
dpc-3493	238	24	and	and	CCONJ
dpc-3493	238	25	il-12/23	il-12/23	ADJ
dpc-3493	238	26	inhibitors	inhibitor	NOUN
dpc-3493	238	27	compared	compare	VERB
dpc-3493	238	28	to	to	ADP
dpc-3493	238	29	il-17	il-17	ADV
dpc-3493	238	30	and	and	CCONJ
dpc-3493	238	31	il-23	il-23	VERB
dpc-3493	238	32	inhibitors	inhibitor	NOUN
dpc-3493	238	33	[	[	X
dpc-3493	238	34	6	6	NUM
dpc-3493	238	35	]	]	PUNCT
dpc-3493	238	36	.	.	PUNCT
dpc-3493	239	1	in	in	ADP
dpc-3493	239	2	our	our	PRON
dpc-3493	239	3	study	study	NOUN
dpc-3493	239	4	,	,	PUNCT
dpc-3493	239	5	we	we	PRON
dpc-3493	239	6	assessed	assess	VERB
dpc-3493	239	7	risankizumab	risankizumab	NOUN
dpc-3493	239	8	and	and	CCONJ
dpc-3493	239	9	guselkumab	guselkumab	NOUN
dpc-3493	239	10	,	,	PUNCT
dpc-3493	239	11	which	which	PRON
dpc-3493	239	12	were	be	AUX
dpc-3493	239	13	recently	recently	ADV
dpc-3493	239	14	introduced	introduce	VERB
dpc-3493	239	15	in	in	ADP
dpc-3493	239	16	the	the	DET
dpc-3493	239	17	treatment	treatment	NOUN
dpc-3493	239	18	of	of	ADP
dpc-3493	239	19	psoriasis	psoriasis	NOUN
dpc-3493	239	20	.	.	PUNCT
dpc-3493	240	1	these	these	DET
dpc-3493	240	2	agents	agent	NOUN
dpc-3493	240	3	may	may	AUX
dpc-3493	240	4	be	be	AUX
dpc-3493	240	5	better	well	ADJ
dpc-3493	240	6	therapeutic	therapeutic	ADJ
dpc-3493	240	7	alternatives	alternative	NOUN
dpc-3493	240	8	for	for	ADP
dpc-3493	240	9	obese	obese	ADJ
dpc-3493	240	10	patients	patient	NOUN
dpc-3493	240	11	.	.	PUNCT
dpc-3493	241	1	in	in	ADP
dpc-3493	241	2	our	our	PRON
dpc-3493	241	3	study	study	NOUN
dpc-3493	241	4	,	,	PUNCT
dpc-3493	241	5	ixekizumab	ixekizumab	NOUN
dpc-3493	241	6	achieved	achieve	VERB
dpc-3493	241	7	the	the	DET
dpc-3493	241	8	best	good	ADJ
dpc-3493	241	9	and	and	CCONJ
dpc-3493	241	10	fastest	fast	ADJ
dpc-3493	241	11	rates	rate	NOUN
dpc-3493	241	12	of	of	ADP
dpc-3493	241	13	pasi	pasi	NOUN
dpc-3493	241	14	75	75	NUM
dpc-3493	241	15	response	response	NOUN
dpc-3493	241	16	at	at	ADP
dpc-3493	241	17	months	month	NOUN
dpc-3493	241	18	1	1	NUM
dpc-3493	241	19	and	and	CCONJ
dpc-3493	241	20	3	3	NUM
dpc-3493	241	21	compared	compare	VERB
dpc-3493	241	22	to	to	ADP
dpc-3493	241	23	other	other	ADJ
dpc-3493	241	24	biological	biological	ADJ
dpc-3493	241	25	agents	agent	NOUN
dpc-3493	241	26	.	.	PUNCT
dpc-3493	242	1	the	the	DET
dpc-3493	242	2	pasi	pasi	NOUN
dpc-3493	242	3	75	75	NUM
dpc-3493	242	4	response	response	NOUN
dpc-3493	242	5	rate	rate	NOUN
dpc-3493	242	6	was	be	AUX
dpc-3493	242	7	75	75	NUM
dpc-3493	242	8	%	%	NOUN
dpc-3493	242	9	(	(	PUNCT
dpc-3493	242	10	n	n	NOUN
dpc-3493	242	11	=	=	SYM
dpc-3493	242	12	12/16	12/16	NUM
dpc-3493	242	13	)	)	PUNCT
dpc-3493	242	14	at	at	ADP
dpc-3493	242	15	month	month	NOUN
dpc-3493	242	16	1	1	NUM
dpc-3493	242	17	and	and	CCONJ
dpc-3493	242	18	87.5	87.5	NUM
dpc-3493	242	19	%	%	NOUN
dpc-3493	242	20	(	(	PUNCT
dpc-3493	242	21	n	n	NOUN
dpc-3493	242	22	=	=	SYM
dpc-3493	242	23	14/16	14/16	NUM
dpc-3493	242	24	)	)	PUNCT
dpc-3493	242	25	at	at	ADP
dpc-3493	242	26	month	month	NOUN
dpc-3493	242	27	  	  	SPACE
dpc-3493	242	28	3	3	NUM
dpc-3493	242	29	.	.	PUNCT
dpc-3493	242	30	etanercept	etanercept	NOUN
dpc-3493	242	31	(	(	PUNCT
dpc-3493	242	32	10	10	NUM
dpc-3493	242	33	%	%	NOUN
dpc-3493	242	34	;	;	PUNCT
dpc-3493	242	35	n	n	NOUN
dpc-3493	242	36	=	=	SYM
dpc-3493	242	37	1/10	1/10	NUM
dpc-3493	242	38	)	)	PUNCT
dpc-3493	242	39	and	and	CCONJ
dpc-3493	242	40	infliximab	infliximab	NOUN
dpc-3493	242	41	(	(	PUNCT
dpc-3493	242	42	35.7	35.7	NUM
dpc-3493	242	43	%	%	NOUN
dpc-3493	242	44	;	;	PUNCT
dpc-3493	242	45	n	n	CCONJ
dpc-3493	242	46	 	 	SPACE
dpc-3493	242	47	=	=	NOUN
dpc-3493	242	48	 	 	SPACE
dpc-3493	242	49	5/14	5/14	NUM
dpc-3493	242	50	)	)	PUNCT
dpc-3493	242	51	seemed	seem	VERB
dpc-3493	242	52	to	to	PART
dpc-3493	242	53	be	be	AUX
dpc-3493	242	54	the	the	DET
dpc-3493	242	55	weakest	weak	ADJ
dpc-3493	242	56	agents	agent	NOUN
dpc-3493	242	57	regarding	regard	VERB
dpc-3493	242	58	achievement	achievement	NOUN
dpc-3493	242	59	of	of	ADP
dpc-3493	242	60	pasi	pasi	NOUN
dpc-3493	242	61	75	75	NUM
dpc-3493	242	62	response	response	NOUN
dpc-3493	242	63	at	at	ADP
dpc-3493	242	64	months	month	NOUN
dpc-3493	242	65	1	1	NUM
dpc-3493	242	66	and	and	CCONJ
dpc-3493	242	67	3	3	NUM
dpc-3493	242	68	.	.	PUNCT
dpc-3493	243	1	regarding	regard	VERB
dpc-3493	243	2	pasi	pasi	NOUN
dpc-3493	243	3	90	90	NUM
dpc-3493	243	4	response	response	NOUN
dpc-3493	243	5	,	,	PUNCT
dpc-3493	243	6	there	there	PRON
dpc-3493	243	7	was	be	VERB
dpc-3493	243	8	no	no	DET
dpc-3493	243	9	significant	significant	ADJ
dpc-3493	243	10	difference	difference	NOUN
dpc-3493	243	11	among	among	ADP
dpc-3493	243	12	biological	biological	ADJ
dpc-3493	243	13	agents	agent	NOUN
dpc-3493	243	14	at	at	ADP
dpc-3493	243	15	month	month	NOUN
dpc-3493	243	16	1	1	NUM
dpc-3493	243	17	.	.	PUNCT
dpc-3493	244	1	however	however	ADV
dpc-3493	244	2	,	,	PUNCT
dpc-3493	244	3	ixekizumab	ixekizumab	NOUN
dpc-3493	244	4	seemed	seem	VERB
dpc-3493	244	5	more	more	ADV
dpc-3493	244	6	successful	successful	ADJ
dpc-3493	244	7	at	at	ADP
dpc-3493	244	8	month	month	NOUN
dpc-3493	244	9	3	3	NUM
dpc-3493	244	10	(	(	PUNCT
dpc-3493	244	11	87.5	87.5	NUM
dpc-3493	244	12	%	%	NOUN
dpc-3493	244	13	;	;	PUNCT
dpc-3493	244	14	n	n	PROPN
dpc-3493	244	15	=	=	NUM
dpc-3493	244	16	14/16	14/16	NUM
dpc-3493	244	17	)	)	PUNCT
dpc-3493	244	18	.	.	PUNCT
dpc-3493	245	1	only	only	ADV
dpc-3493	245	2	one	one	NUM
dpc-3493	245	3	patient	patient	NOUN
dpc-3493	245	4	achieved	achieve	VERB
dpc-3493	245	5	pasi	pasi	NOUN
dpc-3493	245	6	90	90	NUM
dpc-3493	245	7	response	response	NOUN
dpc-3493	245	8	at	at	ADP
dpc-3493	245	9	month	month	NOUN
dpc-3493	245	10	3	3	NUM
dpc-3493	245	11	with	with	ADP
dpc-3493	245	12	etanercept	etanercept	NOUN
dpc-3493	245	13	.	.	PUNCT
dpc-3493	246	1	when	when	SCONJ
dpc-3493	246	2	the	the	DET
dpc-3493	246	3	rates	rate	NOUN
dpc-3493	246	4	of	of	ADP
dpc-3493	246	5	pasi	pasi	NOUN
dpc-3493	246	6	90	90	NUM
dpc-3493	246	7	response	response	NOUN
dpc-3493	246	8	were	be	AUX
dpc-3493	246	9	considered	consider	VERB
dpc-3493	246	10	,	,	PUNCT
dpc-3493	246	11	no	no	DET
dpc-3493	246	12	significant	significant	ADJ
dpc-3493	246	13	difference	difference	NOUN
dpc-3493	246	14	was	be	AUX
dpc-3493	246	15	observed	observe	VERB
dpc-3493	246	16	among	among	ADP
dpc-3493	246	17	biological	biological	ADJ
dpc-3493	246	18	agents	agent	NOUN
dpc-3493	246	19	at	at	ADP
dpc-3493	246	20	moth	moth	NOUN
dpc-3493	246	21	1	1	NUM
dpc-3493	246	22	,	,	PUNCT
dpc-3493	246	23	while	while	SCONJ
dpc-3493	246	24	ixekizumab	ixekizumab	NOUN
dpc-3493	246	25	seemed	seem	VERB
dpc-3493	246	26	better	well	ADV
dpc-3493	246	27	at	at	ADP
dpc-3493	246	28	month	month	NOUN
dpc-3493	246	29	3	3	NUM
dpc-3493	246	30	(	(	PUNCT
dpc-3493	246	31	87.5	87.5	NUM
dpc-3493	246	32	%	%	NOUN
dpc-3493	246	33	(	(	PUNCT
dpc-3493	246	34	n	n	NOUN
dpc-3493	246	35	=	=	NOUN
dpc-3493	246	36	14/16	14/16	NUM
dpc-3493	246	37	)	)	PUNCT
dpc-3493	246	38	.	.	PUNCT
dpc-3493	247	1	at	at	ADP
dpc-3493	247	2	month	month	NOUN
dpc-3493	247	3	3	3	NUM
dpc-3493	247	4	,	,	PUNCT
dpc-3493	247	5	etanercept	etanercept	NOUN
dpc-3493	247	6	seemed	seem	VERB
dpc-3493	247	7	to	to	PART
dpc-3493	247	8	be	be	AUX
dpc-3493	247	9	the	the	DET
dpc-3493	247	10	weakest	weak	ADJ
dpc-3493	247	11	agent	agent	NOUN
dpc-3493	247	12	regarding	regard	VERB
dpc-3493	247	13	pasi	pasi	NOUN
dpc-3493	247	14	90	90	NUM
dpc-3493	247	15	response	response	NOUN
dpc-3493	247	16	as	as	SCONJ
dpc-3493	247	17	only	only	ADV
dpc-3493	247	18	one	one	NUM
dpc-3493	247	19	patient	patient	NOUN
dpc-3493	247	20	in	in	ADP
dpc-3493	247	21	this	this	DET
dpc-3493	247	22	subgroup	subgroup	NOUN
dpc-3493	247	23	achieved	achieve	VERB
dpc-3493	247	24	pasi	pasi	NOUN
dpc-3493	247	25	90	90	NUM
dpc-3493	247	26	.	.	PUNCT
dpc-3493	248	1	a	a	DET
dpc-3493	248	2	recent	recent	ADJ
dpc-3493	248	3	meta	meta	ADJ
dpc-3493	248	4	-	-	PUNCT
dpc-3493	248	5	analysis	analysis	NOUN
dpc-3493	248	6	supports	support	VERB
dpc-3493	248	7	the	the	DET
dpc-3493	248	8	findings	finding	NOUN
dpc-3493	248	9	of	of	ADP
dpc-3493	248	10	the	the	DET
dpc-3493	248	11	present	present	ADJ
dpc-3493	248	12	study	study	NOUN
dpc-3493	248	13	[	[	X
dpc-3493	248	14	26	26	NUM
dpc-3493	248	15	]	]	PUNCT
dpc-3493	248	16	.	.	PUNCT
dpc-3493	249	1	according	accord	VERB
dpc-3493	249	2	to	to	ADP
dpc-3493	249	3	that	that	PRON
dpc-3493	249	4	meta	meta	ADJ
dpc-3493	249	5	-	-	PUNCT
dpc-3493	249	6	analysis	analysis	NOUN
dpc-3493	249	7	,	,	PUNCT
dpc-3493	249	8	infliximab	infliximab	NOUN
dpc-3493	249	9	,	,	PUNCT
dpc-3493	249	10	ixekizumab	ixekizumab	NOUN
dpc-3493	249	11	,	,	PUNCT
dpc-3493	249	12	brodalumab	brodalumab	NOUN
dpc-3493	249	13	,	,	PUNCT
dpc-3493	249	14	secukinumab	secukinumab	NOUN
dpc-3493	249	15	,	,	PUNCT
dpc-3493	249	16	risankizumab	risankizumab	NOUN
dpc-3493	249	17	,	,	PUNCT
dpc-3493	249	18	and	and	CCONJ
dpc-3493	249	19	guselkumab	guselkumab	NOUN
dpc-3493	249	20	were	be	AUX
dpc-3493	249	21	superior	superior	ADJ
dpc-3493	249	22	to	to	ADP
dpc-3493	249	23	ustekinumab	ustekinumab	NOUN
dpc-3493	249	24	and	and	CCONJ
dpc-3493	249	25	three	three	NUM
dpc-3493	249	26	other	other	ADJ
dpc-3493	249	27	tnf	tnf	PROPN
dpc-3493	249	28	-	-	PUNCT
dpc-3493	249	29	α	α	PROPN
dpc-3493	249	30	inhibitors	inhibitor	NOUN
dpc-3493	249	31	(	(	PUNCT
dpc-3493	249	32	adalimumab	adalimumab	NOUN
dpc-3493	249	33	,	,	PUNCT
dpc-3493	249	34	certolizumab	certolizumab	NOUN
dpc-3493	249	35	,	,	PUNCT
dpc-3493	249	36	and	and	CCONJ
dpc-3493	249	37	etanercept	etanercept	NOUN
dpc-3493	249	38	)	)	PUNCT
dpc-3493	249	39	in	in	ADP
dpc-3493	249	40	terms	term	NOUN
dpc-3493	249	41	of	of	ADP
dpc-3493	249	42	pasi	pasi	NOUN
dpc-3493	249	43	90	90	NUM
dpc-3493	249	44	response	response	NOUN
dpc-3493	249	45	rates	rate	NOUN
dpc-3493	249	46	.	.	PUNCT
dpc-3493	250	1	ustekinumab	ustekinumab	NOUN
dpc-3493	250	2	and	and	CCONJ
dpc-3493	250	3	adalimumab	adalimumab	NOUN
dpc-3493	250	4	were	be	AUX
dpc-3493	250	5	also	also	ADV
dpc-3493	250	6	superior	superior	ADJ
dpc-3493	250	7	to	to	PART
dpc-3493	250	8	etanercept	etanercept	VERB
dpc-3493	250	9	.	.	PUNCT
dpc-3493	251	1	these	these	DET
dpc-3493	251	2	findings	finding	NOUN
dpc-3493	251	3	are	be	AUX
dpc-3493	251	4	in	in	ADP
dpc-3493	251	5	agreement	agreement	NOUN
dpc-3493	251	6	with	with	ADP
dpc-3493	251	7	our	our	PRON
dpc-3493	251	8	study	study	NOUN
dpc-3493	251	9	.	.	PUNCT
dpc-3493	252	1	in	in	ADP
dpc-3493	252	2	another	another	DET
dpc-3493	252	3	meta	meta	ADJ
dpc-3493	252	4	-	-	PUNCT
dpc-3493	252	5	analysis	analysis	NOUN
dpc-3493	252	6	,	,	PUNCT
dpc-3493	252	7	it	it	PRON
dpc-3493	252	8	was	be	AUX
dpc-3493	252	9	suggested	suggest	VERB
dpc-3493	252	10	that	that	SCONJ
dpc-3493	252	11	il-17	il-17	ADV
dpc-3493	252	12	,	,	PUNCT
dpc-3493	252	13	il-12/23	il-12/23	PROPN
dpc-3493	252	14	,	,	PUNCT
dpc-3493	252	15	and	and	CCONJ
dpc-3493	252	16	il-23	il-23	NOUN
dpc-3493	252	17	inhibitors	inhibitor	NOUN
dpc-3493	252	18	have	have	VERB
dpc-3493	252	19	comparable	comparable	ADJ
dpc-3493	252	20	efficacy	efficacy	NOUN
dpc-3493	252	21	profiles	profile	NOUN
dpc-3493	252	22	in	in	ADP
dpc-3493	252	23	terms	term	NOUN
dpc-3493	252	24	of	of	ADP
dpc-3493	252	25	pasi	pasi	NOUN
dpc-3493	252	26	75	75	NUM
dpc-3493	252	27	and	and	CCONJ
dpc-3493	252	28	pasi	pasi	VERB
dpc-3493	252	29	100	100	NUM
dpc-3493	252	30	response	response	NOUN
dpc-3493	252	31	rates	rate	NOUN
dpc-3493	252	32	and	and	CCONJ
dpc-3493	252	33	that	that	SCONJ
dpc-3493	252	34	these	these	DET
dpc-3493	252	35	agents	agent	NOUN
dpc-3493	252	36	are	be	AUX
dpc-3493	252	37	superior	superior	ADJ
dpc-3493	252	38	to	to	ADP
dpc-3493	252	39	tnf	tnf	PROPN
dpc-3493	252	40	-	-	PUNCT
dpc-3493	252	41	α	α	NOUN
dpc-3493	252	42	inhibitors	inhibitor	NOUN
dpc-3493	253	1	[	[	X
dpc-3493	253	2	27	27	NUM
dpc-3493	253	3	]	]	PUNCT
dpc-3493	253	4	.	.	PUNCT
dpc-3493	254	1	guselkumab	guselkumab	NOUN
dpc-3493	254	2	was	be	AUX
dpc-3493	254	3	the	the	DET
dpc-3493	254	4	most	most	ADV
dpc-3493	254	5	commonly	commonly	ADV
dpc-3493	254	6	used	use	VERB
dpc-3493	254	7	agent	agent	NOUN
dpc-3493	254	8	after	after	ADP
dpc-3493	254	9	switching	switch	VERB
dpc-3493	254	10	treatments	treatment	NOUN
dpc-3493	254	11	(	(	PUNCT
dpc-3493	254	12	75	75	NUM
dpc-3493	254	13	%	%	NOUN
dpc-3493	254	14	;	;	PUNCT
dpc-3493	254	15	n	n	NOUN
dpc-3493	254	16	=	=	SYM
dpc-3493	254	17	6	6	NUM
dpc-3493	254	18	)	)	PUNCT
dpc-3493	254	19	;	;	PUNCT
dpc-3493	254	20	however	however	ADV
dpc-3493	254	21	,	,	PUNCT
dpc-3493	254	22	the	the	DET
dpc-3493	254	23	number	number	NOUN
dpc-3493	254	24	of	of	ADP
dpc-3493	254	25	patients	patient	NOUN
dpc-3493	254	26	who	who	PRON
dpc-3493	254	27	received	receive	VERB
dpc-3493	254	28	secukinumab	secukinumab	NOUN
dpc-3493	254	29	after	after	SCONJ
dpc-3493	254	30	switching	switch	VERB
dpc-3493	254	31	was	be	AUX
dpc-3493	254	32	highest	high	ADJ
dpc-3493	254	33	(	(	PUNCT
dpc-3493	254	34	n	n	NOUN
dpc-3493	254	35	=	=	SYM
dpc-3493	254	36	31	31	NUM
dpc-3493	254	37	)	)	PUNCT
dpc-3493	254	38	(	(	PUNCT
dpc-3493	254	39	table	table	NOUN
dpc-3493	254	40	3	3	NUM
dpc-3493	254	41	)	)	PUNCT
dpc-3493	254	42	.	.	PUNCT
dpc-3493	255	1	adalimumab	adalimumab	NOUN
dpc-3493	255	2	and	and	CCONJ
dpc-3493	255	3	etanercept	etanercept	NOUN
dpc-3493	255	4	(	(	PUNCT
dpc-3493	255	5	tnf	tnf	PROPN
dpc-3493	255	6	-	-	PUNCT
dpc-3493	255	7	α	α	PROPN
dpc-3493	255	8	inhibitors	inhibitor	NOUN
dpc-3493	255	9	)	)	PUNCT
dpc-3493	255	10	were	be	AUX
dpc-3493	255	11	the	the	DET
dpc-3493	255	12	most	most	ADV
dpc-3493	255	13	commonly	commonly	ADV
dpc-3493	255	14	changed	change	VERB
dpc-3493	255	15	biological	biological	ADJ
dpc-3493	255	16	agents	agent	NOUN
dpc-3493	255	17	.	.	PUNCT
dpc-3493	256	1	in	in	ADP
dpc-3493	256	2	our	our	PRON
dpc-3493	256	3	study	study	NOUN
dpc-3493	256	4	,	,	PUNCT
dpc-3493	256	5	it	it	PRON
dpc-3493	256	6	was	be	AUX
dpc-3493	256	7	seen	see	VERB
dpc-3493	256	8	that	that	SCONJ
dpc-3493	256	9	smoking	smoking	NOUN
dpc-3493	256	10	habit	habit	NOUN
dpc-3493	256	11	was	be	AUX
dpc-3493	256	12	not	not	PART
dpc-3493	256	13	a	a	DET
dpc-3493	256	14	significant	significant	ADJ
dpc-3493	256	15	parameter	parameter	NOUN
dpc-3493	256	16	in	in	ADP
dpc-3493	256	17	terms	term	NOUN
dpc-3493	256	18	of	of	ADP
dpc-3493	256	19	achieving	achieve	VERB
dpc-3493	256	20	pasi	pasi	NOUN
dpc-3493	256	21	75	75	NUM
dpc-3493	256	22	or	or	CCONJ
dpc-3493	256	23	pasi	pasi	VERB
dpc-3493	256	24	90	90	NUM
dpc-3493	256	25	responses	response	NOUN
dpc-3493	256	26	in	in	ADP
dpc-3493	256	27	the	the	DET
dpc-3493	256	28	groups	group	NOUN
dpc-3493	256	29	of	of	ADP
dpc-3493	256	30	patients	patient	NOUN
dpc-3493	256	31	with	with	ADP
dpc-3493	256	32	bmi	bmi	NOUN
dpc-3493	256	33	of	of	ADP
dpc-3493	256	34	<	<	PROPN
dpc-3493	256	35	30	30	NUM
dpc-3493	256	36	and	and	CCONJ
dpc-3493	256	37	bmi	bmi	NOUN
dpc-3493	256	38	of	of	ADP
dpc-3493	256	39	≥30	≥30	PROPN
dpc-3493	256	40	in	in	ADP
dpc-3493	256	41	comparisons	comparison	NOUN
dpc-3493	256	42	among	among	ADP
dpc-3493	256	43	biological	biological	ADJ
dpc-3493	256	44	agents	agent	NOUN
dpc-3493	256	45	or	or	CCONJ
dpc-3493	256	46	when	when	SCONJ
dpc-3493	256	47	biological	biological	ADJ
dpc-3493	256	48	agents	agent	NOUN
dpc-3493	256	49	were	be	AUX
dpc-3493	256	50	compared	compare	VERB
dpc-3493	256	51	with	with	ADP
dpc-3493	256	52	systemic	systemic	ADJ
dpc-3493	256	53	conventional	conventional	ADJ
dpc-3493	256	54	agents	agent	NOUN
dpc-3493	256	55	.	.	PUNCT
dpc-3493	257	1	based	base	VERB
dpc-3493	257	2	on	on	ADP
dpc-3493	257	3	a	a	DET
dpc-3493	257	4	meta	meta	ADJ
dpc-3493	257	5	-	-	PUNCT
dpc-3493	257	6	analysis	analysis	NOUN
dpc-3493	257	7	,	,	PUNCT
dpc-3493	257	8	it	it	PRON
dpc-3493	257	9	is	be	AUX
dpc-3493	257	10	known	know	VERB
dpc-3493	257	11	that	that	SCONJ
dpc-3493	257	12	smoking	smoking	NOUN
dpc-3493	257	13	facilitates	facilitate	VERB
dpc-3493	257	14	drug	drug	NOUN
dpc-3493	257	15	-	-	PUNCT
dpc-3493	257	16	induced	induce	VERB
dpc-3493	257	17	psoriasis	psoriasis	NOUN
dpc-3493	257	18	development	development	NOUN
dpc-3493	257	19	in	in	ADP
dpc-3493	257	20	patients	patient	NOUN
dpc-3493	257	21	with	with	ADP
dpc-3493	257	22	inflammatory	inflammatory	ADJ
dpc-3493	257	23	bowel	bowel	NOUN
dpc-3493	257	24	disease	disease	NOUN
dpc-3493	257	25	,	,	PUNCT
dpc-3493	257	26	and	and	CCONJ
dpc-3493	257	27	it	it	PRON
dpc-3493	257	28	was	be	AUX
dpc-3493	257	29	also	also	ADV
dpc-3493	257	30	reported	report	VERB
dpc-3493	257	31	that	that	SCONJ
dpc-3493	257	32	obesity	obesity	NOUN
dpc-3493	257	33	further	far	ADV
dpc-3493	257	34	increases	increase	VERB
dpc-3493	257	35	the	the	DET
dpc-3493	257	36	risk	risk	NOUN
dpc-3493	257	37	of	of	ADP
dpc-3493	257	38	drug	drug	NOUN
dpc-3493	257	39	-	-	PUNCT
dpc-3493	257	40	induced	induce	VERB
dpc-3493	257	41	psoriasis	psoriasis	NOUN
dpc-3493	258	1	[	[	X
dpc-3493	258	2	28,29	28,29	NUM
dpc-3493	258	3	]	]	X
dpc-3493	258	4	.	.	PUNCT
dpc-3493	259	1	the	the	DET
dpc-3493	259	2	rate	rate	NOUN
dpc-3493	259	3	of	of	ADP
dpc-3493	259	4	concomitant	concomitant	ADJ
dpc-3493	259	5	psychiatric	psychiatric	ADJ
dpc-3493	259	6	disorders	disorder	NOUN
dpc-3493	259	7	was	be	AUX
dpc-3493	259	8	higher	high	ADJ
dpc-3493	259	9	in	in	ADP
dpc-3493	259	10	the	the	DET
dpc-3493	259	11	group	group	NOUN
dpc-3493	259	12	treated	treat	VERB
dpc-3493	259	13	with	with	ADP
dpc-3493	259	14	biological	biological	ADJ
dpc-3493	259	15	agents	agent	NOUN
dpc-3493	259	16	(	(	PUNCT
dpc-3493	259	17	16.7	16.7	NUM
dpc-3493	259	18	%	%	NOUN
dpc-3493	259	19	;	;	PUNCT
dpc-3493	259	20	n	n	PROPN
dpc-3493	259	21	=	=	SYM
dpc-3493	259	22	37	37	NUM
dpc-3493	259	23	)	)	PUNCT
dpc-3493	259	24	compared	compare	VERB
dpc-3493	259	25	to	to	ADP
dpc-3493	259	26	the	the	DET
dpc-3493	259	27	group	group	NOUN
dpc-3493	259	28	treated	treat	VERB
dpc-3493	259	29	with	with	ADP
dpc-3493	259	30	systemic	systemic	ADJ
dpc-3493	259	31	conventional	conventional	ADJ
dpc-3493	259	32	agents	agent	NOUN
dpc-3493	259	33	(	(	PUNCT
dpc-3493	259	34	22.3	22.3	NUM
dpc-3493	259	35	%	%	NOUN
dpc-3493	259	36	;	;	PUNCT
dpc-3493	259	37	n	n	PROPN
dpc-3493	259	38	=	=	SYM
dpc-3493	259	39	23	23	NUM
dpc-3493	259	40	)	)	PUNCT
dpc-3493	260	1	(	(	PUNCT
dpc-3493	260	2	p	p	X
dpc-3493	260	3	=	=	NOUN
dpc-3493	260	4	0.121	0.121	NUM
dpc-3493	260	5	)	)	PUNCT
dpc-3493	260	6	.	.	PUNCT
dpc-3493	261	1	based	base	VERB
dpc-3493	261	2	on	on	ADP
dpc-3493	261	3	this	this	DET
dpc-3493	261	4	finding	finding	NOUN
dpc-3493	261	5	,	,	PUNCT
dpc-3493	261	6	it	it	PRON
dpc-3493	261	7	can	can	AUX
dpc-3493	261	8	be	be	AUX
dpc-3493	261	9	suggested	suggest	VERB
dpc-3493	261	10	that	that	SCONJ
dpc-3493	261	11	higher	high	ADJ
dpc-3493	261	12	rates	rate	NOUN
dpc-3493	261	13	of	of	ADP
dpc-3493	261	14	treatment	treatment	NOUN
dpc-3493	261	15	success	success	NOUN
dpc-3493	261	16	and	and	CCONJ
dpc-3493	261	17	better	well	ADJ
dpc-3493	261	18	profiles	profile	NOUN
dpc-3493	261	19	of	of	ADP
dpc-3493	261	20	adverse	adverse	ADJ
dpc-3493	261	21	effects	effect	NOUN
dpc-3493	261	22	with	with	ADP
dpc-3493	261	23	the	the	DET
dpc-3493	261	24	use	use	NOUN
dpc-3493	261	25	of	of	ADP
dpc-3493	261	26	biological	biological	ADJ
dpc-3493	261	27	agents	agent	NOUN
dpc-3493	261	28	compared	compare	VERB
dpc-3493	261	29	to	to	ADP
dpc-3493	261	30	systemic	systemic	ADJ
dpc-3493	261	31	conventional	conventional	ADJ
dpc-3493	261	32	agents	agent	NOUN
dpc-3493	261	33	may	may	AUX
dpc-3493	261	34	have	have	AUX
dpc-3493	261	35	improved	improve	VERB
dpc-3493	261	36	the	the	DET
dpc-3493	261	37	psychological	psychological	ADJ
dpc-3493	261	38	status	status	NOUN
dpc-3493	261	39	of	of	ADP
dpc-3493	261	40	the	the	DET
dpc-3493	261	41	patients	patient	NOUN
dpc-3493	261	42	.	.	PUNCT
dpc-3493	262	1	in	in	ADP
dpc-3493	262	2	a	a	DET
dpc-3493	262	3	study	study	NOUN
dpc-3493	262	4	of	of	ADP
dpc-3493	262	5	91	91	NUM
dpc-3493	262	6	patients	patient	NOUN
dpc-3493	262	7	in	in	ADP
dpc-3493	262	8	which	which	PRON
dpc-3493	262	9	the	the	DET
dpc-3493	262	10	risk	risk	NOUN
dpc-3493	262	11	of	of	ADP
dpc-3493	262	12	psychiatric	psychiatric	ADJ
dpc-3493	262	13	illness	illness	NOUN
dpc-3493	262	14	and	and	CCONJ
dpc-3493	262	15	suicide	suicide	NOUN
dpc-3493	262	16	was	be	AUX
dpc-3493	262	17	investigated	investigate	VERB
dpc-3493	262	18	,	,	PUNCT
dpc-3493	262	19	it	it	PRON
dpc-3493	262	20	was	be	AUX
dpc-3493	262	21	reported	report	VERB
dpc-3493	262	22	that	that	SCONJ
dpc-3493	262	23	the	the	DET
dpc-3493	262	24	risk	risk	NOUN
dpc-3493	262	25	of	of	ADP
dpc-3493	262	26	10	10	NUM
dpc-3493	262	27	original	original	ADJ
dpc-3493	262	28	article	article	NOUN
dpc-3493	262	29	|	|	ADV
dpc-3493	262	30	dermatol	dermatol	ADJ
dpc-3493	262	31	pract	pract	NOUN
dpc-3493	262	32	concept	concept	NOUN
dpc-3493	262	33	.	.	PUNCT
dpc-3493	263	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	263	2	2	2	NUM
dpc-3493	263	3	.	.	PUNCT
dpc-3493	264	1	chen	chen	PROPN
dpc-3493	264	2	yj	yj	PROPN
dpc-3493	264	3	,	,	PUNCT
dpc-3493	264	4	wu	wu	PROPN
dpc-3493	264	5	cy	cy	PROPN
dpc-3493	264	6	,	,	PUNCT
dpc-3493	264	7	chen	chen	PROPN
dpc-3493	264	8	tj	tj	PROPN
dpc-3493	264	9	,	,	PUNCT
dpc-3493	264	10	et	et	PROPN
dpc-3493	264	11	al	al	PROPN
dpc-3493	264	12	.	.	PUNCT
dpc-3493	265	1	the	the	DET
dpc-3493	265	2	risk	risk	NOUN
dpc-3493	265	3	of	of	ADP
dpc-3493	265	4	cancer	cancer	NOUN
dpc-3493	265	5	in	in	ADP
dpc-3493	265	6	patients	patient	NOUN
dpc-3493	265	7	with	with	ADP
dpc-3493	265	8	psoriasis	psoriasis	NOUN
dpc-3493	265	9	:	:	PUNCT
dpc-3493	265	10	a	a	DET
dpc-3493	265	11	population	population	NOUN
dpc-3493	265	12	-	-	PUNCT
dpc-3493	265	13	based	base	VERB
dpc-3493	265	14	cohort	cohort	NOUN
dpc-3493	265	15	study	study	NOUN
dpc-3493	265	16	in	in	ADP
dpc-3493	265	17	taiwan	taiwan	PROPN
dpc-3493	265	18	.	.	PUNCT
dpc-3493	266	1	j	j	PROPN
dpc-3493	266	2	am	be	AUX
dpc-3493	266	3	acad	acad	ADJ
dpc-3493	266	4	dermatol	dermatol	NOUN
dpc-3493	266	5	.	.	PUNCT
dpc-3493	267	1	2011;65(1):84	2011;65(1):84	NUM
dpc-3493	267	2	-	-	SYM
dpc-3493	267	3	91	91	NUM
dpc-3493	267	4	.	.	PUNCT
dpc-3493	268	1	doi	doi	NOUN
dpc-3493	268	2	:	:	PUNCT
dpc-3493	268	3	10.1016	10.1016	NUM
dpc-3493	268	4	/	/	SYM
dpc-3493	268	5	j.jaad.2010.04.046	j.jaad.2010.04.046	PROPN
dpc-3493	268	6	.	.	PUNCT
dpc-3493	269	1	pmid	pmid	NOUN
dpc-3493	269	2	:	:	PUNCT
dpc-3493	269	3	21458106	21458106	NUM
dpc-3493	269	4	.	.	PUNCT
dpc-3493	270	1	3	3	X
dpc-3493	270	2	.	.	X
dpc-3493	270	3	gonzález	gonzález	PROPN
dpc-3493	270	4	-	-	PUNCT
dpc-3493	270	5	parra	parra	PROPN
dpc-3493	270	6	s	s	PROPN
dpc-3493	270	7	,	,	PUNCT
dpc-3493	270	8	daudén	daudén	VERB
dpc-3493	270	9	e.	e.	PROPN
dpc-3493	270	10	psoriasis	psoriasis	NOUN
dpc-3493	270	11	and	and	CCONJ
dpc-3493	270	12	depression	depression	NOUN
dpc-3493	270	13	:	:	PUNCT
dpc-3493	270	14	the	the	DET
dpc-3493	270	15	role	role	NOUN
dpc-3493	270	16	of	of	ADP
dpc-3493	270	17	inflammation	inflammation	NOUN
dpc-3493	270	18	.	.	PUNCT
dpc-3493	271	1	actas	actas	PROPN
dpc-3493	271	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-3493	271	3	(	(	PUNCT
dpc-3493	271	4	engl	engl	PROPN
dpc-3493	271	5	ed	ed	NOUN
dpc-3493	271	6	)	)	PUNCT
dpc-3493	271	7	.	.	PUNCT
dpc-3493	272	1	2019;110(1):12	2019;110(1):12	NUM
dpc-3493	272	2	-	-	SYM
dpc-3493	272	3	19	19	NUM
dpc-3493	272	4	.	.	PUNCT
dpc-3493	272	5	doi	doi	NOUN
dpc-3493	272	6	:	:	PUNCT
dpc-3493	272	7	10.1016	10.1016	NUM
dpc-3493	272	8	/	/	SYM
dpc-3493	272	9	j.ad.2018.05.009	j.ad.2018.05.009	PROPN
dpc-3493	272	10	.	.	PUNCT
dpc-3493	273	1	pmid	pmid	NOUN
dpc-3493	273	2	:	:	PUNCT
dpc-3493	273	3	30509759	30509759	NUM
dpc-3493	273	4	.	.	PUNCT
dpc-3493	274	1	4	4	X
dpc-3493	274	2	.	.	X
dpc-3493	274	3	sales	sale	NOUN
dpc-3493	274	4	r	r	PROPN
dpc-3493	274	5	,	,	PUNCT
dpc-3493	274	6	torres	torre	VERB
dpc-3493	274	7	t.	t.	NOUN
dpc-3493	274	8	psoriasis	psoriasis	NOUN
dpc-3493	274	9	and	and	CCONJ
dpc-3493	274	10	metabolic	metabolic	NOUN
dpc-3493	274	11	syndrome	syndrome	NOUN
dpc-3493	274	12	.	.	PUNCT
dpc-3493	275	1	acta	acta	PROPN
dpc-3493	275	2	dermatovenerol	dermatovenerol	PROPN
dpc-3493	275	3	croat	croat	PROPN
dpc-3493	275	4	.	.	PUNCT
dpc-3493	276	1	2014;22(3):169	2014;22(3):169	NUM
dpc-3493	276	2	-	-	PUNCT
dpc-3493	276	3	174	174	NUM
dpc-3493	276	4	.	.	PUNCT
dpc-3493	277	1	pmid	pmid	NOUN
dpc-3493	277	2	:	:	PUNCT
dpc-3493	277	3	25230056	25230056	NUM
dpc-3493	277	4	.	.	PUNCT
dpc-3493	278	1	5	5	X
dpc-3493	278	2	.	.	PUNCT
dpc-3493	278	3	jensen	jensen	PROPN
dpc-3493	278	4	p	p	PROPN
dpc-3493	278	5	,	,	PUNCT
dpc-3493	278	6	skov	skov	NOUN
dpc-3493	278	7	l.	l.	NOUN
dpc-3493	278	8	psoriasis	psoriasis	NOUN
dpc-3493	278	9	and	and	CCONJ
dpc-3493	278	10	obesity	obesity	NOUN
dpc-3493	278	11	.	.	PUNCT
dpc-3493	279	1	dermatology	dermatology	NOUN
dpc-3493	279	2	.	.	PUNCT
dpc-3493	280	1	2016	2016	NUM
dpc-3493	280	2	;	;	PUNCT
dpc-3493	280	3	232(6):633	232(6):633	NUM
dpc-3493	280	4	-	-	SYM
dpc-3493	280	5	639	639	NUM
dpc-3493	280	6	.	.	PUNCT
dpc-3493	281	1	doi	doi	NOUN
dpc-3493	281	2	:	:	PUNCT
dpc-3493	281	3	10.1159/000455840	10.1159/000455840	NUM
dpc-3493	281	4	.	.	PUNCT
dpc-3493	282	1	pmid	pmid	NOUN
dpc-3493	282	2	:	:	PUNCT
dpc-3493	282	3	28226326	28226326	NUM
dpc-3493	282	4	.	.	PUNCT
dpc-3493	283	1	6	6	NUM
dpc-3493	283	2	.	.	X
dpc-3493	283	3	anghel	anghel	PROPN
dpc-3493	283	4	f	f	PROPN
dpc-3493	283	5	,	,	PUNCT
dpc-3493	283	6	nitusca	nitusca	PROPN
dpc-3493	283	7	d	d	PROPN
dpc-3493	283	8	,	,	PUNCT
dpc-3493	283	9	cristodor	cristodor	PROPN
dpc-3493	283	10	p.	p.	PROPN
dpc-3493	283	11	body	body	NOUN
dpc-3493	283	12	mass	mass	PROPN
dpc-3493	283	13	index	index	NOUN
dpc-3493	283	14	influence	influence	NOUN
dpc-3493	283	15	for	for	ADP
dpc-3493	283	16	the	the	DET
dpc-3493	283	17	personalization	personalization	NOUN
dpc-3493	283	18	of	of	ADP
dpc-3493	283	19	the	the	DET
dpc-3493	283	20	monoclonal	monoclonal	NOUN
dpc-3493	283	21	antibodies	antibodie	VERB
dpc-3493	283	22	therapy	therapy	NOUN
dpc-3493	283	23	for	for	ADP
dpc-3493	283	24	psoriasis	psoriasis	NOUN
dpc-3493	283	25	.	.	PUNCT
dpc-3493	284	1	life	life	NOUN
dpc-3493	284	2	(	(	PUNCT
dpc-3493	284	3	basel	basel	PROPN
dpc-3493	284	4	)	)	PUNCT
dpc-3493	284	5	.	.	PUNCT
dpc-3493	285	1	2021;11(12):1316	2021;11(12):1316	X
dpc-3493	285	2	.	.	PUNCT
dpc-3493	285	3	doi	doi	NOUN
dpc-3493	285	4	:	:	PUNCT
dpc-3493	285	5	10.3390	10.3390	NUM
dpc-3493	285	6	/life11121316	/life11121316	PUNCT
dpc-3493	285	7	.	.	PUNCT
dpc-3493	286	1	pmid	pmid	NOUN
dpc-3493	286	2	:	:	PUNCT
dpc-3493	286	3	34947847	34947847	NUM
dpc-3493	286	4	.	.	PUNCT
dpc-3493	287	1	pmcid	pmcid	NOUN
dpc-3493	287	2	:	:	PUNCT
dpc-3493	287	3	pmc8703749	pmc8703749	NOUN
dpc-3493	287	4	.	.	PUNCT
dpc-3493	288	1	7	7	X
dpc-3493	288	2	.	.	X
dpc-3493	288	3	ogawa	ogawa	PROPN
dpc-3493	288	4	k	k	PROPN
dpc-3493	288	5	,	,	PUNCT
dpc-3493	288	6	okada	okada	PROPN
dpc-3493	288	7	y.	y.	PROPN
dpc-3493	288	8	the	the	DET
dpc-3493	288	9	current	current	ADJ
dpc-3493	288	10	landscape	landscape	NOUN
dpc-3493	288	11	of	of	ADP
dpc-3493	288	12	psoriasis	psoriasis	NOUN
dpc-3493	288	13	genetics	genetic	NOUN
dpc-3493	288	14	in	in	ADP
dpc-3493	288	15	2020	2020	NUM
dpc-3493	288	16	.	.	PUNCT
dpc-3493	289	1	j	j	PROPN
dpc-3493	289	2	dermatol	dermatol	NOUN
dpc-3493	289	3	sci	sci	PROPN
dpc-3493	289	4	.	.	PUNCT
dpc-3493	290	1	2020;99(1):2	2020;99(1):2	NUM
dpc-3493	290	2	-	-	SYM
dpc-3493	290	3	8	8	NUM
dpc-3493	290	4	.	.	PUNCT
dpc-3493	291	1	doi	doi	NOUN
dpc-3493	291	2	:	:	PUNCT
dpc-3493	291	3	10.1016	10.1016	NUM
dpc-3493	291	4	/	/	SYM
dpc-3493	291	5	j	j	PROPN
dpc-3493	291	6	.jdermsci.2020.05.008	.jdermsci.2020.05.008	NUM
dpc-3493	291	7	.	.	PUNCT
dpc-3493	292	1	pmid	pmid	NOUN
dpc-3493	292	2	:	:	PUNCT
dpc-3493	292	3	32536600	32536600	NUM
dpc-3493	292	4	.	.	PUNCT
dpc-3493	293	1	8	8	X
dpc-3493	293	2	.	.	X
dpc-3493	293	3	orloff	orloff	PROPN
dpc-3493	293	4	jn	jn	PROPN
dpc-3493	293	5	,	,	PUNCT
dpc-3493	293	6	kaminetsky	kaminetsky	PROPN
dpc-3493	293	7	jr	jr	PROPN
dpc-3493	293	8	,	,	PUNCT
dpc-3493	293	9	aziz	aziz	PROPN
dpc-3493	293	10	m.	m.	NOUN
dpc-3493	293	11	psoriasis	psoriasis	NOUN
dpc-3493	293	12	and	and	CCONJ
dpc-3493	293	13	obesity	obesity	NOUN
dpc-3493	293	14	:	:	PUNCT
dpc-3493	293	15	a	a	DET
dpc-3493	293	16	review	review	NOUN
dpc-3493	293	17	of	of	ADP
dpc-3493	293	18	the	the	DET
dpc-3493	293	19	current	current	ADJ
dpc-3493	293	20	literature	literature	NOUN
dpc-3493	293	21	.	.	PUNCT
dpc-3493	294	1	skin	skin	NOUN
dpc-3493	294	2	the	the	DET
dpc-3493	294	3	journal	journal	NOUN
dpc-3493	294	4	of	of	ADP
dpc-3493	294	5	cutaneous	cutaneous	ADJ
dpc-3493	294	6	medicine	medicine	NOUN
dpc-3493	294	7	.	.	PUNCT
dpc-3493	295	1	2018;2(6	2018;2(6	NUM
dpc-3493	295	2	)	)	PUNCT
dpc-3493	295	3	.	.	PUNCT
dpc-3493	296	1	doi	doi	NOUN
dpc-3493	296	2	:	:	PUNCT
dpc-3493	296	3	10.25251	10.25251	NUM
dpc-3493	296	4	/	/	SYM
dpc-3493	296	5	skin.2.6.4	skin.2.6.4	CCONJ
dpc-3493	296	6	.	.	PUNCT
dpc-3493	297	1	9	9	X
dpc-3493	297	2	.	.	X
dpc-3493	297	3	barros	barros	PROPN
dpc-3493	297	4	g	g	PROPN
dpc-3493	297	5	,	,	PUNCT
dpc-3493	297	6	duran	duran	NOUN
dpc-3493	297	7	p	p	NOUN
dpc-3493	297	8	,	,	PUNCT
dpc-3493	297	9	vera	vera	NOUN
dpc-3493	297	10	i	i	NOUN
dpc-3493	297	11	,	,	PUNCT
dpc-3493	297	12	bermúdez	bermúdez	PROPN
dpc-3493	297	13	v.	v.	ADP
dpc-3493	297	14	exploring	explore	VERB
dpc-3493	297	15	the	the	DET
dpc-3493	297	16	links	link	NOUN
dpc-3493	297	17	between	between	ADP
dpc-3493	297	18	obesity	obesity	NOUN
dpc-3493	297	19	and	and	CCONJ
dpc-3493	297	20	psoriasis	psoriasis	NOUN
dpc-3493	297	21	:	:	PUNCT
dpc-3493	297	22	a	a	DET
dpc-3493	297	23	comprehensive	comprehensive	ADJ
dpc-3493	297	24	review	review	NOUN
dpc-3493	297	25	.	.	PUNCT
dpc-3493	298	1	int	int	PROPN
dpc-3493	298	2	j	j	PROPN
dpc-3493	298	3	mol	mol	ADP
dpc-3493	298	4	sci	sci	PROPN
dpc-3493	298	5	.	.	PUNCT
dpc-3493	299	1	2022;23(14):7499	2022;23(14):7499	NUM
dpc-3493	299	2	.	.	PUNCT
dpc-3493	300	1	doi	doi	NOUN
dpc-3493	300	2	:	:	PUNCT
dpc-3493	300	3	10.3390	10.3390	NUM
dpc-3493	300	4	/	/	SYM
dpc-3493	300	5	ijms23147499	ijms23147499	PROPN
dpc-3493	300	6	.	.	PUNCT
dpc-3493	301	1	pmid	pmid	NOUN
dpc-3493	301	2	:	:	PUNCT
dpc-3493	301	3	35886846	35886846	NUM
dpc-3493	301	4	.	.	PUNCT
dpc-3493	302	1	pmcid	pmcid	NOUN
dpc-3493	302	2	:	:	PUNCT
dpc-3493	302	3	pmc9321445	pmc9321445	NOUN
dpc-3493	302	4	.	.	PUNCT
dpc-3493	303	1	10	10	NUM
dpc-3493	303	2	.	.	PUNCT
dpc-3493	304	1	armstrong	armstrong	PROPN
dpc-3493	304	2	aw	aw	INTJ
dpc-3493	304	3	,	,	PUNCT
dpc-3493	304	4	read	read	VERB
dpc-3493	304	5	c.	c.	PROPN
dpc-3493	304	6	pathophysiology	pathophysiology	NOUN
dpc-3493	304	7	,	,	PUNCT
dpc-3493	304	8	clinical	clinical	ADJ
dpc-3493	304	9	presentation	presentation	NOUN
dpc-3493	304	10	,	,	PUNCT
dpc-3493	304	11	and	and	CCONJ
dpc-3493	304	12	treatment	treatment	NOUN
dpc-3493	304	13	of	of	ADP
dpc-3493	304	14	psoriasis	psoriasis	NOUN
dpc-3493	304	15	:	:	PUNCT
dpc-3493	304	16	a	a	DET
dpc-3493	304	17	review	review	NOUN
dpc-3493	304	18	.	.	PUNCT
dpc-3493	305	1	jama	jama	PROPN
dpc-3493	305	2	.	.	PUNCT
dpc-3493	306	1	2020;323(19	2020;323(19	PROPN
dpc-3493	306	2	):	):	PUNCT
dpc-3493	306	3	1945	1945	NUM
dpc-3493	306	4	-	-	SYM
dpc-3493	306	5	1960	1960	NUM
dpc-3493	306	6	.	.	PUNCT
dpc-3493	307	1	doi	doi	NOUN
dpc-3493	307	2	:	:	PUNCT
dpc-3493	307	3	10.1001	10.1001	NUM
dpc-3493	307	4	/	/	SYM
dpc-3493	307	5	jama.2020.4006	jama.2020.4006	PROPN
dpc-3493	307	6	.	.	PUNCT
dpc-3493	308	1	pmid	pmid	NOUN
dpc-3493	308	2	:	:	PUNCT
dpc-3493	308	3	32427307	32427307	NUM
dpc-3493	308	4	.	.	PUNCT
dpc-3493	309	1	11	11	NUM
dpc-3493	309	2	.	.	PUNCT
dpc-3493	310	1	kong	kong	PROPN
dpc-3493	310	2	y	y	PROPN
dpc-3493	310	3	,	,	PUNCT
dpc-3493	310	4	zhang	zhang	PROPN
dpc-3493	310	5	s	s	PROPN
dpc-3493	310	6	,	,	PUNCT
dpc-3493	310	7	wu	wu	PROPN
dpc-3493	310	8	r	r	PROPN
dpc-3493	310	9	,	,	PUNCT
dpc-3493	310	10	et	et	PROPN
dpc-3493	310	11	al	al	PROPN
dpc-3493	310	12	.	.	PUNCT
dpc-3493	311	1	new	new	ADJ
dpc-3493	311	2	insights	insight	NOUN
dpc-3493	311	3	into	into	ADP
dpc-3493	311	4	different	different	ADJ
dpc-3493	311	5	adipokines	adipokine	NOUN
dpc-3493	311	6	in	in	ADP
dpc-3493	311	7	linking	link	VERB
dpc-3493	311	8	the	the	DET
dpc-3493	311	9	pathophysiology	pathophysiology	NOUN
dpc-3493	311	10	of	of	ADP
dpc-3493	311	11	obesity	obesity	NOUN
dpc-3493	311	12	and	and	CCONJ
dpc-3493	311	13	psoriasis	psoriasis	NOUN
dpc-3493	311	14	.	.	PUNCT
dpc-3493	312	1	lipids	lipids	ADP
dpc-3493	312	2	health	health	NOUN
dpc-3493	312	3	dis	dis	PROPN
dpc-3493	312	4	.	.	PUNCT
dpc-3493	313	1	2019;18(1):171	2019;18(1):171	NUM
dpc-3493	313	2	.	.	PUNCT
dpc-3493	314	1	doi	doi	NOUN
dpc-3493	314	2	:	:	PUNCT
dpc-3493	314	3	10.1186	10.1186	NUM
dpc-3493	314	4	/	/	SYM
dpc-3493	314	5	s12944	s12944	NOUN
dpc-3493	314	6	-	-	PUNCT
dpc-3493	314	7	019	019	NUM
dpc-3493	314	8	-1115	-1115	PROPN
dpc-3493	314	9	-	-	PUNCT
dpc-3493	314	10	3	3	NUM
dpc-3493	314	11	.	.	PUNCT
dpc-3493	315	1	pmid	pmid	NOUN
dpc-3493	315	2	:	:	PUNCT
dpc-3493	315	3	31521168	31521168	NUM
dpc-3493	315	4	.	.	PUNCT
dpc-3493	316	1	pmcid	pmcid	NOUN
dpc-3493	316	2	:	:	PUNCT
dpc-3493	316	3	pmc6745073	pmc6745073	NOUN
dpc-3493	316	4	.	.	PUNCT
dpc-3493	317	1	12	12	NUM
dpc-3493	317	2	.	.	PUNCT
dpc-3493	318	1	snekvik	snekvik	PROPN
dpc-3493	318	2	i	i	PRON
dpc-3493	318	3	,	,	PUNCT
dpc-3493	318	4	smith	smith	PROPN
dpc-3493	318	5	ch	ch	PROPN
dpc-3493	318	6	,	,	PUNCT
dpc-3493	318	7	nilsen	nilsen	PROPN
dpc-3493	318	8	til	til	PROPN
dpc-3493	318	9	,	,	PUNCT
dpc-3493	318	10	et	et	PROPN
dpc-3493	318	11	al	al	PROPN
dpc-3493	318	12	.	.	PROPN
dpc-3493	318	13	obesity	obesity	PROPN
dpc-3493	318	14	,	,	PUNCT
dpc-3493	318	15	waist	waist	NOUN
dpc-3493	318	16	circumference	circumference	NOUN
dpc-3493	318	17	,	,	PUNCT
dpc-3493	318	18	weight	weight	NOUN
dpc-3493	318	19	change	change	NOUN
dpc-3493	318	20	,	,	PUNCT
dpc-3493	318	21	and	and	CCONJ
dpc-3493	318	22	risk	risk	NOUN
dpc-3493	318	23	of	of	ADP
dpc-3493	318	24	incident	incident	NOUN
dpc-3493	318	25	psoriasis	psoriasis	NOUN
dpc-3493	318	26	:	:	PUNCT
dpc-3493	318	27	prospective	prospective	ADJ
dpc-3493	318	28	data	datum	NOUN
dpc-3493	318	29	from	from	ADP
dpc-3493	318	30	the	the	DET
dpc-3493	318	31	hunt	hunt	NOUN
dpc-3493	318	32	study	study	NOUN
dpc-3493	318	33	.	.	PUNCT
dpc-3493	319	1	j	j	PROPN
dpc-3493	319	2	invest	invest	VERB
dpc-3493	319	3	dermatol	dermatol	NOUN
dpc-3493	319	4	.	.	PUNCT
dpc-3493	320	1	2017;137(12):2484	2017;137(12):2484	NUM
dpc-3493	320	2	-	-	SYM
dpc-3493	320	3	2490	2490	NUM
dpc-3493	320	4	.	.	PUNCT
dpc-3493	321	1	doi	doi	NOUN
dpc-3493	321	2	:	:	PUNCT
dpc-3493	321	3	10.1016	10.1016	NUM
dpc-3493	321	4	/	/	SYM
dpc-3493	321	5	j.jid.2017.07.822	j.jid.2017.07.822	NOUN
dpc-3493	321	6	.	.	PUNCT
dpc-3493	322	1	pmid	pmid	NOUN
dpc-3493	322	2	:	:	PUNCT
dpc-3493	322	3	28780086	28780086	NUM
dpc-3493	322	4	.	.	PUNCT
dpc-3493	323	1	13	13	NUM
dpc-3493	323	2	.	.	PUNCT
dpc-3493	324	1	ko	ko	PROPN
dpc-3493	324	2	sh	sh	PROPN
dpc-3493	324	3	,	,	PUNCT
dpc-3493	324	4	chi	chi	PROPN
dpc-3493	324	5	cc	cc	PROPN
dpc-3493	324	6	,	,	PUNCT
dpc-3493	324	7	yeh	yeh	PROPN
dpc-3493	324	8	ml	ml	PROPN
dpc-3493	324	9	,	,	PUNCT
dpc-3493	324	10	wang	wang	PROPN
dpc-3493	324	11	sh	sh	PROPN
dpc-3493	324	12	,	,	PUNCT
dpc-3493	324	13	tsai	tsai	PROPN
dpc-3493	324	14	ys	ys	PROPN
dpc-3493	324	15	,	,	PUNCT
dpc-3493	324	16	hsu	hsu	PROPN
dpc-3493	324	17	my	my	PRON
dpc-3493	324	18	.	.	PUNCT
dpc-3493	324	19	lifestyle	lifestyle	NOUN
dpc-3493	324	20	changes	change	NOUN
dpc-3493	324	21	for	for	ADP
dpc-3493	324	22	treating	treat	VERB
dpc-3493	324	23	psoriasis	psoriasis	NOUN
dpc-3493	324	24	.	.	PUNCT
dpc-3493	325	1	cochrane	cochrane	NOUN
dpc-3493	325	2	database	database	PROPN
dpc-3493	325	3	syst	syst	PROPN
dpc-3493	325	4	rev	rev	PROPN
dpc-3493	325	5	.	.	PROPN
dpc-3493	326	1	2019;7(7):cd011972	2019;7(7):cd011972	NUM
dpc-3493	326	2	.	.	PUNCT
dpc-3493	326	3	doi	doi	PROPN
dpc-3493	326	4	:	:	PUNCT
dpc-3493	327	1	10.1002/14651858.cd011972	10.1002/14651858.cd011972	NUM
dpc-3493	327	2	.	.	PUNCT
dpc-3493	328	1	pub2	pub2	PROPN
dpc-3493	328	2	.	.	PUNCT
dpc-3493	329	1	pmid	pmid	NOUN
dpc-3493	329	2	:	:	PUNCT
dpc-3493	329	3	31309536	31309536	NUM
dpc-3493	329	4	.	.	PUNCT
dpc-3493	330	1	pmcid	pmcid	NOUN
dpc-3493	330	2	:	:	PUNCT
dpc-3493	330	3	pmc6629583	pmc6629583	NOUN
dpc-3493	330	4	.	.	PUNCT
dpc-3493	331	1	14	14	NUM
dpc-3493	331	2	.	.	PUNCT
dpc-3493	332	1	llamas	llamas	PROPN
dpc-3493	332	2	-	-	PUNCT
dpc-3493	332	3	velasco	velasco	PROPN
dpc-3493	332	4	m	m	PROPN
dpc-3493	332	5	,	,	PUNCT
dpc-3493	332	6	ovejero	ovejero	ADJ
dpc-3493	332	7	-	-	PUNCT
dpc-3493	332	8	merino	merino	NOUN
dpc-3493	332	9	e	e	NOUN
dpc-3493	332	10	,	,	PUNCT
dpc-3493	332	11	salgado	salgado	PROPN
dpc-3493	332	12	-	-	PROPN
dpc-3493	332	13	boquete	boquete	PROPN
dpc-3493	332	14	l.	l.	PROPN
dpc-3493	332	15	obesidad	obesidad	PROPN
dpc-3493	332	16	:	:	PUNCT
dpc-3493	332	17	factor	factor	NOUN
dpc-3493	332	18	de	de	X
dpc-3493	332	19	riesgo	riesgo	PROPN
dpc-3493	332	20	para	para	PROPN
dpc-3493	332	21	psoriasis	psoriasis	NOUN
dpc-3493	332	22	y	y	PROPN
dpc-3493	332	23	covid-19	covid-19	PROPN
dpc-3493	333	1	[	[	X
dpc-3493	333	2	obesity	obesity	NOUN
dpc-3493	333	3	a	a	DET
dpc-3493	333	4	risk	risk	NOUN
dpc-3493	333	5	factor	factor	NOUN
dpc-3493	333	6	for	for	ADP
dpc-3493	333	7	psoriasis	psoriasis	NOUN
dpc-3493	333	8	and	and	CCONJ
dpc-3493	333	9	covid-19	covid-19	PROPN
dpc-3493	333	10	]	]	PUNCT
dpc-3493	333	11	.	.	PUNCT
dpc-3493	334	1	actas	actas	PROPN
dpc-3493	334	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-3493	334	3	.	.	PUNCT
dpc-3493	335	1	2021;112(6):489	2021;112(6):489	NUM
dpc-3493	335	2	-	-	SYM
dpc-3493	335	3	494	494	NUM
dpc-3493	335	4	.	.	PUNCT
dpc-3493	336	1	doi	doi	NOUN
dpc-3493	336	2	:	:	PUNCT
dpc-3493	336	3	10.1016	10.1016	NUM
dpc-3493	336	4	/	/	SYM
dpc-3493	336	5	j.ad.2020.12.001	j.ad.2020.12.001	PROPN
dpc-3493	336	6	.	.	PUNCT
dpc-3493	337	1	pmid	pmid	NOUN
dpc-3493	337	2	:	:	PUNCT
dpc-3493	337	3	34629472	34629472	NUM
dpc-3493	337	4	.	.	PUNCT
dpc-3493	338	1	pmcid	pmcid	NOUN
dpc-3493	338	2	:	:	PUNCT
dpc-3493	338	3	pmc7977150	pmc7977150	ADJ
dpc-3493	338	4	.	.	PUNCT
dpc-3493	339	1	15	15	X
dpc-3493	339	2	.	.	PUNCT
dpc-3493	340	1	özyurt	özyurt	PROPN
dpc-3493	340	2	k	k	PROPN
dpc-3493	340	3	,	,	PUNCT
dpc-3493	340	4	avcı	avcı	PROPN
dpc-3493	340	5	a	a	PRON
dpc-3493	340	6	,	,	PUNCT
dpc-3493	340	7	ertaş	ertaş	NOUN
dpc-3493	340	8	r	r	NOUN
dpc-3493	340	9	,	,	PUNCT
dpc-3493	340	10	ulaş	ulaş	ADJ
dpc-3493	340	11	y	y	PROPN
dpc-3493	340	12	,	,	PUNCT
dpc-3493	340	13	akkuş	akkuş	PROPN
dpc-3493	340	14	mr	mr	PROPN
dpc-3493	340	15	,	,	PUNCT
dpc-3493	340	16	özlü	özlü	PROPN
dpc-3493	340	17	e	e	PROPN
dpc-3493	340	18	,	,	PUNCT
dpc-3493	340	19	et	et	PROPN
dpc-3493	340	20	al	al	PROPN
dpc-3493	340	21	.	.	PROPN
dpc-3493	340	22	psortaksis	psortaksis	PROPN
dpc-3493	340	23	:	:	PUNCT
dpc-3493	340	24	kayseri	kayseri	PROPN
dpc-3493	340	25	sağlık	sağlık	VERB
dpc-3493	340	26	uygulama	uygulama	PROPN
dpc-3493	340	27	ve	ve	PROPN
dpc-3493	340	28	araştırma	araştırma	PROPN
dpc-3493	340	29	merkezi	merkezi	PROPN
dpc-3493	340	30	dermatoloji	dermatoloji	PROPN
dpc-3493	340	31	kliniği’nde	kliniği’nde	PROPN
dpc-3493	340	32	kullanılan	kullanılan	PROPN
dpc-3493	340	33	yeni	yeni	PROPN
dpc-3493	340	34	bir	bir	NOUN
dpc-3493	340	35	psoriasis	psoriasis	NOUN
dpc-3493	340	36	hasta	hasta	PROPN
dpc-3493	340	37	kayıt	kayıt	PROPN
dpc-3493	340	38	sistemi	sistemi	PROPN
dpc-3493	340	39	.	.	PROPN
dpc-3493	341	1	turk	turk	PROPN
dpc-3493	341	2	dermatoloji	dermatoloji	PROPN
dpc-3493	341	3	derg	derg	PROPN
dpc-3493	341	4	.	.	PUNCT
dpc-3493	342	1	2018;12(1):23–7	2018;12(1):23–7	NOUN
dpc-3493	342	2	.	.	PUNCT
dpc-3493	343	1	doi	doi	NOUN
dpc-3493	343	2	:	:	PUNCT
dpc-3493	343	3	10.4274	10.4274	NUM
dpc-3493	343	4	/tdd.3418	/tdd.3418	NOUN
dpc-3493	343	5	16	16	NUM
dpc-3493	343	6	.	.	PUNCT
dpc-3493	344	1	sun	sun	PROPN
dpc-3493	344	2	l	l	PROPN
dpc-3493	344	3	,	,	PUNCT
dpc-3493	344	4	liu	liu	PROPN
dpc-3493	344	5	w	w	PROPN
dpc-3493	344	6	,	,	PUNCT
dpc-3493	344	7	zhang	zhang	PROPN
dpc-3493	344	8	lj	lj	PROPN
dpc-3493	344	9	.	.	PUNCT
dpc-3493	345	1	the	the	DET
dpc-3493	345	2	role	role	NOUN
dpc-3493	345	3	of	of	ADP
dpc-3493	345	4	toll	toll	NOUN
dpc-3493	345	5	-	-	PUNCT
dpc-3493	345	6	like	like	ADJ
dpc-3493	345	7	receptors	receptor	NOUN
dpc-3493	345	8	in	in	ADP
dpc-3493	345	9	skin	skin	NOUN
dpc-3493	345	10	host	host	NOUN
dpc-3493	345	11	defense	defense	NOUN
dpc-3493	345	12	,	,	PUNCT
dpc-3493	345	13	psoriasis	psoriasis	NOUN
dpc-3493	345	14	,	,	PUNCT
dpc-3493	345	15	and	and	CCONJ
dpc-3493	345	16	atopic	atopic	NOUN
dpc-3493	345	17	dermatitis	dermatitis	NOUN
dpc-3493	345	18	.	.	PUNCT
dpc-3493	346	1	j	j	PROPN
dpc-3493	346	2	immunol	immunol	NOUN
dpc-3493	346	3	res	re	NOUN
dpc-3493	346	4	.	.	PUNCT
dpc-3493	346	5	2019;2019:1824624	2019;2019:1824624	NUM
dpc-3493	346	6	.	.	PUNCT
dpc-3493	347	1	doi	doi	NOUN
dpc-3493	347	2	:	:	PUNCT
dpc-3493	347	3	10.1155/2019/1824624	10.1155/2019/1824624	NUM
dpc-3493	347	4	.	.	PUNCT
dpc-3493	348	1	pmid	pmid	NOUN
dpc-3493	348	2	:	:	PUNCT
dpc-3493	348	3	31815151	31815151	NUM
dpc-3493	348	4	.	.	PUNCT
dpc-3493	349	1	pmcid	pmcid	NOUN
dpc-3493	349	2	:	:	PUNCT
dpc-3493	349	3	pmc6877906	pmc6877906	PROPN
dpc-3493	349	4	.	.	PUNCT
dpc-3493	350	1	17	17	NUM
dpc-3493	350	2	.	.	PUNCT
dpc-3493	351	1	zhang	zhang	PROPN
dpc-3493	351	2	lj	lj	PROPN
dpc-3493	351	3	.	.	PUNCT
dpc-3493	351	4	type1	type1	PROPN
dpc-3493	351	5	interferons	interferon	NOUN
dpc-3493	351	6	potential	potential	ADJ
dpc-3493	351	7	initiating	initiate	VERB
dpc-3493	351	8	factors	factor	NOUN
dpc-3493	351	9	linking	link	VERB
dpc-3493	351	10	skin	skin	NOUN
dpc-3493	351	11	wounds	wound	NOUN
dpc-3493	351	12	with	with	ADP
dpc-3493	351	13	psoriasis	psoriasis	NOUN
dpc-3493	351	14	pathogenesis	pathogenesis	NOUN
dpc-3493	351	15	.	.	PUNCT
dpc-3493	352	1	front	front	ADJ
dpc-3493	352	2	immunol	immunol	NOUN
dpc-3493	352	3	.	.	PUNCT
dpc-3493	353	1	2019;10:1440	2019;10:1440	NUM
dpc-3493	353	2	.	.	PUNCT
dpc-3493	353	3	doi	doi	NOUN
dpc-3493	353	4	:	:	PUNCT
dpc-3493	353	5	10.3389	10.3389	NUM
dpc-3493	353	6	/	/	SYM
dpc-3493	353	7	fimmu.2019.01440	fimmu.2019.01440	PROPN
dpc-3493	353	8	.	.	PUNCT
dpc-3493	354	1	pmid	pmid	NOUN
dpc-3493	354	2	:	:	PUNCT
dpc-3493	354	3	31293591	31293591	NUM
dpc-3493	354	4	.	.	PUNCT
dpc-3493	355	1	pmcid	pmcid	ADJ
dpc-3493	355	2	:	:	PUNCT
dpc-3493	355	3	pmc6603083	pmc6603083	NOUN
dpc-3493	355	4	.	.	PUNCT
dpc-3493	356	1	psychiatric	psychiatric	ADJ
dpc-3493	356	2	illness	illness	NOUN
dpc-3493	356	3	and	and	CCONJ
dpc-3493	356	4	suicide	suicide	NOUN
dpc-3493	356	5	increased	increase	VERB
dpc-3493	356	6	with	with	ADP
dpc-3493	356	7	the	the	DET
dpc-3493	356	8	incidence	incidence	NOUN
dpc-3493	356	9	of	of	ADP
dpc-3493	356	10	comorbidities	comorbiditie	NOUN
dpc-3493	356	11	,	,	PUNCT
dpc-3493	356	12	and	and	CCONJ
dpc-3493	356	13	therefore	therefore	ADV
dpc-3493	356	14	all	all	DET
dpc-3493	356	15	patients	patient	NOUN
dpc-3493	356	16	with	with	ADP
dpc-3493	356	17	psoriasis	psoriasis	NOUN
dpc-3493	356	18	should	should	AUX
dpc-3493	356	19	be	be	AUX
dpc-3493	356	20	receive	receive	VERB
dpc-3493	356	21	psychiatric	psychiatric	ADJ
dpc-3493	356	22	evaluation	evaluation	NOUN
dpc-3493	356	23	[	[	X
dpc-3493	356	24	30	30	NUM
dpc-3493	356	25	]	]	PUNCT
dpc-3493	356	26	according	accord	VERB
dpc-3493	356	27	to	to	ADP
dpc-3493	356	28	a	a	DET
dpc-3493	356	29	meta	meta	ADJ
dpc-3493	356	30	-	-	PUNCT
dpc-3493	356	31	analysis	analysis	NOUN
dpc-3493	356	32	,	,	PUNCT
dpc-3493	356	33	joint	joint	ADJ
dpc-3493	356	34	involvement	involvement	NOUN
dpc-3493	356	35	in	in	ADP
dpc-3493	356	36	cases	case	NOUN
dpc-3493	356	37	of	of	ADP
dpc-3493	356	38	psoriasis	psoriasis	NOUN
dpc-3493	356	39	mostly	mostly	ADV
dpc-3493	356	40	develops	develop	VERB
dpc-3493	356	41	among	among	ADP
dpc-3493	356	42	patients	patient	NOUN
dpc-3493	356	43	with	with	ADP
dpc-3493	356	44	more	more	ADV
dpc-3493	356	45	common	common	ADJ
dpc-3493	356	46	and	and	CCONJ
dpc-3493	356	47	severe	severe	ADJ
dpc-3493	356	48	skin	skin	NOUN
dpc-3493	356	49	lesions	lesion	NOUN
dpc-3493	356	50	and	and	CCONJ
dpc-3493	356	51	higher	high	ADJ
dpc-3493	356	52	pasi	pasi	NOUN
dpc-3493	356	53	scores	score	NOUN
dpc-3493	356	54	[	[	X
dpc-3493	356	55	31	31	NUM
dpc-3493	356	56	]	]	PUNCT
dpc-3493	356	57	.	.	PUNCT
dpc-3493	357	1	it	it	PRON
dpc-3493	357	2	was	be	AUX
dpc-3493	357	3	also	also	ADV
dpc-3493	357	4	suggested	suggest	VERB
dpc-3493	357	5	that	that	SCONJ
dpc-3493	357	6	joint	joint	ADJ
dpc-3493	357	7	involvement	involvement	NOUN
dpc-3493	357	8	is	be	AUX
dpc-3493	357	9	not	not	PART
dpc-3493	357	10	related	relate	VERB
dpc-3493	357	11	to	to	ADP
dpc-3493	357	12	disease	disease	NOUN
dpc-3493	357	13	type	type	NOUN
dpc-3493	357	14	(	(	PUNCT
dpc-3493	357	15	plaque	plaque	NOUN
dpc-3493	357	16	,	,	PUNCT
dpc-3493	357	17	guttate	guttate	ADJ
dpc-3493	357	18	,	,	PUNCT
dpc-3493	357	19	pustular	pustular	ADJ
dpc-3493	357	20	,	,	PUNCT
dpc-3493	357	21	erythrodermic	erythrodermic	NOUN
dpc-3493	357	22	,	,	PUNCT
dpc-3493	357	23	etc	etc	X
dpc-3493	357	24	)	)	PUNCT
dpc-3493	358	1	[	[	X
dpc-3493	358	2	32	32	NUM
dpc-3493	358	3	]	]	PUNCT
dpc-3493	358	4	.	.	PUNCT
dpc-3493	359	1	it	it	PRON
dpc-3493	359	2	is	be	AUX
dpc-3493	359	3	important	important	ADJ
dpc-3493	359	4	to	to	PART
dpc-3493	359	5	diagnose	diagnose	VERB
dpc-3493	359	6	joint	joint	ADJ
dpc-3493	359	7	involvement	involvement	NOUN
dpc-3493	359	8	in	in	ADP
dpc-3493	359	9	psoriasis	psoriasis	NOUN
dpc-3493	359	10	as	as	SCONJ
dpc-3493	359	11	permanent	permanent	ADJ
dpc-3493	359	12	joint	joint	ADJ
dpc-3493	359	13	damage	damage	NOUN
dpc-3493	359	14	may	may	AUX
dpc-3493	359	15	occur	occur	VERB
dpc-3493	359	16	at	at	ADP
dpc-3493	359	17	as	as	ADV
dpc-3493	359	18	early	early	ADJ
dpc-3493	359	19	as	as	ADP
dpc-3493	359	20	6	6	NUM
dpc-3493	359	21	months	month	NOUN
dpc-3493	359	22	among	among	ADP
dpc-3493	359	23	untreated	untreated	ADJ
dpc-3493	359	24	cases	case	NOUN
dpc-3493	359	25	[	[	X
dpc-3493	359	26	33,34	33,34	NOUN
dpc-3493	359	27	]	]	PUNCT
dpc-3493	359	28	.	.	PUNCT
dpc-3493	360	1	it	it	PRON
dpc-3493	360	2	is	be	AUX
dpc-3493	360	3	currently	currently	ADV
dpc-3493	360	4	unclear	unclear	ADJ
dpc-3493	360	5	which	which	PRON
dpc-3493	360	6	patients	patient	NOUN
dpc-3493	360	7	with	with	ADP
dpc-3493	360	8	psoriasis	psoriasis	NOUN
dpc-3493	360	9	will	will	AUX
dpc-3493	360	10	develop	develop	VERB
dpc-3493	360	11	joint	joint	ADJ
dpc-3493	360	12	involvement	involvement	NOUN
dpc-3493	360	13	;	;	PUNCT
dpc-3493	360	14	however	however	ADV
dpc-3493	360	15	,	,	PUNCT
dpc-3493	360	16	there	there	PRON
dpc-3493	360	17	are	be	VERB
dpc-3493	360	18	some	some	DET
dpc-3493	360	19	factors	factor	NOUN
dpc-3493	360	20	implied	imply	VERB
dpc-3493	360	21	in	in	ADP
dpc-3493	360	22	joint	joint	ADJ
dpc-3493	360	23	involvement	involvement	NOUN
dpc-3493	360	24	.	.	PUNCT
dpc-3493	361	1	obesity	obesity	NOUN
dpc-3493	361	2	,	,	PUNCT
dpc-3493	361	3	trauma	trauma	NOUN
dpc-3493	361	4	,	,	PUNCT
dpc-3493	361	5	nail	nail	NOUN
dpc-3493	361	6	dystrophy	dystrophy	NOUN
dpc-3493	361	7	,	,	PUNCT
dpc-3493	361	8	and	and	CCONJ
dpc-3493	361	9	the	the	DET
dpc-3493	361	10	localization	localization	NOUN
dpc-3493	361	11	of	of	ADP
dpc-3493	361	12	psoriasis	psoriasis	NOUN
dpc-3493	361	13	lesions	lesion	NOUN
dpc-3493	361	14	(	(	PUNCT
dpc-3493	361	15	scalp	scalp	NOUN
dpc-3493	361	16	and	and	CCONJ
dpc-3493	361	17	intergluteal	intergluteal	ADJ
dpc-3493	361	18	region	region	NOUN
dpc-3493	361	19	)	)	PUNCT
dpc-3493	361	20	may	may	AUX
dpc-3493	361	21	be	be	AUX
dpc-3493	361	22	predictive	predictive	ADJ
dpc-3493	361	23	of	of	ADP
dpc-3493	361	24	potential	potential	ADJ
dpc-3493	361	25	joint	joint	ADJ
dpc-3493	361	26	involvement	involvement	NOUN
dpc-3493	361	27	[	[	X
dpc-3493	361	28	32,34	32,34	NUM
dpc-3493	361	29	]	]	X
dpc-3493	361	30	.	.	PUNCT
dpc-3493	362	1	in	in	ADP
dpc-3493	362	2	our	our	PRON
dpc-3493	362	3	study	study	NOUN
dpc-3493	362	4	,	,	PUNCT
dpc-3493	362	5	the	the	DET
dpc-3493	362	6	joint	joint	ADJ
dpc-3493	362	7	involvement	involvement	NOUN
dpc-3493	362	8	rate	rate	NOUN
dpc-3493	362	9	was	be	AUX
dpc-3493	362	10	lower	low	ADJ
dpc-3493	362	11	in	in	ADP
dpc-3493	362	12	the	the	DET
dpc-3493	362	13	group	group	NOUN
dpc-3493	362	14	treated	treat	VERB
dpc-3493	362	15	with	with	ADP
dpc-3493	362	16	biological	biological	ADJ
dpc-3493	362	17	agents	agent	NOUN
dpc-3493	362	18	(	(	PUNCT
dpc-3493	362	19	35.9	35.9	NUM
dpc-3493	362	20	%	%	NOUN
dpc-3493	362	21	;	;	PUNCT
dpc-3493	362	22	n	n	PROPN
dpc-3493	362	23	=	=	SYM
dpc-3493	362	24	71	71	NUM
dpc-3493	362	25	)	)	PUNCT
dpc-3493	362	26	compared	compare	VERB
dpc-3493	362	27	to	to	ADP
dpc-3493	362	28	patients	patient	NOUN
dpc-3493	362	29	treated	treat	VERB
dpc-3493	362	30	with	with	ADP
dpc-3493	362	31	systemic	systemic	ADJ
dpc-3493	362	32	conventional	conventional	ADJ
dpc-3493	362	33	agents	agent	NOUN
dpc-3493	362	34	(	(	PUNCT
dpc-3493	362	35	17.4	17.4	NUM
dpc-3493	362	36	%	%	NOUN
dpc-3493	362	37	;	;	PUNCT
dpc-3493	362	38	n	n	PROPN
dpc-3493	362	39	=	=	SYM
dpc-3493	362	40	18	18	NUM
dpc-3493	362	41	)	)	PUNCT
dpc-3493	362	42	,	,	PUNCT
dpc-3493	362	43	and	and	CCONJ
dpc-3493	362	44	this	this	DET
dpc-3493	362	45	difference	difference	NOUN
dpc-3493	362	46	was	be	AUX
dpc-3493	362	47	significant	significant	ADJ
dpc-3493	362	48	(	(	PUNCT
dpc-3493	362	49	p	p	X
dpc-3493	362	50	=	=	NOUN
dpc-3493	362	51	0.003	0.003	NUM
dpc-3493	362	52	)	)	PUNCT
dpc-3493	362	53	.	.	PUNCT
dpc-3493	363	1	this	this	PRON
dpc-3493	363	2	may	may	AUX
dpc-3493	363	3	be	be	AUX
dpc-3493	363	4	due	due	ADJ
dpc-3493	363	5	to	to	ADP
dpc-3493	363	6	the	the	DET
dpc-3493	363	7	longer	long	ADJ
dpc-3493	363	8	disease	disease	NOUN
dpc-3493	363	9	duration	duration	NOUN
dpc-3493	363	10	and	and	CCONJ
dpc-3493	363	11	cases	case	NOUN
dpc-3493	363	12	being	be	AUX
dpc-3493	363	13	more	more	ADJ
dpc-3493	363	14	refractory	refractory	NOUN
dpc-3493	363	15	to	to	ADP
dpc-3493	363	16	other	other	ADJ
dpc-3493	363	17	treatments	treatment	NOUN
dpc-3493	363	18	among	among	ADP
dpc-3493	363	19	the	the	DET
dpc-3493	363	20	patients	patient	NOUN
dpc-3493	363	21	treated	treat	VERB
dpc-3493	363	22	with	with	ADP
dpc-3493	363	23	biological	biological	ADJ
dpc-3493	363	24	agents	agent	NOUN
dpc-3493	363	25	.	.	PUNCT
dpc-3493	364	1	it	it	PRON
dpc-3493	364	2	is	be	AUX
dpc-3493	364	3	apparent	apparent	ADJ
dpc-3493	364	4	that	that	SCONJ
dpc-3493	364	5	joint	joint	ADJ
dpc-3493	364	6	involvement	involvement	NOUN
dpc-3493	364	7	is	be	AUX
dpc-3493	364	8	a	a	DET
dpc-3493	364	9	good	good	ADJ
dpc-3493	364	10	predictor	predictor	NOUN
dpc-3493	364	11	of	of	ADP
dpc-3493	364	12	the	the	DET
dpc-3493	364	13	achievement	achievement	NOUN
dpc-3493	364	14	of	of	ADP
dpc-3493	364	15	pasi	pasi	NOUN
dpc-3493	364	16	75	75	NUM
dpc-3493	364	17	and	and	CCONJ
dpc-3493	364	18	pasi	pasi	VERB
dpc-3493	364	19	90	90	NUM
dpc-3493	364	20	responses	response	NOUN
dpc-3493	364	21	.	.	PUNCT
dpc-3493	365	1	pruritus	pruritus	PROPN
dpc-3493	365	2	was	be	AUX
dpc-3493	365	3	more	more	ADV
dpc-3493	365	4	common	common	ADJ
dpc-3493	365	5	among	among	ADP
dpc-3493	365	6	patients	patient	NOUN
dpc-3493	365	7	treated	treat	VERB
dpc-3493	365	8	with	with	ADP
dpc-3493	365	9	systemic	systemic	ADJ
dpc-3493	365	10	conventional	conventional	ADJ
dpc-3493	365	11	agents	agent	NOUN
dpc-3493	365	12	(	(	PUNCT
dpc-3493	365	13	86.5	86.5	NUM
dpc-3493	365	14	%	%	NOUN
dpc-3493	365	15	;	;	PUNCT
dpc-3493	365	16	n	n	PROPN
dpc-3493	365	17	=	=	SYM
dpc-3493	365	18	45	45	NUM
dpc-3493	365	19	)	)	PUNCT
dpc-3493	365	20	compared	compare	VERB
dpc-3493	365	21	to	to	ADP
dpc-3493	365	22	those	those	PRON
dpc-3493	365	23	treated	treat	VERB
dpc-3493	365	24	with	with	ADP
dpc-3493	365	25	biological	biological	ADJ
dpc-3493	365	26	agents	agent	NOUN
dpc-3493	365	27	(	(	PUNCT
dpc-3493	365	28	77	77	NUM
dpc-3493	365	29	%	%	NOUN
dpc-3493	365	30	;	;	PUNCT
dpc-3493	365	31	n	n	NOUN
dpc-3493	365	32	=	=	NOUN
dpc-3493	365	33	171	171	NUM
dpc-3493	365	34	)	)	PUNCT
dpc-3493	365	35	.	.	PUNCT
dpc-3493	366	1	pruritus	pruritus	PROPN
dpc-3493	366	2	seemed	seem	VERB
dpc-3493	366	3	to	to	PART
dpc-3493	366	4	be	be	AUX
dpc-3493	366	5	slightly	slightly	ADV
dpc-3493	366	6	more	more	ADV
dpc-3493	366	7	common	common	ADJ
dpc-3493	366	8	in	in	ADP
dpc-3493	366	9	cases	case	NOUN
dpc-3493	366	10	of	of	ADP
dpc-3493	366	11	chronic	chronic	ADJ
dpc-3493	366	12	and	and	CCONJ
dpc-3493	366	13	refractory	refractory	NOUN
dpc-3493	366	14	disease	disease	NOUN
dpc-3493	366	15	.	.	PUNCT
dpc-3493	367	1	when	when	SCONJ
dpc-3493	367	2	all	all	DET
dpc-3493	367	3	patients	patient	NOUN
dpc-3493	367	4	treated	treat	VERB
dpc-3493	367	5	with	with	ADP
dpc-3493	367	6	biological	biological	ADJ
dpc-3493	367	7	agents	agent	NOUN
dpc-3493	367	8	and	and	CCONJ
dpc-3493	367	9	systemic	systemic	ADJ
dpc-3493	367	10	conventional	conventional	ADJ
dpc-3493	367	11	agents	agent	NOUN
dpc-3493	367	12	were	be	AUX
dpc-3493	367	13	compared	compare	VERB
dpc-3493	367	14	,	,	PUNCT
dpc-3493	367	15	it	it	PRON
dpc-3493	367	16	was	be	AUX
dpc-3493	367	17	found	find	VERB
dpc-3493	367	18	that	that	SCONJ
dpc-3493	367	19	biological	biological	ADJ
dpc-3493	367	20	agents	agent	NOUN
dpc-3493	367	21	were	be	AUX
dpc-3493	367	22	more	more	ADV
dpc-3493	367	23	successful	successful	ADJ
dpc-3493	367	24	in	in	ADP
dpc-3493	367	25	achieving	achieve	VERB
dpc-3493	367	26	pasi	pasi	NOUN
dpc-3493	367	27	75	75	NUM
dpc-3493	367	28	and	and	CCONJ
dpc-3493	367	29	pasi	pasi	VERB
dpc-3493	367	30	90	90	NUM
dpc-3493	367	31	responses	response	NOUN
dpc-3493	367	32	among	among	ADP
dpc-3493	367	33	both	both	CCONJ
dpc-3493	367	34	obese	obese	ADJ
dpc-3493	367	35	and	and	CCONJ
dpc-3493	367	36	non	non	ADJ
dpc-3493	367	37	-	-	ADJ
dpc-3493	367	38	obese	obese	ADJ
dpc-3493	367	39	patients	patient	NOUN
dpc-3493	367	40	.	.	PUNCT
dpc-3493	368	1	non	non	ADJ
dpc-3493	368	2	-	-	ADJ
dpc-3493	368	3	obese	obese	ADJ
dpc-3493	368	4	patients	patient	NOUN
dpc-3493	368	5	achieved	achieve	VERB
dpc-3493	368	6	pasi	pasi	NOUN
dpc-3493	368	7	75	75	NUM
dpc-3493	368	8	and	and	CCONJ
dpc-3493	368	9	pasi	pasi	VERB
dpc-3493	368	10	90	90	NUM
dpc-3493	368	11	responses	response	NOUN
dpc-3493	368	12	more	more	ADV
dpc-3493	368	13	readily	readily	ADV
dpc-3493	368	14	than	than	ADP
dpc-3493	368	15	obese	obese	ADJ
dpc-3493	368	16	patients	patient	NOUN
dpc-3493	368	17	.	.	PUNCT
dpc-3493	369	1	based	base	VERB
dpc-3493	369	2	on	on	ADP
dpc-3493	369	3	our	our	PRON
dpc-3493	369	4	results	result	NOUN
dpc-3493	369	5	,	,	PUNCT
dpc-3493	369	6	new	new	ADJ
dpc-3493	369	7	generation	generation	NOUN
dpc-3493	369	8	biological	biological	ADJ
dpc-3493	369	9	agents	agent	NOUN
dpc-3493	369	10	(	(	PUNCT
dpc-3493	369	11	secukinumab	secukinumab	NOUN
dpc-3493	369	12	,	,	PUNCT
dpc-3493	369	13	ixekizumab	ixekizumab	NOUN
dpc-3493	369	14	,	,	PUNCT
dpc-3493	369	15	risankizumab	risankizumab	NOUN
dpc-3493	369	16	,	,	PUNCT
dpc-3493	369	17	and	and	CCONJ
dpc-3493	369	18	guselkumab	guselkumab	NOUN
dpc-3493	369	19	)	)	PUNCT
dpc-3493	369	20	may	may	AUX
dpc-3493	369	21	be	be	AUX
dpc-3493	369	22	used	use	VERB
dpc-3493	369	23	by	by	ADP
dpc-3493	369	24	obese	obese	ADJ
dpc-3493	369	25	patients	patient	NOUN
dpc-3493	369	26	without	without	ADP
dpc-3493	369	27	any	any	DET
dpc-3493	369	28	superiority	superiority	NOUN
dpc-3493	369	29	of	of	ADP
dpc-3493	369	30	one	one	NUM
dpc-3493	369	31	drug	drug	NOUN
dpc-3493	369	32	over	over	ADP
dpc-3493	369	33	the	the	DET
dpc-3493	369	34	others	other	NOUN
dpc-3493	369	35	.	.	PUNCT
dpc-3493	370	1	given	give	VERB
dpc-3493	370	2	that	that	SCONJ
dpc-3493	370	3	these	these	DET
dpc-3493	370	4	agents	agent	NOUN
dpc-3493	370	5	have	have	AUX
dpc-3493	370	6	more	more	ADV
dpc-3493	370	7	favorable	favorable	ADJ
dpc-3493	370	8	adverse	adverse	ADJ
dpc-3493	370	9	effect	effect	NOUN
dpc-3493	370	10	profiles	profile	NOUN
dpc-3493	370	11	than	than	ADP
dpc-3493	370	12	systemic	systemic	ADJ
dpc-3493	370	13	conventional	conventional	ADJ
dpc-3493	370	14	agents	agent	NOUN
dpc-3493	370	15	,	,	PUNCT
dpc-3493	370	16	it	it	PRON
dpc-3493	370	17	would	would	AUX
dpc-3493	370	18	be	be	AUX
dpc-3493	370	19	more	more	ADV
dpc-3493	370	20	appropriate	appropriate	ADJ
dpc-3493	370	21	to	to	PART
dpc-3493	370	22	prescribe	prescribe	VERB
dpc-3493	370	23	these	these	DET
dpc-3493	370	24	agents	agent	NOUN
dpc-3493	370	25	rather	rather	ADV
dpc-3493	370	26	than	than	ADP
dpc-3493	370	27	tnf	tnf	PROPN
dpc-3493	370	28	-	-	PUNCT
dpc-3493	370	29	α	α	NOUN
dpc-3493	370	30	inhibitors	inhibitor	NOUN
dpc-3493	370	31	or	or	CCONJ
dpc-3493	370	32	ustekinumab	ustekinumab	NOUN
dpc-3493	370	33	(	(	PUNCT
dpc-3493	370	34	il12/23	il12/23	NOUN
dpc-3493	370	35	inhibitor	inhibitor	NOUN
dpc-3493	370	36	)	)	PUNCT
dpc-3493	370	37	.	.	PUNCT
dpc-3493	371	1	for	for	ADP
dpc-3493	371	2	patients	patient	NOUN
dpc-3493	371	3	with	with	ADP
dpc-3493	371	4	joint	joint	ADJ
dpc-3493	371	5	involvement	involvement	NOUN
dpc-3493	371	6	,	,	PUNCT
dpc-3493	371	7	treatment	treatment	NOUN
dpc-3493	371	8	with	with	ADP
dpc-3493	371	9	biological	biological	ADJ
dpc-3493	371	10	agents	agent	NOUN
dpc-3493	371	11	may	may	AUX
dpc-3493	371	12	be	be	AUX
dpc-3493	371	13	considered	consider	VERB
dpc-3493	371	14	in	in	ADP
dpc-3493	371	15	the	the	DET
dpc-3493	371	16	early	early	ADJ
dpc-3493	371	17	stages	stage	NOUN
dpc-3493	371	18	of	of	ADP
dpc-3493	371	19	the	the	DET
dpc-3493	371	20	disease	disease	NOUN
dpc-3493	371	21	.	.	PUNCT
dpc-3493	372	1	references	reference	NOUN
dpc-3493	372	2	1	1	NUM
dpc-3493	372	3	.	.	PUNCT
dpc-3493	372	4	vizzardi	vizzardi	PROPN
dpc-3493	372	5	e	e	PROPN
dpc-3493	372	6	,	,	PUNCT
dpc-3493	372	7	raddino	raddino	ADJ
dpc-3493	372	8	r	r	NOUN
dpc-3493	372	9	,	,	PUNCT
dpc-3493	372	10	teli	teli	PROPN
dpc-3493	372	11	m	m	PROPN
dpc-3493	372	12	,	,	PUNCT
dpc-3493	372	13	gorga	gorga	PROPN
dpc-3493	372	14	e	e	PROPN
dpc-3493	372	15	,	,	PUNCT
dpc-3493	372	16	brambilla	brambilla	NOUN
dpc-3493	372	17	g	g	PROPN
dpc-3493	372	18	,	,	PUNCT
dpc-3493	372	19	dei	dei	PROPN
dpc-3493	372	20	cas	cas	PROPN
dpc-3493	372	21	l.	l.	PROPN
dpc-3493	372	22	psoriasis	psoriasis	PROPN
dpc-3493	372	23	and	and	CCONJ
dpc-3493	372	24	cardiovascular	cardiovascular	ADJ
dpc-3493	372	25	diseases	disease	NOUN
dpc-3493	372	26	.	.	PUNCT
dpc-3493	373	1	acta	acta	PROPN
dpc-3493	373	2	cardiol	cardiol	PROPN
dpc-3493	373	3	.	.	PUNCT
dpc-3493	374	1	2010;65(3):337	2010;65(3):337	NUM
dpc-3493	374	2	-	-	PUNCT
dpc-3493	374	3	340	340	NUM
dpc-3493	374	4	.	.	PUNCT
dpc-3493	375	1	doi	doi	NOUN
dpc-3493	375	2	:	:	PUNCT
dpc-3493	375	3	10.2143	10.2143	NUM
dpc-3493	375	4	/	/	SYM
dpc-3493	375	5	ac.65.3.2050351	ac.65.3.2050351	NOUN
dpc-3493	375	6	.	.	PUNCT
dpc-3493	376	1	pmid	pmid	NOUN
dpc-3493	376	2	:	:	PUNCT
dpc-3493	376	3	20666273	20666273	NUM
dpc-3493	376	4	.	.	PUNCT
dpc-3493	377	1	original	original	ADJ
dpc-3493	377	2	article	article	NOUN
dpc-3493	377	3	|	|	ADV
dpc-3493	377	4	dermatol	dermatol	ADJ
dpc-3493	377	5	pract	pract	NOUN
dpc-3493	377	6	concept	concept	NOUN
dpc-3493	377	7	.	.	PUNCT
dpc-3493	378	1	2024;14(1):e2024058	2024;14(1):e2024058	NUM
dpc-3493	378	2	11	11	NUM
dpc-3493	378	3	27	27	NUM
dpc-3493	378	4	.	.	PUNCT
dpc-3493	379	1	bai	bai	PROPN
dpc-3493	379	2	f	f	PROPN
dpc-3493	379	3	,	,	PUNCT
dpc-3493	379	4	li	li	PROPN
dpc-3493	379	5	gg	gg	PROPN
dpc-3493	379	6	,	,	PUNCT
dpc-3493	379	7	liu	liu	PROPN
dpc-3493	379	8	q	q	PROPN
dpc-3493	379	9	,	,	PUNCT
dpc-3493	379	10	niu	niu	PROPN
dpc-3493	379	11	x	x	PROPN
dpc-3493	379	12	,	,	PUNCT
dpc-3493	379	13	li	li	PROPN
dpc-3493	379	14	r	r	PROPN
dpc-3493	379	15	,	,	PUNCT
dpc-3493	379	16	ma	ma	PROPN
dpc-3493	379	17	h.	h.	PROPN
dpc-3493	379	18	short	short	ADJ
dpc-3493	379	19	-	-	PUNCT
dpc-3493	379	20	term	term	NOUN
dpc-3493	379	21	efficacy	efficacy	NOUN
dpc-3493	379	22	and	and	CCONJ
dpc-3493	379	23	safety	safety	NOUN
dpc-3493	379	24	of	of	ADP
dpc-3493	379	25	il-17	il-17	PRON
dpc-3493	379	26	,	,	PUNCT
dpc-3493	379	27	il-12/23	il-12/23	PROPN
dpc-3493	379	28	,	,	PUNCT
dpc-3493	379	29	and	and	CCONJ
dpc-3493	379	30	il-23	il-23	NOUN
dpc-3493	379	31	inhibitors	inhibitor	NOUN
dpc-3493	379	32	brodalumab	brodalumab	VERB
dpc-3493	379	33	,	,	PUNCT
dpc-3493	379	34	secukinumab	secukinumab	NOUN
dpc-3493	379	35	,	,	PUNCT
dpc-3493	379	36	ixekizumab	ixekizumab	NOUN
dpc-3493	379	37	,	,	PUNCT
dpc-3493	379	38	ustekinumab	ustekinumab	NOUN
dpc-3493	379	39	,	,	PUNCT
dpc-3493	379	40	guselkumab	guselkumab	NOUN
dpc-3493	379	41	,	,	PUNCT
dpc-3493	379	42	tildrakizumab	tildrakizumab	NOUN
dpc-3493	379	43	,	,	PUNCT
dpc-3493	379	44	and	and	CCONJ
dpc-3493	379	45	risankizumab	risankizumab	VERB
dpc-3493	379	46	for	for	ADP
dpc-3493	379	47	the	the	DET
dpc-3493	379	48	treatment	treatment	NOUN
dpc-3493	379	49	of	of	ADP
dpc-3493	379	50	moderate	moderate	ADJ
dpc-3493	379	51	to	to	ADP
dpc-3493	379	52	severe	severe	ADJ
dpc-3493	379	53	plaque	plaque	NOUN
dpc-3493	379	54	psoriasis	psoriasis	NOUN
dpc-3493	379	55	:	:	PUNCT
dpc-3493	379	56	a	a	DET
dpc-3493	379	57	systematic	systematic	ADJ
dpc-3493	379	58	review	review	NOUN
dpc-3493	379	59	and	and	CCONJ
dpc-3493	379	60	network	network	NOUN
dpc-3493	379	61	meta	meta	ADJ
dpc-3493	379	62	-	-	PUNCT
dpc-3493	379	63	analysis	analysis	NOUN
dpc-3493	379	64	of	of	ADP
dpc-3493	379	65	randomized	randomized	ADJ
dpc-3493	379	66	controlled	control	VERB
dpc-3493	379	67	trials	trial	NOUN
dpc-3493	379	68	.	.	PUNCT
dpc-3493	380	1	j	j	PROPN
dpc-3493	380	2	immunol	immunol	NOUN
dpc-3493	380	3	res	re	NOUN
dpc-3493	380	4	.	.	PUNCT
dpc-3493	381	1	2019;2019:2546161	2019;2019:2546161	NUM
dpc-3493	381	2	.	.	PUNCT
dpc-3493	382	1	doi	doi	NOUN
dpc-3493	382	2	:	:	PUNCT
dpc-3493	382	3	10.1155/2019/2546161	10.1155/2019/2546161	NUM
dpc-3493	382	4	.	.	PUNCT
dpc-3493	383	1	pmid	pmid	NOUN
dpc-3493	383	2	:	:	PUNCT
dpc-3493	383	3	31583255	31583255	NUM
dpc-3493	383	4	.	.	PUNCT
dpc-3493	384	1	pmcid	pmcid	NOUN
dpc-3493	384	2	:	:	PUNCT
dpc-3493	384	3	pmc6754904	pmc6754904	ADJ
dpc-3493	384	4	.	.	PUNCT
dpc-3493	385	1	28	28	NUM
dpc-3493	385	2	.	.	PUNCT
dpc-3493	385	3	george	george	PROPN
dpc-3493	385	4	la	la	PROPN
dpc-3493	385	5	,	,	PUNCT
dpc-3493	385	6	gadani	gadani	PROPN
dpc-3493	385	7	a	a	PRON
dpc-3493	385	8	,	,	PUNCT
dpc-3493	385	9	cross	cross	VERB
dpc-3493	385	10	rk	rk	NOUN
dpc-3493	385	11	,	,	PUNCT
dpc-3493	385	12	jambaulikar	jambaulikar	PROPN
dpc-3493	385	13	g	g	PROPN
dpc-3493	385	14	,	,	PUNCT
dpc-3493	385	15	ghazi	ghazi	PROPN
dpc-3493	385	16	lj	lj	PROPN
dpc-3493	385	17	.	.	PROPN
dpc-3493	385	18	psoriasiform	psoriasiform	PROPN
dpc-3493	385	19	skin	skin	NOUN
dpc-3493	385	20	lesions	lesion	NOUN
dpc-3493	385	21	are	be	AUX
dpc-3493	385	22	caused	cause	VERB
dpc-3493	385	23	by	by	ADP
dpc-3493	385	24	anti	anti	ADJ
dpc-3493	385	25	-	-	ADJ
dpc-3493	385	26	tnf	tnf	ADJ
dpc-3493	385	27	agents	agent	NOUN
dpc-3493	385	28	used	use	VERB
dpc-3493	385	29	for	for	ADP
dpc-3493	385	30	the	the	DET
dpc-3493	385	31	treatment	treatment	NOUN
dpc-3493	385	32	of	of	ADP
dpc-3493	385	33	inflammatory	inflammatory	ADJ
dpc-3493	385	34	bowel	bowel	NOUN
dpc-3493	385	35	disease	disease	NOUN
dpc-3493	385	36	.	.	PUNCT
dpc-3493	386	1	dig	dig	VERB
dpc-3493	386	2	dis	dis	PROPN
dpc-3493	386	3	sci	sci	PROPN
dpc-3493	386	4	.	.	PUNCT
dpc-3493	387	1	2015;60(11):3424	2015;60(11):3424	NUM
dpc-3493	387	2	-	-	NUM
dpc-3493	387	3	3430	3430	NUM
dpc-3493	387	4	.	.	PUNCT
dpc-3493	388	1	doi	doi	NOUN
dpc-3493	388	2	:	:	PUNCT
dpc-3493	388	3	10.1007	10.1007	NUM
dpc-3493	388	4	/	/	SYM
dpc-3493	388	5	s10620	s10620	PROPN
dpc-3493	388	6	-	-	PUNCT
dpc-3493	388	7	015	015	NUM
dpc-3493	388	8	-	-	PUNCT
dpc-3493	388	9	3763	3763	NUM
dpc-3493	388	10	-	-	PUNCT
dpc-3493	388	11	0	0	NUM
dpc-3493	388	12	.	.	PUNCT
dpc-3493	389	1	pmid	pmid	NOUN
dpc-3493	389	2	:	:	PUNCT
dpc-3493	389	3	26115749	26115749	NUM
dpc-3493	389	4	.	.	PUNCT
dpc-3493	390	1	29	29	NUM
dpc-3493	390	2	.	.	X
dpc-3493	391	1	yang	yang	PROPN
dpc-3493	391	2	m	m	PROPN
dpc-3493	391	3	,	,	PUNCT
dpc-3493	391	4	liu	liu	PROPN
dpc-3493	391	5	w	w	PROPN
dpc-3493	391	6	,	,	PUNCT
dpc-3493	391	7	deng	deng	PROPN
dpc-3493	391	8	q	q	PROPN
dpc-3493	391	9	,	,	PUNCT
dpc-3493	391	10	liang	liang	PROPN
dpc-3493	391	11	z	z	PROPN
dpc-3493	391	12	,	,	PUNCT
dpc-3493	391	13	wang	wang	PROPN
dpc-3493	391	14	q.	q.	VERB
dpc-3493	391	15	the	the	DET
dpc-3493	391	16	incidence	incidence	NOUN
dpc-3493	391	17	of	of	ADP
dpc-3493	391	18	psoriasis	psoriasis	NOUN
dpc-3493	391	19	among	among	ADP
dpc-3493	391	20	smokers	smoker	NOUN
dpc-3493	391	21	and/or	and/or	CCONJ
dpc-3493	391	22	former	former	ADJ
dpc-3493	391	23	smokers	smoker	NOUN
dpc-3493	391	24	inflammatory	inflammatory	ADJ
dpc-3493	391	25	bowel	bowel	NOUN
dpc-3493	391	26	diseases	disease	NOUN
dpc-3493	391	27	patients	patient	NOUN
dpc-3493	391	28	treated	treat	VERB
dpc-3493	391	29	with	with	ADP
dpc-3493	391	30	tumor	tumor	NOUN
dpc-3493	391	31	necrosis	necrosis	NOUN
dpc-3493	391	32	factor	factor	NOUN
dpc-3493	391	33	antagonist	antagonist	NOUN
dpc-3493	391	34	:	:	PUNCT
dpc-3493	391	35	a	a	DET
dpc-3493	391	36	systematic	systematic	ADJ
dpc-3493	391	37	review	review	NOUN
dpc-3493	391	38	and	and	CCONJ
dpc-3493	391	39	meta	meta	ADJ
dpc-3493	391	40	-	-	PUNCT
dpc-3493	391	41	analysis	analysis	NOUN
dpc-3493	391	42	.	.	PUNCT
dpc-3493	392	1	medicine	medicine	NOUN
dpc-3493	392	2	(	(	PUNCT
dpc-3493	392	3	baltimore	baltimore	PROPN
dpc-3493	392	4	)	)	PUNCT
dpc-3493	392	5	.	.	PUNCT
dpc-3493	393	1	2021;100(42):e27510	2021;100(42):e27510	X
dpc-3493	393	2	.	.	PUNCT
dpc-3493	394	1	doi	doi	NOUN
dpc-3493	394	2	:	:	PUNCT
dpc-3493	394	3	10.1097	10.1097	NUM
dpc-3493	394	4	/	/	SYM
dpc-3493	394	5	md.0000000000027510	md.0000000000027510	PROPN
dpc-3493	394	6	.	.	PUNCT
dpc-3493	395	1	pmid	pmid	NOUN
dpc-3493	395	2	:	:	PUNCT
dpc-3493	395	3	34678884	34678884	NUM
dpc-3493	395	4	.	.	PUNCT
dpc-3493	396	1	pmcid	pmcid	NOUN
dpc-3493	396	2	:	:	PUNCT
dpc-3493	396	3	pmc8542134	pmc8542134	PROPN
dpc-3493	396	4	.	.	PUNCT
dpc-3493	397	1	30	30	NUM
dpc-3493	397	2	.	.	PUNCT
dpc-3493	398	1	pompili	pompili	PROPN
dpc-3493	398	2	m	m	PROPN
dpc-3493	398	3	,	,	PUNCT
dpc-3493	398	4	innamorati	innamorati	PROPN
dpc-3493	398	5	m	m	PROPN
dpc-3493	398	6	,	,	PUNCT
dpc-3493	398	7	trovarelli	trovarelli	PROPN
dpc-3493	398	8	s	s	PART
dpc-3493	398	9	,	,	PUNCT
dpc-3493	398	10	et	et	PROPN
dpc-3493	398	11	al	al	PROPN
dpc-3493	398	12	.	.	PROPN
dpc-3493	398	13	suicide	suicide	NOUN
dpc-3493	398	14	risk	risk	NOUN
dpc-3493	398	15	and	and	CCONJ
dpc-3493	398	16	psychiatric	psychiatric	ADJ
dpc-3493	398	17	comorbidity	comorbidity	NOUN
dpc-3493	398	18	in	in	ADP
dpc-3493	398	19	patients	patient	NOUN
dpc-3493	398	20	with	with	ADP
dpc-3493	398	21	psoriasis	psoriasis	NOUN
dpc-3493	398	22	.	.	PUNCT
dpc-3493	399	1	j	j	PROPN
dpc-3493	399	2	int	int	PROPN
dpc-3493	399	3	med	med	PROPN
dpc-3493	399	4	res	re	NOUN
dpc-3493	399	5	.	.	PUNCT
dpc-3493	400	1	2016;44(1	2016;44(1	NUM
dpc-3493	400	2	suppl):61	suppl):61	PROPN
dpc-3493	400	3	-	-	PROPN
dpc-3493	400	4	66	66	NUM
dpc-3493	400	5	.	.	PUNCT
dpc-3493	401	1	doi	doi	NOUN
dpc-3493	401	2	:	:	PUNCT
dpc-3493	401	3	10.1177/0300060515593253	10.1177/0300060515593253	NUM
dpc-3493	401	4	.	.	PUNCT
dpc-3493	402	1	pmid	pmid	NOUN
dpc-3493	402	2	:	:	PUNCT
dpc-3493	402	3	27683142	27683142	NUM
dpc-3493	402	4	.	.	PUNCT
dpc-3493	403	1	pmcid	pmcid	ADJ
dpc-3493	403	2	:	:	PUNCT
dpc-3493	403	3	pmc5536523	pmc5536523	NOUN
dpc-3493	403	4	.	.	PUNCT
dpc-3493	404	1	31	31	NUM
dpc-3493	404	2	.	.	PUNCT
dpc-3493	405	1	pouw	pouw	PROPN
dpc-3493	405	2	jn	jn	PROPN
dpc-3493	405	3	,	,	PUNCT
dpc-3493	405	4	jacobs	jacobs	PROPN
dpc-3493	405	5	me	i	PRON
dpc-3493	405	6	,	,	PUNCT
dpc-3493	405	7	balak	balak	PROPN
dpc-3493	405	8	dmw	dmw	PROPN
dpc-3493	405	9	,	,	PUNCT
dpc-3493	405	10	van	van	PROPN
dpc-3493	405	11	laar	laar	PROPN
dpc-3493	405	12	jm	jm	PROPN
dpc-3493	405	13	,	,	PUNCT
dpc-3493	405	14	welsing	welse	VERB
dpc-3493	405	15	pmj	pmj	PROPN
dpc-3493	405	16	,	,	PUNCT
dpc-3493	405	17	leijten	leijten	PROPN
dpc-3493	405	18	efa	efa	PROPN
dpc-3493	405	19	.	.	PUNCT
dpc-3493	406	1	do	do	AUX
dpc-3493	406	2	patients	patient	NOUN
dpc-3493	406	3	with	with	ADP
dpc-3493	406	4	psoriatic	psoriatic	ADJ
dpc-3493	406	5	arthritis	arthritis	NOUN
dpc-3493	406	6	have	have	VERB
dpc-3493	406	7	more	more	ADV
dpc-3493	406	8	severe	severe	ADJ
dpc-3493	406	9	skin	skin	NOUN
dpc-3493	406	10	disease	disease	NOUN
dpc-3493	406	11	than	than	ADP
dpc-3493	406	12	patients	patient	NOUN
dpc-3493	406	13	with	with	ADP
dpc-3493	406	14	psoriasis	psoriasis	NOUN
dpc-3493	406	15	only	only	ADV
dpc-3493	406	16	?	?	PUNCT
dpc-3493	407	1	a	a	DET
dpc-3493	407	2	systematic	systematic	ADJ
dpc-3493	407	3	review	review	NOUN
dpc-3493	407	4	and	and	CCONJ
dpc-3493	407	5	meta	meta	ADJ
dpc-3493	407	6	-	-	PUNCT
dpc-3493	407	7	analysis	analysis	NOUN
dpc-3493	407	8	.	.	PUNCT
dpc-3493	408	1	dermatology	dermatology	NOUN
dpc-3493	408	2	.	.	PUNCT
dpc-3493	409	1	2022;238(6):11081119	2022;238(6):11081119	NUM
dpc-3493	409	2	.	.	PUNCT
dpc-3493	409	3	doi	doi	PROPN
dpc-3493	409	4	:	:	PUNCT
dpc-3493	409	5	10.1159/000524231	10.1159/000524231	NUM
dpc-3493	409	6	.	.	PUNCT
dpc-3493	410	1	pmid	pmid	NOUN
dpc-3493	410	2	:	:	PUNCT
dpc-3493	410	3	35551372	35551372	NUM
dpc-3493	410	4	.	.	PUNCT
dpc-3493	411	1	pmcid	pmcid	NOUN
dpc-3493	411	2	:	:	PUNCT
dpc-3493	411	3	pmc9677854	pmc9677854	ADJ
dpc-3493	411	4	.	.	PUNCT
dpc-3493	412	1	32	32	NUM
dpc-3493	412	2	.	.	PUNCT
dpc-3493	413	1	rouzaud	rouzaud	PROPN
dpc-3493	413	2	m	m	PROPN
dpc-3493	413	3	,	,	PUNCT
dpc-3493	413	4	sevrain	sevrain	PROPN
dpc-3493	413	5	m	m	PROPN
dpc-3493	413	6	,	,	PUNCT
dpc-3493	413	7	villani	villani	PROPN
dpc-3493	413	8	ap	ap	PROPN
dpc-3493	413	9	,	,	PUNCT
dpc-3493	413	10	et	et	PROPN
dpc-3493	413	11	al	al	PROPN
dpc-3493	413	12	.	.	PROPN
dpc-3493	413	13	is	be	AUX
dpc-3493	413	14	there	there	PRON
dpc-3493	413	15	a	a	DET
dpc-3493	413	16	psoriasis	psoriasis	NOUN
dpc-3493	413	17	skin	skin	NOUN
dpc-3493	413	18	phenotype	phenotype	NOUN
dpc-3493	413	19	associated	associate	VERB
dpc-3493	413	20	with	with	ADP
dpc-3493	413	21	psoriatic	psoriatic	ADJ
dpc-3493	413	22	arthritis	arthritis	NOUN
dpc-3493	413	23	?	?	PUNCT
dpc-3493	414	1	systematic	systematic	ADJ
dpc-3493	414	2	literature	literature	PROPN
dpc-3493	414	3	review	review	PROPN
dpc-3493	414	4	.	.	PUNCT
dpc-3493	415	1	j	j	PROPN
dpc-3493	415	2	eur	eur	PROPN
dpc-3493	415	3	acad	acad	PROPN
dpc-3493	415	4	dermatol	dermatol	NOUN
dpc-3493	415	5	venereol	venereol	ADV
dpc-3493	415	6	.	.	PUNCT
dpc-3493	416	1	2014;28	2014;28	NUM
dpc-3493	416	2	suppl	suppl	PROPN
dpc-3493	416	3	5:17	5:17	NUM
dpc-3493	416	4	-	-	SYM
dpc-3493	416	5	26	26	NUM
dpc-3493	416	6	.	.	PUNCT
dpc-3493	417	1	doi	doi	NOUN
dpc-3493	417	2	:	:	PUNCT
dpc-3493	417	3	10.1111	10.1111	NUM
dpc-3493	417	4	/	/	SYM
dpc-3493	417	5	jdv.12562	jdv.12562	NOUN
dpc-3493	417	6	.	.	PUNCT
dpc-3493	418	1	pmid	pmid	NOUN
dpc-3493	418	2	:	:	PUNCT
dpc-3493	418	3	24985559	24985559	NUM
dpc-3493	418	4	.	.	PUNCT
dpc-3493	419	1	33	33	NUM
dpc-3493	419	2	.	.	PUNCT
dpc-3493	420	1	haroon	haroon	PROPN
dpc-3493	420	2	m	m	PROPN
dpc-3493	420	3	,	,	PUNCT
dpc-3493	420	4	gallagher	gallagher	PROPN
dpc-3493	420	5	p	p	PROPN
dpc-3493	420	6	,	,	PUNCT
dpc-3493	420	7	fitzgerald	fitzgerald	PROPN
dpc-3493	420	8	o.	o.	PROPN
dpc-3493	420	9	diagnostic	diagnostic	ADJ
dpc-3493	420	10	delay	delay	NOUN
dpc-3493	420	11	of	of	ADP
dpc-3493	420	12	more	more	ADJ
dpc-3493	420	13	than	than	ADP
dpc-3493	420	14	6	6	NUM
dpc-3493	420	15	months	month	NOUN
dpc-3493	420	16	contributes	contribute	VERB
dpc-3493	420	17	to	to	ADP
dpc-3493	420	18	poor	poor	ADJ
dpc-3493	420	19	radiographic	radiographic	ADJ
dpc-3493	420	20	and	and	CCONJ
dpc-3493	420	21	functional	functional	ADJ
dpc-3493	420	22	outcome	outcome	NOUN
dpc-3493	420	23	in	in	ADP
dpc-3493	420	24	psoriatic	psoriatic	ADJ
dpc-3493	420	25	arthritis	arthritis	NOUN
dpc-3493	420	26	.	.	PUNCT
dpc-3493	421	1	ann	ann	PROPN
dpc-3493	421	2	rheum	rheum	PROPN
dpc-3493	421	3	dis	dis	PROPN
dpc-3493	421	4	.	.	PUNCT
dpc-3493	422	1	2015;74(6):1045	2015;74(6):1045	NUM
dpc-3493	422	2	-	-	SYM
dpc-3493	422	3	1050	1050	NUM
dpc-3493	422	4	.	.	PUNCT
dpc-3493	423	1	doi	doi	NOUN
dpc-3493	423	2	:	:	PUNCT
dpc-3493	423	3	10.1136	10.1136	NUM
dpc-3493	423	4	/	/	SYM
dpc-3493	423	5	annrheumdis-2013	annrheumdis-2013	NOUN
dpc-3493	423	6	-	-	NOUN
dpc-3493	423	7	204858	204858	NUM
dpc-3493	423	8	.	.	PUNCT
dpc-3493	424	1	pmid	pmid	NOUN
dpc-3493	424	2	:	:	PUNCT
dpc-3493	424	3	24525911	24525911	NUM
dpc-3493	424	4	.	.	PUNCT
dpc-3493	425	1	34	34	NUM
dpc-3493	425	2	.	.	PUNCT
dpc-3493	425	3	scher	scher	PROPN
dpc-3493	425	4	ju	ju	PROPN
dpc-3493	425	5	,	,	PUNCT
dpc-3493	425	6	ogdie	ogdie	VERB
dpc-3493	425	7	a	a	PRON
dpc-3493	425	8	,	,	PUNCT
dpc-3493	425	9	merola	merola	PROPN
dpc-3493	425	10	jf	jf	PROPN
dpc-3493	425	11	,	,	PUNCT
dpc-3493	425	12	ritchlin	ritchlin	PROPN
dpc-3493	425	13	c.	c.	PROPN
dpc-3493	425	14	preventing	prevent	VERB
dpc-3493	425	15	psoriatic	psoriatic	ADJ
dpc-3493	425	16	arthritis	arthritis	NOUN
dpc-3493	425	17	:	:	PUNCT
dpc-3493	425	18	focusing	focus	VERB
dpc-3493	425	19	on	on	ADP
dpc-3493	425	20	patients	patient	NOUN
dpc-3493	425	21	with	with	ADP
dpc-3493	425	22	psoriasis	psoriasis	NOUN
dpc-3493	425	23	at	at	ADP
dpc-3493	425	24	increased	increase	VERB
dpc-3493	425	25	risk	risk	NOUN
dpc-3493	425	26	of	of	ADP
dpc-3493	425	27	transition	transition	NOUN
dpc-3493	425	28	.	.	PUNCT
dpc-3493	426	1	nat	nat	PROPN
dpc-3493	426	2	rev	rev	PROPN
dpc-3493	426	3	rheumatol	rheumatol	NOUN
dpc-3493	426	4	.	.	PUNCT
dpc-3493	427	1	2019;15(3):153	2019;15(3):153	NUM
dpc-3493	427	2	-	-	SYM
dpc-3493	427	3	166	166	NUM
dpc-3493	427	4	.	.	PUNCT
dpc-3493	428	1	doi	doi	NOUN
dpc-3493	428	2	:	:	PUNCT
dpc-3493	428	3	10.1038	10.1038	NUM
dpc-3493	428	4	/	/	SYM
dpc-3493	428	5	s41584	s41584	NOUN
dpc-3493	428	6	-	-	PUNCT
dpc-3493	428	7	019	019	NUM
dpc-3493	428	8	-	-	PUNCT
dpc-3493	428	9	0175	0175	NUM
dpc-3493	428	10	-	-	PUNCT
dpc-3493	428	11	0	0	NUM
dpc-3493	428	12	.	.	PUNCT
dpc-3493	429	1	pmid	pmid	NOUN
dpc-3493	429	2	:	:	PUNCT
dpc-3493	429	3	30742092	30742092	NUM
dpc-3493	429	4	.	.	PUNCT
dpc-3493	430	1	18	18	NUM
dpc-3493	430	2	.	.	PUNCT
dpc-3493	431	1	guo	guo	PROPN
dpc-3493	431	2	z	z	PROPN
dpc-3493	431	3	,	,	PUNCT
dpc-3493	431	4	yang	yang	PROPN
dpc-3493	431	5	y	y	PROPN
dpc-3493	431	6	,	,	PUNCT
dpc-3493	431	7	liao	liao	PROPN
dpc-3493	431	8	y	y	PROPN
dpc-3493	431	9	,	,	PUNCT
dpc-3493	431	10	shi	shi	PROPN
dpc-3493	431	11	y	y	PROPN
dpc-3493	431	12	,	,	PUNCT
dpc-3493	431	13	zhang	zhang	PROPN
dpc-3493	431	14	lj	lj	PROPN
dpc-3493	431	15	.	.	PUNCT
dpc-3493	432	1	emerging	emerge	VERB
dpc-3493	432	2	roles	role	NOUN
dpc-3493	432	3	of	of	ADP
dpc-3493	432	4	adipose	adipose	ADJ
dpc-3493	432	5	tissue	tissue	NOUN
dpc-3493	432	6	in	in	ADP
dpc-3493	432	7	the	the	DET
dpc-3493	432	8	pathogenesis	pathogenesis	NOUN
dpc-3493	432	9	of	of	ADP
dpc-3493	432	10	psoriasis	psoriasis	NOUN
dpc-3493	432	11	and	and	CCONJ
dpc-3493	432	12	atopic	atopic	NOUN
dpc-3493	432	13	dermatitis	dermatitis	NOUN
dpc-3493	432	14	in	in	ADP
dpc-3493	432	15	obesity	obesity	NOUN
dpc-3493	432	16	.	.	PUNCT
dpc-3493	433	1	jid	jid	PROPN
dpc-3493	433	2	innov	innov	PROPN
dpc-3493	433	3	.	.	PUNCT
dpc-3493	434	1	2021;2(1):100064	2021;2(1):100064	X
dpc-3493	434	2	.	.	PUNCT
dpc-3493	435	1	doi	doi	NOUN
dpc-3493	435	2	:	:	PUNCT
dpc-3493	435	3	10.1016	10.1016	NUM
dpc-3493	435	4	/	/	SYM
dpc-3493	435	5	j	j	PROPN
dpc-3493	435	6	.xjidi.2021.100064	.xjidi.2021.100064	PROPN
dpc-3493	435	7	.	.	PUNCT
dpc-3493	436	1	pmid	pmid	NOUN
dpc-3493	436	2	:	:	PUNCT
dpc-3493	436	3	35024685	35024685	NUM
dpc-3493	436	4	.	.	PUNCT
dpc-3493	437	1	pmcid	pmcid	NOUN
dpc-3493	437	2	:	:	PUNCT
dpc-3493	437	3	pmc8659781	pmc8659781	ADJ
dpc-3493	437	4	.	.	PUNCT
dpc-3493	438	1	19	19	NUM
dpc-3493	438	2	.	.	PUNCT
dpc-3493	438	3	budu	budu	PROPN
dpc-3493	438	4	-	-	PUNCT
dpc-3493	438	5	aggrey	aggrey	VERB
dpc-3493	438	6	a	a	DET
dpc-3493	438	7	,	,	PUNCT
dpc-3493	438	8	brumpton	brumpton	PROPN
dpc-3493	438	9	b	b	PROPN
dpc-3493	438	10	,	,	PUNCT
dpc-3493	438	11	tyrrell	tyrrell	PROPN
dpc-3493	438	12	j	j	PROPN
dpc-3493	438	13	,	,	PUNCT
dpc-3493	438	14	et	et	PROPN
dpc-3493	438	15	al	al	PROPN
dpc-3493	438	16	.	.	PROPN
dpc-3493	438	17	evidence	evidence	NOUN
dpc-3493	438	18	of	of	ADP
dpc-3493	438	19	a	a	DET
dpc-3493	438	20	causal	causal	ADJ
dpc-3493	438	21	relationship	relationship	NOUN
dpc-3493	438	22	between	between	ADP
dpc-3493	438	23	body	body	NOUN
dpc-3493	438	24	mass	mass	NOUN
dpc-3493	438	25	index	index	NOUN
dpc-3493	438	26	and	and	CCONJ
dpc-3493	438	27	psoriasis	psoriasis	NOUN
dpc-3493	438	28	:	:	PUNCT
dpc-3493	438	29	a	a	DET
dpc-3493	438	30	mendelian	mendelian	ADJ
dpc-3493	438	31	randomization	randomization	NOUN
dpc-3493	438	32	study	study	NOUN
dpc-3493	438	33	.	.	PUNCT
dpc-3493	439	1	plos	plos	PROPN
dpc-3493	439	2	med	med	PROPN
dpc-3493	439	3	.	.	PUNCT
dpc-3493	440	1	2019;16(1):e1002739	2019;16(1):e1002739	X
dpc-3493	440	2	.	.	PUNCT
dpc-3493	440	3	doi	doi	NOUN
dpc-3493	440	4	:	:	PUNCT
dpc-3493	440	5	10.1371	10.1371	NUM
dpc-3493	440	6	/	/	SYM
dpc-3493	440	7	journal.pmed.1002739	journal.pmed.1002739	PROPN
dpc-3493	440	8	.	.	PUNCT
dpc-3493	441	1	pmid	pmid	PROPN
dpc-3493	441	2	:	:	PUNCT
dpc-3493	441	3	30703100	30703100	NUM
dpc-3493	441	4	.	.	PUNCT
dpc-3493	442	1	pmcid	pmcid	NOUN
dpc-3493	442	2	:	:	PUNCT
dpc-3493	442	3	pmc6354959	pmc6354959	NOUN
dpc-3493	442	4	.	.	PUNCT
dpc-3493	443	1	20	20	NUM
dpc-3493	443	2	.	.	PUNCT
dpc-3493	444	1	snekvik	snekvik	PROPN
dpc-3493	444	2	i	i	PRON
dpc-3493	444	3	,	,	PUNCT
dpc-3493	444	4	smith	smith	PROPN
dpc-3493	444	5	ch	ch	PROPN
dpc-3493	444	6	,	,	PUNCT
dpc-3493	444	7	nilsen	nilsen	PROPN
dpc-3493	444	8	til	til	PROPN
dpc-3493	444	9	,	,	PUNCT
dpc-3493	444	10	et	et	PROPN
dpc-3493	444	11	al	al	PROPN
dpc-3493	444	12	.	.	PROPN
dpc-3493	444	13	obesity	obesity	PROPN
dpc-3493	444	14	,	,	PUNCT
dpc-3493	444	15	waist	waist	NOUN
dpc-3493	444	16	circumference	circumference	NOUN
dpc-3493	444	17	,	,	PUNCT
dpc-3493	444	18	weight	weight	NOUN
dpc-3493	444	19	change	change	NOUN
dpc-3493	444	20	,	,	PUNCT
dpc-3493	444	21	and	and	CCONJ
dpc-3493	444	22	risk	risk	NOUN
dpc-3493	444	23	of	of	ADP
dpc-3493	444	24	incident	incident	NOUN
dpc-3493	444	25	psoriasis	psoriasis	NOUN
dpc-3493	444	26	:	:	PUNCT
dpc-3493	444	27	prospective	prospective	ADJ
dpc-3493	444	28	data	datum	NOUN
dpc-3493	444	29	from	from	ADP
dpc-3493	444	30	the	the	DET
dpc-3493	444	31	hunt	hunt	NOUN
dpc-3493	444	32	study	study	NOUN
dpc-3493	444	33	.	.	PUNCT
dpc-3493	445	1	j	j	PROPN
dpc-3493	445	2	invest	invest	VERB
dpc-3493	445	3	dermatol	dermatol	NOUN
dpc-3493	445	4	.	.	PUNCT
dpc-3493	446	1	2017;137(12):2484	2017;137(12):2484	NUM
dpc-3493	446	2	-	-	SYM
dpc-3493	446	3	2490	2490	NUM
dpc-3493	446	4	.	.	PUNCT
dpc-3493	447	1	doi	doi	NOUN
dpc-3493	447	2	:	:	PUNCT
dpc-3493	447	3	10.1016	10.1016	NUM
dpc-3493	447	4	/	/	SYM
dpc-3493	447	5	j.jid.2017.07.822	j.jid.2017.07.822	NOUN
dpc-3493	447	6	.	.	PUNCT
dpc-3493	448	1	pmid	pmid	NOUN
dpc-3493	448	2	:	:	PUNCT
dpc-3493	448	3	28780086	28780086	NUM
dpc-3493	448	4	.	.	PUNCT
dpc-3493	449	1	21	21	NUM
dpc-3493	449	2	.	.	X
dpc-3493	450	1	fleming	fleme	VERB
dpc-3493	450	2	p	p	NOUN
dpc-3493	450	3	,	,	PUNCT
dpc-3493	450	4	kraft	kraft	PROPN
dpc-3493	450	5	j	j	PROPN
dpc-3493	450	6	,	,	PUNCT
dpc-3493	450	7	gulliver	gulliver	VERB
dpc-3493	450	8	wp	wp	PROPN
dpc-3493	450	9	,	,	PUNCT
dpc-3493	450	10	lynde	lynde	PROPN
dpc-3493	450	11	c.	c.	PROPN
dpc-3493	450	12	the	the	DET
dpc-3493	450	13	relationship	relationship	NOUN
dpc-3493	450	14	of	of	ADP
dpc-3493	450	15	obesity	obesity	NOUN
dpc-3493	450	16	with	with	ADP
dpc-3493	450	17	the	the	DET
dpc-3493	450	18	severity	severity	NOUN
dpc-3493	450	19	of	of	ADP
dpc-3493	450	20	psoriasis	psoriasis	NOUN
dpc-3493	450	21	:	:	PUNCT
dpc-3493	450	22	a	a	DET
dpc-3493	450	23	systematic	systematic	ADJ
dpc-3493	450	24	review	review	NOUN
dpc-3493	450	25	.	.	PUNCT
dpc-3493	451	1	j	j	PROPN
dpc-3493	451	2	cutan	cutan	PROPN
dpc-3493	451	3	med	med	ADJ
dpc-3493	451	4	surg	surg	NOUN
dpc-3493	451	5	.	.	PUNCT
dpc-3493	452	1	2015;19(5):450	2015;19(5):450	NUM
dpc-3493	452	2	-	-	SYM
dpc-3493	452	3	456	456	NUM
dpc-3493	452	4	.	.	PUNCT
dpc-3493	453	1	doi	doi	NOUN
dpc-3493	453	2	:	:	PUNCT
dpc-3493	453	3	10.1177/1203475415586332	10.1177/1203475415586332	NUM
dpc-3493	453	4	.	.	PUNCT
dpc-3493	454	1	pmid	pmid	NOUN
dpc-3493	454	2	:	:	PUNCT
dpc-3493	454	3	26271963	26271963	NUM
dpc-3493	454	4	.	.	PUNCT
dpc-3493	455	1	22	22	NUM
dpc-3493	455	2	.	.	PUNCT
dpc-3493	455	3	hafidi	hafidi	VERB
dpc-3493	455	4	me	i	PRON
dpc-3493	455	5	,	,	PUNCT
dpc-3493	455	6	buelna	buelna	ADJ
dpc-3493	455	7	-	-	PUNCT
dpc-3493	455	8	chontal	chontal	ADJ
dpc-3493	455	9	m	m	PROPN
dpc-3493	455	10	,	,	PUNCT
dpc-3493	455	11	sánchez	sánchez	PROPN
dpc-3493	455	12	-	-	PUNCT
dpc-3493	455	13	muñoz	muñoz	PROPN
dpc-3493	455	14	f	f	PROPN
dpc-3493	455	15	,	,	PUNCT
dpc-3493	455	16	carbó	carbó	PROPN
dpc-3493	455	17	r.	r.	PROPN
dpc-3493	455	18	adipogenesis	adipogenesis	PROPN
dpc-3493	455	19	:	:	PUNCT
dpc-3493	455	20	a	a	DET
dpc-3493	455	21	necessary	necessary	ADJ
dpc-3493	455	22	but	but	CCONJ
dpc-3493	455	23	harmful	harmful	ADJ
dpc-3493	455	24	strategy	strategy	NOUN
dpc-3493	455	25	.	.	PUNCT
dpc-3493	456	1	int	int	PROPN
dpc-3493	456	2	j	j	PROPN
dpc-3493	456	3	mol	mol	ADP
dpc-3493	456	4	sci	sci	PROPN
dpc-3493	456	5	.	.	PUNCT
dpc-3493	457	1	2019;20(15):3657	2019;20(15):3657	X
dpc-3493	457	2	.	.	PUNCT
dpc-3493	458	1	doi	doi	NOUN
dpc-3493	458	2	:	:	PUNCT
dpc-3493	458	3	10.3390	10.3390	NUM
dpc-3493	458	4	/	/	SYM
dpc-3493	458	5	ijms20153657	ijms20153657	PROPN
dpc-3493	458	6	.	.	PUNCT
dpc-3493	459	1	pmid	pmid	NOUN
dpc-3493	459	2	:	:	PUNCT
dpc-3493	459	3	31357412	31357412	NUM
dpc-3493	459	4	.	.	PUNCT
dpc-3493	460	1	pmcid	pmcid	ADJ
dpc-3493	460	2	:	:	PUNCT
dpc-3493	460	3	pmc6696444	pmc6696444	NOUN
dpc-3493	460	4	.	.	PUNCT
dpc-3493	461	1	23	23	NUM
dpc-3493	461	2	.	.	PUNCT
dpc-3493	462	1	kyriakou	kyriakou	PROPN
dpc-3493	462	2	a	a	PROPN
dpc-3493	462	3	,	,	PUNCT
dpc-3493	462	4	patsatsi	patsatsi	PROPN
dpc-3493	462	5	a	a	NOUN
dpc-3493	462	6	,	,	PUNCT
dpc-3493	462	7	sotiriadis	sotiriadi	NOUN
dpc-3493	462	8	d	d	PROPN
dpc-3493	462	9	,	,	PUNCT
dpc-3493	462	10	goulis	goulis	PROPN
dpc-3493	462	11	dg	dg	PROPN
dpc-3493	462	12	.	.	PUNCT
dpc-3493	463	1	serum	serum	PROPN
dpc-3493	463	2	leptin	leptin	PROPN
dpc-3493	463	3	,	,	PUNCT
dpc-3493	463	4	resistin	resistin	NOUN
dpc-3493	463	5	,	,	PUNCT
dpc-3493	463	6	and	and	CCONJ
dpc-3493	463	7	adiponectin	adiponectin	NOUN
dpc-3493	463	8	concentrations	concentration	NOUN
dpc-3493	463	9	in	in	ADP
dpc-3493	463	10	psoriasis	psoriasis	NOUN
dpc-3493	463	11	:	:	PUNCT
dpc-3493	463	12	a	a	DET
dpc-3493	463	13	meta	meta	ADJ
dpc-3493	463	14	-	-	PUNCT
dpc-3493	463	15	analysis	analysis	NOUN
dpc-3493	463	16	of	of	ADP
dpc-3493	463	17	observational	observational	ADJ
dpc-3493	463	18	studies	study	NOUN
dpc-3493	463	19	.	.	PUNCT
dpc-3493	464	1	dermatology	dermatology	NOUN
dpc-3493	464	2	.	.	PUNCT
dpc-3493	465	1	2017;233(5):378	2017;233(5):378	NUM
dpc-3493	465	2	-	-	SYM
dpc-3493	465	3	389	389	NUM
dpc-3493	465	4	.	.	PUNCT
dpc-3493	466	1	doi	doi	NOUN
dpc-3493	466	2	:	:	PUNCT
dpc-3493	466	3	10.1159/000481882	10.1159/000481882	NUM
dpc-3493	466	4	.	.	PUNCT
dpc-3493	467	1	pmid	pmid	NOUN
dpc-3493	467	2	:	:	PUNCT
dpc-3493	467	3	29232663	29232663	NUM
dpc-3493	467	4	.	.	PUNCT
dpc-3493	468	1	24	24	NUM
dpc-3493	468	2	.	.	PUNCT
dpc-3493	468	3	li	li	PROPN
dpc-3493	468	4	rc	rc	PROPN
dpc-3493	468	5	,	,	PUNCT
dpc-3493	468	6	krishnamoorthy	krishnamoorthy	PROPN
dpc-3493	468	7	p	p	X
dpc-3493	468	8	,	,	PUNCT
dpc-3493	468	9	derohannessian	derohannessian	PROPN
dpc-3493	468	10	s	s	PROPN
dpc-3493	468	11	,	,	PUNCT
dpc-3493	468	12	et	et	PROPN
dpc-3493	468	13	al	al	PROPN
dpc-3493	468	14	.	.	PUNCT
dpc-3493	468	15	psoriasis	psoriasis	NOUN
dpc-3493	468	16	is	be	AUX
dpc-3493	468	17	associated	associate	VERB
dpc-3493	468	18	with	with	ADP
dpc-3493	468	19	decreased	decrease	VERB
dpc-3493	468	20	plasma	plasma	NOUN
dpc-3493	468	21	adiponectin	adiponectin	NOUN
dpc-3493	468	22	levels	level	NOUN
dpc-3493	468	23	independently	independently	ADV
dpc-3493	468	24	of	of	ADP
dpc-3493	468	25	cardiometabolic	cardiometabolic	ADJ
dpc-3493	468	26	risk	risk	NOUN
dpc-3493	468	27	factors	factor	NOUN
dpc-3493	468	28	.	.	PUNCT
dpc-3493	469	1	clin	clin	PROPN
dpc-3493	469	2	exp	exp	NOUN
dpc-3493	469	3	dermatol	dermatol	NOUN
dpc-3493	469	4	.	.	PUNCT
dpc-3493	470	1	2014;39(1):19	2014;39(1):19	NUM
dpc-3493	470	2	-	-	SYM
dpc-3493	470	3	24	24	NUM
dpc-3493	470	4	.	.	PUNCT
dpc-3493	470	5	doi	doi	NOUN
dpc-3493	470	6	:	:	PUNCT
dpc-3493	470	7	10.1111	10.1111	NUM
dpc-3493	470	8	/	/	SYM
dpc-3493	470	9	ced.12250	ced.12250	PROPN
dpc-3493	470	10	.	.	PUNCT
dpc-3493	471	1	pmid	pmid	NOUN
dpc-3493	471	2	:	:	PUNCT
dpc-3493	471	3	24341476	24341476	NUM
dpc-3493	471	4	.	.	PUNCT
dpc-3493	472	1	pmcid	pmcid	ADJ
dpc-3493	472	2	:	:	PUNCT
dpc-3493	472	3	pmc3869034	pmc3869034	NOUN
dpc-3493	472	4	.	.	PUNCT
dpc-3493	473	1	25	25	NUM
dpc-3493	473	2	.	.	PUNCT
dpc-3493	474	1	puig	puig	PROPN
dpc-3493	474	2	l.	l.	PROPN
dpc-3493	474	3	obesity	obesity	NOUN
dpc-3493	474	4	and	and	CCONJ
dpc-3493	474	5	psoriasis	psoriasis	NOUN
dpc-3493	474	6	:	:	PUNCT
dpc-3493	474	7	body	body	NOUN
dpc-3493	474	8	weight	weight	NOUN
dpc-3493	474	9	and	and	CCONJ
dpc-3493	474	10	body	body	NOUN
dpc-3493	474	11	mass	mass	NOUN
dpc-3493	474	12	index	index	NOUN
dpc-3493	474	13	influence	influence	NOUN
dpc-3493	474	14	the	the	DET
dpc-3493	474	15	response	response	NOUN
dpc-3493	474	16	to	to	ADP
dpc-3493	474	17	biological	biological	ADJ
dpc-3493	474	18	treatment	treatment	NOUN
dpc-3493	474	19	.	.	PUNCT
dpc-3493	475	1	j	j	PROPN
dpc-3493	475	2	eur	eur	PROPN
dpc-3493	475	3	acad	acad	PROPN
dpc-3493	475	4	dermatol	dermatol	NOUN
dpc-3493	475	5	venereol	venereol	NOUN
dpc-3493	475	6	.	.	PUNCT
dpc-3493	476	1	2011;25(9):1007	2011;25(9):1007	NUM
dpc-3493	476	2	-	-	SYM
dpc-3493	476	3	1011	1011	NUM
dpc-3493	476	4	.	.	PUNCT
dpc-3493	477	1	doi	doi	NOUN
dpc-3493	477	2	:	:	PUNCT
dpc-3493	477	3	10.1111	10.1111	NUM
dpc-3493	477	4	/	/	SYM
dpc-3493	477	5	j.1468	j.1468	PROPN
dpc-3493	477	6	-3083.2011.04065.x	-3083.2011.04065.x	NOUN
dpc-3493	477	7	.	.	PUNCT
dpc-3493	478	1	pmid	pmid	NOUN
dpc-3493	478	2	:	:	PUNCT
dpc-3493	478	3	21492252	21492252	NUM
dpc-3493	478	4	.	.	PUNCT
dpc-3493	479	1	26	26	NUM
dpc-3493	479	2	.	.	PUNCT
dpc-3493	480	1	sbidian	sbidian	PROPN
dpc-3493	480	2	e	e	PROPN
dpc-3493	480	3	,	,	PUNCT
dpc-3493	480	4	chaimani	chaimani	X
dpc-3493	480	5	a	a	PRON
dpc-3493	480	6	,	,	PUNCT
dpc-3493	480	7	garcia	garcia	PROPN
dpc-3493	480	8	-	-	PUNCT
dpc-3493	480	9	doval	doval	PROPN
dpc-3493	481	1	i	i	PROPN
dpc-3493	481	2	,	,	PUNCT
dpc-3493	481	3	et	et	PROPN
dpc-3493	481	4	al	al	PROPN
dpc-3493	481	5	.	.	PUNCT
dpc-3493	482	1	systemic	systemic	ADJ
dpc-3493	482	2	pharmacological	pharmacological	ADJ
dpc-3493	482	3	treatments	treatment	NOUN
dpc-3493	482	4	for	for	ADP
dpc-3493	482	5	chronic	chronic	ADJ
dpc-3493	482	6	plaque	plaque	NOUN
dpc-3493	482	7	psoriasis	psoriasis	NOUN
dpc-3493	482	8	:	:	PUNCT
dpc-3493	482	9	a	a	DET
dpc-3493	482	10	network	network	NOUN
dpc-3493	482	11	meta	meta	NOUN
dpc-3493	482	12	-	-	PUNCT
dpc-3493	482	13	analysis	analysis	NOUN
dpc-3493	482	14	.	.	PUNCT
dpc-3493	483	1	cochrane	cochrane	NOUN
dpc-3493	483	2	database	database	PROPN
dpc-3493	483	3	syst	syst	PROPN
dpc-3493	483	4	rev	rev	PROPN
dpc-3493	483	5	.	.	PROPN
dpc-3493	483	6	202;4(4):cd011535	202;4(4):cd011535	NUM
dpc-3493	483	7	.	.	PUNCT
dpc-3493	484	1	doi	doi	NOUN
dpc-3493	484	2	:	:	PUNCT
dpc-3493	484	3	10.1002/14651858.cd011535.pub4	10.1002/14651858.cd011535.pub4	NUM
dpc-3493	484	4	.	.	PUNCT
dpc-3493	485	1	pmid	pmid	NOUN
dpc-3493	485	2	:	:	PUNCT
dpc-3493	485	3	33871055	33871055	NUM
dpc-3493	485	4	.	.	PUNCT
dpc-3493	486	1	pmcid	pmcid	NOUN
dpc-3493	486	2	:	:	PUNCT
dpc-3493	486	3	pmc8408312	pmc8408312	VERB
dpc-3493	486	4	.	.	PUNCT